crgs20191231

0001437749-20-006298.txt : 20200327 0001437749-20-006298.hdr.sgml : 20200327 20200327140631 ACCESSION NUMBER: 0001437749-20-006298 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200327 DATE AS OF CHANGE: 20200327 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CurAegis Technologies, Inc. CENTRAL INDEX KEY: 0001063197 STANDARD INDUSTRIAL CLASSIFICATION: MOTOR VEHICLE PARTS & ACCESSORIES [3714] IRS NUMBER: 161509512 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-24455 FILM NUMBER: 20750627 BUSINESS ADDRESS: STREET 1: 1999 MT. READ BLVD. STREET 2: BUILDING #3 CITY: ROCHESTER STATE: NY ZIP: 14615 BUSINESS PHONE: 585-254-1100 MAIL ADDRESS: STREET 1: 1999 MT. READ BLVD. STREET 2: BUILDING #3 CITY: ROCHESTER STATE: NY ZIP: 14615 FORMER COMPANY: FORMER CONFORMED NAME: TORVEC INC DATE OF NAME CHANGE: 19980610 10-K 1 crgs20191231_10k.htm FORM 10-K crgs20191231_10k.htm

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

(Mark One)

☑

Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Fiscal Year Ended DECEMBER 31, 2019

☐

Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Transition Period from to

Commission file number 000-24455

CURAEGIS TECHNOLOGIES, INC.

(Name of Small Business Issuer in its charter)

NEW YORK		16-1509512
(State or other jurisdiction of		(I.R.S. Employer Identification No.)
incorporation or organization)

350 Linden Oaks
Rochester, New York		14625
(Address of principal executive offices)		(Zip Code)

Issuer’s Telephone Number, including Area Code: (585) 254-1100

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
none	n/a	n/a

Securities registered pursuant to Section 12(g) of the Exchange Act:

Trading symbol: CRGS

Title of Class: $.01 par value common voting stock

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.

Yes ☐ No ☑

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☑

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes ☑ No ☐

Table of Contents

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

(Check one):

Large accelerated filer ☐

Accelerated filer ☐

Non-accelerated filer ☐

Smaller reporting company ☑

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☑

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. $5,554,000.

State the number of shares outstanding of each of the issuer’s classes of common equity, as of March 27, 2020: 51,187,236

Table of Contents

CURAEGIS TECHNOLOGIES, INC.

TABLE OF CONTENTS

		PAGE
PART I

Item 1. Business		5

Item 1A. Risk Factors		7

Item 1B. Unresolved Staff Comments		11

Item 2. Properties		11

Item 3. Legal Proceedings		11

Item 4. Mine Safety Disclosures		11

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities		12

Item 6. Selected Financial Data		13

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations		13

Item 7A. Quantitative and Qualitative Disclosures about Market Risk		18

Item 8. Financial Statements and Supplementary Data		18

	Report of Independent Registered Public Accounting Firm	20

	Consolidated Balance Sheets as of December 31, 2019 and 2018	21

	Consolidated Statements of Operations for each of the years ended December 31, 2019 and December 31, 2018	22

	Consolidated Statements of Changes in Stockholders’ Deficiency for each of the years ended December 31, 2019 and December 31, 2018	23

	Consolidated Statements of Cash Flows for each of the years ended December 31, 2019 and December 31, 2018	24

	Notes to Consolidated Financial Statements	25

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure		40

Item 9A. Controls and Procedures		40

Item 9B. Other Information		40

Table of Contents

PART III

Item 10. Directors, Executive Officers and Corporate Governance	41

Item 11. Executive Compensation	48

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters		52

Item 13. Certain Relationships and Related Transactions, and Director Independence		55

Item 14. Principal Accountant Fees and Services		56

PART IV

Item 15. Exhibits, Financial Statement Schedules		56

EXHIBIT INDEX		57


	Exhibit 3.1
	Exhibit 3.2
	Exhibit 3.3
	Exhibit 3.4
	Exhibit 3.5
	Exhibit 3.6
	Exhibit 3.7
	Exhibit 3.8
	Exhibit 3.9
	Exhibit 3.10
	Exhibit 10.1
	Exhibit 10.2
	Exhibit 10.3
	Exhibit 10.4
	Exhibit 10.5
	Exhibit 10.6
	Exhibit 10.7
	Exhibit 10.8
	Exhibit 10.9
	Exhibit 10.10
	Exhibit 10.11
	Exhibit 10.12
	Exhibit 10.13
	Exhibit 10.14
	Exhibit 10.15
	Exhibit 10.16
	Exhibit 10.17
	Exhibit 10.18
	Exhibit 10.19
	Exhibit 10.20
	Exhibit 10.21
	Exhibit 10.22
	Exhibit 10.23
	Exhibit 10.24
	Exhibit 10.25
	Exhibit 10.26
	Exhibit 10.27
	Exhibit 10.28
	Exhibit 10.29
	Exhibit 10.30
	Exhibit 10.31
	Exhibit 10.32
	Exhibit 10.33
	Exhibit 10.34
	Exhibit 10.35
	Exhibit 10.36
	Exhibit 10.37
	Exhibit 21
	Exhibit 23.1
	Exhibit 24
	Exhibit 31.1
	Exhibit 31.2
	Exhibit 32
	Exhibit 33
	Exhibit 34
	Exhibit 35
	Exhibit 36
	Exhibit 37
	Exhibit 38
	Exhibit 39
	Exhibit 40
	Exhibit 41
	Exhibit 42
	Exhibit 43
	Exhibit 44
	Exhibit 45
	Exhibit 46
	Exhibit 47
	Exhibit 48
	Exhibit 49
	Exhibit 50
	Exhibit 51
	Exhibit 52
	Exhibit 53

SIGNATURE PAGE		62

Table of Contents

PART I

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements. This report contains certain forward-looking statements that are based on the beliefs of management as well as assumptions made by and information currently available to management. The statements contained in this report relating to matters that are not historical facts are forward-looking statements that involve risks and uncertainties, including, but not limited to, future demand for our products and services, the successful commercialization of our products, general domestic and global economic conditions, government and environmental regulations, competition and customer strategies, changes in our business strategy or development plans, capital deployment, business disruptions, including those caused by fires, raw material supplies, technical failures, environmental regulations, and other risks and uncertainties, certain of which are beyond our control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may differ materially from those forward-looking statements set forth herein. When used in this report, the words “anticipate”, “believe”, “estimate” or “expect” or words of similar import are intended to identify forward-looking statements. For further discussion of certain of the matters described above and other risks and uncertainties, see “Risk Factors” in Item 1A of this annual report.

Undue reliance should not be placed on our forward-looking statements. Except as required by law, we disclaim any obligation to update any factors or to publicly announce the results of any revisions to any of the forward-looking statements contained in this annual report on Form 10-K to reflect new information, future events or other developments.

As used in this annual report, unless otherwise indicated, the terms “we”, “our”, “us”, “the Company” and “CurAegis” refer to CurAegis Technologies, Inc.

Item 1. BUSINESS

History and Development of Our Technology

CurAegis Technologies, Inc. (“CurAegis”, “the Company”) was incorporated as a New York business corporation in September 1996 under the name Torvec, Inc. The Company’s name was changed to CurAegis Technologies, Inc. in 2016 in connection with the establishment of its two business divisions. The CURA (Circadian User Risk Assessment) division is engaged in the fatigue management business and the Aegis division is engaged in the power and hydraulic business.

The Company develops and markets advanced technologies in the areas of safety, wellness and power. The Company is focused on the commercialization of a wellness and safety system (the myCadian system) and a uniquely designed hydraulic pump that will be smaller, lighter, less expensive and more efficient than current technology. The Company has not had significant revenue-producing operations.

It is important to note, regarding both the CURA and Aegis products, that the cycle time from the initiation of the sales process to revenue realization can be highly variable especially as a start-up entity. In addition to the activities to be undertaken to implement our plan of operations, we may expand and/or refocus our activities depending upon future circumstances and developments.

CURA Division: the myCadian system

The Company’s CURA division has developed a proprietary technology designed to (i) measure the decrease in a person’s alertness and (ii) to train individuals on how to improve alertness levels. The myCadian system will enable the user to anticipate and avert undesired or disastrous situations caused by the degradation of alertness. With the information provided from the myCadian software analytics, employees can work with Z-Coach our proprietary sleep training and education solution to correct sleep issues and improve overall wellness.

The myCadian platform is designed to predict and detect a degradation of alertness in a user. The myCadian platform will support multiple wearable technology including IOS and android devices. The myCadian system will include:

	●	a risk assessment that identifies the degradation of alertness that may affect a wearer’s ability to perform tasks,
	●	real-time reporting that distills complex user data into actionable information on mobile devices,
	●	predictive reporting for a user to take action when alertness begins to wane, before fatigue becomes dangerous,
	●	flexible settings to provide employers a customized tool using their defined safety criteria and to create protocols for action,
	●	pricing that makes it affordable across a broad-based workforce, and
	●	the Z-Coach wellness program.

The Z-Coach wellness program is a key component of the myCadian system. Z-Coach learning topics include: Risks and Costs of Fatigue, Fundamentals of Sleep, Fatigue Mitigation and Countermeasures. Z-Coach participants gain an awareness of the dangers inherent in the lack of sleep and learn to utilize lifestyle tools to make changes to improve their health, mood, productivity and safety.

Table of Contents

Aegis Division: Hydraulic Pump

During 2019, the Company initiated discussions with investment bankers and certain hydraulics companies to evaluate the possible monetization of the AEGIS technologies. Management believes these technologies have the potential to fundamentally shift the design and manufacture of future products in the hydraulics pump and motor industries.

The Aegis hydraulic pump technology has been designed to bring to the marketplace a unique concept in hydraulic pumps and motors that will be:

	●	smaller, lighter and less expensive than conventional pumps and motors,
	●	more efficient, and
	●	unique in its ability to scale larger, allowing more powerful pumps and motors.

The Company has completed a production prototype and is working to align the prototype capability with specific customer applications. The Company has achieved significant milestones in the design and testing of this prototype. Engineering testing and design of the pump and motor functionality is continuing. Our engineering team has progressively made adjustments to traditional valve and piston technologies which have resulted in improvement in the measured efficiency of the pump. We have filed for patent protection for our novel non-rotating pump concept and continue to file patents as a engineering breakthroughs in our design are identified.

Competition, Industry and Market Acceptance

Competition in both the wearable device market and the hydraulic industry is, and is expected to remain, intense. The competition ranges from development stage companies to major domestic and international companies, many of which have financial, technical, marketing, sales, manufacturing, distribution and other resources significantly greater than ours. As we commercialize our technologies we expect to compete based on performance, uniqueness of design, reliability, and price. There can be no assurance that our technologies and products will not be rendered obsolete by developments in competing technologies that are currently under development or that may be developed in the future or that our competitors could market competing products that obtain market acceptance more rapidly than ours.

We believe that the technologies we are developing have significant advantages relative to similar products manufactured in the worldwide wearable device and hydraulic marketplaces. With respect to our hydraulic mechanical technologies, we believe that our development efforts represent a paradigm shift with respect to presently known technology. With respect to our wearable device technology, we believe that our development efforts are focused on a market that is seeking a better solution to predicting an individual’s level of alertness. Although we have not generated significant revenues from the commercialization of our technologies, we continue to focus our efforts toward those areas where we believe we can get to market quickly and successfully.

Patents, Trade Secrets and Trademarks

Our ability to compete effectively depends in part on our ability to maintain the proprietary nature of our technology, products and manufacturing processes. We principally rely upon patent, trademark, trade secrets and contract law to establish and protect our proprietary rights. Despite our efforts to protect our proprietary information, there can be no assurance that others will not either develop the same or similar information independently or obtain access to our proprietary information. In addition, there can be no assurance that we would prevail if we asserted our intellectual property rights against third parties, or that third parties will not successfully assert infringement claims against us in the future.

The Company has five published patents: two hardware technology patents associated with the CURA business and three hydraulic pump and motor related technologies associated with the Aegis business. We have several patent applications in process in various countries including the United States, Europe and Asia.

All key employees are required to enter into agreements providing for confidentiality and the assignment of rights to inventions made by them while employed by us. These agreements also contain certain non-competition and non-solicitation provisions effective during the employment term and for varying periods thereafter depending on position and location. There can be no assurance that we will be able to enforce these agreements. All of our employees agree to abide by the terms of a Code of Ethics policy that provides for the confidentiality of certain information received during the course of their employment.

Trademarks are an important aspect of our business. The following are our registered trademarks: CurAegis^®, myCadian™, CurAegis™, CURA™ and Z-Coach™.

Website

Our website address is www.CurAegis.com. We make our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and, if applicable, amendments to those reports, available on the investor information portion of our website. The reports are free of charge and are available as soon as reasonably practicable after they are filed with the Securities and Exchange Commission. We have posted our Corporate Governance guidelines, Board committee charters and Code of Ethics to the investor information portion of our website. This information is available in print to any shareholder upon request. All requests for these documents should be made to our chief financial officer by calling (585) 254-1100.

Table of Contents

Engineering, Research and Development

For the years ended December 31, 2019 and 2018, the Company spent approximately $809,000 and $1,262,000, respectively on product engineering, design, development and testing on its technology and products.

Employees

As of December 31, 2019, we employed a total of 7 employees, 2 of which are primarily devoted to engineering, design and development, and 5 focused on corporate operations and administration. All of these individuals are employed in the U.S. None of our employees is represented by a labor union.

Executive Officers

Our executive officers as of December 31, 2019, were as follows:

Richard A. Kaplan has served as chief executive officer and as a director since October 2010. He was named president of the Company in October 2019 upon the retirement of Keith Gleasman. From 2000 to 2010, Mr. Kaplan was the chief executive officer of Pictometry International Corp., a visual information systems company that experienced exponential growth under his leadership. Previously, Mr. Kaplan led and developed a number of other successful businesses in industries including retail floor covering, advertising and marketing, computer software, real estate development and human resource development.

Mr. Kaplan currently is on the boards of two companies: Caldwell Manufacturing and Viggi Corporation. He has also been very active in the community in academic institutions and charitable organizations, including present roles on the Board of Trustees at Rochester Institute of Technology (“RIT”), Nazareth College, and the University of Rochester Medical Center as well as directorships at Venture Creations (an RIT business incubator), Camp Good Days and Special Times, Rochester’s Child, Rochester Broadway Theatre League, George Eastman House, the Center for Governmental Research. Mr. Kaplan’s business success and contributions within the community have been recognized by multiple awards, including the prestigious Herbert W. Vanden Brul Entrepreneurial Award presented by the RIT E. Philip Saunders College of Business in April 2007. Mr. Kaplan was also designated the “Businessperson of the Year” in 2007. In 2012, he was inducted into the Rochester Business Hall of Fame. Mr. Kaplan has an extensive background in economics, accounting, management and executive leadership. He is regularly sought out by startups, universities and other organizations for which he has done private consulting and guest lecturing on marketing, economics and organizational development. He attended Rochester Institute of Technology and the University of Buffalo where he majored in accounting and minored in economics.

Mr. Kaplan retired as the Company's chief executive officer and president on March 19, 2020 and continues as a member of the Company's board of directors.

James Donnelly has served as chief operating officer since October 2019. From January 2017 to October 2019, Mr. Donnelly served as the Company’s senior vice-president of sales and marketing. Prior to CurAegis, Jim served as the Vice President of Business Development for Six15 Technologies. Preceding the formation of Six15 in June of 2012, Jim was the Director of Defense and Augmented Reality Sales for Vuzix Corporation. He holds a B.S. in Business Administration from LeMoyne College and sits on two boards in the Rochester area within the non-profit sector.

Mr. Donnelly was appointed as the Company's chief executive officer and president effective March 26, 2020.

Kathleen A. Browne has served as chief financial officer, corporate secretary and principal accounting officer since April 2015. Prior to joining the Company, Ms. Browne was the sole owner of a professional services and consulting business. From 2007 to 2015 she served as chief financial officer in several development stage public businesses including: U-Vend, Inc. and NaturalNano, Inc. Ms. Browne also served as the Controller and Chief Accountant for Paychex (2001-2004) and W. R. Grace (1996-2001). Ms. Browne spent thirteen years in public accounting with PricewaterhouseCoopers. Ms. Browne is a CPA with a degree in accounting from St. John Fisher College in Rochester, NY.

Item 1A. RISK FACTORS

We face a variety of risks inherent in perfecting our technologies to production-ready models and in our efforts to commercialize these technologies to generate revenues and profits. Below are certain significant risks that could adversely affect us and our prospects. Because of the following risks and uncertainties, our past financial performance should not be considered as an indicator of future performance.

We are a company focused on developing new technology and have not generated significant revenues.

We have a limited operating history and have not generated significant revenues since our founding in 1996. If revenue-generating sales and/or licenses of our technologies do not materialize or do not materialize on a timely basis, we will be compelled to seek additional equity financing or to incur additional debt to sustain operations which could have a material adverse effect on our business, financial condition and results of operations.

Table of Contents

The results of engineering and development efforts may be uncertain and there can be no assurance of the commercial success of our technologies or future products.

The development of our products and services is complex and costly. Some products currently under development or future product developments, including specific product features or functions, may not be technologically successful. In addition, the cost and length of our product development may be greater than we anticipate and we may experience delays in future product development or problems in design or quality of our products. Unanticipated problems in developing products and services could also divert substantial research and development resources, which may impair our ability to develop products and services and could substantially increase our costs. If new or enhanced product and service introductions are delayed or not successful, we may not be able to achieve an acceptable return, if any, on our product and development efforts. Even if our resulting products are technologically successful, they may not achieve market acceptance or compete effectively with our competitors’ products.

Our efforts to develop the CURA software platform, designed to measure a degradation of alertness in a person’s ability to perform a task or job, may not be technologically successful. We continue to design and refine the myCadian software focused on optimizing the user experience.

Our efforts to develop and monetize our Aegis hydraulic pump, an innovative hydraulic pump that is smaller, lighter, and more efficient and cost competitive than other such pumps in the market, may not be successful.

The timetable for our product development may be longer than we anticipate and we may experience delays in future product development or may elect not to pursue such development. Even if one or more of our resulting products or product features is technologically successful, it may not achieve market acceptance or compete effectively with our competitors’ technologies. In addition, there can be no assurance that our patent applications will result in patents being issued or that current or additional patents will afford protection against competitors.

The Company is exposed to the potential of cyber security risks that could affect unauthorized access to our technology, product designs, testing and development as well as to our internal financial and operating systems.

The Company's products, services and systems used in internal communications and customer and third-party interactions include the storage, processing and transmission of sensitive data. This can include intellectual property, proprietary and confidential data, and personnel information. A successful breach, employee malfeasance, or security access error could result in access to and potentially unauthorized disclosure, modification, misuse, loss or destruction of Company, customer, or other third-party data or systems. If such a breach were to occur, the Company would be at risk of loss of access to critical data or systems through ransomware, destructive attacks or other means, business delays, service and system disruptions or denials of service.

We are continuing to develop our fatigue management business and we cannot predict our future results from operations of that business.

We entered the fatigue management business in October 2014. We are continuing to develop and test our fatigue management product and consequently there are currently only nominal revenues from this line of business. Given our lack of operating history in this line of business, it is difficult to predict our future results. Investors should consider the risks and uncertainties that we have encountered and may continue to encounter as a pre-revenue-stage company in a new and unproven market. These uncertainties include:

	●	our ability to design and engineer products having the desired features in a cost-efficient manner,
	●	consumer demand for and acceptance of our products,
	●	our ability to be successful in the highly competitive mobile APP market,
	●	our ability to demonstrate the benefits of our products to end users, and
	●	our ability to raise additional capital as needed on commercially acceptable terms.

We continue the development of our software based on our present technology but have not generated meaningful product sales. While we believe that we have a reasonable understanding of the approximate cost it will take to finalize the software APP, such costs are only estimated. If we are unable to control our cost to design and develop our software products, we may not be as successful generating profit margins that we expect, which could adversely affect our financial condition or business.

If we are unable to adequately protect our intellectual property, our anticipated competitive advantage may disappear.

Our success will be determined in part by our ability to retain and obtain United States and foreign patent protection for our technology. Because of the substantial length of time and expense associated with developing new technology, we place considerable importance on patent protection. We intend to continue to rely on a combination of patent protection, technical measures, and nondisclosure agreements with our employees, suppliers and customers to establish and protect the ideas, concepts and documentation of technology developed by us. Our ability to compete and the ability of our business to grow could suffer if these intellectual property rights are not adequately protected. There can be no assurance that our patent applications will result in patents being issued or that current or future patents will afford protection against competitors. Failure of our patents, trademarks, non-disclosure agreements and other measures to provide protection of our technology and our intellectual property rights could enable our competitors to more effectively compete with us and have an adverse effect on our business, financial condition and results of operations. In addition, our trade secrets and proprietary know-how may otherwise become known or be independently discovered by others. No guarantee can be given that others will not independently develop substantially equivalent proprietary information or techniques, or otherwise gain access to our proprietary technology. In addition, we may be required to litigate in the future to enforce our intellectual property rights, or to defend against claims of infringement or invalidity. Any such litigation could result in substantial costs and diversion of resources and could have a material adverse effect on our business, financial condition or results of operations, and there can be no assurances of the success of any such litigation.

Table of Contents

Although we believe that our technology does not and will not infringe upon the patents or violate the proprietary rights of others, it is possible such infringement or violation has occurred or may occur which could have a material adverse effect on our business.

Our business is heavily reliant upon patented and patentable technology. We are not aware of any infringement by us. In the event that products we sell are determined or alleged to infringe upon the patents or proprietary rights of others, we could be required to modify our products or obtain a license for the manufacture and/or sale of such products. In such event, there can be no assurance that we would be able to do so in a timely manner, upon acceptable terms and conditions, or at all, and the failure to do any of the foregoing could have a material adverse effect upon our business. Moreover, there can be no assurance that we will have the financial or other resources necessary to enforce or defend a patent infringement or proprietary rights violation action. In addition, if our products or proposed products are determined or alleged to infringe or likely to infringe upon the patents or proprietary rights of others, we could be subject to injunctive relief and, under certain circumstances, become liable for damages, which could also have a material adverse effect on our business and our financial condition.

If we fail to retain our key personnel and attract and retain additional qualified personnel, we might not be able to pursue our growth strategy.

Our future success depends upon the continued service of our management team and engineering staff who possess longstanding industry and first-hand knowledge of our technology designs, products and operations. The loss of any of our key employees could negatively impact our ability to pursue our growth strategy and conduct operations. Although we believe that our relationship with these individuals is positive, there can be no assurance that the services of these individuals will continue to be available to us in the future.

Future growth in our business could make it difficult to manage our resources.

If we are successful in executing our business plan, we will place a significant strain on our business operations, management, and financial resources. Significant growth in our business may require us to expand our production capabilities, improve our operational, financial and information systems, and to effectively grow and manage our employee base. There can be no assurance that we will be able to successfully manage such a substantial expansion of our business, including attracting and retaining qualified personnel. Any failure to properly manage our future growth could negatively impact our business and operating results.

We cannot predict our future capital needs and we may not be able to secure additional financing.

To date we have relied on sales of our equity securities and debt financing to finance our operations. We will need to raise additional funds in the future to fund our working capital needs, to fund the expansion of our business, to complete development, testing and marketing of our products, or to make strategic acquisitions or investments. We will require additional equity or debt financings, collaborative arrangements with corporate partners or funds from other sources for these purposes. No assurance can be given that necessary funds will be available for us to finance our development on acceptable terms, if at all. Furthermore, such additional financings would involve substantial dilution of our stockholders or may require that we relinquish rights to certain of our technologies or products. In addition, we may experience operational difficulties and delays due to working capital restrictions. If adequate funds are not available from operations or additional sources of financing, we may have to delay or scale back our growth plans.

There is currently a limited public market for our Common Stock, which may result in volatility and negatively impacting our trading price, and potentially causing investors to have difficulty when trying to sell the Common Stock issuable upon conversion of their shares.

We are not required to meet certain quantitative and qualitative listing standards established by stock exchanges for the protection of investors. The market for our Common Stock is extremely limited, meaning that at any time and from time to time, there may not be enough sellers in the market to fill purchase orders and/or enough buyers in the market to fill sell orders for transactions where a given price is stipulated (i.e. “limit orders”). Such orders, therefore, may expire unfilled. Our Common Stock is volatile, meaning that purchase and/or sell orders for a numerically small number of shares (e.g. 500) may have a disproportionate positive or negative impact on the trading price at any time during any given trading day but especially, during the first and the last half-hour of trading. The market for our Common Stock is disproportionately influenced by market makers (i.e. broker/dealers) who agree to buy a limited number of shares of our Common Stock (e.g. 500 share blocks) during the course of a given trading day at various specified prices (the “bid”) who may negatively affect the trading price by periodically “lowering the bid” for our Common Stock without regard to company performance and/or disclosure of material events regarding our activities.

Our Common Stock is deemed to be a “penny stock,” which may make it more difficult for investors to sell their shares due to suitability requirements.

Unless the trading price for our Common Stock is $5.00 or more, the stock is classified as a “penny stock” by the Securities and Exchange Commission. This classification means that broker/dealers are required to determine whether our stock is a “suitable” investment for their customers, required to disclose to the customer certain bids, offers and quotations in our stock at least two days before executing a transaction and additionally are required to deliver certain information regarding the risks generally associated with penny stocks (e.g. lack of liquidity, volatility and the potential that the investor will lose his entire investment) at least two days prior to executing a penny stock transaction. These requirements may reduce the number of individuals who otherwise may purchase our Common Stock in the open market.

Table of Contents

We may issue additional shares of capital stock in the future, which would cause dilution to all shareholders.

As of December 31, 2019, we are authorized to issue up to 400,000,000 shares of our Common Stock, of which a total of 156,515,539 shares are outstanding or are reserved for future issuance due to outstanding stock options, warrants or the conversion of convertible debt or preferred stock. As of December 31, 2019, we have the authority to issue an additional 243,484,461 shares of Common Stock without obtaining shareholder approval.

We are authorized to issue up to 100,000,000 shares of our Preferred Stock, of which a total of 43,961,221 shares have been issued and are outstanding. As of December 31, 2019, our board has the authority to approve the issuance of an additional 56,038,779 shares of Preferred Stock subject to the approval of the holders of the outstanding Preferred Stock.

In the future, we may need to raise additional capital through the issuance of equity securities to finance our operations. Prior issuances of stock have resulted in substantial dilution to our shareholders, and such dilution will continue if we are required to finance our business with additional sales of our stock. Any issuance of additional shares of our Common Stock or Preferred Stock will dilute the percentage ownership interest of all shareholders and will dilute the book value per share of the Common Stock issuable upon conversion of the Shares.

The exercise of our outstanding options and warrants and conversion of our preferred stock may depress our stock price.

As of December 31, 2019, we had outstanding stock options and warrants to purchase an aggregate of 18,472,207 shares of our Common Stock at exercise prices ranging from $0.22 to $5.00 per share. In addition, we had 44,737,077 shares of Preferred Stock (including the impact of accrued dividends) convertible into shares of our Common Stock at a 1:1 ratio. To the extent that these securities are converted into Common Stock, dilution to our shareholders will occur, which may result in a decrease in the market price of our Common Stock.

Certain investors in our equity securities have significant voting power over management and corporate transactions.

As of December 31, 2019, we have one principal shareholder who controls approximately 42% of our outstanding voting securities. This principal shareholder and one board member together control approximately 47% of our outstanding voting securities. If these shareholders act together, they will be able to exert significant control over our management and affairs requiring shareholder approval, including approval of significant corporate transactions.

We do not anticipate paying dividends in the foreseeable future, and the lack of dividends may have a negative effect on the stock price.

We have never declared or paid any cash dividends on our stock. We currently intend to retain our future earnings to support operations and to commercialize our products and, therefore, do not anticipate paying any cash dividends on our capital stock in the foreseeable future.

The terms of any future financing arrangements may restrict our operations.

In the future, we may enter into financing arrangements with financial institutions or other lenders. These financing arrangements would likely require us to satisfy many financial covenants that could limit our ability to incur other indebtedness, pay dividends or engage in certain other types of transactions in the future.

Our ability to realize potential value from our net operating loss carry-forwards is highly speculative and subject to numerous material uncertainties.

As part of our business strategy we plan to explore whether there are opportunities to realize potential value from our net operating loss carry-forwards (“NOL Strategy”). Our net operating loss carry-forwards permit us to apply our net operating losses from prior fiscal years to taxable income in future years in order to reduce our tax liability. As we have incurred losses since our inception, we are unable to realize value from our net operating loss carry-forwards unless we become profitable, either through the commercialization of the products we are developing or through the acquisition of a profitable company. The success of a NOL Strategy will be predicated on maintaining the value of and utilizing all or substantially all of our net operating loss carry-forwards to offset future taxable income of our company or any acquired company. This strategy would be adversely affected if we are unable to realize value from, or otherwise preserve and utilize, our net operating loss carry-forwards, including for any of the following reasons, none of which we have explored or researched as of December 31, 2019:

●

Past Ownership Changes. In the event that we are deemed to have undergone an “ownership change” as defined in Section 382(g)(1) of the Internal Revenue Code (the “Code”), our net operating loss carry-forwards generated prior to the ownership change would be subject to annual limitations, which could reduce, eliminate, or defer the utilization of these losses. Generally, an “ownership change” occurs if the percentage of the stock owned by one or more “5-percent shareholders” (as that term is defined for purposes of Section 382 of the Code) has increased by more than 50 percentage points over the lowest percentage of stock owned by those shareholders at any time during the “testing period”, which is generally the preceding three-year period.

Table of Contents

	●	Future Ownership Changes. Even if an ownership change has not occurred in the past, there is still the potential for an ownership change to occur under Section 382 of the Code as a result of future changes in stock ownership. For example, our issuance of additional stock in the future will result in additional ownership change.

	●	Equity Structure Shift. Certain equity structure shifts, including certain reorganization type-transactions, public offerings, and similar transactions that give rise to a change in the ownership of the Company may result in a limitation or prohibition on the use of the net operating loss carry-forwards. Additionally, the IRS has viewed an acquisition of an ownership percentage in a company that is represented by certain equity instruments, including certain preferred stock, debt instruments, or stock options, as indicative of a transfer of a beneficial ownership interest in a company under Section 382 of the Code. Accordingly, when those instruments are issued, there could be an unintended ownership change that results in a limitation or prohibition on the use of the net operating loss carry-forwards.

	●	De Facto Liquidation. In order to preserve our net operating loss carry-forwards, there must not be a “de facto liquidation” of the Company. The IRS has interpreted a “de facto liquidation” to include sales or the discontinuation of the current business of a company.

In light of the significant uncertainties inherent in the forward-looking statements made by us, the inclusion of such information should not be regarded as a representation by us or any other person that the results or conditions described in such statements or our objectives and plans will be achieved. Important factors could affect our results and could cause results to differ materially from those expressed in our forward-looking statements. Such factors may be updated from time to time in our periodic filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Item 1B. UNRESOLVED STAFF COMMENTS

Not Applicable.

Item 2. PROPERTIES

We occupy 5,600 square feet of leased office space located at 350 Linden Oaks, Rochester, New York. In August 2019, we entered into a short-term sub-lease agreement through December 30, 2022. The current rental rate is $5,491 per month ($65,900 per annum) for the initial twelve months of the lease agreement. The Agreement allows for annual 5% increases from this initial lease rental rate effective on: August 1, 2020, August 1, 2021 and August 1, 2022. We believe that, given our present circumstances, these offices are sufficient to meet our anticipated operational requirements for the next twelve months.

Item 3. LEGAL PROCEEDINGS

There are no litigation matters, actions and/or proceedings to which we are a party or to which our properties are subject.

Item 4. MINE SAFETY DISCLOSURES

Not Applicable.

Table of Contents

PART II

Item 5. MARKET FOR COMMON EQUITY, RELATED SHAREHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock is traded on the over-the-counter market which is an alternative stock exchange listing for companies that either choose not to be listed on a U.S. stock exchange or do not meet the relevant listing requirements. The over-the-counter market and the broker-dealer activities in the market are regulated by the Financial Industry Regulatory Authority (“FINRA”), the U.S. Securities and Exchange Commission (“SEC”) and various state regulators.

Our common stock is regularly quoted on the OTC Link System, an inter-dealer quotation system, operated by OTC Markets Group Inc. OTC Markets Group has developed the OTC Market Tiers in order to bring increased clarity, transparency and disclosure to the OTC market. Quotations for our common stock within the OTC Market Tiers are found on the OTCQB which is limited to companies whose quoted equity is registered with the SEC and that are current in their reporting requirements.

The following table presents the range of high and low bid prices for our common stock for each quarter during the last two calendar years. The source of the high and low bid price information is the OTCQB. The market represented by the OTCQB is extremely limited, is heavily influenced by market makers and the price for our common stock quoted on the OTCQB is not necessarily a reliable indication of the value of our common stock. We also believe that the price of our common stock is significantly impacted by short-selling. Quotations reflect inter-dealer prices, without retail mark-up, mark-down or commission and may not represent actual transactions.

2019	High		Low
1st Quarter	$	0.30	$	0.15
2nd Quarter	$	0.24	$	0.10
3rd Quarter	$	0.20	$	0.05
4th Quarter	$	0.14	$	0.01

2018	High		Low
1st Quarter	$	0.47	$	0.25
2nd Quarter	$	0.40	$	0.20
3rd Quarter	$	0.36	$	0.10
4th Quarter	$	0.49	$	0.15

Holders of Common Stock

As of December 31, 2019, we had approximately 334 shareholders of record of our common stock. As of December 31, 2019, we had 50,979,964 common shares issued and outstanding.

Dividend Policy on Common Stock

We have not paid any dividends on our common stock since the inception of the Company. The declaration or payment of dividends, if any, on our common stock is within the discretion of the board of directors and will depend upon our earnings, capital requirements, financial condition and other relevant factors. Given our current financial condition, the board of directors does not anticipate payment of any dividends on our common stock in the foreseeable future.

The declaration and payment of dividends on our common stock is limited by provisions of the New York Business Corporation Law which permits the payment of dividends only, if after the dividends are paid, a company’s net assets are at least equal to its stated capital. Payment of dividends on our common stock is also subordinated to the requirement that we pay all current and accumulated dividends on our Class A and Class B Preferred Shares prior to the payment of any dividends on our common stock.

Table of Contents

Securities Authorized for Issuance under Equity Compensation Plans as of December 31, 2019:

Plan Category	Number of securities to be issued upon exercise of outstanding options, warrants and rights			Weighted average exercise price of outstanding options, warrants and rights			Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in col.)

Equity compensation plans approved by security holders		10,740,500	(1)	$	0.45			2,159,500
Equity compensation plans not approved by security holders		1,223,000	(2)	$	1.04	(3)	None
Total		11,963,500						2,159,500

(1)	Represents the aggregate number of common stock options outstanding under the 2011 and 2016 Stock Option Plans, as well as other stock options granted to certain executive officers and non-management directors.
(2)	Represents common stock warrants issued to certain business, engineering, financial, and technical consultants.
(3)	Excludes the impact of 1,750,000 unvested warrants with no determined exercise price.

Unregistered Sales of Equity Securities and Use of Proceeds

The Company issued a total of $1,800,000 of convertible promissory and demand notes to accredited investors during the year ended December 31, 2019. The convertible promissory and demand notes were offered and sold without registration under the Securities Act of 1933 pursuant to Rule 506(c) of Regulation D under the Securities Act of 1933. The offerings were made only to “accredited investors” as defined in Rule 501(a) of Regulation D under the Securities Act of 1933. Subsequent to December 31, 2019 and up to the filing of this Form 10K, the Company issued an additional $435,000 of convertible notes.

Reports to Shareholders

We furnish our shareholders with an annual report containing audited financial statements and such other periodic reports as we may determine to be appropriate or as may be required by law. We comply with periodic reporting, proxy solicitation and certain other requirements of the Securities Exchange Act of 1934.

Transfer Agent and Registrar

Continental Stock Transfer & Trust Company has been appointed as our Transfer Agent and Registrar for our common stock and for our preferred stock. Continental’s mailing address is One State Street, New York, New York 10004, and the main telephone number is (212) 509-4000.

Item 6. SELECTED FINANCIAL DATA

As a smaller reporting company, we are not required to include information otherwise required by this Item.

Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis should be read in conjunction with the accompanying Consolidated Financial Statements and Notes thereto appearing elsewhere in this Form 10-K.

Impact of COVID-19 Outbreak

Subsequent to year-end 2019, the World Health Organization declared a novel coronavirus (COVID-19) outbreak as a public health emergency. There have been mandates from international, federal, state and local authorities requiring forced closures of various businesses, schools and other facilities and organizations. While the closures and limitations on movement, domestically and internationally, are expected to be temporary, if the outbreak continues on its current trajectory the duration of the supply chain disruption could reduce the availability, or result in delays, of material or supplies to or from the Company, which in turn could materially interrupt the Company's business operations. Given the speed and frequency of continuously evolving developments with respect to this pandemic, the Company cannot reasonably estimate the magnitude of the impacts to its results of operations.

Table of Contents

Overall Business Strategy

CURA Division: the myCadian system

	●	a risk assessment that identifies the degradation of alertness that may affect a wearer’s ability to perform tasks,
	●	real-time reporting that distills complex user data into actionable information on mobile devices,
	●	predictive reporting for a user to take action when alertness begins to wane, before fatigue becomes dangerous,
	●	flexible settings to provide employers a customized tool using their defined safety criteria and to create protocols for action,
	●	pricing that makes it affordable across a broad-based workforce, and
	●	the Z-Coach wellness program.

Aegis Division: Hydraulic Pump

The Aegis hydraulic pump technology has been designed to bring to the marketplace a unique concept in hydraulic pumps and motors that will be:

●

smaller, lighter and less expensive than conventional pumps and motors,

●

more efficient, and

●

unique in its ability to scale larger, allowing more powerful pumps and motors.

The Company has completed a production prototype and is working to align the prototype capability with specific customer applications. The Company achieved significant milestones in the design and testing of this prototype. Engineering testing and design of the pump and motor functionality is continuing. Our engineering team has progressively made adjustments to traditional valve and piston technologies which have resulted in improvement in the measured efficiency of the pump. We have filed for patent protection for our novel non-rotating group pump concept and continue to file patents as a engineering breakthroughs in our design are identified.

In addition to the activities to be undertaken to implement our plan of operation detailed above, we may expand and/or refocus our marketing activities depending upon future circumstances and developments. Information regarding the Company and all of our inventions, including regular updates on technological and business developments, can be found on our website, www.CurAegis.com. The website and its contents are not incorporated by reference into this report.

Table of Contents

Results of Operations for the years ended December 31, 2019 and 2018

Revenue, Cost of Revenue and Loss on Revenue

	For the year ended December 31,					Variance
	2019		2018			Incr (decr)
CURA revenue	$	15,000	$	37,000		$	(22,000	)
Cost of revenue		13,000		110,000			(97,000	)
Earnings (loss) on revenue	$	2,000	$	(73,000	)	$	75,000

The Company recorded $15,000 and $37,000 in CURA revenue during the years ended December 31, 2019 and 2018, respectively. Revenue from Z-Coach stand-alone sales aggregated $13,000 and $26,000 for the years ended December 31, 2019 and 2018, respectively. During the year ended December 31, 2018, the Company recognized $11,000 in revenue from sales of the CURA system.

During the year ended December 31, 2019, fifty-one Z-Coach Aviation subscriptions were sold to five customers resulting in total customer sales of $7,000. As of December 31, 2019, and December 31, 2018, the Company has deferred revenue of $4,000 and $9,000, respectively attributed to Z-Coach subscription revenue that will be recognized ratably as our performance obligations are satisfied.

The Company recorded $13,000 and $110,000 in cost of revenue during the years ended December 31, 2019 and December 31, 2018, respectively. The cost of revenue includes software amortization and hosting fees incurred to provide the Z-Coach product to subscribers. Software amortization is based upon the straight-line amortization of the capitalized software over an estimated useful life of 36 months. The Z-Coach software was fully amortized in 2019.

The Z-Coach modules have been designed for a range of industry professionals, including aviation, trucking and busing industry and for corporate workers. The Z-Coach training module provides fatigue safety training over a twelve-month subscription period. The user has unlimited access to this tool during the subscription period. Customers are billed at the acceptance of the subscription and revenue is recognized ratably over the subscription period as our performance obligations are satisfied and when collection is reasonably assured.

Engineering and Development Costs and Expenses

	For the year ended December 31,				Variance
	2019		2018		Incr (decr)
Wages and benefits	$	502,000	$	731,000	$	(229,000	)
Professional fee and advisors		242,000		305,000		(63,000	)
Parts and shop supplies		12,000		102,000		(90,000	)
Computer and software maintenance		13,000		45,000		(32,000	)
Depreciation and amortization		22,000		38,000		(16,000	)
Other costs and expenses		11,000		11,000		-
		802,000		1,232,000		(430,000	)
Stock based compensation		7,000		30,000		(23,000	)
Total Engineering and Development	$	809,000	$	1,262,000	$	(453,000	)

Engineering and development expenses decreased during the year ended December 31, 2019 compared to the year ended December 31, 2018 due to: decrease in wages, professional fees and reduced spending for parts and shop supplies. Reduced headcount effected computer and software expenses reflecting reduction in number of subscription-based software programs. These decreases reflect reduced spending as a result of more focused engineering efforts as the Company gets closer to product commercialization. Engineering headcount was two and six professionals as of December 31, 2019 and 2018, respectively.

Table of Contents

General and Administrative Costs and Expenses

	For the year ended December 31,				Variance
	2019		2018		Incr (decr)
Wages and benefits	$	838,000	$	1,195,000	$	(357,000	)
Professional fees and advisors		210,000		199,000		11,000
Facilities and occupancy		137,000		153,000		(16,000	)
Insurance		87,000		87,000		-
Sales and marketing		62,000		30,000		32,000
Patents		45,000		150,000		(105,000	)
Travel		31,000		44,000		(13,000	)
Computer and software maintenance		29,000		37,000		(8,000	)
Shareholder		36,000		53,000		(17,000	)
Depreciation and amortization		2,000		8,000		(6,000	)
Other costs and expenses		40,000		53,000		(13,000	)
		1,517,000		2,009,000		(492,000	)
Stock based compensation		119,000		150,000		(31,000	)
Total General and Administrative	$	1,636,000	$	2,159,000	$	(523,000	)

General and administrative expense decreased during the year ended December 31, 2019 compared to the year ended December 31, 2018 primarily due to: headcount decreases in our sales and operations teams and reduced spending for patent costs. General and administrative headcount was five and nine at December 31, 2019 and 2018, respectively.

Provision for Inventory and Impairment Loss

The Company recorded a provision for excess inventory during the year ended December 31, 2018 based on changes in customer demand and technology developments. Inventory on hand at December 31, 2019 and December 31, 2018 has been fully reserved. The Company recognized $15,000 as a recovery of previously reserved inventory items upon the sale of certain of these components during the year ended December 31, 2019.

During the year ended December 31, 2018, the Company recorded an impairment charge of $17,000 on certain property and equipment that was no longer of use in the Company’s product development.

Non-operating Expense

	For the year ended December 31,						Variance
	2019			2018			Incr/decr
Interest expense	$	(1,233,000	)	$	(1,057,000	)	$	176,000
Debt issuance cost		(333,000	)		-			333,000
Vendor penalty		(300,000	)		-			300,000
Other income		18,000			1,000			(17,000	)
	$	(1,848,000	)	$	(1,056,000	)	$	792,000

Interest expense increased by $176,000 for the year ended December 31, 2019 compared to the prior year. The Company has $10,310,000 in face value of convertible notes outstanding compared to $9,160,000 at December 31, 2018. During the year ended December 31, 2019, the Company recognized $1,233,000 in interest expense on the convertible, demand and promissory notes which includes $748,000 of amortization on debt discount that is classified as interest expense.

The increase in interest expense since 2018 reflects $650,000 of new 2019 convertible notes with an interest rate of 6% per annum issued since 2018, interest on $650,000 of demand notes with an interest rate of 6% per annum issued in the third quarter of 2019, and amortization of debt discount on July 2018 notes issued in the first half of 2019. The 2019 interest expense also reflects the interest incurred on the 6% unsecured promissory notes.

During 2019, the Company and the third-party vendor agreed to a $300,000 penalty payable to the vendor to reflect the aging on this outstanding liability.

During the year ended December 31, 2018 the Company recognized $1,057,000 in interest expense on the convertible notes including $627,000 of amortization on debt discount classified as interest expense related to the convertible notes.

Net Loss for the years ended December 31, 2019 and 2018

The net loss for the year ended December 31, 2019 was $4,276,000, compared with a net loss in the year ended December 31, 2018 of $6,308,000. The net loss attributable to common stockholders for the year ended December 31, 2019 was $4,494,000 as compared to $6,526,000 for the year ended December 31, 2018. The weighted average basic and diluted common shares outstanding amounted to 50,601,000 and 49,781,000 for each of the years ended December 31, 2019 and 2018, respectively. Basic and diluted loss per common share for each of the years ended December 31, 2019 and 2018 were $0.09 and $0.13 respectively.

Preferred stock dividends of $218,000 were recorded in the years ended December 31, 2019 and December 31, 2018.

Liquidity and Capital Resources

During the year ended December 31, 2019 we used $2,260,000 of cash in operating activities. A net loss of $4,276,000 was adjusted for $1,326,000 in non-cash expenses for: amortization of debt discount, depreciation and amortization, the non-cash expense recognized for the fair market value of share rights issued with demand notes, stock-based compensation and interest paid in common shares during the year. The Company reported $690,000 in changes in working capital components during the year ended December 31, 2019. The decrease in cash used in operations in the year ended December 31, 2019 compared to the year ended December 31, 2018 was driven primarily by the decrease in the net loss and the provision for inventory reserve taken in 2018.

Table of Contents

During the year ended December 31, 2019, the Company received net proceeds of $925,000 in senior convertible debt, $650,000 in demand notes and $800,000 in unsecured subordinated promissory notes. The Company repaid $150,000 in unsecured promissory notes during the third quarter of 2019 resulting in $2,225,000 in net cash provided by financing activities.

During the year ended December 31, 2018 we used $3,530,000 of cash in operating activities. A net loss of $6,308,000 was adjusted for $2,784,000 in non-cash expenses for: amortization of debt discount, depreciation and amortization, stock-based compensation, a reserve for inventory and an asset impairment, and interest paid in common shares during the year. The Company reported $6,000 in changes in working capital components during the year ended December 31, 2018. During the year ended December 31, 2018, the Company received net proceeds of $3,388,000 in senior convertible debt and $1,000 in proceeds from the exercise of a common stock warrant.

Current Cash Outlook and Management Plans

As of December 31, 2019, we have cash on hand of $18,000, negative working capital of $4,545,000, a stockholders’ deficiency of $12,203,000 and an accumulated deficit of $91,425,000. During the year ended December 31, 2019 we raised $2,375,000 in proceeds through the issuance of demand notes, convertible notes and promissory notes. The proceeds from these private placements have been used to support the ongoing development and marketing of our core technologies and product initiatives.

Management estimates that the 2020 cash needs will be approximately $1.5 to 2 million, based upon the cash used in operations in the fourth quarter of 2019. As of December 31, 2019, the Company’s cash on hand is not sufficient to cover the Company’s future working capital requirements. This raises substantial doubt as to the Company’s ability to continue as a going concern. Management continues to use its best efforts to develop financing opportunities to fund the development and commercialization of the CURA and Aegis products.

Since inception, we have financed our operations by the sale of our securities and debt financings. We need to raise additional funds to meet our working capital needs, to fund expansion of our business, to complete development, testing and marketing of our products, or to make strategic acquisitions or investments. No assurance can be given that necessary funds will be available for us to finance our development on acceptable terms, if at all. Furthermore, such additional financings will involve dilution to our shareholders or may require that we relinquish rights to certain of our technologies or products. In addition, we will experience operational difficulties and delays due to working capital restrictions. If adequate funds are not available from additional sources of financing, we will have to delay or scale back our growth plans.

The Company’s ability to fund its current and future commitments from its available cash depends on a number of factors. These factors include the Company’s ability to (i) launch and generate sales from the CURA products or (ii) generate proceeds from the monetization of our hydraulic technologies. If these and other factors are not met, the Company would need to raise funds in order to meet its working capital needs and pursue its growth strategy. Although there can be no such assurances, management believes that sources for these additional funds will be available through either current or future investors.

Critical Accounting Policies

Revenue Recognition

The Company has two sources of revenue: (i) from the sale of CURA products and (ii) from stand-alone Z-Coach subscriptions. Revenue from the sale of CURA products is recognized upon the shipment to a customer and upon the company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach Program provides fatigue training over an annual subscription period of twelve months. The Z-Coach Program allows the user unlimited access during the annual subscription period. Customers are billed at the acceptance of the subscription, and revenue is recognized ratably over the subscription period as our performance obligations are satisfied and when collection is reasonably assured. Our collection terms provide customers standard terms of net 30 days. Future performance obligations are reflected in deferred revenue.

Income Taxes

We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax basis of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized.

We account for uncertain tax positions using a more-likely-than-not recognition threshold based on the technical merits of the tax position taken. Tax benefits that meet the more-likely-than-not recognition threshold should be measured as the largest amount of tax benefits, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement in the financial statements. It is our policy to recognize interest and penalties related to income tax matters as general and administrative expenses. As of December 31, 2019 and December 31, 2018, there were no accrued interest or penalties related to uncertain tax positions.

Table of Contents

Stock-Based Compensation

FASB ASC 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the requisite service period (generally the vesting period) in the consolidated financial statements based on their fair values on the grant date. The impact of forfeitures that may occur prior to vesting is also estimated and considered in the amount recognized. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity in accordance with FASB ASC 718-10.

No tax benefits were attributed to the stock-based compensation expense because a valuation allowance was maintained for substantially all net deferred tax assets.

FASB ASC 505-50, “Equity-Based Payments to Non-Employees,” requires all share-based payments to non-employees, including grants of stock options, to be recognized in the consolidated financial statements as compensation expense over the service period of the consulting arrangement or until performance conditions are expected to be met. Using a Black-Scholes valuation model, we periodically reassess the fair value of non-employee options as service conditions are met, which generally aligns with the vesting period of the options, and we adjust the expense recognized in the consolidated financial statements accordingly.

FASB ASC 718-20 requires that modifications of the terms or conditions of equity awards be treated as an exchange of the original award for a new award. Incremental compensation cost is measured as the excess, if any, of the fair value of the modified award over the fair value of the original award immediately before its terms are modified.

Impact of Inflation

Inflation has not had a significant impact on our operations to date and we are currently unable to determine the extent inflation may impact our operations in future periods.

Quarterly Fluctuations

Since we are currently focused on developing our technologies for commercialization and we have not yet engaged in significant revenue producing operations, we do not have any meaningful quarterly fluctuations that impact our financial performance.

Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company, we are not required to include information otherwise required by this Item.

Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Table of Contents

CURAEGIS TECHNOLOGIES, INC.
Contents
Financial Statements

	PAGE

Report of Independent Registered Public Accounting Firm	20

Consolidated Balance Sheets as of December 31, 2019 and 2018	21

Consolidated Statements of Operations for each of the years ended December 31, 2019 and December 31, 2018	22

Consolidated Statements of Changes in Stockholders’ Deficiency for each of the years ended December 31, 2019 and 2018	23

Consolidated Statements of Cash Flows for each of the years ended December 31, 2019 and December 31, 2018	24

Notes to Consolidated Financial Statements	25

Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders of

CurAegis Technologies, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of CurAegis Technologies, Inc. and its subsidiaries (the “Company”) as of December 31, 2019 and 2018 the related consolidated statements of operations, changes in stockholders’ deficiency and cash flows for the years then ended, and the related notes to the consolidated financial statements (collectively, the financial statements). In our opinion, the financial statements presented fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

Adoption of Accounting Standard Update (ASU) 2016-02, Leases (Topic 842)

As discussed in Note 7 to the consolidated financial statements, the Company has changed its method of accounting for leases in 2019 due to the adoption of ASU 2016-02, Leases (Topic 842) and the related amendments.

Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has suffered recurring losses from operations and its total liabilities exceed its total assets. This raises substantial doubt about the Company’s ability to continue as a going concern. Management's plans in regard to these matters are described in Note 1. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ Freed Maxick CPAs, P.C.

We have served as the Company’s auditor since 2011.

Buffalo, New York

March 27, 2020

Table of Contents

CURAEGIS TECHNOLOGIES, INC.

CONSOLIDATED BALANCE SHEETS

	December 31,
	2019			2018
ASSETS
Current Assets:
Cash	$	18,000		$	53,000
Prepaid expenses and other current assets		2,000			25,000
Total current assets		20,000			78,000

Right to use asset (net)		193,000			-
Property and equipment (net)		38,000			62,000
Software (net)		-			10,000
Total non-current assets		231,000			72,000

Total Assets	$	251,000		$	150,000

LIABILITIES AND STOCKHOLDERS' DEFICIENCY
Current Liabilities:
Liability for inventory held at vendor	$	1,764,000		$	1,462,000
Demand notes		650,000			-
Senior convertible notes (net)		647,000			-
Promissory notes		425,000			-
Accounts payable		420,000			323,000
Accrued interest		509,000			166,000
Current right to use obligation		64,000			-
Other current liabilities		36,000			40,000
Accrued wages and benefits		50,000			35,000
Total current liabilities		4,565,000			2,026,000

Non-current right to use obligation		126,000			-
Senior convertible notes (net)		7,763,000			6,603,000
Total Liabilities		12,454,000			8,629,000

Commitments and other matters (Note 16)		-			-

Stockholders' Deficiency:
Preferred stock, $.01 par value, 100,000,000 shares authorized
Series C, voting, convertible, no dividend, shares issued and outstanding at December 31, 2019 and 2018: 15,687,500 and 15,687,500, respectively		157,000			157,000
Series C-2, voting, convertible, no dividend, shares issued and outstanding at December 31, 2019 and 2018: 24,500,000 and 24,500,000, respectively		245,000			245,000
Series C-3, voting, convertible, no dividend, shares issued and outstanding at December 31, 2019 and 2018: 3,238,000 and 3,268,000, respectively		32,000			33,000
Class A, non-voting, convertible, cumulative dividend $.40 per share per annum, shares issued and outstanding at December 31, 2019 and 2018: 468,221 and 468,221, respectively		5,000			5,000
Class B, non-voting, convertible, cumulative dividend $.50 per share per annum, shares issued and outstanding at December 31, 2019 and 2018: 67,500 and 67,500, respectively		1,000			1,000
Common stock, $.01 par value, 400,000,000 shares authorized; shares issued and outstanding at December 31, 2019 and 2018: 50,979,964 and 50,364,549, respectively		510,000			504,000
Additional paid-in capital		78,272,000			77,725,000
Accumulated deficit		(91,425,000	)		(87,149,000	)
Total Stockholders' Deficiency		(12,203,000	)		(8,479,000	)

Total Liabilities and Stockholders' Deficiency	$	251,000		$	150,000

See notes to consolidated financial statements.

Table of Contents

CURAEGIS TECHNOLOGIES, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

	For the Year Ended December 31,
	2019			2018

Revenue and Cost of revenue:
CURA revenue	$	15,000		$	37,000
Cost of revenue		13,000			110,000
Gross margin (loss) on revenue		2,000			(73,000	)

Costs and expenses:
Provision (recovery) inventory reserve		(15,000	)		1,741,000
Impairment loss		-			17,000
Engineering and development		809,000			1,262,000
General and administrative		1,636,000			2,159,000
Total costs and expenses		2,430,000			5,179,000
Loss from operations		(2,428,000	)		(5,252,000	)

Non-operating expense:
Interest expense		(1,233,000	)		(1,057,000	)
Debt issuance cost		(333,000	)		-
Vendor penalty		(300,000	)		-
Other income		18,000			1,000
Non-operating expense		(1,848,000	)		(1,056,000	)

Loss before income taxes		(4,276,000	)		(6,308,000	)
Income taxes		-			-
Net loss		(4,276,000	)		(6,308,000	)

Preferred stock dividends		218,000			218,000
Net loss attributable to common stockholders	$	(4,494,000	)	$	(6,526,000	)
Net loss per share attributable to common stockholders
Basic and Diluted	$	(0.09	)	$	(0.13	)
Weighted average number of shares of common stock
Basic and Diluted		50,601,000			49,781,000

See notes to consolidated financial statements.

Table of Contents

CURAEGIS TECHNOLOGIES, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIENCY

									For the Year Ended December 31, 2019


	Class C Preferred Stock				Class C-2 Preferred Stock				Class C-3 Preferred Stock						Class A Preferred Stock				Class B Preferred Stock				Common Stock				Additional Paid in		Accumulated			Total Stockholders'
	Shares		Amount		Shares		Amount		Shares			Amount			Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Deficiency

Balance At January 1, 2019		15,687,500	$	157,000		24,500,000	$	245,000		3,268,000		$	33,000			468,221	$	5,000		67,500	$	1,000		50,364,549	$	504,000	$	77,725,000	$	(87,149,000	)	$	(8,479,000	)

Conversion of C3 Preferred Shares to common stock										(30,000	)		(1,000	)										30,000		1,000							-
Issuance of warrants with convertible note																												65,000					65,000
Stock-based compensation																												126,000					126,000
Common shares issued for interest																								195,415		2,000		42,000					44,000
Common shares issued with convertible notes																								195,000		2,000		19,000					21,000
Common shares issued with demand notes																								195,000		1,000		19,000					20,000
Share rights issued with demand notes																												276,000					276,000
Net Loss																														(4,276,000	)		(4,276,000	)
Balance At December 31, 2019		15,687,500	$	157,000		24,500,000	$	245,000		3,238,000		$	32,000			468,221	$	5,000		67,500	$	1,000		50,979,964	$	510,000	$	78,272,000	$	(91,425,000	)	$	(12,203,000	)

													For the Year Ended December 31, 2018



	Class C Preferred Stock						Class C-2 Preferred Stock						Class C-3 Preferred Stock						Class A Preferred Stock				Class B Preferred Stock				Common Stock				Additional Paid in		Accumulated			Total Stockholders'
	Shares			Amount			Shares			Amount			Shares			Amount			Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Deficiency

Balance At January 1, 2018		15,937,500		$	159,000			25,000,000		$	250,000			3,388,000		$	34,000			468,221	$	5,000		67,500	$	1,000		48,979,546	$	490,000	$	76,494,000	$	(80,841,000	)	$	(3,408,000	)


Conversion of C Preferred Shares to common stock		(250,000	)		(2,000	)																						250,000		2,000							-
Conversion of C2 Preferred Shares to common stock								(500,000	)		(5,000	)																500,000		5,000							-
Conversion of C3 Preferred Shares to common stock														(120,000	)		(1,000	)										120,000		1,000							-
Issuance of warrants with convertible note																																557,000					557,000
Stock-based compensation																																180,000					180,000
Common shares issued for interest																												320,853		3,000		77,000					80,000
Beneficial conversion feature on convertible note																																369,000					369,000
Common shares issued upon note conversions																												190,150		2,000		47,000					49,000
Exercise of common stock warrant																												4,000		1,000		1,000					2,000
Net Loss																																		(6,308,000	)		(6,308,000	)
Balance At December 31, 2018		15,687,500		$	157,000			24,500,000		$	245,000			3,268,000		$	33,000			468,221	$	5,000		67,500	$	1,000		50,364,549	$	504,000	$	77,725,000	$	(87,149,000	)	$	(8,479,000	)

See notes to consolidated financial statements.

Table of Contents

CURAEGIS TECHNOLOGIES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

	For the Year Ended December 31,
	2019			2018
Cash flows from operating activities:
Net loss	$	(4,276,000	)	$	(6,308,000	)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of discount reported as interest		748,000			627,000
Depreciation and amortization		132,000			138,000
Fair market value of share rights issued with demand notes		276,000			-
Stock-based compensation		126,000			180,000
Interest paid in shares		44,000			81,000
Provision for inventory reserve		-			1,741,000
Impairment of capitalized shop equipment		-			17,000
Changes in working capital items:
Accounts receivable		-			8,000
Prepaid expenses and other current assets		23,000			2,000
Liability for inventory held at vendor		302,000			(216,000	)
Accounts payable		63,000			172,000
Accrued interest		299,000			79,000
Accrued wages and benefits		7,000			(12,000	)
Other current liabilities		(4,000	)		(39,000	)
Net cash used in operating activities		(2,260,000	)		(3,530,000	)

Cash flows from financing activities:
Proceeds from issuance of senior convertible notes (net)		925,000			3,388,000
Proceeds from demand notes		650,000			-
Proceeds from promissory notes		800,000			-
Repayment of promissory notes		(150,000	)		-
Proceeds from exercise of common stock warrant		-			1,000
Net cash provided by financing activities		2,225,000			3,389,000

Net decrease in cash		(35,000	)		(141,000	)
Cash at beginning of year		53,000			194,000
Cash at end of year	$	18,000		$	53,000

Supplemental Disclosures:
Cash used for payment of interest	$	86,000		$	271,000
Right to use asset	$	279,000		$	-
Exchange of promissory notes for convertible notes	$	225,000		$	-
Debt discount related to issuance of convertible notes	$	91,000		$	933,000
Common shares issued in payment of interest	$	44,000		$	80,000
Conversion of preferred shares to common	$	1,000		$	8,000
Common shares issued upon conversion of debt	$	-		$	49,000

See notes to consolidated financial statements.

Table of Contents

CURAEGIS TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - THE COMPANY AND BASIS OF PRESENTATION

CURA Division: the myCadian system

The Company’s CURA division has developed a proprietary technology designed to (i) measure the decrease in a person’s alertness and (ii) to train individuals on how to improve alertness levels. The myCadian system will enable the user to anticipate and avert undesired or disastrous situations caused by the degradation of alertness. With the information provided from the myCadian software analytics, employees can work with Z-Coach, our proprietary sleep training and education solution to correct sleep issues and improve overall wellness.

	●	a risk assessment that identifies the degradation of alertness that may affect a wearer’s ability to perform tasks,
	●	real-time reporting that distills complex user data into actionable information on mobile devices,
	●	predictive reporting for a user to take action when alertness begins to wane, before fatigue becomes dangerous,
	●	flexible settings to provide employers a customized tool using their defined safety criteria and to create protocols for action,
	●	pricing that makes it affordable across a broad-based workforce, and
	●	the Z-Coach wellness program.

Aegis Division: Hydraulic Pump

The Aegis hydraulic pump technology has been designed to bring to the marketplace a unique concept in hydraulic pumps and motors that will be:

	●	smaller, lighter and less expensive than conventional pumps and motors,
	●	more efficient, and
	●	unique in its ability to scale larger, allowing more powerful pumps and motors.

The Company has completed a production prototype and is working to align the prototype capability with specific customer applications. The Company achieved significant milestones in the design and testing of this prototype and engineering testing and design of pump and motor functionality is continuing. Our engineering team has progressively made adjustments to traditional valve and piston technologies which have resulted in improvement in the measured efficiency of the pump. We have filed for patent protection for our novel non-rotating group pump concept and continue to file patents as a engineering breakthroughs in our design are identified.

Table of Contents

Current Cash Outlook and Management Plans

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Consolidation: The financial statements include the accounts of the Company, our wholly owned subsidiary Iso-Torque Corporation, and our majority-owned subsidiary, Ice Surface Development, Inc. (56% owned). These subsidiaries are non-operational.

Use of Estimates: The preparation of financial statements in conformity with U.S. generally accepted accounting principles (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates are subject to a high degree of judgment and potential change. Actual results could differ from those estimates.

Reclassifications: Certain reclassifications may have been made to prior year balances to conform to the current year’s presentation.

Cash: We maintain cash at financial institutions which periodically may exceed federally insured amounts. We have a corporate credit card program through our primary financial institution, JPMorgan Chase Bank, N.A. In connection with this, the Company granted a security interest to the bank in our money market account to act as collateral for the activity within the corporate card program, up to $5,000.

Accounts Receivable: We carry our accounts receivable at invoice amount less an allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and establish an allowance for doubtful accounts, based on a history of past write-offs and collections and current credit conditions. We do not accrue interest on past due invoices. The allowance for doubtful accounts was zero at December 31, 2019 and December 31, 2018.

Inventory: Inventory is stated at the lower of cost or net realizable value with cost determined under the average cost method. We record provisions for excess, obsolete or slow-moving inventory based on changes in customer demand, technology developments or other economic factors. Inventory on hand at December 31, 2019 and 2018 has been fully reserved.

Depreciation and amortization: Depreciation and amortization are computed using the straight-line method. Depreciation and amortization expense for the years ended December 31, 2019 and 2018 are as follows:

	For Years ended December 31,
	2019		2018
Amortization right-to-use asset	$	98,000	$	-
Software		10,000		92,000
Property and equipment		24,000		46,000
	$	132,000	$	138,000

Table of Contents

Right to use building asset: The FASB issued ASU No. 2016-02, “Leases,” which requires a lessee to recognize on its balance sheet the assets and liabilities related to long-term leases that were classified as operating leases under previous guidance. An asset is recognized related to the Company's ability to retain the economic benefits and control of the underlying asset. A corresponding liability is recognized related to the Company's obligation to make lease payments over the term of the lease.

The standard became effective for the Company January 1, 2019. The Company utilized the modified retrospective approach to measure the right to use operating lease agreement associated with the office building used for our business operations located in Rochester, New York. The adoption of this accounting standard did not impact our consolidated loss from operations and had no impact on cash flows.

Software, Property and Equipment: Capitalized software, property and equipment are stated at cost. Estimated useful lives for capitalized software is 3 years and for property and equipment is 5 to 7 years. Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense).

Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may be indicated. The carrying amount is compared to the estimated discounted cash flows and if there is an excess such amount is recorded as impairment.

During the year ended December 31, 2018 we recorded an impairment charge of $17,000 on certain property and equipment.

Fair Value of Financial Instruments: As defined by U.S. GAAP, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A hierarchy for ranking the quality and reliability of the information is used to determine fair values. Assets and liabilities carried at fair value will be classified and disclosed in one of the following three categories:

Level 1: Quoted market prices in active markets for identical assets or liabilities

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data

Level 3: Unobservable inputs that are not corroborated by market data

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The Financial Accounting Standards Board’s (“FASB”) guidance for the disclosure about fair value of financial instruments requires disclosure of an estimate of the fair value of certain financial instruments. The fair value of financial instruments pursuant to FASB’s guidance for the disclosure about fair value of financial instruments approximated their carrying values at December 31, 2019 and December 31, 2018. The carrying amount of cash, prepaid expenses and other current assets, liability for inventory, accounts payable, accrued expenses, demand and promissory notes approximates their fair value due to their short maturity. The senior convertible notes can be converted into common stock with an underlying value of $3,436,000 as of December 31, 2019 based on the trading price on December 31, 2019.

Revenue Recognition and Deferred Revenue: On January 1, 2018, the Company adopted FASB ASC 606, "Revenue from Contracts with Customers" and all related amendments for all contracts using the modified retrospective method. There was no impact upon the adoption of FASB ASC 606. The Company has determined that the adoption of this standard did not require a cumulative effect adjustment. For contracts where performance obligations are satisfied at a point in time, the Company recognizes revenue when the product is shipped to the customer. For contracts where the performance obligation is satisfied over time, as in the Z-Coach sales, the Company recognizes revenue over the subscription period. Revenue from the sale of the Company's products is recognized net of cash discounts, sales returns and allowances. The Company has two sources of revenue: (i) from the sale of MyCadian system products and (ii) from stand-alone Z-Coach subscriptions.

The Company's net revenue is derived primarily from domestic customers. For the year ended December 31, 2019 net revenue from products transferred over time amounted to $13,000 and net revenue from products transferred at a point in time amounted to $2,000. One customer accounted for 43% of total Z-Coach subscription sales made during the year ended December 31, 2019. Our collection terms provide customers standard terms of net 30 days. Future performance obligations are reflected in deferred revenue.

CURA revenue is recognized (a) upon receipt of payment at the point of sale of the CURA app, (b) upon the delivery of myCadian products and (c) upon the company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach Program provides fatigue training over an annual subscription period of twelve months. The Z-Coach Program allows the user unlimited access during the annual subscription period. Customers are billed at the acceptance of the subscription, and revenue is recognized ratably over the subscription period as our performance obligations are satisfied and when collection is reasonably assured. Our collection terms provide customers standard terms of net 30 days.

Table of Contents

Engineering and Development and Patents: Engineering and development costs and patent expenses are charged to operations as incurred. Engineering and development include personnel-related costs, materials and supplies, depreciation and consulting services. Patent costs for the years ended December 31, 2019 and 2018 amounted to $45,000 and $150,000, respectively, and are included in general and administrative expenses.

Stock-based Compensation: FASB Accounting Standards Codification (“ASC”) 718-10 requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the service period (generally the vesting period) in the consolidated financial statements based on their fair values on the grant date. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity in accordance with FASB ASC 718-10. No tax benefits were attributed to the stock-based compensation expense because a valuation allowance was maintained for substantially all net deferred tax assets.

During 2018, the Company adopted FASB ASU 2018-07, “Equity-Based Payments to Non-Employees,” which requires all share-based payments to non-employees, including grants of stock options, to be recognized in the consolidated financial statements as expense generally over the service period of the consulting arrangement or as performance conditions are expected to be met. The Company utilized a modified retrospective approach effective as of January 1, 2018 in the adoption of this accounting guidance which resulted in a $10,000 reduction of stock compensation expense previously reported. FASB ASC 718-20 requires that modifications of the terms or conditions of equity awards be treated as an exchange of the original award for a new award. Incremental compensation cost is measured as the excess, if any, of the fair value of the modified award over the fair value of the original award immediately before its terms are modified.

Income Taxes: We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax basis of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized.

We account for uncertain tax positions using a more-likely-than-not recognition threshold based on the technical merits of the tax position taken. Tax benefits that meet the more-likely-than-not recognition threshold should be measured as the largest amount of tax benefits, determined on a cumulative probability basis, which is more likely than not to be realized upon ultimate settlement in the financial statements. It is our policy to recognize interest and penalties related to income tax matters as general and administrative expenses. As of December 31, 2019, and December 31, 2018, there were no accrued interest or penalties related to uncertain tax positions.

Loss per Common Share: FASB’s ASC 260-10 (“Earnings Per Share”) requires the presentation of basic earnings per share, which is based on weighted average common stock outstanding, and dilutive earnings per share, which gives effect to options, warrants and convertible securities in periods when they are dilutive. At December 31, 2019 and 2018, we excluded 105,535,575 and 94,784,206 potential common shares, respectively, relating to convertible preferred stock, convertible notes, future share rights issued with demand notes, options and warrants outstanding from the diluted net loss per common share calculation because their inclusion would be anti-dilutive. In addition, we excluded 625,000 warrants from the diluted net loss per common share calculation at December 31, 2019 and 2018 as the conditions for their vesting are not time-based.

NOTE 3 – INVENTORY AND RELATED VENDOR LIABILITY

At December 31, 2019 and 2018 inventory consisted of:

	December 31,
	2019			2018
Raw materials	$	1,665,000		$	1,678,000
Finished goods		69,000			69,000
		1,734,000			1,747,000
Less: Reserve		(1,734,000	)		(1,747,000	)
Inventory (net)	$	-		$	-

Liability for inventory held at vendor	$	1,764,000		$	1,462,000

During 2017, the Company initiated a purchase order with a third-party vendor to manufacture and assemble the myCadian watch. In connection with this agreement, the Company agreed to a cancellation charge for products purchased on behalf of the Company in the instance that the purchase order is subsequently modified, delayed or cancelled. At December 31, 2018, the Company had a reserve of $1,747,000 reflecting a full reserve for all inventory on-hand at that date. Management will evaluate this reserve in future reporting periods.

During 2019, the Company and the third-party vendor agreed to a $300,000 penalty payable to the vendor to reflect the aging on this outstanding liability.

Table of Contents

NOTE 4 - DEMAND NOTE

The Company entered into a credit facility with a commercial bank in 2019 for up to $1,500,000 in advances to support working capital needs of the business. The demand notes issued in connection with this commercial bank are supported by individual co-borrowing agreements from certain accredited investors. In connection with this credit agreement, the Company entered into a general security agreement that provides the bank a continuing security interest in all of the Company's personal property and fixtures.

The co-borrowers participating in this credit facility received 30,000 common shares for each $100,000 in principal co-borrowed. The fair market value of these shares was estimated on the date of the note issuance and is reflected in debt issuance costs. The co-borrowers were also granted the right to purchase common shares up to the amount co-borrowed, at a price per share determined based on the closing price of the Company’s common stock one day prior to the agreement. The fair market value of these future rights is reflected in debt issuance costs in the results of operations. The price per share for the future share rights is fixed at the higher of the closing price of the Company’s common stock one day prior to the co-borrowing arrangement or $0.15 per share. Each co-borrower has the right to purchase these common shares until the indebtedness is paid in full or within five business days after the consummation of the sale of the Company’s Aegis division.

At December 31, 2019, the Company had issued $650,000 in demand notes and issued 195,000 shares of common stock in connection with the co-borrowing demand notes. The common shares issued in connection with the co-borrowing demand notes were valued at $21,000 on the date of issuance and have been reported in debt issuance costs. Coincident with the issuance of these notes, these co-borrowers also received the right to purchase up to 4,333,333 shares of the Company’s common stock at a fixed price of $0.15 per share. The fair market value of these future share rights was estimated at $276,000 on the date of the issuance of the notes utilizing the Black Scholes valuation model and has been reported in debt issuance costs.

Advances drawn under this facility have been issued as demand notes with an adjustable interest rate set at the bank’s prime rate, which was 4.75% December 31, 2019. The Company incurred $37,000 in debt issuance costs related to bank and legal fees incurred in connection with this credit facility.

The shares of the Company’s Common Stock are being offered and sold in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933 (“Securities Act”), as amended, and Rule 506 of Regulation D as promulgated by the United States Securities and Exchange Commission thereunder. The shares of the Company’s Common Stock will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

NOTE 5 - SENIOR CONVERTIBLE NOTES AND WARRANTS

At December 31, 2019, the Company had $10,310,000 in convertible notes outstanding which have been presented net of unamortized debt discounts of $1,900,000, resulting in a carrying value of $8,410,000. The 2019 convertible notes have been presented in current liabilities as of December 31, 2019 as these notes mature on the earlier of the Aegis monetization event or five years from the date of issuance. As of December 31, 2018, the Company had $9,160,000 in convertible notes outstanding, presented net of unamortized debt discounts of $2,557,000 resulting in a carrying value of $6,603,000.

Scheduled maturities on the Company’s convertible note are: $650,000 in the twelve months ending 2020; $2,990,000 in the twelve months ending December 31, 2021; $2,775,000 in the twelve months ending in December 31, 2022; $3,395,000 in the twelve months ending December 31, 2023 and $500,000 thereafter.

Included in the face value of convertible notes outstanding at December 31, 2019 and December 31, 2018, is $2,477,000 and $2,252,000, respectively in convertible notes payable to six of our directors and $1,170,000 in convertible notes payable to an investor that is deemed an affiliate.

	Total			2019 6% Notes			JULY 2018 Notes			2018 Notes			2017 6% Notes			2016 6% Notes

Face value 12/31/18	$	9,160,000		$	-		$	1,175,000		$	625,000		$	4,370,000		$	2,990,000
Notes issued		1,150,000			650,000			500,000			-			-			-
Face value 12/31/19	$	10,310,000		$	650,000		$	1,675,000		$	625,000		$	4,370,000		$	2,990,000

Debt discount 12/31/18	$	(2,557,000	)	$	-		$	(360,000	)	$	(231,000	)	$	(456,000	)	$	(1,510,000	)
Debt discount issued		(91,000	)		(26,000	)		(65,000	)		-			-			-
Amortization reported as interest		748,000			23,000			72,000			46,000			94,000			513,000
Debt discount 12/31/19	$	(1,900,000	)	$	(3,000	)	$	(353,000	)	$	(185,000	)	$	(362,000	)	$	(997,000	)


Senior convertible notes (net) 12/31/19	$	8,410,000		$	647,000		$	1,322,000		$	440,000		$	4,008,000		$	1,993,000

Table of Contents

2019 Convertible Notes

The board of directors authorized the issuance of up to $2.5 million in 6% Convertible Promissory Notes (the “2019 Convertible Notes”) in connection with the May 28, 2019 Securities Purchase Agreement (the “2019 SPA”). The 2019 Convertible Notes mature on the earlier of: five days after the sale of substantially all of the assets of the Aegis division or five years from the date of issuance.

The conversion rate of the notes is fixed at the greater of $0.15 per share and the closing market price of the Company’s common stock on the trading day immediately prior to the issuance of the note. Investors receive 30,000 shares of common stock for each $100,000 investment in the 2019 Convertible Notes. The notes were offered in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933 as amended (the "Securities Act") and Rule 506(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule 501(a) of Regulation D under the Securities Act.

During the year ended December 31, 2019, the Company issued $650,000 in new notes and allocated $26,000 of the proceeds to debt discount based on the estimated fair value of the common shares issued and debt issuance costs on the date of investment. During the year ended December 31, 2019, the Company recorded $40,000 in interest expense which includes $23,000 of amortization on debt discount.

JULY 2018 Convertible Notes

The board of directors authorized the issuance of up to $2.5 million in non-interest bearing Senior Convertible Promissory Notes and Warrants (the “JULY 2018 Convertible Notes”) in connection with the July 24, 2018 Securities Purchase Agreement (the “JULY 2018 SPA”). The JULY 2018 Convertible Notes have a five-year maturity. In April 2019, the Company’s board approved a resolution to complete this offering.

The conversion rate of the notes was fixed at $0.25 per share as determined at the close of business on July 24, 2018. Investors in this offering were granted warrants to purchase common shares equal to 10% or 25% of the number of shares issuable upon the conversion of the notes based upon the amount of their investment. The warrants have a fixed exercise price of $0.25 and a ten-year term from the date of issuance. The notes were offered in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933 as amended (the "Securities Act") and Rule 506(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule 501(a) of Regulation D under the Securities Act.

During the year ended December 31, 2019, the Company issued $500,000 in new convertible notes and allocated $65,000 of the proceeds to debt discount based on the estimated fair value of the warrants issued and debt issuance costs incurred on the date of investment. In connection with the issuance of these convertible notes, the Company issued 350,000 warrants with an exercise price of $0.25 per share and a 10-year term.

During the year ended December 31, 2019 and December 31, 2018, the Company recorded $72,000 and $20,000 respectively in interest expense which includes amortization of debt discount.

During the year ended December 31, 2018, the Company issued $1,175,000, in convertible notes and allocated $380,000, of the proceeds to debt discount based on the estimated fair value of the warrants issued and debt issuance costs incurred on the date of investment. In connection with the issuance of these convertible notes, the Company issued 590,000 warrants with an exercise price of $0.25 per share and a 10-year term.

2018 Convertible Notes

The board of directors authorized the issuance of up to $1 million in non-interest bearing Senior Convertible Promissory Notes and Warrants (the “2018 Convertible Notes”) in connection with the May 8, 2018 Securities Purchase Agreement (the “2018 SPA”). The 2018 Convertible Notes have five-year maturity. On July 19, 2018, the Company’s board approved a resolution to complete this offering.

The conversion rate of the notes was fixed at $0.25 per share as determined at the close of business on May 8, 2018. Investors in this offering were granted warrants to purchase common stock equal to 10% or 25% of the number of shares issuable upon the conversion of the notes based upon the amount of their investment. The warrants have a fixed exercise price of $0.25 and a ten-year term from the date of issuance. The notes were offered in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1933 as amended (the "Securities Act") and Rule 506(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule 501(a) of Regulation D under the Securities Act.

During the year ended December 31, 2019 and December 31, 2018, the Company recorded $45,000 and $19,000 respectively in interest expense which reflects the amortization of debt discount.

Table of Contents

2017 Convertible Notes

The board of directors authorized the issuance of up to $5 million in 6% Senior Convertible Promissory Notes and Warrants (the “2017 Convertible Notes”) in connection with the May 31, 2017 Securities Purchase Agreement (as amended, the “2017 SPA”). The 2017 Convertible Notes have a five-year maturity and a fixed annual interest rate of 6%. Investors in this offering were granted warrants to purchase warrants equal to 10% or 25% of the number of shares issuable upon the conversion of the notes based upon the amount of their investment.

The conversion rate of the 2017 Notes was originally set at $0.50 per share and subsequently modified in November 2018 to $0.333 per share. The exercise price of related warrants issued in connection with the 2017 Notes was also subsequently modified in November 2018 to $0.333 per share. The 2017 Convertible Notes were offered in a private placement exempt from registration under Section 4(a)(2) of the Securities Act and Rule 506(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule 501(a) of Regulation D under the Securities Act.

During the year ended December 31, 2019 and December 31, 2018 the Company recorded $356,000 and $355,000, respectively, in interest expense including $94,000 and $105,000, respectively of amortization of debt discount.

2016 Convertible Notes

The board of directors authorized, and the Company issued, $3 million in 6% Senior Convertible Promissory Notes and Warrants (the “2016 Convertible Notes”) in connection with the August 25, 2016 Securities Purchase Agreement (the “2016 SPA”). The 2016 Convertible Notes have five-year maturity dates ranging from August 2021 through December 2021 and a fixed annual interest rate of 6%.

The conversion rate of the notes was fixed at $0.25 per share as determined at the close of business on August 25, 2016. The investors were granted warrants to purchase an aggregate number of shares of common stock equal to 10% of the number of shares issuable upon the conversion of the notes. The warrants have a fixed exercise price of $0.25 and a ten-year term from the date of issuance. The notes were offered in a private placement exempt from registration under Section 4(a)(2) of the Securities Act of 1934, as amended and Rule 506(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule 501(a) of Regulation D under the Securities Act of 1933.

During the year ended December 31, 2019 and December 31, 2018 the Company recorded $692,000 and $664,000, respectively, in interest expense including $513,000 and $483,000, respectively of amortization of debt discount.

NOTE 6- UNSECURED SUBORDINATED PROMISSORY NOTES

During the year ended December 31, 2019, the Company issued $800,000, in unsecured subordinated promissory notes to the Company’s Chief Executive Officer and to another board member. These notes bear interest at a rate of 6% per annum and have a maturity date of ninety days from the date of issuance. As of December 31, 2019, all promissory notes outstanding were payable to our Chief Executive Officer and aggregated $425,000 at this date. The maturity dates on the outstanding promissory notes have been amended to reflect a June 30, 2020 date.

During 2019, the Company paid off $150,000 and converted $225,000 of the promissory notes to 2019 convertible notes. The Company recognized interest expense of $15,000 on these notes during the year ended December 31, 2019.

NOTE 7 - RIGHT TO USE BUILDING ASSET

The FASB issued ASU No. 2016-02, “Leases,” which requires a lessee to recognize in its balance sheet the assets and liabilities related to long-term leases that were classified as operating leases under previous guidance. An asset is recognized related to the right to use the underlying asset and a liability is recognized related to the obligation to make lease payments over the term of the lease. The standard became effective for the Company January 1, 2019.

As of January 1, 2019, the Company utilized the modified retrospective approach to measure the right to use operating lease agreement associated with the office building located at 1999 Mt. Read Blvd in Rochester New York. The adoption of this accounting standard did not impact our consolidated loss from operations and had no impact on cash flows. Upon adoption, the Company determined the present value of future lease costs at $257,000, which included monthly rental, common area costs, and taxes. The Company assumed an incremental borrowing rate of 6% as the building lease agreement did not include an implicit rate. The right-to-use asset included two, one-year renewal options that ran through May 2021. On September 1, 2019, the Company vacated this property at the request of the landlord and relocated to a new office. The Company terminated the lease obligation without penalty or liability for unused periods associated with the original lease obligation and as such, the Company did not incur an impairment as a result of this change in lease term. Operating lease costs for this lease aggregated $80,000 for year ended December 31, 2019.

Table of Contents

On August 1, 2019, the Company entered into an operating lease obligation for office space located at 350 Linden Oaks in Rochester New York. The Company determined the present value of future lease costs at the inception of the lease was $212,000. The Company assumed an incremental borrowing rate of 6% as the building lease agreement did not include an implicit rate. The lease has a termination date of December 30, 2022. Operating lease costs for the year ended December 31, 2019 were $26,000 with future maturing lease obligations as follows: $64,000 in 2020; $64,000 in 2021 and $63,000 in 2022. Total future lease payments are $212,000 including imputed interest of $21,000.

NOTE 8 - SOFTWARE

The Company investment in software for the CURA division have been amortized over an estimated useful life of 3 years. Amortization expense recognized for the year ended December 31, 2019 and 2018 was $10,000 and $92,000, respectively. All capitalized software was fully amortized as of December 31, 2019. The net value of capitalized software at December 31, 2018 was $10,000.

NOTE 9 - PROPERTY AND EQUIPMENT

At December 31, 2019 and 2018 property and equipment consist of the following:

	December 31, 2019			December 31, 2018
Office equipment	$	199,000		$	249,000
Shop equipment		132,000			182,000
Leasehold improvements		-			253,000
		331,000			684,000
Less accumulated depreciation		(293,000	)		(622,000	)
Net property and equipment	$	38,000		$	62,000

Depreciation expense for the years December 31, 2019 and 2018 was $24,000 and $46,000 respectively.

NOTE 10 - BUSINESS SEGMENTS

The Company has two operating business segments. The CURA business operates in the fatigue management industry and the Aegis business is focused in the power and hydraulic industry.

Segment information for the year ended December 31, 2019 for the Company’s business segments follows:

	CURA			Aegis			Corporate			Total

Revenue	$	15,000		$	-		$	-		$	15,000
Gross margin		2,000			-			-			2,000
Loss from operations		(614,000	)		(513,000	)		(1,301,000	)		(2,428,000	)
Non-operating expense		-			-			(1,848,000	)		(1,848,000	)
Net loss	$	(614,000	)	$	(513,000	)	$	(3,149,000	)	$	(4,276,000	)

Stock based compensation	$	3,000		$	17,000		$	106,000		$	126,000
Depreciation and amortization	$	14,000		$	18,000		$	100,000		$	132,000
Assets at December 31, 2019	$	1,000		$	36,000		$	214,000		$	251,000

Segment information for the year ended December 31, 2018 for the Company’s business segments follows:

	CURA			Aegis			Corporate			Total

Revenue	$	37,000		$	-		$	-		$	37,000
Gross margin (loss) on revenue		(73,000)			-			-			(73,000)
Loss from operations		(3,155,000	)		(658,000	)		(1,439,000	)		(5,252,000	)
Non-operating expense		-			-			(1,056,000	)		(1,056,000	)
Net loss	$	(3,155,000	)	$	(658,000	)	$	(2,495,000	)	$	(6,308,000	)

Stock based compensation	$	1,000		$	44,000		$	135,000		$	180,000
Depreciation and amortization	$	110,000		$	20,000		$	8,000		$	138,000
Assets at December 31, 2018	$	15,000		$	54,000		$	81,000		$	150,000

Table of Contents

NOTE 11 - INCOME TAXES

We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax bases of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than not that some portion or all of the deferred tax assets will not be realized.

The provision (benefit) for income taxes for the years ended December 31, 2019 and 2018 is summarized below:

	2019			2018
Current tax expense (benefit):
Federal	$	-		$	-
State		-			-

Deferred tax expense (benefit):
Federal		583,000			1,093,000
State		131,000			252,000
Change in valuation allowance		(714,000	)		(1,345,000	)
Provision for income tax	$	-		$	-

The difference between income taxes at the statutory federal income tax rate and income taxes reported in the statements of operations for each of the years ended December 31, 2019 and 2018 is attributable to the following:

	2019			2018
Income tax benefit at federal statutory rate	$	(898,000	)	$	(1,325,000	)
State income tax (benefit), net of effect of federal taxes		(103,000	)		(199,000	)
Non-deductible debt discount		157,000			132,000
Convertible debt interest expense		96,000			-
Debt issuance expense		70,000			-
Other		(36,000	)		47,000
Increase in valuation allowance		714,000			1,345,000
Provision for income taxes	$	-		$	-

The deferred tax asset at December 31, 2019 and 2018 consists of the following:

	2019			2018
Deferred income tax assets:
Net operating loss carryforwards	$	3,277,000		$	3,044,000
Deferred startup costs		11,224,000			10,787,000
Stock-based compensation		1,321,000			1,302,000
Other		141,000			117,000
		15,963,000			15,250,000
Less: Valuation allowance		(15,963,000	)		(15,250,000	)
Net deferred tax asset	$	-		$	-

Table of Contents

At December 31, 2019, we have approximately $12,799,000 and $12,095,000 of adjusted federal net operating loss carryforwards and New York State net operating loss carryforwards, respectively, to offset future taxable income. These net operating losses begin expiring in 2023 through 2038. Beginning with tax years starting after December 31, 2017, NOL’s created can be carried forward indefinitely, however they can only be utilized in any given year, up to 80% of taxable income in that year. In addition, we have $249,000 of research and development tax credits carryforwards to offset future tax. These credits expire in 2039. Furthermore, from the date of inception through 2019, we have accumulated approximately $43,413,000 of adjusted deferred startup costs. Start-up costs will be amortized over a 15-year period beginning in the year we begin an active trade or business, with the exception of a nominal portion of these costs related to the sale of CURA software currently being amortized. We have provided a full valuation allowance on the net deferred tax assets due to uncertainty of realization through future earnings.

The amortization period for a nominal portion of the startup expenses, $273,000, under IRC Section 195 began in 2018 because the active trade or business related to those startup expenses commenced. The Company received revenue in 2018 and 2019 for the sale of subscription software services and demos of the CURA watch. An inventory reserve was booked in 2018 based on changes in technology developments. A full reserve was recorded for all inventory on hand and the Company is no longer pursuing sales of the related product. The Company expects CURA software sales will continue to be relevant to the Company's business. An election was made in 2018 to begin to amortize the IRC Section 195 costs related to the CURA software’s original cost, and modifications, which the Company is currently reselling. The remaining Section 195 costs will be amortized over a 15-year period beginning in the year the Company begins as an active trade or business.

Based upon the change in ownership rules under Section 382 of the Internal Revenue Act of 1986, if a company issues common stock or other equity instruments convertible into common shares which results in an ownership change exceeding a 50% limitation threshold over a rolling three-year time frame as imposed by that Section, all of that company's net operating loss carryforwards may be significantly limited as to the amount of use in a particular year. Utilization of the NOL carry-forwards may be subject to an annual limitation in the case of sufficient equity ownership changes under Section 382 of the tax law or the NOLs may expire unutilized.

Reconciliations of the beginning and ending amounts of unrecognized tax benefits for the years ended December 31, 2019 and 2018 are as follows:

	2019		2018
Balance as of January 1	$	1,112,000	$	1,112,000
Additions based on tax positions related to current year		-		-
Additions based on enacted tax change in state rate		-		-
Additions for tax positions of prior years		-		-
Reductions for tax positions of prior years		-		-
Reductions based on enacted changes in tax rates		-		-
Settlements		-		-
Balance as of December 31	$	1,112,000	$	1,112,000

Tax years that remain subject to examination for our major tax jurisdictions include the years ended December 31, 2016 through December 31, 2019. NOL's generated in previous years may also be subject to examination.

NOTE 12 - PREFERRED and COMMON STOCK

Common Stock

We have authorized 400,000,000 shares of common stock, with a par value of $0.01 per share.

During the year ended December 31, 2019 the Company issued 30,000 shares of common stock in connection with a conversion notice received from a preferred Series C-3 shareholder, 195,415 shares of common stock in payment of interest on the Company’s 2016, 2017 and 2019 Convertible Notes and 390,000 shares of common stock in connection with the issuance of 2019 Convertible Notes and Demand Notes.

During the year ended December 31, 2018, the Company issued 874,000 shares of common stock in connection with conversion notices received from various preferred shareholders and warrant exercises and 320,853 shares at $0.25 per share in payment of interest on the Company’s 2016 and 2017 Convertible Notes. The company also issued 190,150 common shares at $0.25 per share to note holders that initiated conversion of their debt during the year ended December 31, 2018.

Preferred Stock

Our certificate of incorporation permits the Company to issue up to 100,000,000 shares of $.01 par value preferred stock. The board of directors has the authority to allocate these shares into as many separate classes of preferred as it deems appropriate and with respect to each class, designate the number of preferred shares issuable and the relative rights, preferences, seniority with respect to other classes and to our common stock and any limitations and/or restrictions that may be applicable without obtaining shareholder approval.

Class A Preferred Stock We have authorized the issuance of up to 3,300,000 Class A Non-Voting Cumulative Convertible Preferred Shares. Each Class A Preferred Share is convertible after a one year holding period, at the holder’s election, into one share of our common stock. The conversion rate is subject to adjustment in the event of the issuance of our common stock as a dividend or distribution and in the case of the subdivision or combination of our common stock. The Class A Preferred has no voting rights, except with respect to matters directly impacting upon the rights and privileges accorded to such Class.

The holders of the Class A Preferred are entitled to receive cumulative preferential dividends in the amount of $.40 per share of Class A Preferred for each annual dividend period. Dividends payable on the Class A Preferred will be paid in cash out of any funds legally available for the payment of dividends or, in the discretion of the board, will be paid in Class A Preferred at a rate of 1 share of Class A Preferred for each $4.00 of dividends. If dividends are paid in shares of Class A Preferred, such dividend shares are not entitled to accumulate additional dividends and themselves may be converted into the common stock of the Company on a one for one basis. Holders of Class A Preferred are permitted to request that dividends payable in Class A Preferred be immediately converted into shares of our common stock. At times, our board may elect to settle the dividends through the issuance of common stock in lieu of cash. Accumulated and unpaid dividends on the Class A Preferred will not bear interest. Class A Preferred shares are also entitled to participate pro rata in dividends declared and/or distributions made with respect to all classes of our outstanding equity. We may, in the absolute discretion of our board, redeem at any time and from time to time from any source of funds legally available any and all of the outstanding Class A Preferred at the redemption price of $4.00 per Class A Preferred, plus all unpaid accumulated dividends payable with respect to each Class A Preferred Share.

At December 31, 2019 and 2018, there were 468,221 outstanding shares of Class A Preferred stock, of which 8,709 shares resulted from the settlement of dividends due to conversion, and those shares no longer accrue dividends. The value of dividends payable upon the conversion of the remaining 468,221 outstanding shares of Class A Preferred stock amounted to approximately $2,713,000 and $2,530,000 at December 31, 2019 and 2018, respectively.

Table of Contents

In the event of a liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred shareholders, Class A Preferred shareholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class A Preferred shareholders’ liquidation preference was approximately $2,713,000 and $2,530,000 at December 31, 2019 and 2018, respectively. In the event of liquidation, dissolution or winding up of the Company, unpaid accumulated dividends on the Class A Preferred are payable in Class A Preferred at a rate of 1 share of Class A Preferred for each $4.00 of dividends.

Class B Preferred Stock The Company authorized the issuance of up to 300,000 Class B Non-Voting, Cumulative Convertible Preferred Shares to fund the business operations of Iso-Torque Corporation, an entity incorporated to separately commercialize the Company’s Iso-Torque differential technology.

Each Class B Preferred Share is convertible after a one year holding period, at the holder’s election, into one share of our common stock or one share of the common stock of Iso-Torque Corporation. The conversion rate is subject to adjustment in the event of the issuance of the Company’s or Iso-Torque Corporation’s common stock as a dividend or distribution and in the case of the subdivision or combination of such common stock. The Class B Preferred has no voting rights, except with respect to matters directly impacting upon the rights and privileges accorded to such Class.

Subject to the dividend rights and privileges of our Class A Preferred, the holders of the Class B Preferred are entitled to receive cumulative dividends in the amount of $.50 per share of Class B Preferred for each annual dividend period. Dividends payable on the Class B Preferred will be paid in cash out of any funds legally available for the payment of dividends or, in the discretion of the board, will be paid in Class B Preferred at a rate of 1 share of Class B Preferred for each $5.00 of dividends. If dividends are paid in shares of Class B Preferred, such dividend shares are not entitled to accumulate additional dividends and themselves may be converted into the common stock of the Company on a one for one basis. Holders of Class B Preferred are permitted to request that dividends payable in Class B Preferred be immediately converted into shares of our common stock. Accumulated and unpaid dividends on the Class B Preferred will not bear interest. Class B Preferred shares are also entitled to participate pro rata in dividends declared and/or distributions made with respect to all classes of our outstanding equity. We may, in the absolute discretion of our board, redeem at any time and from time to time from any source of funds legally available any and all of the outstanding Class B Preferred at the redemption price of $5.00 per Class B Preferred, plus all unpaid accumulated dividends payable with respect to each Class B Preferred Share.

Depending upon our cash position, from time to time we may request that a converting preferred shareholder receiving dividends in cash consent to receive shares of restricted common stock in lieu thereof. For the years ended December 31, 2019 and 2018, we settled no Class B Preferred dividends.

At December 31, 2019, dividends payable upon the conversion of 67,500 outstanding shares of Class B Preferred amounted to approximately $488,000. In the event of liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred shareholders and our Class A Preferred shareholders, Class B Preferred shareholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class B Preferred shareholders’ liquidation preference was $488,000 and $454,000 at December 31, 2019 and 2018, respectively. In the event of a liquidation, dissolution or winding up of the Company, unpaid accumulated dividends on the Class B Preferred are payable in Class B Preferred shares at a rate of 1 share of Class B Preferred for each $5.00 of dividends.

Series C Preferred Stock We have authorized and issued 16,250,000 shares of Series C Voting Convertible Preferred Stock. Each Series C Preferred share is convertible, at the holder’s election, into one share of our common stock. The conversion rate is subject to adjustment in the event of the issuance of common stock as a dividend or distribution, and the subdivision or combination of the outstanding common stock.

The Series C Preferred shares have a liquidation preference at their stated value per share of $0.40 that is senior to our common stock, and the Company’s Class A Non-Voting Cumulative Convertible Preferred Shares and Class B Non-Voting Cumulative Convertible Preferred Shares. The liquidation preference is payable upon a liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, or upon a deemed liquidation of the Company.

The Series C Preferred shares have no right to receive dividends and have no redemption right. The Series C Preferred shares vote with the common stock on an as-converted basis.

During the year ended December 31, 2019 Series C Preferred shareholders converted 250,000 of Series C Preferred into common stock. At December 31, 2019 and 2018, there were 15,687,500 shares of Series C Preferred stock outstanding. The value of the Series C Preferred shareholders’ liquidation preference was $6,275,000 at December 31, 2019 and 2018.

Series C-2 Preferred Stock In March 2014, the board of directors authorized, and Class A Preferred, Class B Preferred and Series C Preferred shareholders approved, a series of preferred stock, namely 25,000,000 shares of Series C-2 Voting Convertible Preferred Stock.

Table of Contents

Each Series C-2 Preferred Share is convertible, at the holder’s election, into one share of our common stock, par value $0.01 per share. The conversion rate is subject to adjustment in the event of the issuance of common stock as a dividend or distribution, and the subdivision or combination of the outstanding common stock or a reorganization, recapitalization, reclassification, consolidation or merger of the Company.

The Series C-2 Preferred Shares have a liquidation preference at their stated value per share of $0.20 that ranks pari passu to our existing Series C Voting Convertible Preferred Shares and is senior to our common stock, and our Class A Non-Voting Cumulative Convertible Preferred Shares and Class B Non-Voting Cumulative Convertible Preferred Shares. The liquidation preference is payable upon a liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, or upon a deemed liquidation of the Company. A deemed liquidation includes, unless decided by the holders of at least two-thirds of the Series C-2 Preferred Shares, any consolidation, merger, or reorganization of the Company in which the shareholders of the Company own less than fifty percent of the voting power of the resultant entity, or an acquisition to which the Company is a party in which at least fifty percent of the Company’s voting power is transferred, or the sale, lease, exclusive license or transfer of all or substantially all of the assets or intellectual property of the Company other than to a wholly owned subsidiary.

The Series C-2 Preferred Shares are not entitled to receive preferred dividends and have no redemption right, but are entitled to participate, on an as converted basis; with holders of outstanding shares of common stock in dividends and distributions on liquidation after all preferred shares have received payment in full of any preferred dividends or liquidation preferences. The Series C-2 Preferred Shares vote with the common stock on an as-converted basis.

We may not, without approval of the holders of at least two-thirds of the Series C-2 Preferred Shares, (i) create any class or series of stock that is pari passu or senior to the Series C-2 Preferred Shares; (ii) create any class or series of stock that would share in the liquidation preference of the Series C-2 Preferred Shares or that is entitled to dividends payable other than in common stock or Series C-2 Preferred Shares of its own series, (iii) acquire any equity security or pay any dividend, except dividends on a class or series of stock that is junior to the Series C Preferred Shares, payable in such junior stock, (iv) reissue any Series C-2 Preferred Shares, (v) declare or pay any dividend that would impair the payment of the liquidation preference of the Series C-2 Preferred Shares, (vi) authorize or issue any additional Preferred Shares, (vii) change the Certificate of Incorporation to adversely affect the rights of the holders of the Series C-2 Preferred Shares, or (viii) authorize, commit to or consummate any liquidation, dissolution or winding up in which the liquidation preference of the Series C-2 Preferred Shares would not be paid in full.

The Series C-2 Preferred Shares have not been registered under the Securities Act of 1933, as amended, or the Securities Act, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

During 2018, Series C-2 Preferred shareholders converted 500,000 of Series C-2 Preferred into common stock. At December 31, 2019 and 2018, there were 24,500,000 shares of Preferred C-2 stock outstanding. The value of the Series C-2 Preferred shareholders’ liquidation preference was $4,900,000 at December 31, 2019 and 2018.

In connection with the issuance of the Series C-2 Preferred Shares, the Company entered into an Investors’ Rights Agreement on September 23, 2011 (the “Investors’ Rights Agreement”). Pursuant to the Investors’ Rights Agreement, the Company granted registration rights to the investors covering Common Stock issued on the conversion of the Preferred Shares or exercise of the Warrants or other shares issued in connection with the Transaction (the “Underlying Shares”). The registration rights are triggered when the Company is eligible to utilize Form S-3, and until such time as (i) the Company is sold, (ii) dissolved, or (iii) the Underlying Shares are eligible for resale without restriction in a three-month period under Rule 144. Investors holding shares for sale to receive at least $500,000 in gross proceeds have the right to make the demand up to one time in any such twelve-month period. The Investors’ Rights Agreement also contains a right of first offer for the future issuance of any equity securities of the Company.

Pursuant to the terms of the Investors’ Rights Agreement, the Company may not (i) grant any equity based compensation; (ii) reduce the per-share exercise price or conversion price of any equity based compensation; (iii) create or incur indebtedness in excess of $1,000,000 in the aggregate at any time, or (iv) guarantee the indebtedness of any third party except for trade account payables arising in the ordinary course of business, without the consent of the lead investor. In the event the Company grants any equity based compensation or reduces the per-share exercise price or conversion price of any equity based compensation in violation of the terms of the Investors’ Rights Agreement, and with the effect that additional equity interests are issuable as a result, then the Company shall be obligated to immediately issue to each Investor such aggregate number of additional shares of Common Stock so that immediately following such violation such Investor’s ownership percentage is unaffected by the violation.

The Investors also agreed to “Market Stand-off” provisions that may be requested by an underwriter in an underwritten public offering by the Company. In addition, pursuant to the terms of the Investors’ Rights Agreement, as long as the lead investor may acquire at least 3,000,000 shares of Common Stock by conversion or exercise of his Series C Securities, (i) the lead investor is entitled to inspect the properties, assets, business and operation of the Company and discuss its business and affairs with its officers, consultants, directors and key employees, (ii) the Company shall invite the lead investor or his representative to attend all meetings of the Board of Directors and provide all information provided to directors for such purpose, and (iii) at his request, the Company shall cause him to be appointed to serve as a director until the following annual meeting of shareholders and until a successor is elected.

Table of Contents

Series C-3 Preferred Stock In 2015, the board of directors authorized and the Class A Preferred, Class B Preferred, Series C Preferred and C-2 Preferred shareholders approved, a series of preferred stock, namely 10,000,000 shares of Series C-3 Voting Convertible Preferred Stock.

In 2015, the Company commenced the offering of up to $2,500,000 of the Series C-3 Preferred Shares at the price of $0.25 per share in a private placement pursuant to Rule 506(c) of Regulation D under the Securities Act of 1933. The offering was made only to “accredited investors” as defined in Rule 501(a) of Regulation D under the Securities Act of 1933. The Series C-3 Preferred Shares are convertible into shares of the Company’s common stock at the rate of one-to-one, subject to adjustment in some circumstances.

The Series C-3 Preferred Shares have an aggregate liquidation preference, ranking pari passu with the Series C Preferred Shares and Series C-2 Preferred Shares and senior to the company’s common stock, the Class A Preferred Shares and Class B Preferred Shares. The Series C-3 Preferred Shares are not entitled to receive preferred dividends and have no redemption rights, but are entitled to participate, on an as converted basis, with holders of the company’s common stock in dividends and distributions. The Series C-3 Preferred Shares vote with the Company’s common stock on an as-converted basis and have certain protective provisions.

The Series C-3 Preferred Shares have not been registered under the Securities Act of 1933. Accordingly, those shares and the shares of common stock issuable upon their conversion are “restricted securities” within the meaning of Rule 144 under the Securities Act of 1933 and may not be offered for resale or resold or otherwise transferred except pursuant to a registration statement under the Securities Act of 1933 or an applicable exemption from registration requirements.

During the year ended December 31, 2019, the Company issued 30,000 shares of common stock in connection with conversion notices received from a Series C-3 convertible preferred shareholder. During the year ended December 31, 2018, the Company issued 120,000 shares of common stock in connection with conversion notices received from Series C-3 convertible preferred shareholders. At December 31, 2019 and 2018, there were 3,238,000 and 3,268,000 shares of Preferred C-3 stock outstanding, respectively.

NOTE 13 - STOCK OPTIONS

The shareholders approved the 2011 and 2016 Stock Option Plans (the “2016 Plan” and the “2011 Plan”) which provide for the grant of up to 6,000,000 common stock options to provide equity incentives to directors, officers, employees and consultants. Two types of options may be granted under the plans: non-qualified stock options and incentive stock options.

Under the plans, non-qualified stock options may be granted to our officers, directors, employees and outside consultants. Incentive stock options may be granted only to our employees, including officers and directors who are also employees. In the case of incentive stock options, the exercise price may not be less than such fair market value and in the case of an employee who owns more than 10% of our common stock, the exercise price may not be less than 110% of such market price. Options generally are exercisable for ten years from the date of grant, except that the exercise period for incentive stock options granted to any employee who owns more than 10% of our stock may not be greater than five years.

As of December 31, 2019, there are 2,159,500 options are available for future grant under these plans.

Summary For the years ended December 31, 2019 and 2018, compensation expense related to stock option awards amounted to $126,000 and $180,000, respectively. As of December 31, 2019, there was approximately $105,000 of unrecognized compensation costs related to outstanding stock options, which are expected to be recognized over a weighted average term of 11 months.

No employee stock options were granted in the year ended December 31, 2019. During the year ended December 31, 2018, the Company granted 1,787,500 stock options to employees and non-employee board members. The weighted average grant date fair value of stock options granted during the year ended December 31, 2018 was $0.23. The total grant date fair value of stock options vested during the years ended December 31, 2019 and 2018 was approximately $173,000 and $412,000, respectively.

The fair value of options granted was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:

	2019		2018
Expected term (years)		-		5.4
Expected forfeiture rate		-		0%
Risk-free rate		-		2.8%
Volatility		-		137%
Dividend yield		-		0.0%

Table of Contents

The average risk-free interest rate is based on the U.S. treasury security rate in effect as of the grant date. We determined expected volatility using the historical closing stock price. The expected life was generally determined using the simplified method as we do not believe we have sufficient historical stock option exercise experience on which to base the expected term.

The following summarizes the activity of all of our outstanding stock options for the year ended December 31, 2019:

	Shares			Weighted Average Exercise Price		Average Remaining Contractual Term (years)		Aggregate Intrinsic Value

Outstanding at January 1, 2019		11,028,500		$	0.49		3.8	$	94,000
Granted		-			-
Exercised		-			-
Canceled or expired		(288,000	)		0.28

Outstanding at December 31, 2019		10,740,500		$	0.50		2.6	$	-

Exercisable at December 31, 2019		7,522,750		$	0.55		2.3	$	-

During the year ended December 31, 2019, 288,000 options were canceled due to employee turnover, no options expired unexercised, and no options were exercised. During the year ended December 31, 2018, no options were exercised and 441,000 options were cancelled due to employee turnover, no options expired unexercised and no options were exercised. As of December 31, 2019, the exercise prices on outstanding stock options ranged from $.22 per share to $1.58 per share.

NOTE 14 - WARRANTS

The following summarizes the activity of our outstanding warrants as of December 31, 2019:

						Weighted
			Weighted			Average
			Average			Remaining			Aggregate
			Exercise			Contractual			Intrinsic
	Shares		Price			Term			Value

Outstanding at January 1, 2019		7,381,707	$	0.46	(a)		7.0	(b)	$	39,000
Granted		350,000		0.25
Exercised		-		-
Canceled or expired		-		-

Outstanding at December 31, 2019		7,731,707	$	0.45	(a)		6.2	(b)	$	33,000

Exercisable at December 31, 2019		7,106,707	$	0.49			6.2	(c)	$	33,000

	(a)	The weighted average exercise price for warrants outstanding excludes 1,750,000 warrants in each period with no determined exercise price.
	(b)	The weighted average remaining contractual term for warrants outstanding excludes 743,500 warrants with no expiration date.
	(c)	The weighted average remaining contractual term for warrants exercisable excludes 118,500 warrants with no expiration date.

NOTE 15 - RELATED PARTY TRANSACTIONS

As of December 31, 2019, and December 31, 2018, the Company had outstanding $2,477,000 and $2,252,000, respectively, in senior convertible notes held by six members of our board of directors. These notes represent 9,388,378 of potential shares of common stock at December 31, 2019 and 7,888,378 at December 31, 2018. The Company granted 1,239,288 warrants to these board members in connection with their investment in the convertible notes. During 2019, the Company issued 60,000 and 7,500 common shares to the Company's Chief Executive Officer and to another board member in connection with their investment in the 2019 Convertible Notes, as further described in Note 5. The Company had $164,000 and $33,000 in accrued interest on convertible and promissory notes due to board members outstanding at December 31, 2019 and December 31, 2018, respectively.

Table of Contents

As of December 31, 2019, and December 31, 2018, the Company had outstanding a $1,170,000 senior convertible note held by an investor that is deemed an affiliate. This note represents 4,680,000 of potential shares of common stock as of these reporting dates. Underlying warrants associated with this note represent 468,000 of potential shares of common stock. At December 31, 2019 and December 31, 2018, the Company had $88,000 and $17,000 respectively, in accrued interest outstanding on this convertible note.

During 2019, the Company issued unsecured subordinated promissory notes of $800,000 of which $225,000 was subsequently converted into 2019 convertible notes and $150,000 was repaid resulting in $425,000 of outstanding promissory notes payable to our Chief Executive Officer as of December 31, 2019. The unsecured promissory notes have maturity date of June 30, 2020 and accrue interest at 6% per annum. Accrued and unpaid interest due on the promissory notes was $15,000 as of December 31, 2019.

NOTE 16 — COMMITMENTS AND OTHER MATTERS

401(k) Retirement Benefit Plan: The Company has a defined contribution 401(k) plan covering substantially all employees. Employees can contribute a portion of their salary or wages as prescribed under Section 401(k) of the Internal Revenue Code and, subject to certain limitations, we may, at management’s discretion, authorize an employer contribution based on a portion of the employees' contributions. At the present time, the Company does not provide for an employer match. During 2019 and 2018, we incurred administrative expenses of approximately $2,000 in each year related to this plan.

NOTE 17- SUBSEQUENT EVENTS

2019 Convertible Notes

Subsequent to December 31, 2019, the Company issued $435,000 in new 2019 convertible notes and 112,500 of new common shares to the investors in these notes.

Common Shares Issued in Payment of Interest Expense

Subsequent to December 31, 2019, the Company issued 94,772 shares of common stock representing $14,000 in payment of interest to noteholders.

Stock Compensation Grants

Subsequent to December 31, 2019, the Company granted 2,100,000 incentive stock options exercisable for 10 years from the date of grant at prices ranging from $0.12 to $0.15 per share.

Table of Contents

Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

Item 9A. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

James R. Donnelly, our chief executive officer and Kathleen A. Browne our principal accounting officer, as of December 31, 2019, have informed the board of directors that, based upon their evaluation of the Company’s disclosure controls and procedures as of the end of the period covered by this annual report (Form 10-K), such disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports we submit under the Securities Exchange Act of 1934, as amended, is accumulated and communicated to management (including the chief executive officer) as appropriate, to allow timely decisions regarding required disclosure.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining an adequate System of internal control over financial reporting as such term is defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Securities Exchange Act of 1934, as amended. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our consolidated financial statements. Our internal control over financial reporting is supported by a program of appropriate reviews by management, written policies and guidelines, careful selection and training of qualified personnel, and a written code of conduct adopted by our board of directors, applicable to all Company directors and all officers, consultants and employees.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements and even when determined to be effective, can only provide reasonable assurance with respect to financial statement preparation and presentation. Also, projections or any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. The audit committee of our board of directors meets with our independent registered public accounting firm and management periodically to discuss internal control over financial reporting, auditing and financial reporting matters. The audit committee reviews with our independent registered public accountants the scope and the results of the audit effort. The audit committee’s report can be found in the definitive proxy statement issued in connection with the Company’s 2020 annual meeting of shareholders.

Management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2019. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in the 2013 “Internal Control—Integrated Framework”. Based upon its assessment, management concluded that as of December 31, 2019 internal control over financial reporting is effective.

This annual report does not include an attestation report of our independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our independent registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit us to provide only management’s report in this annual report.

This report shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liabilities of that section, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

Item 9B. OTHER INFORMATION

None

Table of Contents

PART III

ITEM 10.

DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Our directors are elected to serve until the next annual meeting of shareholders and until his successor shall have been duly elected and qualified. Certain information with respect to our directors is presented below.

Thomas F. Bonadio, age 70, has served as a director since November 2010. Mr. Bonadio is the Founder and Senior Counsel of the Bonadio Group. After graduation from St. John Fisher College in 1971, Mr. Bonadio spent seven years with Arthur Andersen & Co. in Rochester, New York. In 1978, he started the Bonadio Group, which now is the largest CPA firm in New York state (outside of Manhattan) and the 42nd largest in the United States. Current annual revenue of approximately $120 million, with more than 850 employees. Each year since 1988, the Bonadio Group has been named a Rochester Top 100 growth company by the Rochester Business Journal.

Mr. Bonadio is chairman of the CurAegis Audit Committee. He also serves on multiple private and public boards. In addition to other community activities, he has been active in many community organizations and not-for-profit boards. He has also served as a member of the Monroe County Jobs Creation Task Force and the St. John Fisher Alumni Activities Committee. He is a past chairman of the Board of Trustees of St. John Fisher College. Mr. Bonadio serves as a member of the Board of Directors of Paychex Inc. and is a member of that company’s Audit Committee; and he heads the audit committees of Royal Oak Realty Trust (formerly Buckingham Properties Group) and previously served as the head of the Audit Committee of Conceptus, Inc. a NASDAQ listed public entity. Mr. Bonadio was also a past member of the Board of Directors of Moore Stephens North America, the nation’s sixth-largest accounting firm association.

Mr. Bonadio’s success and contributions within the community have been recognized by multiple awards, including: the prestigious Herbert W. Vanden Brul Award presented by the Rochester Institute of Technology in 2016; Managing Partner Elite by Accounting Today in 2013, the Rochester Business Hall of Fame in 2010, Businessperson of the Year in 2009 by the Rochester Chamber of Commerce, and in 1990, the Accounting Alumnus of the Year Award from St. John Fisher College. Recently, Mr. Bonadio was honored as a Rochester Business Journal business ICON.

Mr. Bonadio is a member of the American Institute of Certified Public Accountants and the New York State Society of Certified Public Accountants. Mr. Bonadio has a B.B.A. degree in accounting and an Honorary Doctorate from St. John Fisher College. He was certified as a CPA in 1973.

James R. Donnelly, age 41, was appointed as a director of the board in March 2020. Mr. Donnelly served as the chief operating officer of the Company since October 2019. From January 2017 to October 2019, he served as the Company's senior vice-president of Sales and Marketing. Prior to joining CurAegis, Jim served as the vice-president of Bbusiness Development for Six15 Technologies. Preceding the formation of Six15 in June 2012, Jim was director of Defense and Augmented Reality Sales for Vizix Corporation. Jim holds a B.S. in Business Administration from LeMoyne College and sits on two non-profit boards in the Rocheste area.

Lance F. Drummond, age 65, Lance Drummond has served as a director since December 2018. Mr. Drummond is currently a board member for Federal Home Loan Mortgage Corporation (Freddie Mac) since 2015 where he has served on the Audit Committee and Chair of the Compensation and Human Capital Committee. He is a board member for United Community Bank Inc. since 2018, where he serves on the Risk Committee, Nominating and Governance Committee and Compensation Committee. He is also a member of the Public Board of Governors or the Financial Industry Regulatory Authority (FINRA) where he serves on the Management Compensation Committee and the Audit Committee.

Mr. Drummond earned a bachelor’s degree in Business Management from Boston University, a Master’s degree in Business Administration from the Simon Business School at the University of Rochester and a Master’s degree in Management Science from MIT. Mr. Drummond received the MIT Sloan Fellowship in 1994 and the Aspen Institute’s Henry Crown Fellowship in 1998.

Table of Contents

Mr. Drummond’s professional experience includes: twenty-six years at Eastman Kodak Company in a variety of technology and general management positions including as Chief Operating Officer for the Kodak’s professional products division, Bank of America where he served as Service and Fulfillment Operations executive for Global Technology and Operations and Digital Channels executive for the Consumer Banking Division. At Fiserv, he was Executive Vice President of Human Resources and Shared Services. Prior to retiring from TD Canada Trust, he was Executive Vice President of Operations and Technology.

Keith E. Gleasman, age 72, is a co-founder of the Company and has served as a member of the Company’s board of directors since its inception in 1996. Mr. Gleasman served as president of the Company upon its inception through his retirement in September 2019. From 2010 to 2016, he served as the vice president of marketing. From 2005 to 2010 he also held the title of chief technology officer. From 1985-1988, Mr. Gleasman was the vice president of sales for the Power Systems Division of Gleason Works. Mr. Gleasman is a co-inventor on a notable number of the Company’s patents. His strengths include his marketing and sales executive experience, in addition to his design and development knowledge. His particular expertise has been in the area of defining and demonstrating products to persons within all levels of the automotive industry, race crew members, educators and students. He has spent virtually his entire career involved with inventing and manufacturing new and creative mechanical components for the automotive industry, working closely with his father, Vernon E. Gleasman. Mr. Gleasman earned his B.S. degree from Ashland University in Ashland, Ohio.

Walter A. L. Johnson, age 66, is the Executive Director of the Rochester Data Science Consortium and the New York State Center of Excellence for Data Science. He was Vice President of the Palo Alto Research Center (Xerox PARC), managing their Intelligent Systems Laboratory in Palo Alto until 2014 at which time he moved to Rochester to integrate Xerox’s Webster Research Center into PARC. Previously, Dr. Johnson served as Senior Vice President of Operations at SkyGrid, Inc., a real-time financial news analytics startup, as well as the Vice President of Strategy and Business Development at Uppercase, Inc., a tablet PC startup acquired by Microsoft in a $45M transaction. He is a former scientist in PARC’s groundbreaking Human-Computer Interaction group, where he specialized in intelligent interfaces for mobile and ubiquitous computing applications. His work on an embedded document application environment for multifunction devices led to the creation of a special enterprise-level division of Xerox, for which he received the Xerox President’s Award and the PARC Excellence in Science and Technology award. He also served as the Vice President of Strategic Operations at 12 Entrepreneuring, a business incubator in San Francisco. He holds 15 United States patents. Dr. Johnson obtained his Ph.D. in Cognitive Psychology from the University of Pittsburgh, and B.A. and MA. degrees in Cognitive Psychology at the University of Arizona.

Richard A. Kaplan, age 74, has served as a director since October 2010. From 2010 to March 2020, Mr. Kaplan was the chief executive officer and president of the Company. From 2000 to 2010, Mr. Kaplan was the chief executive officer of Pictometry International Corp., a visual information systems company that experienced exponential growth under his leadership. Previously, Mr. Kaplan led and developed a number of other successful businesses in industries including retail floor covering, advertising and marketing, computer software, real estate development and human resource development. Mr. Kaplan currently is on the board of Viggi Corporation. He has been very active in the community in academic institutions and charitable organizations, including present roles on the Board of Trustees at Rochester Institute of Technology, Nazareth College and the University of Rochester Medical Center as well as directorships at Venture Creations (an RIT business incubator), Camp Good Days and Special Times, Rochester’s Child, Rochester Broadway Theatre League, George Eastman House, and the Center for Governmental Research.

Mr. Kaplan’s business success and contributions within the community have been recognized by multiple awards, including the prestigious Herbert W. Vanden Brul Entrepreneurial Award presented by RIT’s E. Philip Saunders College of Business in April 2007. Mr. Kaplan was designated the “Businessperson of the Year” in 2007. In 2012, he was inducted into the Rochester Business Hall of Fame. Mr. Kaplan has an extensive background in economics, accounting, management and executive leadership. He is regularly sought out by startups, universities and other organizations for which he has provided private consulting and guest lecturing on marketing, economics and organizational development. He attended Rochester Institute of Technology and the University of Buffalo where he majored in accounting and minored in economics.

Aaron Newman, age 48, is a serial entrepreneur having founded five successful startups: BlocWatch, CloudCheckr, Techrigy, DbSecure, and Application Security, Inc. He currently sits on the board of CloudCheckr. Aaron authored the books Enterprise 2.0, printed by McGraw-Hill, and the Oracle Security Handbook, printed by Oracle Press. He is an acclaimed international speaker on technology topics and has been awarded multiple patents in database security and social media. Prior to DbSecure, Aaron held technology positions at Price Waterhouse, Bankers Trust, and as an independent IT consultant. Aaron proudly served in the U.S. Army during the First Gulf War. Aaron currently serves as a Trustee of the Strong National Museum of Play, Nazareth College, MCC Foundation, Greater Rochester Chamber of Commerce, and the Rochester Police Foundation.

E. Philip Saunders, age 82, has served as a director since November 2010. Since 1990, Mr. Saunders has been the chief executive officer of Saunders Management Co., a firm that he owns. He also is chairman of the board of Genesee Regional Bank and Valley Fuels and serves on the board of directors for American Rock Salt, Lewis Tree, Paul Smiths, Passero Associates, Royal Oak Realty Trust, Western New York Energy, University of Rochester, Rochester Institute of Technology and the Young Entrepreneurs Academy.

Mr. Saunders’ previous business history includes owner/founder of Truckstops of America, owner/founder of Travel Ports of America, Inc. which later merged with TravelCenters of America, owner of W.W. Griffith Oil Corp., owner/founder of Sugar Creek Corp., owner of Econocar International, owner of Richardson Foods, chief executive officer of American Rock Salt, and senior vice president of Ryder Systems.

Table of Contents

Mr. Saunders’ past services have included membership on the boards of directors of several organizations, including Rochester General Hospital, Excellus Blue Cross/Blue Shield, Security-Norstar Ryder Systems, and the Boy Scouts of America-Steuben Area Council. He has received numerous awards for his contributions to the community, including the Herbert W. Vanden Brul Entrepreneurial Award from the Rochester Institute of Technology’s College of Business (now known as the E. Philip Saunders College of Business), a Doctorate of Commercial Science from Paul Smiths College, the Teddi Award from Camp Good Days and Special Times and the Livingston County Citizen of the Year. He was elected to the Rochester Business Hall of Fame in 2004. Mr. Saunders is a member of Livonia Central School Athletic Hall of Fame and the National Association of Travel Centers Hall of Fame and was the recipient of the 2018 Rochester Business Journal Icon Award.

Gary A. Siconolfi, age 68, has served as a director since October 2002, and has been the Company’s board chair since 2005. Since 1995, Mr. Siconolfi has been the sole owner of his own commercial real estate business. Mr. Siconolfi acted as an advisor to the Company from 1999 through 2002, at which time he joined the board. From 1984 to 1995, he was the owner and president of Panorama Dodge, Inc., Penfield, New York and from 1989 to 1995 he was the owner and president of Panorama Collision, Inc., East Rochester, New York, where he started and managed a highly successful auto/truck dealership and collision business. Prior to opening the dealership and collision business, Mr. Siconolfi acquired extensive knowledge in the automotive industry, working in sales, sales management and general management at various automotive businesses. He has completed more than 100 programs sponsored by Chrysler Corporation, Ford Motor Company and General Motors in fields such as management, sales management, sales, customer relations, human resources and service training, and he has earned numerous awards given by these companies.

Information About Executive Officers

The Company’s executive officers are James R. Donnelly, the Company's Chief Executive Officer and Kathleen A. Browne, Chief Financial Officer and Secretary.

Relationships and Agreements

There are no family relationships among any of the directors or executive officers of the Company. There are no agreements or arrangements for the nomination or the appointment of any persons to the board of directors.

Kathleen A. Browne, age 64, has served as chief financial officer, corporate secretary, and principal accounting officer since April 2015. From 2007 to 2015, Ms. Browne managed her own professional services and consulting business. Ms. Browne provided consulting services to the Company from April 2015 through August 2015 and joined the Company in September 2015. From 2007 to 2015 she served as chief financial officer in several development stage businesses including U-Vend, Inc. and NaturalNano, Inc. Ms. Browne also served as the Controller and Chief Accountant for Paychex (2001-2004) and W. R. Grace (1996-2001). Ms. Browne spent thirteen years in public accounting with PricewaterhouseCoopers. Ms. Browne is a CPA with a degree in accounting from St. John Fisher College in Rochester, NY.

Table of Contents

CORPORATE GOVERNANCE

CurAegis believes it is important to disclose to you a summary of our major corporate governance practices. Some of these practices have been in place since the Company’s inception. Others have been adopted in response to legislative and regulatory changes.

We will continue to assess our corporate governance practices and refine them as are appropriate due to changed circumstances. We will share any future changes with you on an ongoing basis.

A. Role of the Board of Directors---Board Leadership Structure

All corporate authority resides in the board of directors as the representative of the shareholders. The board has delegated authority to management to implement the Company’s mission of maximizing long-term shareholder value while adhering to the laws of the jurisdictions where we operate and at all times observing the highest ethical standards. With respect to its relationship to management, the board’s role is not to manage but to provide independent oversight of management’s decisions.

Management’s responsibilities include the development and implementation of the Company’s strategic plans, utilization of company resources, authorization of spending limits and the authority to hire consultants and employees and terminate their services. The board retains responsibility to recommend candidates to the shareholders for election to the board of directors. The board retains responsibility for selection and evaluation of the chief executive officer, determination of senior management compensation, approval of the annual budget, and assurance of adequate financial and accounting systems, procedures and controls. The board also provides advice and counsel to senior management on a regular basis.

All major decisions are considered by the board as a whole; however, the board has chosen to exercise certain of its responsibilities through committees of the board. The board has established three standing committees - an Audit Committee, a Nominating Committee, and a Governance and Compensation Committee.

Consistent with the Company’s view of our board of directors’ and management’s distinct but mutually supportive roles described above, the Company has chosen to separate the positions of board chairman and chief executive officer. The role of the board chairman is to set board agendas, priorities and procedures to facilitate the board in its review and oversight function. The role of the chief executive officer is to establish and implement the Company’s strategic direction, subject to board oversight.

Risk Oversight

The board oversees the Company’s risk management process through regular discussions of the Company’s credit, liquidity, operational, compliance and similar risks with senior management both during and outside of regularly scheduled board meetings. In addition, the Audit Committee assists the board by administering such oversight function with respect to risks relating to the Company’s accounting and financial controls.

Annual Meeting Attendance

It is the Company's policy that all directors attend the annual shareholders meeting. All persons who were directors on the date of last year's annual shareholders' meeting attended such meeting either in person or by telephonic conference, except for Thomas F. Bonadio, Thomas Labus, E. Philip Saunders, and Gary Siconolfi.

B. Operation of the Board of Directors

During 2019 the Board of Directors met 5 times and took official action 7 times during the period from January 1, 2019 through December 31, 2019. During this period, our directors as a group participated in, either in person or by telephonic conference as permitted by the Company's Bylaws, approximately 90% of the total number of meetings held and/or actions taken during the period for which they were directors and 88% of the total number of meetings and/or actions taken by the committees of the board on which they served during the period for which were members of such committee(s).

Code of Ethics / Committee Charters

The board has adopted, implemented and published on the Company’s website (www.CurAegis.com) the Company’s code of business conduct which applies to all members of the Board, all executive and financial officers and all employees and consultants of the Company, its divisions and its subsidiaries. The code mandates that all Company personnel observe the highest standards of business and personal conduct in the performance of their duties and responsibilities, especially in dealing with other Company personnel, our shareholders, the general public, the business community, customers, suppliers, and governmental authorities. It addresses conflicts of interest, corporate opportunities, confidentiality, fair dealing, protection and proper use of corporate assets, compliance with laws, rules, and regulations and requires the reporting of any illegal or unethical behavior.

We require our employees, our officers, and directors to talk to supervisors, managers or other appropriate personnel to report and discuss any known or suspected unethical, illegal or criminal activity involving the Company and/or its employees. We have established a process which allows employees, officers, and directors to anonymously report any known or suspected violation of policies and rules set forth in the code of business conduct.

Table of Contents

Waivers or amendments of the code's provisions are generally not permitted, may be granted only by the board of directors, and if granted, will be disclosed promptly by the Company by posting the waiver or amendment on the Company’s website and by filing a current report (Form 8-K) with the Securities and Exchange Commission. There were no waivers and/or amendments of the code during 2019.

The board has also adopted, implemented and posted on the Company’s website the Company’s financial integrity and compliance program. The program mandates that the Company's results of operations and financial position must be recorded in accordance with the requirements of law and generally accepted accounting principles and that all books, records, and accounts must be maintained in reasonable detail so that they accurately and fairly reflect the business transactions and disposition of assets of the Company. The written policy requires all personnel responsible for the preparation of financial information to ensure that the Company's financial policies and internal control procedures are followed and holds each person involved in creating, processing and recording financial information accountable for the integrity of the financial reporting process. The program establishes a network for the receipt, retention, and treatment of complaints received by the Company regarding accounting, internal accounting controls or auditing matters and provides for the submission (including the confidential anonymous submission) by Company personnel of any concerns they might have regarding questionable accounting or auditing practices.

The board adopted an Audit Committee charter delineating the composition and the responsibilities of the Audit Committee which became effective on April 17, 2000. The charter was revised by the board effective January 15, 2003 and July 21, 2011. The charter is on the Company's website.

On November 9, 2004, the board adopted a Nominating Committee charter delineating the composition and responsibilities of the Nominating Committee. The Nominating Committee charter is on the Company’s website.

Committees of the Board

The Audit Committee

Members:

Thomas F. Bonadio, chairman

Lance F. Drummond

E. Philip Saunders

Number of Meetings in 2019: 4

The primary function of the Audit Committee as stated in its charter is to assist the board of directors in fulfilling its oversight responsibilities relating to: (i) the integrity of the Company’s financial statements; (ii) the Company’s compliance with legal and regulatory requirements, including requirements for implementing effective internal controls over financial reporting and programs to detect fraud; (iii) the independent auditor’s qualifications and independence; and (iv) the performance of the Company’s independent auditor, who shall be ultimately accountable and report to the Committee.

The Committee shall prepare the report required by the rules of the Securities and Exchange Commission to be included in the Company’s annual proxy statement.

In addition to the powers and responsibilities expressly delegated to the Committee pursuant to the Audit Committee charter, the Committee is empowered to exercise any other powers and carry out any other responsibilities delegated to it by the board of directors from time to time consistent with the Company’s bylaws. While acting within the scope of the powers and responsibilities specified in the charter and delegated to it by the board, the Committee has and may exercise all the powers and authority of the board.

All members of the Audit Committee are "independent" as independence is defined in Nasdaq Marketplace Rule 4200(a)(15) and as defined by Rule 10A-3(b)(1)(ii) promulgated by the Securities and Exchange Commission. Thomas F. Bonadio has been appointed the Audit Committee's "financial expert" as defined by the Audit Committee's charter in accordance with rules promulgated by the Securities and Exchange Commission.

The Nominating Committee

Gary A. Siconolfi, chairman

Number of Meetings in 2019: 1

Table of Contents

As specified in its charter, the purpose of the Nominating Committee is to identify, consider and recommend qualified individuals to the Board for election as directors, including the slate of directors that the board proposes for election by shareholders at the annual meeting. The charter sets forth the following policy and procedures with respect to the consideration of any director candidates recommended by security holders.

Shareholders wishing to directly nominate candidates for election to the board of directors at an annual meeting must do so by giving notice in writing to the chairman of the Nominating Committee, CurAegis Technologies, Inc., 350 Linden Oaks Rochester, New York 14625. The notice with respect to any annual meeting must be delivered to the chairman not less than 120 days prior to the first anniversary of the preceding year's annual meeting. The notice shall set forth (a) the name and address of the shareholder who intends to make the nomination; (b) the name, age, business address and residence address of each nominee; (c) the principal occupation or employment of each nominee; (d) the class and number of shares of CurAegis securities which are beneficially owned by each nominee and by the nominating shareholder; (e) any other information concerning the nominee that must be disclosed in nominee and proxy solicitations pursuant to Regulation 14A of the Securities Exchange Act of 1934; and (f) the executed consent of each nominee to serve as a director of CurAegis if elected.

Nominations submitted in accordance with the foregoing procedure will be considered and voted upon by the Nominating Committee. Any shareholder nominee recommended by the Committee and proposed by the board for election at the next annual meeting of shareholders shall be included in the Company's proxy statement for such annual meeting.

The Nominating Committee charter also sets forth the qualifications and a specific description of skills that members of the board of the Company should possess, regardless of by whom nominated.

In recommending candidates, the Committee shall consider the candidates' mix of skills, experience with businesses and other organizations of comparable size, reputation, background and time availability (in light of anticipated needs), the interplay of the candidate's experience with the experience of other board members, the extent to which the candidate would be a desirable addition to the board and any committees of the board and any other factors the Committee deems appropriate. At a minimum, the Committee shall address the following skill sets in evaluating director candidates: accounting or finance, business or management experience, industry knowledge, customer base experience or perspective, international marketing, and business experience, strategic planning and leadership experience.

Directors should possess the highest personal and professional ethics, integrity and values, and be committed to representing the long-term interest of the shareholders. They must also have an inquisitive and objective perspective, practical wisdom and mature judgment. The board should represent diverse experience at policy-making levels in business, government, education and technology, and in areas that are relevant to the Company's worldwide activities.

Directors must be willing to devote sufficient time to carrying out their duties and responsibilities effectively and should be committed to serving on the board for an extended period of time. Directors should consider offering their resignation in the event that significant change in their personal circumstances, including their health, family responsibilities, or a change in their principal job responsibilities, would preclude them from devoting sufficient time to carrying out their responsibilities effectively.

The board does not believe that arbitrary term limits on director service are appropriate, nor does it believe that directors should expect to be re-nominated automatically. The contribution of each member as a member of a committee or the board shall be evaluated each year by the Committee before his re-nomination is recommended to the board.

All members of the Nominating Committee are “independent” as defined in Rule 10A-3(b)(1)(ii) promulgated by the Securities and Exchange Commission and as defined by Nasdaq Marketplace Rule 4200(a)(15).

The Governance and Compensation Committee

Number of Meetings in 2019: 1

The purpose of the Governance and Compensation Committee is to monitor the effectiveness of management’s policies and decisions including the execution of the Company's strategies in order to ensure that the Company represents the shareholders' interests, including optimizing long term as well as short term financial returns. The Committee develops and recommends to the board corporate governance principles and guidelines and reviews the charter and composition of each committee of the board and makes recommendations to the board for the adoption of or revisions to committee charters, the creation of additional committees or the elimination of committees.

Table of Contents

The Committee also:

(1)

establishes and reviews the overall executive compensation philosophy and strategy of the Company and oversees the Company’s various compensation programs and plans;

(2)

reviews on its own and taking into account shareholder advice on executive compensation policies, makes recommendations to the board of directors on employment and business consultants compensation policies, forms and levels of annual compensation, including specifically, the performance and level of annual compensation of the executive officers and top management personnel of the Company;

(3)

specifically reviews the annual compensation of the chief executive officer in the light of established goals and objectives and based upon such evaluation and taking into consideration shareholder advice on such compensation, makes specific recommendations to the board regarding such compensation;

(4)

reviews and makes recommendations to the board on the operation, performance, and administration of the Company's employee benefit plans.

All members of the Committee must be independent within the meaning of Rule 10A-3(b)(1)(ii) promulgated by the Securities and Exchange Commission and Nasdaq Marketplace Rule 4200(a)(15).

C. Shareholder Communications

We encourage all shareholders to communicate with management and with our directors, including our independent directors. Any shareholder wishing to communicate directly with management should e-mail or address regular mail to:

Officer

Mailing Address

E-mail

James Donnelly

Chief Executive Officer and President

CurAegis Technologies, Inc.

350 Linden Oaks

Rochester, New York 14625

jdonnelly@curaegis.com

Kathleen A. Browne

Chief Financial Officer

CurAegis Technologies. Inc.

350 Linden Oaks

Rochester, New York 14625

kbrowne@curaegis.com

Any shareholder wishing to communicate directly with any of our independent directors should e-mail as follows:

Thomas F. Bonadio	tbonadio@bonadio.com

Lance F. Drummond	Lance.drummond@outlook.com

Keith Gleasman	keithgleasman@gmail.com

Walter A. L. Johnson	waljohnson@rochester.edu

Richard A. Kaplan	dickkaplan3@gmail.com

Aaron C. Newman	aaron@newman-family.com

E. Philip Saunders	PhilS@saundersmgt.com

Gary A. Siconolfi	garysic1951@gmail.com

Regular mail may be addressed to:	CurAegis Independent Directors c/o CurAegis, Inc. 350 Linden Oaks Rochester, New York 14625 Attention: Kathleen A. Browne

Table of Contents

Section 16(a) Beneficial Ownership Reporting Compliance

Section 16(a) of the Securities Exchange Act of 1934 requires our directors, our executive officers and persons who own more than 10% of our common stock to file initial reports of ownership (Form 3) and reports of changes in ownership of our common stock (Forms 4 and 5) with the Securities and Exchange Commission. These persons are required by SEC regulations to furnish us with copies of all section 16(a) reports they file.

Based upon Company records and other information, we believe that for the year ended December 31, 2019, and for the period January 1, 2019, through March 29, 2020, all directors and executive officers complied with all applicable Section 16(a) filing requirements.

ITEM 11. EXECUTIVE COMPENSATION

SUMMARY COMPENSATION TABLE

FOR YEARS ENDED DECEMBER 31, 2019 and 2018

Name and Principal Position	Year	Salary		Bonus		Stock Awards		Option Awards (4)		Non- Equity Incentive Plan Compensation		Change in Pension Value and Non- qualified Deferred Compensation Earnings		All Other Compensation		Total
(a)	(b)	(c)		(d)		(e)		(f)		(g)		(h)		(i)		(j)

Richard A. Kaplan,	2019	$	50,000	$	0	$	0	$	0	$	0	$	0	$	15,000	$	65,000
CEO (1)	2018	$	50,000	$	0	$	0	$	0	$	0	$	0	$	15,000	$	65,000

James R. Donnelly, COO (2)	2019	$	175,000	$	0	$	0	$	0	$	0	$	0	$	0	$	175,000

Kathleen A.	2019	$	200,000	$	0	$	0	$	0	$	0	$	0	$	0	$	200,000
Browne, CFO (3)	2018	$	200,000	$	0	$	0	$	21,000	$	0	$	0	$	0	$	221,000

	(1)	Mr. Kaplan served as the Company’s chief executive officer for the years ended December 31, 2019 and 2018. He received an annual salary of $50,000 and $15,000 annual car allowance each year in this role.
	(2)	Mr. Donnelly served as the Company’s chief operating officer for the year ended December 31, 2019.

(3)

Ms. Browne served as the Company’s chief financial officer for the years ended December 31, 2019 and 2018.

(4)

Represents the total grant date fair value of option awards computed in accordance with FASB ASC 718. Ms. Browne received one award in 2018: 100,000 shares on May 7, 2018, with an exercise price of $0.23 per share, 10-year expiration and vesting in 25% tranches annually. The Black-Scholes option-pricing model was used to value the cost of the option grants at approximately $21,000, which is being recognized ratably over the estimated vesting periods of the respective grants.

Table of Contents

OUTSTANDING EQUITY AWARDS AT DECEMBER 31, 2019

	Option Awards										Stock Awards
Name	Number of Securities Underlying Unexercised Options: Exercisable		Number of Securities Underlying Unexercised Options: Unexer- cisable		Equity Incentive Plan Awards: Number of Securities Underlying Unexercised Unearned Options		Option Exercise Price ($)		Option Expira- tion Date		Number of Shares or Units of Stock That Have Not Vested		Market Value of Shares or Units of Stock That Have Not Vested ($)		Equity Incentive Plan Awards: Number of Unearned Shares, Units or Other Rights That Have Not Vested		Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That have Not Vested ($)
(a)	(b)		(c)		(d)		(e)		(f)		(g)		(h)		(i)		(j)

Richard A. Kaplan, CEO (1)		3,000,000		2,150,000		0	$	0.36		2020		0	$	0		0	$	0

James R. Donnelly, COO (2)		100,000		150,000		0	$	0.23		2028		0	$	0		0	$	0

Kathleen A. Browne, CFO (3)		25,000		0		0	$	0.28		2025		0	$	0		0	$	0
		0		25,000		0	$	0.53		2026		0	$	0		0	$	0
		75,000		25,000		0	$	0.62		2026		0	$	0		0	$	0
		50,000		50,000		0	$	0.23		2028		0	$	0		0	$	0

(1)	On September 30, 2010, Mr. Kaplan was granted an option to acquire 5,150,000 shares of the Company's $.01 par value common stock exercisable for a period of ten years at $.36 per common share. The option vests as follows: 1,000,000 shares immediately; 1,000,000 shares upon the closing price of the Company's common stock reaching $1.00 per share; another 1,000,000 upon the closing price reaching $2.00 per share; another 1,000,000 upon the closing price reaching $3.00 per share and the balance of 1,150,000 upon the closing price reaching $4.00 per share. As of December 31, 2019, 3,000,000 options have vested under the option agreement.

(2)	On May 7, 2018, Mr. Donnelly was granted an option to acquire 250,000 shares of the Company’s $0.01 par value common stock exercisable for a period of ten years at $0.23 per common share. The option vests as flows: 37,500 shares on the grant date; 62,500 on the first, second and third anniversaries of the grant; and 25, 000 on the fourth anniversary of the grant. At December 31, 2019, 100,000 options have vested under the option agreement.

(3)	On September 1, 2015, Ms. Browne was granted an option to acquire 25,000 shares of the Company’s $.01 par value common stock exercisable for a period of ten years at $.28 per common share. The grant vests in 25% tranches on each successive anniversary of the grant. At December 31, 2019, 25,000 options have vested under the option agreement. On January 14, 2016, Ms. Browne was granted an option to acquire 25,000 shares of the Company’s $.01 par value common stock exercisable for a period of ten years at $.53 per common share. The shares vests upon the closing price of the Company's common stock reaching $5.00 per share. At December 31, 2019, none of these options have vested. On December 21, 2016, Ms. Browne was granted an option to acquire 100,000 shares of the Company’s $.01 par value common stock exercisable for a period of ten years at $.62 per common share. The grant vests in 25% tranches on each successive anniversary of the grant. At December 31, 2019, 75,000 of these options have vested. On May 7, 2018, Ms. Browne was granted an option to acquire 100,000 shares of the Company’s $.01 par value common stock exercisable for a period of ten years at $.23 per common share. The grant vests annually in 25% tranches. At December 31, 2019, 50,000 of these options have vested.

Table of Contents

DIRECTOR COMPENSATION TABLE FOR THE YEAR ENDED DECEMBER 31, 2019

Name (a)	Fees Earned or Paid in Cash (b)		Stock Award (c)		Option Awards (d)		Non-Equity Incentive Plan Compensation (e)		Change in Pension Value and Nonqualified Deferred Compensation Earnings (f)		All Other Compensation (g)		Total (h)
Thomas F. Bonadio	$	0	$	0	$	21,750	$	0	$	0	$	0	$	21,750
William W. Destler	$	0	$	0	$	21,750	$	0	$	0	$	0	$	21,750
Lance F. Drummond	$	0	$	0	$	58,500	$	0	$	0	$	0	$	58,500
E. Philip Saunders	$	0	$	0	$	21,750	$	0	$	0	$	0	$	21,750

On August 1, 2018, the Company made a grant of 75,000 options to the following board members: Thomas F. Bonadio, William W. Destler and E. Phil Saunders. These options have an exercise price of $0.32 per share, exercisable for 10 years, and with annual vesting of 25% upon the anniversary date of the option grant.

On November 11, 2018, the Company made a grant of 150,000 options to Lance F. Drummond with an exercise price of $0.26 per share, exercisable for 10 years which were fully vested upon the date of the grant. Also, on November 11, 2018, the Company made a grant of 100,000 options to Lance F. Drummond with an exercise price of $0.26 per share, exercisable for 10 years with annual vesting of 25% upon the anniversary date of the option grant.

A. Discussion of Director Compensation

Participation in the Company’s 2011 and 2016 Stock Option Plans

Directors are eligible to be granted options under the company’s 2011 and 2016 Stock Option Plan (“the Option Plans”) as a component of the board’s strategy for recruiting and retaining outstanding individuals in the service of the Company and for aligning their interests with the interests of the Company’s shareholders. The Company’s shareholders approved the Option Plans at annual meetings of shareholders. The Option Plans are the only Company plans the members of the board of directors are entitled to receive equity compensation for their performance of services as directors and members of committees created by the board.

Reimbursement of Board Expenses

The board has a policy of providing for the reimbursement of expenses incurred by members of the Company’s board of directors. The reimbursement policy applies to all non-employee directors and provides for the reimbursement of all reasonable out-of-pocket expenditures incurred on behalf of the Company, including but not limited to:

	a)	travel costs for board meeting attendance, such as hotel, meals, and transportation;
	b)	airfare based upon reasonable commercial rates; and
	c)	mileage for personal vehicles used for CurAegis business reimbursed at the applicable Internal Revenue Service rate in force at the time the vehicle is used.

No reimbursement is to be made unless authorized by the Company’s chief executive officer or its chief financial officer.

Table of Contents

B. Discussion of Management Compensation

In recent years, corporate governance commentators and advisors have advocated and increasingly, governmental regulatory authorities, including the Securities and Exchange Commission, are mandating, that public companies, such as CurAegis, initiate procedures to ensure that our shareholders have input on our named executive officer compensation programs (the “say on pay” movement). Basically, our named executive officer compensation policies and programs are designed to attract, motivate, and retain the key executives who are responsible to drive our success and enhance shareholder value. Pay that reflects performance and alignment of that pay with the interests of long-term shareholders are key principles that underlie our executive officer compensation program design.

Our board of directors values and encourages constructive dialogue on executive compensation and other important governance topics with our shareholders, to whom it is ultimately accountable. At the 2011 annual meeting, the Company’s shareholders approved the board’s proposal to seek shareholder advice on executive compensation on an annual basis, consistent with the board’s view such an annual procedure is the most effective means to obtain current information on investor sentiment about our executive compensation philosophy, policies, and procedures.

On September 30, 2010, the Company granted a stock option for 5,150,000 common shares exercisable for ten years at an exercise price of $0.36 per common share to Richard A. Kaplan upon his appointment as the Company’s chief executive officer. The option vests and is exercisable as follows: 1,000,000 options vest and are exercisable immediately upon grant; a second 1,000,000 options vest and are exercisable upon the trading price of the Company’s common stock closing at a minimum of $1.00 per share; a third 1,000,000 options vest and are exercisable upon the trading price of the Company’s common stock closing at a minimum of $2.00 per share; a fourth 1,000,000 options vest and are exercisable upon the trading price of the Company’s common stock closing at a minimum of $3.00 per share and the balance of the options, namely 1,150,000 options, vest and are exercisable upon the trading price of the Company’s common stock closing at a minimum of $4.00 per share.

On October 1, 2019, the Company named James Donnelly as its chief operating officer. Mr. Donnelly receives a salary of $175,000 per annum for the year ended December 31, 2019. Mr. Donnelly is entitled to participate in all employee benefit plans as are provided from time to time for senior executives. On May 7, 2018, Mr. Donnelly was granted an option to acquire 250,000 shares of the Company’s $0.01 par value common stock exercisable for a period of ten years at $0.23 per common share. The option vests as flows: 37,500 shares on the grant date; 62,500 on the first, second and third anniversaries of the grant; and 25,000 on the fourth anniversary of the grant. At December 31, 2019, 100,000 options have vested under the option agreement.

On September 1, 2015, the Company engaged Kathleen A. Browne as its chief financial and accounting officer. Ms. Browne’s compensation was $200,000 per annum for the years ended December 31, 2019 and 2018. Ms. Browne is entitled to participate in all employee benefit plans as are provided from time to time for senior executives. If the Company terminates the executive, removes her as CFO, or a change in control of the Company occurs, the executive is entitled to 6 months’ severance pay.

On September 1, 2015, Ms. Browne was granted an option exercisable for 10 years to acquire 25,000 shares of the Company’s common stock at $0.28 per share. The option vests and is exercisable as follows: 6,250 options vest and become exercisable on each of September 1, 2016, 2017, 2018 and 2019. On January 14, 2016, Ms. Browne was granted an option to acquire 25,000 shares of the Company’s $.01 par value common stock exercisable for a period of ten years at $.53 per common share. The shares vests upon the price of the Company's common stock reaching $5.00 per share. On December 21, 2016, the executive was granted an option to acquire 100,000 shares of the Company’s $.01 par value common stock exercisable for a period of ten years at $.62 per common share. This grant vests in 25% tranches on each successive anniversary of the grant. On May 7, 2018, Ms. Browne was granted an option to acquire 100,000 shares of the Company’s $.01 par value common stock exercisable for a period of ten years at $0.23 per common share, This grant vests in 25% tranches annually.

Table of Contents

ITEM 12.

SECURITY OWNERSHIP OF CERTAIN OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

STOCK OWNERSHIP BY DIRECTORS, OFFICERS AND 5 PERCENT OWNERS

Common Stock

The following table sets forth certain information regarding the beneficial ownership of the Company’s common stock by (i) each person who is known by the Company to own of record or beneficially more than 5% of the outstanding common stock, (ii) each of the Company’s directors, nominees and named executive officers, and (iii) all current directors and executive officers of the Company as a group. The first two columns of the table set forth beneficial ownership information for such persons as of March 1, 2020. For purposes of this table, beneficial ownership has been determined in accordance with the provisions of Rule 13d-3 under the Exchange Act, under which, in general, a person is deemed to be the beneficial owner of a security if that person has or shares the power to vote or to direct the voting of the security or the power to dispose or to direct the disposition of the security, or if he or she has the right to acquire the beneficial ownership of the security within 60 days.

Name of Beneficial Owner	Position with the Company	Number of Shares Owned			Percent of Shares Outstanding ⁽¹⁾

Thomas F. Bonadio	Director		731,415	⁽²⁾		1.4
Lance F. Drummond	Director		262,583	⁽³⁾	< 1
Keith E. Gleasman	Director		4,862,575	⁽⁴⁾		9.5
Walter A. L. Johnson	Director		50,000	⁽⁵⁾	< 1
Richard A. Kaplan	Director		9,327,210	(6)	15.5
Aaron C. Newman	Director		50,000	⁽⁷⁾	< 1
E. Philip Saunders	Director		5,145,627	⁽⁸⁾		9.1
Gary A. Siconolfi	Chairman of the Board		1,149,333	⁽⁹⁾		2.2

James R. Donnelly	Chief Executive Officer, President and Director		100,000	⁽¹⁰⁾	< 1
Kathleen A. Browne	Chief Financial & Principal Accounting Officer		350,000	⁽¹¹⁾	< 1

All Directors and Executive Officers as a Group			22,028,743	^(2)-(13)		30.5

B. Thomas Golisano	Investor		48,969,250	⁽¹²⁾		49.0
Robert August	Investor		2,840,811	⁽¹³⁾		5.3

(1)

The calculations in these columns are based upon 51,187,236 shares of common stock outstanding on March 1, 2020, plus the number of shares of common stock subject to outstanding options, warrants and convertible debt held by the person with respect to whom the percentage is reported on such date. The shares of common stock underlying such options, warrants, convertible debt and similar rights, are deemed outstanding for purposes of computing the percentage of the person holding such options but are not deemed outstanding for the purpose of computing the percentage of any other person. The calculations also assume the convertibility of each share of Series C Preferred Stock, C-2 Preferred Stock and Series C-3 Preferred Stock into one share of common stock.

(2)

Thomas F. Bonadio: includes (i)150,150 shares issuable upon conversion of Convertible Note issued November 7, 2017; (ii) 15,015 shares issuable upon the exercise of a warrant issued November 7, 2017 exercisable for 10 years at an exercise price of $0.333 per share; (iii) 160,000 Series C-3 Preferred shares issued on February 20, 2016 convertible into common shares; (iv) 125,000 Class C Preferred shares and a warrant issued on September 23, 2011 for 12,500 common shares exercisable for 10 years at an exercise price equal to the greater of $.01 per share or 80% of the volume weighted average sale price per share of the Company’s common stock for the 10 consecutive trading days immediately prior to exercise; (v) 18,750 common shares that may be purchased through the exercise of a common stock option granted on August 1, 2018, exercisable for 10 years from the date of grant at an exercise price of $0.32 per share; and (vi) 250,000 common shares which may be purchased through the exercise of a 10-year stock option granted on January 27, 2011 at an exercise price of $.90 per common share.

Table of Contents

(3)

Lance F. Drummond: includes (i) 75,075 shares issuable upon conversion of a Convertible Note issued March 2, 2018; (ii) 7,508 shares issuable upon the exercise of a warrant issued on March 2, 2018 exercisable for 10 years at an exercise price of $0.333 per share; (iii) 175,000 shares issuable upon the exercise of an option granted November 28, 2018 with an exercise price of $0.26 per share exercisable for 10 years from the date of grant; and (iv) 5,000 shares issuable upon the exercise of an option granted January 12, 2018 exercisable for 10 years at an exercise price of $0.31 per share.

(4)	Keith E. Gleasman: The address for Mr. Gleasman is 350 Linden Oaks. Rochester, NY 14625.

(5)	Walter A. L. Johnson: includes 50,000 shares issuable upon the exercise of an option granted February 24, 2020 with an exercise price of $0.09 per share exercisable for 10 years from the date of grant.

(6)

Richard A. Kaplan: includes (i) 1,200,000 shares issuable upon conversion of Convertible Notes issued during the period from September 4, 2018 and December 26, 2018; (ii) 120,000 shares issuable upon the exercise of warrants issued during the period from September 4, 2018 and December 26, 2018 exercisable for 10 years at an exercise price of $0.25 per share; (iii) 100,000 shares issuable upon the conversion of a Convertible Note issued on July 10, 2018; (iv) 10,000 shares issuable upon the exercise of warrants issued on July 10, 2018 exercisable for 10 years at an exercise price of $0.25 per share; (v) 1,501,052 shares issuable upon conversion of Convertible Notes issued during the period July 12, 2017 and April 17, 2018; (vi) 375,375 shares issuable upon the exercise of warrants issued during the period July 12, 2017 and April 17, 2018 exercisable for 10 years at an exercise price of $0.333 per share; (vii) 570,000 shares issuable upon conversion of a Convertible Note issued December 16, 2016; (viii) 57,000 shares issuable upon the exercise of warrants issued on December 16, 2016 exercisable for 10 years at an exercise price of $0.25 per share; (ix) 900,000 Series C-3 Preferred shares issued on February 20, 2016 convertible into common shares; (x) 3,000,000 common shares which may be acquired upon the exercise of a 10-year non-qualified stock option granted on September 30, 2010 at an exercise price of $.36 per share. The balance of the option, namely 2,150,000 common shares will vest when the Company’s stock price reaches certain targets as set forth in the stock option agreement; and (xi) 1,333,333 future share rights issuable upon conversion of a Convertible Note issued August 16, 2019 at an exercise price of $0.15 per share.

(7)	Aaron C. Newman: includes 50,000 shares issuable upon the exercise of an option granted February 24, 2020 with an exercise price of $0.09 per share exercisable for 10 years from the date of grant.

(8)

E. Philip Saunders: includes (i) 1,501,502 shares issuable upon the conversion of a Convertible Note issued November 20, 2017; (ii) 375,375 shares issuable upon the exercise of a warrant issued November 20, 2017 for 10 years at an exercise price of $0.333 per share; (iii) 2,000,000 shares issuable upon conversion of a Convertible Note issued August 25, 2016; (iv) 200,000 shares issuable upon the exercise of warrants issued on August 25, 2016 exercisable for 10 years at an exercise price of $0.25 per share; (v) 400,000 Series C-3 Preferred shares issued on February 20, 2016 convertible into common shares; (vi) 18,750 common shares which may be purchased through the exercise of stock option granted on August 1, 2018, exercisable for 10 years from the date of grant at an exercise price of $0.32 per share; (vii) 250,000 common shares which may be purchased through the exercise of a 10-year stock option granted on January 27, 2011, at an exercise price of $.90 per common share; and (viii) 400,000 future share rights issuable upon conversion of a Convertible Note issued in the first quarter of 2020 at an exercise price of $0.15 per share.

(9)

Gary A. Siconolfi: includes (i) 240,000 shares issuable upon conversion of a Convertible Note issued December 19, 2016; (ii) 24,000 shares issuable upon the exercise of warrants issued on December 19, 2016 exercisable for 10 years at an exercise price of $0.25 per share; (iii) 25,000 common shares issuable upon exercise for a warrant for 10 years at an exercise price equal to the greater of $.01 per share or 80% of the volume weighted average sale price per share of the Company’s common stock for the 10 consecutive trading days immediately prior to exercise; and (iv) 100,000 common shares which may be purchased through the exercise of a 10-year stock option granted on November 15, 2013 at an exercise price of $.36 per common share.

Table of Contents

(10)	James R. Donnelly: includes 100,000 common shares issuable upon exercise of a stock option granted May 7, 2018 exercisable for 10 years from date of grant at an exercise price of $0.23 per share.

(11)

Kathleen A. Browne: includes (i) 200,000 shares issuable upon conversion of 200,000 shares of Series C-3 Preferred shares issued on February 20, 2016; (ii) 25,000 common shares issuable upon exercise of a 10-year stock option granted September 1, 2015 at an exercise price of $0.28 per share; (iii) 75,000 common shares issuable upon the exercise of a stock option granted on December 21, 2016 exercisable for 10 years from the date of grant at an exercise price of $0.62 per share; and (iv) 50,000 common shares issuable upon exercise of a stock option granted May 7, 2018 exercisable for 10 years from date of grant at an exercise price of $0.23 per share.

(12)

B. Thomas Golisano: includes (i) 4,680,000 shares issuable upon the conversion of a Convertible Note issued November 7, 2016; (ii) 468,000 shares issuable upon the exercise of warrants issued on November 7, 2016, exercisable for 10 years at an exercise price of $0.25 per share; (iii) 15,212,500 Series C Preferred shares and 24,475,000 Series C-2 Preferred shares, (iv) a warrant issued on September 23, 2011, for 1,521,250 common shares exercisable for 10 years at an exercise price equal to the greater of $.01 per share or 80% of the volume weighted average sale price per share of the Company’s common stock for the 10 consecutive trading days immediately prior to exercise; and (v) 2,500,000 future share rights issuable upon conversion of a Convertible Note issued during the first quarter of 2020 at an exercise price of $0.15 per share. The address for Mr. Golisano is c/o Fishers Asset Management, 1 Fishers Road, Pittsford, New York 14534.

(13)

Robert W. August: includes (i) 750,751 shares issuable upon the conversion of a Convertible Note issued December 29, 2017; (ii) 300,300 shares issuable upon the conversion of a Convertible Note issued February 9, 2018; (iii) 300,300 shares issuable upon the conversion of a Convertible Note issued on May 14, 2018; (iv) 400,000 shares issuable upon the conversion of a Convertible Note issued March 11, 2019; (vi) 666,667 future share rights issuable upon conversion of a Convertible Note issued July 23, 2019 at an exercise price of $0.15 per share; and (vii) 392,793 shares issuable upon the exercise of warrants issued on December 29, 2017, February 9, 2018, May 14, 2018 and March 11, 2019 exercisable for 10 years from the date of grant at exercise prices ranging from $0.15 to $0.333 per share.

Preferred Stock

The following table sets forth certain information regarding the beneficial ownership of the Company’s Series C Preferred Stock, Series C-2 Preferred Stock and Series C-3 Preferred Stock by each person who is known by the Company to own of record or beneficially more than 5% of the outstanding shares of such stock.

Name

Number of

Shares

Beneficially

Owned

Percent of

Shares Outstanding

⁽¹⁾

B. Thomas Golisano

39,687,500

⁽²⁾

91.4%

(1)	The calculations in these columns are based upon 15,687,500 shares of Series C Preferred Stock, 24,500,000 shares of Series C-2 Preferred Stock and 3,238,000 shares of Series C-3 Preferred Stock outstanding on March 1, 2020, plus the number of shares of common stock subject to outstanding options, warrants and convertible stock held by the person with respect to whom the percentage is reported on such date.

(2)	Represents 15,212,500 shares of Series C Preferred Stock and 24,475,000 shares of Series C-2 Preferred Stock Series. The address for Mr. Golisano is c/o Fishers Asset Management, 1 Fishers Road, Pittsford, New York 14534.

Table of Contents

ITEM 13.

CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Director Independence

The Company’s common stock is traded on the OTC Pink Current Information marketplace under the symbol “CRGS”. The Company’s common stock is not “listed” for trading on any stock exchange. Despite the Company’s common stock not being so listed, the board has voluntarily adopted and implemented the Nasdaq Marketplace Rules regulating the composition and operation of the board and its committees as in effect from time to time. Under Nasdaq Marketplace Rules applicable to listed companies, a majority of the board must be independent. This requirement means that a majority of the Company’s board must be composed of persons who are not executive officers or employees of the Company or who have a relationship with the Company which, in the board’s opinion, would interfere with the exercise of independent judgment in carrying out his responsibilities as a director. In addition, a director cannot be considered independent if he is compensated by the Company for any reason other than for service rendered as a member of the board and/or its committees.

Based upon these independence standards and all of the relevant facts and circumstances, the board has affirmatively determined that Thomas F. Bonadio, Lance F. Drummond, Keith Gleasman, Walter A. L. Johnson, Aaron Newman, E. Philip Saunders and Gary A. Siconolfi (constituting 7 members of an 8-person board) are independent. In making this determination, the board noted that none of these directors is an executive officer or employee of the Company.

Policy / Procedure for Review / Approval of Related Party Transactions

Business transactions between the Company and its officers or directors, including companies in which a director or officer (or an immediate family member) has a substantial ownership interest or a company where such director or officer (or an immediate family member) serves as an executive officer (“related party transactions”) are not prohibited. In fact, certain related party transactions can be beneficial to the Company and to its shareholders.

It is important, however, to ensure that any related party transactions are beneficial to the Company. Accordingly, any related party transaction, regardless of amount, is submitted to the Governance and Compensation Committee or the full board of directors in advance for review and approval upon the advice of counsel, which may be outside legal counsel. All existing related party transactions are reviewed at least annually by the Governance and Compensation Committee or the full board of directors.

No related party transaction may be approved by the Committee if such transaction, regardless of its benefit to the Company, would violate the Company’s written code of business conduct and/or its written financial integrity and compliance program.

Any director or officer with an interest in a related party transaction is expected to remove himself from considering the matter and abstain from voting upon it. In all cases, a director or officer with an interest in a related party transaction may not attempt to influence Company personnel in making any decision with respect to the transaction.

Executive Sessions of Independent Directors

The Company’s independent directors regularly meet in executive session without management or non-independent directors present. Currently, Gary A. Siconolfi presides at such executive sessions of the independent directors.

Director and Officer Loans

During the year ended December 31, 2019, the Company issued unsecured subordinated promissory notes to Richard A. Kaplan, a director of the Company on January 23, April 4, May 1, May 15, July 11, September 18, October 3, October 16, November 25, December 11 and December 16, 2019, in the aggregate principal amount of $775,000, and to William Destler, a former director of the Company, on March 26, 2019, in the aggregate principal amount of $25,000. These notes bear interest at a rate of 6% per annum, and the maturity date of each of the notes was initially ninety days from the date of issuance. However, the maturity date of all outstanding notes has been extended to June 30, 2020. The Destler note was repaid in full in July 2019 and is no longer outstanding. As of December 31, 2019, the aggregate principal balance of the notes is $425,000.

During 2019, the Company repaid $150,000 aggregate principal amount of the notes and converted $225,000 aggregate principal amount of the notes to 2019 Convertible Notes. The Company recognized interest expense of $15,000 on the notes during the year ended December 31, 2019.

Table of Contents

ITEM 14.

PRINCIPAL ACCOUNTANT FEES AND SERVICES

Audit Fees

The aggregate amount the Company paid and/or accrued for professional services rendered by Freed Maxick CPAs, P.C. as the Company’s independent registered public accounting firm for each of 2019 and 2018 for the audit of the Company's annual consolidated financial statements included in the Company’s Annual Report on Form 10-K, for the review of the Company's consolidated financial statements included in the Company's Quarterly Reports on Form 10-Q, and for services normally provided in connection with statutory and regulatory filings or engagements was:

Aggregate fees for professional services rendered for the Company for 2019 and 2018 were:

	2019		2018
Audit Fees	$	78,400	$	76,500
Audit Related Fees	$	-	$	-
Tax Fees	$	-	$	-
All Other Fees	$	-	$	-
Total Fees	$	78,400	$	76,500

Audit-Related Fees

The Company did not engage Freed Maxick CPAs, P.C. for any audit-related services in the years ended December 31, 2019 or 2018.

Tax Fees

The Company did not engage Freed Maxick CPAs, P.C. for any tax services for the year ended December 31, 2019, and 2018.

All Other Fees

The Company did not engage Freed Maxick CPAs, P.C. for any other services for the years ended December 31, 2019, and 2018.

Total Fees

The Company has paid and/or accrued fees totaling $78,400 and $76,500 to Freed Maxick CPAs, P.C. for the years ended December 31, 2019, and 2018 respectively.

Pre-Approval Policies and Procedures

Article II of our Audit Committee charter, as amended, specifically provides that the Audit Committee must pre-approve all auditing and legally permissible non-auditing services to be performed by the Company's registered public accounting firm. In accordance with such mandate, the Audit Committee has established a set of procedures governing the pre-approval process. Under the procedure, for each fiscal year, the Committee first shall determine the general nature and scope of the audit, audit-related, tax and other legally permissible non-audit services to be performed by the Company's registered accounting firm. Prior to the performance of any services, the Committee shall require such firm to submit to the Committee one or more engagement letter(s) delineating specific audit, audit-related, tax, and other legally permissible non-audit services to be rendered (together with a schedule of fees with respect to each of such services). Upon receipt of such engagement letter(s), the Committee shall review and approve such engagement letter(s) in advance of the performance of any such services, including the specific advance approval of fees in connection with each of such services. Upon approval and execution of each of such engagement letter(s) by the Committee, the registered public accounting firm shall perform such pre-approved services in accordance with the terms and conditions of each engagement letter and shall not engage in any other services unless each of said services, if any, shall have been specifically approved (including the specific approval of all fees associated therewith) by the Audit Committee in advance of the rendering any such service.

PART IV

Item 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

The following exhibits are filed as part of and incorporated by reference into this annual report:

Table of Contents

EXHIBIT INDEX

3.1	Certificate of Incorporation, incorporated by reference to Form 10-SB/A, Registration Statement, registering Company’s $.01 par value common stock under section 12(g) of the Securities Exchange Act of 1934

3.2	Certificate of Amendment to the Certificate of Incorporation dated August 30, 2000, incorporated by reference to Form SB-2 filed October 19, 2000

3.3	Certificate of Correction dated March 22, 2002, incorporated by reference to Form 10-KSB filed for fiscal year ended December 31, 2002

3.4	By-laws as amended on January 24, 2002, incorporated by reference to Form 10-KSB filed for fiscal year ended December 31, 2002

3.5	Certificate of Amendment to the Certificate of Incorporation dated October 21, 2004 setting forth terms and conditions of Class B Preferred, incorporated by reference to Form 10-QSB filed for fiscal quarter ended December 31, 2004

3.6	Certificate of Amendment to the Certificate of Incorporation dated January 26, 2007 increasing authorized common shares from 40,000,000 to 400,000,000, incorporated by reference to Form 10-K filed for fiscal year ended December 31, 2006

3.7	Certificate of Amendment to the Certificate of Incorporation dated September 21, 2011 setting forth terms and conditions of Class C Preferred, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on September 26, 2011

3.8	Certificate of Amendment to the Certificate of Incorporation of CurAegis, Inc., dated March 28, 2014 setting forth terms and conditions of Series C-2 Preferred, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on March 28, 2014

3.9	Certificate of Amendment to the Certificate of Incorporation of CurAegis, Inc., dated February 29, 2016 setting forth terms and conditions of Series C-3 Preferred, incorporated by reference to Exhibit 3.9 of Form 10-K filed for the fiscal year ended December 31, 2015.

3.10	Certificate of Amendment of Certificate of Incorporation of CurAegis Technologies, Inc., dated June 16, 2016, changing the name to CurAegis Technologies, Inc., incorporated by reference to Exhibit 3.1 to Form 8-K filed with the Securities and Exchange Commission on August 11, 2016

10.1	Stock Option Agreement dated December 31, 2010 between the company and Richard A. Kaplan, incorporated by reference to current report (Form 8-K) filed October 6, 2010*

10.2	Employment Agreement dated October 4, 2010 between the company and Richard A. Kaplan, incorporated by reference to current report (Form 8-K) filed October 6, 2010*

10.3	Stock Option Agreement dated October 18, 2010 between the company and Robert W. Fishback, incorporated by reference to current report (Form 8-K) filed October 22, 2010*

10.4	2011 Stock Option Plan and template agreements to be used to grant options thereunder, incorporated by reference to Annual Report (Form 10-K) filed March 29, 2011*

10.5	Agreement dated December 13, 2010 between Heinrocket Inc. as Consultant and CurAegis, Inc., incorporated by reference to Annual Report (Form 10-K) filed March 29, 2011*

10.6

Securities Purchase Agreement by and among CurAegis, Inc., a New York corporation, B. Thomas Golisano, and each purchaser listed on the Schedule of Purchasers attached thereto, dated September 23, 2011, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on September 26, 2011

Table of Contents

10.7	Form of Warrant to Purchase Common Stock of CurAegis, Inc., incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on September 26, 2011

10.8	Form of Directors Subscription Agreement, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on September 26, 2011

10.9	Investors’ Rights Agreement by and between CurAegis, Inc., a New York corporation, B. Thomas Golisano, Charles T. Graham, and David Still, dated September 23, 2011, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on September 26, 2011

10.10	Letter Agreement between CurAegis, Inc. and SCIRE Corporation, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on December 5, 2013*

10.11	Securities Purchase Agreement by and among CurAegis, Inc., B. Thomas Golisano, and each purchaser listed on the Schedule of Purchasers attached thereto, dated March 28, 2014, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on March 28, 2014

10.12	Amended and Restated Investors’ Rights Agreement by and between CurAegis, Inc., B. Thomas Golisano, Charles T. Graham, and David Still, dated March 28, 2014, incorporated by reference to Form 8-K filed with the Securities and Exchange Commission on March 28, 2014

10.13	Letter Agreement between CurAegis, Inc. and SCIRE Corporation, incorporated by reference to the Annual Report on Form 10-K filed March 3, 2015*

10.14	First Amendment to the CurAegis, Inc. 2011 Stock Option Plan, incorporated by reference to the Annual Report on Form 10-K filed March 3, 2015*

10.15	Compensation Agreement, dated March 3, 2016, between Kathleen A. Browne and CurAegis Technologies, Inc., incorporated by reference to Exhibit 10.1 to Form 10-Q filed with the Securities and Exchange Commission on May 12, 2016*

10.16	Letter Agreement, dated March 24, 2016, between CurAegis Technologies, Inc. and Richard A. Kaplan, incorporated by reference to Exhibit 4.1 to Form 8-K filed with the Securities and Exchange Commission on March 25, 2016*

10.17	Securities Purchase Agreement, dated August 25, 2016, between CurAegis Technologies, Inc. and the investors listed therein, incorporated by reference to Exhibit 4.1 to Form 8-K filed with the Securities and Exchange Commission on September 1, 2016

10.18	Form of Convertible Promissory Note, incorporated by reference to Exhibit 4.2 to Form 8-K filed with the Securities and Exchange Commission on September 1, 2016

10.19	Form of Common Stock Purchase Warrant, incorporated by reference to Exhibit 4.3 to Form 8-K filed with the Securities and Exchange Commission on September 1, 2016

10.20	Form of Securities Purchase Agreement, dated May 31, 2017, incorporated by reference to Exhibit 4.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on July 14, 2017

10.21	Form of 2017 Convertible Promissory Note, incorporated by reference to Exhibit 4.2 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on July 14, 2017

10.22	Form of Common Stock Purchase Warrant, incorporated by reference to Exhibit 4.3 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on July 14, 2017

10.23	Form of Non-Plan Nonqualified Stock Option Agreement, incorporated by reference to Exhibit 4.10 to CurAegis Technologies, Inc. Registration Statement on Form S-8 filed with the Securities and Exchange Commission on August 29, 2017

Table of Contents

10.24	Form of First Amendment to Non-Plan Nonqualified Stock Option Agreement, incorporated by reference to Exhibit 4.11 to CurAegis Technologies, Inc. Registration Statement on Form S-8 filed with the Securities and Exchange Commission on August 29, 2017

10.25	Form of Non-Plan Stock Option Agreement, incorporated by reference to Exhibit 4.12 to CurAegis Technologies, Inc. Registration Statement on Form S-8 filed with the Securities and Exchange Commission on August 29, 2017

10.26	Amendment to Securities Purchase Agreement, made as of August 4, 2017, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 13, 2017

10.27	Amendment to Employment Agreement, dated November 10, 2017, between CurAegis Technologies, Inc., and Richard A. Kaplan, incorporated by reference to Exhibit 10.2 to CurAegis Technologies, Inc. Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 13, 2017

10.28	Amendment No. 2 to Securities Purchase Agreement, made as of November 30, 2017, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on December 6, 2017

10.29	Amendment No. 3 to Securities Purchase Agreement, made as of February 21, 2018, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on February 26, 2018

10.30	Amendment No.4 to Securities Purchase Agreement, made as of March 27, 2018 among the Company and each purchaser executing a signature page thereto, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on March 30, 2018.

10.31	Securities Purchase Agreement dated May 18, 2018, by and between CurAegis Technologies, Inc. and the investors listed therein, incorporated by reference to Exhibit 4.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on July 13,2018.

10.32	Form of Convertible Promissory Note, incorporated by reference to Exhibit 4.2 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on July 13, 2018.

10.33	Form of Common Stock Purchase Warrant, incorporated by reference to Exhibit 4.3 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on July 13, 2018.

10.34	Securities Purchase Agreement dated July 24, 2018, by and between CurAegis Technologies, Inc. and the investors listed therein, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 7, 2018.

10.35	Form of Convertible Promissory Note, incorporated by reference to Exhibit 10.2 to CurAegis Technologies, Inc. Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 7, 2018.

10.36	Form of Common Stock Purchase Warrant, incorporated by reference to Exhibit 10.3 to CurAegis Technologies, Inc. Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 7, 2018.

10.37	Unsecured Subordinated Promissory Note Agreement dated January 23, 2019 by CurAegis Technologies, Inc. for the benefit of Richard A. Kaplan, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on January 29, 2019.

Table of Contents

10.38	Unsecured Subordinated Promissory Note Agreement, dated April 4, 2019, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on April 8, 2019.

10.39	Unsecured Subordinated Promissory Note Agreement, dated March 26, 2019, incorporated by reference to Exhibit 10.2 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on April 8, 2019.

10.40	Unsecured Subordinated Promissory Note Agreement, dated May 1, 2019, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on May 3, 2019.

10.41	Unsecured Subordinated Promissory Note Agreement, dated May 15, 2019, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on May 16, 2019.

10.42	Form of 2019 SPA, incorporated by reference to Exhibit 4.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on June 3, 2019.

10.43	Form of 6% Senior Convertible Promissory Note, incorporated by reference to Exhibit 4.2 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on June 3, 2019.

10.44	Unsecured Subordinated Promissory Note Agreement, dated July 11, 2019, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on July 17, 2019.

10.45	Form of Subscription Agreement, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on July 29, 2019.

10.46	Form of Demand Note, incorporated by reference to Exhibit 10.2 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on July 29, 2019.

10.47	General Security Agreement, incorporated by reference to Exhibit 10.3 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on July 29, 2019.

10.48	Unsecured Subordinated Promissory Note Agreement, dated September 18, 2019 incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on September 24, 2019.

10.49	Unsecured Subordinated Promissory Note Agreement, dated October 3, 2019, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on October 7, 2019.

10.50	Unsecured Subordinated Promissory Note Agreement, dated October 16, 2019, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on October 17, 2019.

10.51	Unsecured Subordinated Promissory Note Agreement, dated November 25, 2019, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on December 2, 2019.

10.52	Unsecured Subordinated Promissory Note Agreement, dated December 11, 2019, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on December 13, 2019.

10.53	Unsecured Subordinated Promissory Note Agreement, dated December 16, 2019, incorporated by reference to Exhibit 10.1 to CurAegis Technologies, Inc. Current Report on Form 8-K filed with the Securities and Exchange Commission on December 20, 2019.

Table of Contents

21	Subsidiaries of the registrant
	Ice Surface Development, Inc. (New York)
	Iso-Torque Corporation (New York)

23.1	Consent of Independent Registered Public Accounting Firm

24	Power of Attorney (included on the signature page to this report)

31.1	Rule 13(a)-14(a)/15(d)-14(a) Certification of Chief Executive Officer

31.2	Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Accounting Officer

32	Section 1350 Certification of Chief Executive Officer and Principal Accounting Officer

101.CAL	XBRL Taxonomy Extension Calculation Linkbase

101.DEF	XBRL Taxonomy Extension Definition Linkbase

101.INS	XBRL Instance Document

101.LAB	XBRL Taxonomy Extension Label Linkbase

101.PRE	XBRL Taxonomy Extension Presentation Linkbase

101.SCH	XBRL Taxonomy Extension Schema Linkbase

* Management contract or compensatory plan or arrangement.

Table of Contents

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the Registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CURAEGIS, INC.
Dated: March 27, 2020	By:	/s/ James R. Donnelly
		James R. Donnelly,
		Chief Executive Officer and President

Dated: March 27, 2020	By:	/s/ Kathleen A. Browne
		Kathleen A. Browne,
		Chief Financial and Accounting Officer

Table of Contents

POWER OF ATTORNEY

KNOW ALL BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints James R. Donnelly and Kathleen A, Browne, or either of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K and any documents related to this report and filed pursuant to the Securities and Exchange Act of 1934, as amended and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their substitute or substitutes may lawfully do or cause to be done by virtue hereof.

In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Dated: March 27, 2020	By:	/s/ James R. Donnelly James R. Donnelly, Chief Executive Officer, President and Director

Dated: March 27, 2020	By:	/s/ Kathleen A. Browne Kathleen A. Browne Chief Financial and Accounting Officer

Dated: March 27, 2020	By:	/s/ Thomas F. Bonadio Thomas F. Bonadio, Director

Dated: March 27, 2020	By:	/s/ Lance F. Drummond Lance F. Drummond, Director

Dated: March 27, 2020	By:	/s/ Keith E. Gleasman Keith E. Gleasman, Director

Dated: March 27, 2020	By:	/s/ Walter A. L. Johnson Walter A. L. Johnson Director

Dated: March 27, 2020	By:	/s/Richard A. Kaplan Richard A. Kaplan Director

Dated: March 27, 2020	By:	/s/ Aaron C. Newman Aaron C. Newman Director

Dated: March 27, 2020	By:	/s/ E. Philip Saunders E. Philip Saunders, Director

Dated: March 27, 2020	By:	/s/ Gary A. Siconolfi Gary A. Siconolfi, Director

EX-23.1 2 ex_173581.htm EXHIBIT 23.1 ex_173581.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Form S-8 Registration Statements (no. 333-2202120) of CurAegis Technologies, Inc. of our report dated March 27, 2020 relating to our audit of the consolidated financial statements, which appear in the Annual Report on Form 10-K of CurAegis Technologies, Inc. for the year ended December 31, 2019.

/s/ Freed Maxick CPAs, P.C.

Buffalo, New York

March 27, 2020

EX-31.1 3 ex_173582.htm EXHIBIT 31.1 ex_173582.htm

EXHIBIT 31.1

CERTIFICATION

I, James R. Donnelly, Chief Executive Officer of CurAegis Technologies, Inc., hereby certifies that:

I have reviewed this annual report on Form 10-K of CurAegis Technologies, Inc.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
	b.	Designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based upon such evaluation; and
	d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 27, 2020	/s/ James R. Donnelly
	James R. Donnelly
	Chief Executive Officer

EX-31.2 4 ex_173583.htm EXHIBIT 31.2 ex_173583.htm

EXHIBIT 31.2

CERTIFICATION

I, Kathleen A. Browne, Principal Accounting Officer of CurAegis Technologies, Inc., hereby certifies that:

I have reviewed this annual report on Form 10-K of CurAegis Technologies, Inc.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal controls over financial reporting, or caused such internal controls over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based upon such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 27, 2020	/s/ Kathleen A. Browne
	Kathleen A. Browne
	Principal Accounting Officer

EX-32 5 ex_173584.htm EXHIBIT 32 ex_173584.htm

EXHIBIT 32

Certificate pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002

In connection with the Annual Report of CurAegis Technologies, Inc. (“CurAegis Technologies”) on Form 10-K for the period ending December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), James R. Donnelly, chief executive officer and Kathleen A. Browne principal accounting officer, of CurAegis Technologies, Inc. certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

	(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of CurAegis Technologies, Inc.

March 27, 2020	/s/ James R. Donnelly
	James R. Donnelly

March 27, 2020	Chief Executive Officer /s/ Kathleen A. Browne Kathleen A. Browne Principal Accounting Officer

Issuer Statement

A signed original of this written statement required by Section 906 has been provided to CurAegis Technologies,
Inc. and will be retained by CurAegis Technologies, Inc. and furnished to the Securities and Exchange Commission
or its staff upon request.

EX-101.INS 6 crgs-20191231.xml XBRL INSTANCE DOCUMENT 43413000 276000 276000 273000 P15Y 2500000 2500000 1000000 5000000 3000000 1500000 2000000 7106707 33000 0.49 P6Y73D 350000 0.25 39000 33000 0.46 0.45 P7Y P6Y73D P1Y P1Y 14000 49000 91000 933000 100000 100000 P5D P5D 333000 P1Y <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">For Years ended</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">December 31,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amortization right-to-use asset</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">98,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Software</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">92,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Property and equipment</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">132,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">138,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table></div> 96000 70000 276000 302000 -216000 26000 65000 380000 91000 -15000 1741000 1000000 3000000 2 1764000 1462000 199000 249000 279000 45000 150000 0.25 0.25 0.1 0.1 0.1 0.25 0.1 8709 8709 2500000 2375000 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Software, Property and Equipment:</div></div> Capitalized software, property and equipment are stated at cost. Estimated useful lives for capitalized software is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> years and for property and equipment is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div> years. Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense). </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be indicated. The carrying amount is compared to the estimated discounted cash flows and if there is an excess such amount is recorded as impairment.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>we recorded an impairment charge of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$17,000</div> on certain property and equipment.</div></div></div></div></div></div> 126000 180000 3000 17000 106000 1000 44000 135000 -500000 500000 -30000 30000 -120000 120000 -250000 250000 195415 94772 195415 320853 -5000 5000 -1000 1000 -1000 1000 -2000 2000 2000 42000 44000 3000 77000 80000 1000 1000 2000 4000 195000 390000 60000 7500 112500 195000 1000 19000 20000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> - WARRANTS</div></div> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The following summarizes the activity of our outstanding warrants as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019:</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div> <table cellpadding="0pt" cellspacing="0pt" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: 0pt; min-width: 700px;"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Weighted</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Average</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Average</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Remaining</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Aggregate</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Exercise</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Contractual</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Intrinsic</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Shares</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Price</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Term</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Value</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at January 1, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,381,707</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.46</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 2%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(a)</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.0</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 2%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(b)</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Canceled or expired</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,731,707</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.45</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 2%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(a)</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.2</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 2%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(b)</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable at December 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,106,707</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.49</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.2</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 2%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(c)</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 9pt;"> </td> <td style="width: 18pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">(a)</div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The weighted average exercise price for warrants outstanding excludes <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,750,000</div></div> warrants in each period with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> determined exercise price.</div> </td> </tr> <tr style="vertical-align: top;"> <td style="width: 9pt;"> </td> <td style="width: 18pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">(b)</div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The weighted average remaining contractual term for warrants outstanding excludes<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">743,500</div></div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"></div> warrants with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> expiration date.</div> </td> </tr> <tr style="vertical-align: top;"> <td style="width: 9pt;"> </td> <td style="width: 18pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">(c)</div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The weighted average remaining contractual term for warrants exercisable excludes <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">118,500</div></div> warrants with <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> expiration date.</div> </td> </tr> </table></div> 300000 118500 118500 743500 743500 -4545000 false --12-31 FY 2019 2019-12-31 10-K 0001063197 51187236 Yes false Non-accelerated Filer Yes 5554000 CurAegis Technologies, Inc. false true No No $.01 par value common voting stock crgs

420000

323000

293000

622000

78272000

77725000

369000

126000

180000

65000

557000

126000

180000

23000

94000

105000

513000

483000

748000

627000

72000

46000

105535575

94784206

625000

1000

36000

214000

251000

15000

54000

81000

150000

20000

78000

231000

72000

10000

92000

17000

10000

18000

53000

194000

-35000

-141000

0.15

0.25

0.333

0.25

4333333

1239288

468000

1239288

468000

1750000

7381707

7731707

0.01

400000000

50979964

50364549

50979964

50364549

510000

504000

0.43

1000

8000

250000

647000

7763000

6603000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019 </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">6% </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Notes</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">JULY</div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018 </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Notes</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018 </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Notes</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017 </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">6% </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Notes</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016 </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">6%</div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Notes</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 28%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Face value 12/31/18</div> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,160,000</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,175,000</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">625,000</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,370,000</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,990,000</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Notes issued</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,150,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">650,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Face value 12/31/19</div></div> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,310,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">650,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,675,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">625,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,370,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,990,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Debt discount 12/31/18</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,557,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(360,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(231,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(456,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,510,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Debt discount issued</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(91,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(26,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(65,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amortization reported as interest</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">748,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">72,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">94,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">513,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Debt discount 12/31/19</div></div> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,900,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">)</div></div></td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">)</div></div></td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(353,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">)</div></div></td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(185,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">)</div></div></td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(362,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">)</div></div></td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(997,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">)</div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td style="padding-bottom: 1px;"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px;"> </td> </tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Senior c</div><div style="display: inline; font-weight: bold;">onvertible </div><div style="display: inline; font-weight: bold;">n</div><div style="display: inline; font-weight: bold;">otes (net) 12/31/19</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,410,000</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">647,000</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,322,000</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">440,000</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,008,000</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,993,000</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> </table></div>

13000

110000

225000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div> - SENIOR CONVERTIBLE NOTES AND WARRANTS</div></div> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div>the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$10,310,000</div> in convertible notes outstanding which have been presented net of unamortized debt discounts of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,900,000,</div> resulting in a carrying value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8,410,000.</div> The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> convertible notes have been presented in current liabilities as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>as these notes mature on the earlier of the Aegis monetization event or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years from the date of issuance. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9,160,000</div> in convertible notes outstanding, presented net of unamortized debt discounts of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,557,000</div> resulting in a carrying value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6,603,000.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Scheduled maturities on the Company’s convertible note are: <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$650,000</div> in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2020;</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,990,000</div> in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2021; </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,775,000</div> in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months ending in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2022; </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,395,000</div> in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2023 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$500,000</div> thereafter.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Included in the face value of convertible notes outstanding at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,477,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,252,000,</div> respectively in convertible notes payable to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">six</div> of our directors and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,170,000</div></div> in convertible notes payable to an investor that is deemed an affiliate. </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2019 </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">6% </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Notes</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">JULY</div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018 </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Notes</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2018 </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Notes</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017 </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">6% </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Notes</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016 </div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">6%</div></div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Notes</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 28%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Face value 12/31/18</div> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,160,000</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,175,000</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">625,000</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,370,000</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,990,000</div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Notes issued</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,150,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">650,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Face value 12/31/19</div></div> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,310,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">650,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,675,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">625,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,370,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,990,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Debt discount 12/31/18</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,557,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(360,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(231,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(456,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,510,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Debt discount issued</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(91,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(26,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(65,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amortization reported as interest</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">748,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">72,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">94,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">513,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Debt discount 12/31/19</div></div> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,900,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">)</div></div></td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">)</div></div></td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(353,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">)</div></div></td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(185,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">)</div></div></td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(362,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">)</div></div></td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; border-bottom: 1px rgb(0, 0, 0); text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(997,000</div></div></td> <td nowrap="nowrap" style="width: 1%; border-bottom: 1px rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">)</div></div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td> </td> <td style="padding-bottom: 1px;"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="padding-bottom: 1px;"> </td> </tr> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Senior c</div><div style="display: inline; font-weight: bold;">onvertible </div><div style="display: inline; font-weight: bold;">n</div><div style="display: inline; font-weight: bold;">otes (net) 12/31/19</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,410,000</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">647,000</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,322,000</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">440,000</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,008,000</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;">$</div></td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,993,000</div></div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> </table> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"></div></div></div></div></div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> <div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> Convertible Notes</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The board of directors authorized the issuance of up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.5</div> million in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6%</div> Convertible Promissory Notes (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">“2019</div> Convertible Notes”) in connection with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 28, 2019 </div>Securities Purchase Agreement (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">“2019</div> SPA”). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> Convertible Notes mature on the earlier of: <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> days after the sale of substantially all of the assets of the Aegis division or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div> years from the date of issuance.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The conversion rate of the notes is fixed at the greater of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.15</div> per share and the closing market price of the Company’s common stock on the trading day immediately prior to the issuance of the note. Investors receive <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,000</div> shares of common stock for each <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$100,000</div> investment in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> Convertible Notes. The notes were offered in a private placement exempt from registration under Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>(a)(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) of the Securities Act of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1933</div> as amended (the "Securities Act") and Rule <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">506</div>(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">501</div>(a) of Regulation D under the Securities Act.  </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div>the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$650,000</div> in new notes and allocated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$26,000</div> of the proceeds to debt discount based on the estimated fair value of the common shares issued and debt issuance costs on the date of investment. During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div>the Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$40,000</div> in interest expense which includes <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$23,000</div> of amortization on debt discount.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> <div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> JULY 2018 </div>Convertible Notes</div></div><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The board of directors authorized the issuance of up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.5</div> million in non-interest bearing Senior Convertible Promissory Notes and Warrants (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> “JULY 2018 </div>Convertible Notes”) in connection with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 24, 2018 </div>Securities Purchase Agreement (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> “JULY 2018 </div>SPA”). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> JULY 2018 </div>Convertible Notes have a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div>-year maturity. In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2019, </div>the Company’s board approved a resolution to complete this offering.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The conversion rate of the notes was fixed at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.25</div> per share as determined at the close of business on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 24, 2018. </div>Investors in this offering were granted warrants to purchase common shares equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> of the number of shares issuable upon the conversion of the notes based upon the amount of their investment. The warrants have a fixed exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.25</div> and a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div>-year term from the date of issuance. The notes were offered in a private placement exempt from registration under Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>(a)(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) of the Securities Act of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1933</div> as amended (the "Securities Act") and Rule <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">506</div>(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">501</div>(a) of Regulation D under the Securities Act.  </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div>the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$500,000</div> in new convertible notes and allocated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$65,000</div> of the proceeds to debt discount based on the estimated fair value of the warrants issued and debt issuance costs incurred on the date of investment. In connection with the issuance of these convertible notes, the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350,000</div> warrants with an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.25</div> per share and a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-year term.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>the Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$72,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$20,000</div> respectively in interest expense which includes amortization of debt discount.  </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,175,000,</div> in convertible notes and allocated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$380,000,</div> of the proceeds to debt discount based on the estimated fair value of the warrants issued and debt issuance costs incurred on the date of investment. In connection with the issuance of these convertible notes, the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">590,000</div> warrants with an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.25</div> per share and a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-year term.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> Convertible Notes</div></div><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The board of directors authorized the issuance of up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1</div> million in non-interest bearing Senior Convertible Promissory Notes and Warrants (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">“2018</div> Convertible Notes”) in connection with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 8, 2018 </div>Securities Purchase Agreement (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">“2018</div> SPA”). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> Convertible Notes have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div>-year maturity. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 19, 2018, </div>the Company’s board approved a resolution to complete this offering.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The conversion rate of the notes was fixed at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.25</div> per share as determined at the close of business on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 8, 2018. </div>Investors in this offering were granted warrants to purchase common stock equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> of the number of shares issuable upon the conversion of the notes based upon the amount of their investment. The warrants have a fixed exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.25</div> and a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div>-year term from the date of issuance. The notes were offered in a private placement exempt from registration under Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>(a)(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) of the Securities Act of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1933</div> as amended (the "Securities Act") and Rule <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">506</div>(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">501</div>(a) of Regulation D under the Securities Act.  </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018, </div>the Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$45,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$19,000</div> respectively in interest expense which reflects the amortization of debt discount.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Convertible Notes</div></div><div style="display: inline; font-weight: bold;"> </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The board of directors authorized the issuance of up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5</div> million in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6%</div> Senior Convertible Promissory Notes and Warrants (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">“2017</div> Convertible Notes”) in connection with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May 31, 2017 </div>Securities Purchase Agreement (as amended, the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">“2017</div> SPA”). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Convertible Notes have a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div>-year maturity and a fixed annual interest rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6%.</div> Investors in this offering were granted warrants to purchase warrants equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> of the number of shares issuable upon the conversion of the notes based upon the amount of their investment. </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The conversion rate of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Notes was originally set at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.50</div> per share and subsequently modified in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2018 </div>to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.333</div> per share. The exercise price of related warrants issued in connection with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Notes was also subsequently modified in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2018 </div>to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.333</div> per share. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> Convertible Notes were offered in a private placement exempt from registration under Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>(a)(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) of the Securities Act and Rule <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">506</div>(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">501</div>(a) of Regulation D under the Securities Act.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>the Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$356,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$355,000,</div> respectively, in interest expense including <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$94,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$105,000,</div> respectively of amortization of debt discount.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> Convertible Notes</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The board of directors authorized, and the Company issued, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3</div> million in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6%</div> Senior Convertible Promissory Notes and Warrants (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">“2016</div> Convertible Notes”) in connection with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 25, 2016 </div>Securities Purchase Agreement (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">“2016</div> SPA”). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> Convertible Notes have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">five</div>-year maturity dates ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2021 </div>through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2021 </div>and a fixed annual interest rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6%.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The conversion rate of the notes was fixed at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.25</div> per share as determined at the close of business on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 25, 2016. </div>The investors were granted warrants to purchase an aggregate number of shares of common stock equal to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> of the number of shares issuable upon the conversion of the notes. The warrants have a fixed exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.25</div> and a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div>-year term from the date of issuance. The notes were offered in a private placement exempt from registration under Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div>(a)(<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div>) of the Securities Act of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1934,</div> as amended and Rule <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">506</div>(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">501</div>(a) of Regulation D under the Securities Act of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1933.</div>  </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>the Company recorded <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$692,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$664,000,</div> respectively, in interest expense including <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$513,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$483,000,</div> respectively of amortization of debt discount.</div></div>

650000

10310000

9160000

1175000

625000

4370000

2990000

10310000

650000

1675000

625000

4370000

2990000

5000

0.15

0.25

0.50

0.333

0.25

30000

9388378

7888378

4680000

0.06

P5Y

P90D

1900000

2557000

360000

231000

456000

1510000

1900000

3000

353000

185000

362000

997000

583000

1093000

37000

131000

252000

15963000

15250000

3277000

3044000

141000

117000

1321000

1302000

15963000

15250000

2000

24000

46000

132000

138000

98000

10000

92000

24000

46000

14000

18000

100000

110000

20000

8000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Depreciation and amortization: </div></div>Depreciation and amortization are computed using the straight-line method.   Depreciation and amortization expense for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> are as follows:</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div> <table style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">For Years ended</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">December 31,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amortization right-to-use asset</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">98,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Software</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">92,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Property and equipment</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">46,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">132,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">138,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: Times New Roman;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"></div></div></div></div></div></div></div></div></div></div>

0.40

0.50

2713000

2530000

488000

218000

-0.09

-0.13

50000

35000

105000

P11Y

0.56

P3Y

11224000

10787000

1636000

2159000

2000

-73000

-4276000

-6308000

<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;">NOTE </div></div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div></div></div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-weight: bold;"> - INCOME TAXES</div></div> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax bases of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> that some portion or all of the deferred tax assets will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be realized.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The provision (benefit) for income taxes for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> is summarized below:</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; text-decoration: underline;">Current tax expense (benefit):</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Federal</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">State</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; text-decoration: underline;">Deferred tax expense (benefit):</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Federal</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">583,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,093,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">State</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">131,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Change in valuation allowance</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(714,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,345,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Provision for income tax</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> </table> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The difference between income taxes at the statutory federal income tax rate and income taxes reported in the statements of operations for each of the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> is attributable to the following:</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Income tax benefit at federal statutory rate</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(898,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,325,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">State income tax (benefit), net of effect of federal taxes</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(103,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(199,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-deductible debt discount</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">157,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">132,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;">Convertible debt interest expense</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">96,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;">Debt issuance expense</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">70,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(36,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;">Increase in valuation allowance</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">714,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,345,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Provision for income taxes</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> </table> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The deferred tax asset at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> consists of the following:</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; text-decoration: underline;">Deferred income tax assets:</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Net operating loss carryforwards</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,277,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,044,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Deferred startup costs</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,224,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,787,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Stock-based compensation</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,321,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,302,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Other</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">141,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">117,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,963,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,250,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; text-decoration: underline;">Less: Valuation allowance</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,963,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(15,250,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Net deferred tax asset</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> </table> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style="width: 100%; margin-left: 0pt; margin-right: 0pt"> <div style="text-align: center; width: 100%"> <div> <div style="text-align: center; font-size: 10pt; font-family: "Times New Roman";"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"></div></div></div></div></div><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019, </div>we have approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$12,799,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$12,095,000</div> of adjusted federal net operating loss carryforwards and New York State net operating loss carryforwards, respectively, to offset future taxable income. These net operating losses begin expiring in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2023</div> through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2038.</div> Beginning with tax years starting after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2017, </div>NOL’s created can be carried forward indefinitely, however they can only be utilized in any given year, up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80%</div> of taxable income in that year. In addition, we have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$249,000</div> of research and development tax credits carryforwards to offset future tax. These credits expire in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2039.</div> Furthermore, from the date of inception through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> we have accumulated approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$43,413,000</div> of adjusted deferred startup costs. Start-up costs will be amortized over a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div>-year period beginning in the year we begin an active trade or business, with the exception of a nominal portion of these costs related to the sale of CURA software currently being amortized. We have provided a full valuation allowance on the net deferred tax assets due to uncertainty of realization through future earnings.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">The amortization period for a nominal portion of the startup expenses, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$273,000,</div> under IRC Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">195</div> began in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> because the active trade or business related to those startup expenses commenced. The Company received revenue in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019</div> for the sale of subscription software services and demos of the CURA watch. An inventory reserve was booked in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> based on changes in technology developments.  A full reserve was recorded for all inventory on hand and the Company is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer pursuing sales of the related product. The Company expects CURA software sales will continue to be relevant to the Company's business.  An election was made in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> to begin to amortize the IRC Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">195</div> costs related to the CURA software’s original cost, and modifications, which the Company is currently reselling. The remaining Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">195</div> costs will be amortized over a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div>-year period beginning in the year the Company begins as an active trade or business.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Based upon the change in ownership rules under Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">382</div> of the Internal Revenue Act of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1986,</div> if a company issues common stock or other equity instruments convertible into common shares which results in an ownership change exceeding a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50%</div> limitation threshold over a rolling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-year time frame as imposed by that Section, all of that company's net operating loss carryforwards <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be significantly limited as to the amount of use in a particular year. Utilization of the NOL carry-forwards <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be subject to an annual limitation in the case of sufficient equity ownership changes under Section <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">382</div> of the tax law or the NOLs <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>expire unutilized.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">  </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Reconciliations of the beginning and ending amounts of unrecognized tax benefits for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> are as follows:</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td colspan="2" style="text-align: center; border-bottom: 1px solid rgb(0, 0, 0);">2019</td> <td style="padding-bottom: 1px;"> </td> <td> </td> <td colspan="2" style="text-align: center; border-bottom: 1px solid rgb(0, 0, 0);">2018</td> <td style="padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%;">Balance as of January 1</td> <td style="width: 1%;"> </td> <td style="width: 1%;">$</td> <td style="width: 12%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,112,000</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;">$</td> <td style="width: 12%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,112,000</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>Additions based on tax positions related to current year</td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>Additions based on enacted tax change in state rate</td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>Additions for tax positions of prior years</td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>Reductions for tax positions of prior years</td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>Reductions based on enacted changes in tax rates</td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%;"> </td> <td style="width: 12%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>Settlements</td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%;"> </td> <td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>Balance as of December 31</td> <td style="width: 1%; padding-bottom: 3px;"> </td> <td style="width: 1%; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,112,000</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt; padding-bottom: 3px;"> </td> <td style="width: 1%; padding-bottom: 3px;"> </td> <td style="width: 1%; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,112,000</div></td> <td nowrap="nowrap" style="width: 1%; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> </table> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">Tax years that remain subject to examination for our major tax jurisdictions include the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2019. </div>NOL's generated in previous years <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>also be subject to examination.</div></div>

714000

1345000

-898000

-1325000

157000

132000

-36000

47000

-103000

-199000

63000

172000

-8000

7000

-12000

299000

79000

-4000

-39000

-23000

-2000

40000

72000

20000

45000

19000

356000

355000

692000

664000

1233000

1057000

15000

86000

271000

509000

166000

164000

33000

88000

17000

69000

1734000

1747000

1665000

1678000

1747000

1734000

1741000

253000

0.06

212000

64000

63000

64000

21000

P1Y

12454000

8629000

251000

150000

4565000

2026000

1500000

650000

8410000

6603000

2477000

2252000

1170000

8410000

647000

1322000

440000

4008000

1993000

3436000

500000

3395000

2775000

2990000

650000

0.0475

132000

182000

2225000

3389000

-2260000

-3530000

-4276000

-6308000

-614000

-513000

-3149000

-3155000

-658000

-2495000

-4276000

-6308000

-4494000

-6526000

-1848000

-1056000

2477000

2252000

1170000

2430000

5179000

-614000

-513000

-1301000

-2428000

-3155000

-658000

-1439000

-5252000

80000

26000

257000

212000

64000

126000

193000

12799000

12095000

36000

40000

18000

1000

44000

81000

0.40

0.20

2713000

2530000

488000

454000

6275000

4900000

6275000

4900000

0.01

0.40

0.50

100000000

3300000

300000

16250000

25000000

10000000

15687500

24500000

3238000

3268000

468221

67500

15687500

24500000

3238000

3268000

468221

67500

15687500

3238000

15687500

157000

245000

32000

33000

5000

1000

2000

25000

650000

500000

1175000

435000

1150000

925000

3388000

650000

800000

1000

331000

684000

38000

62000

P5Y

P7Y

150000

809000

1262000

-91425000

-87149000

13000

2000

15000

37000

0.25

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table style="margin-right: 0pt; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin-left: auto; min-; min-width: 700px;" cellspacing="0pt" cellpadding="0pt"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">December 31,</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2019</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">2018</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 68%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Raw materials</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,665,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,678,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Finished goods</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">69,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">69,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,734,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,747,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less: Reserve</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,734,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,747,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;" nowrap="nowrap">)</td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Inventory (net)</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Liability for inventory held at vendor</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,764,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 13%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,462,000</div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;" nowrap="nowrap"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">CURA</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Aegis</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Corporate</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 52%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Revenue</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Gross margin</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Loss from operations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(614,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(513,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,301,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,428,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-operating expense</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,848,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,848,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(614,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(513,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,149,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4,276,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Stock based compensation</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">106,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">126,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Depreciation and amortization</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">132,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Assets at December 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">214,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">251,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">CURA</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Aegis</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Corporate</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">Total</div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom;"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 52%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Revenue</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Gross margin (loss) on revenue</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(73,000)</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(73,000)</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Loss from operations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,155,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(658,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,439,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,252,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-operating expense</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,056,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,056,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net loss</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,155,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(658,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,495,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(6,308,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Stock based compensation</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">135,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">180,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Depreciation and amortization</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">110,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">138,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Assets at December 31, 2018</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">54,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">81,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">150,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

<div style="display: inline; font-family: times new roman; font-size: 10pt"><table cellpadding="0pt" cellspacing="0pt" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; margin-left: 0pt; margin-right: 0pt; min-; min-width: 700px;"> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Weighted</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Average</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Average</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Remaining</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Aggregate</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"><div style="display: inline; font-weight: bold;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Exercise</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Contractual</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Intrinsic</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Shares</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Price</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Term</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 1%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">Value</div></div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at January 1, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,381,707</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.46</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 2%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(a)</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7.0</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 2%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(b)</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.25</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Canceled or expired</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at December 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,731,707</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.45</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 2%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(a)</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.2</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 2%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(b)</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 9%;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 1%;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255); font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 48%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable at December 31, 2019</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,106,707</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.49</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 2%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div></td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.2</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; width: 2%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(c)</div></div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> </table></div>

1.1

1.37

0.028

6000000

2159500

7522750

0.55

288000

0.28

288000

441000

1787500

2100000

0.23

94000

11028500

10740500

0.49

0.50

0.1

0.12

0.15

0.22

1.58

P10Y

P5Y146D

P2Y109D

P3Y292D

P2Y219D

173000

412000

0.25

15687500

24500000

3268000

468221

67500

50364549

15687500

24500000

3238000

468221

67500

50979964

15937500

25000000

3388000

468221

67500

48979546

425000

44000

80000

30000

874000

190150

500000

30000

120000

190150

320853

195000

2000

47000

49000

21000

2000

19000

21000

-12203000

-8479000

157000

245000

33000

5000

1000

504000

77725000

-87149000

157000

245000

32000

5000

1000

510000

78272000

-91425000

159000

250000

34000

5000

1000

490000

76494000

-80841000

-3408000

249000

1112000

714000

1345000

276000

350000

590000

P10Y

50601000

49781000

The weighted average exercise price for warrants outstanding excludes 1,750,000 warrants in each period with no determined exercise price. The weighted average remaining contractual term for warrants outstanding excludes 743,500 warrants with no expiration date. The weighted average remaining contractual term for warrants exercisable excludes 118,500 warrants with no expiration date. xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0001063197 crgs:The2016ConvertibleNotesMember 2016-08-25 2016-08-25 0001063197 2018-01-01 2018-12-31 0001063197 us-gaap:WarrantMember 2018-01-01 2018-12-31 0001063197 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-12-31 0001063197 us-gaap:OperatingSegmentsMember crgs:AegisDivisionMember 2018-01-01 2018-12-31 0001063197 us-gaap:OperatingSegmentsMember crgs:CURADivisionMember 2018-01-01 2018-12-31 0001063197 crgs:ConvertibleNotesMember srt:AffiliatedEntityMember 2018-01-01 2018-12-31 0001063197 crgs:ConvertibleNotesMember crgs:SixMembersOfTheBoardOfDirectorsMember 2018-01-01 2018-12-31 0001063197 crgs:July2018ConvertibleNotesMember 2018-01-01 2018-12-31 0001063197 crgs:The2016And2017ConvertibleNoteMember 2018-01-01 2018-12-31 0001063197 crgs:The2016ConvertibleNotesMember 2018-01-01 2018-12-31 0001063197 crgs:The2017ConvertibleNotesMember 2018-01-01 2018-12-31 0001063197 crgs:The2018ConvertibleNotesMember 2018-01-01 2018-12-31 0001063197 crgs:PropertyAndEquipmentMember 2018-01-01 2018-12-31 0001063197 crgs:RightToUseBuildingMember 2018-01-01 2018-12-31 0001063197 us-gaap:SoftwareDevelopmentMember 2018-01-01 2018-12-31 0001063197 us-gaap:PreferredClassAMember us-gaap:PreferredStockMember 2018-01-01 2018-12-31 0001063197 us-gaap:PreferredClassBMember 2018-01-01 2018-12-31 0001063197 us-gaap:PreferredClassBMember us-gaap:PreferredStockMember 2018-01-01 2018-12-31 0001063197 crgs:SeriesC2PreferredStockMember 2018-01-01 2018-12-31 0001063197 crgs:SeriesC2PreferredStockMember us-gaap:PreferredStockMember 2018-01-01 2018-12-31 0001063197 crgs:SeriesC3PreferredStockMember 2018-01-01 2018-12-31 0001063197 crgs:SeriesC3PreferredStockMember us-gaap:PreferredStockMember 2018-01-01 2018-12-31 0001063197 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2018-01-01 2018-12-31 0001063197 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001063197 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001063197 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001063197 crgs:The2018ConvertibleNotesMember 2018-05-08 2018-05-08 0001063197 crgs:July2018ConvertibleNotesMember 2018-07-24 2018-07-24 0001063197 crgs:The2019ConvertibleNotesMember crgs:BoardMemberMember 2019-01-01 2019-09-30 0001063197 crgs:The2019ConvertibleNotesMember srt:ChiefExecutiveOfficerMember 2019-01-01 2019-09-30 0001063197 2019-01-01 2019-12-31 0001063197 us-gaap:WarrantMember 2019-01-01 2019-12-31 0001063197 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember crgs:CustomerOneMember 2019-01-01 2019-12-31 0001063197 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-12-31 0001063197 us-gaap:OperatingSegmentsMember crgs:AegisDivisionMember 2019-01-01 2019-12-31 0001063197 us-gaap:OperatingSegmentsMember crgs:CURADivisionMember 2019-01-01 2019-12-31 0001063197 crgs:ConversionOfPromissoryNotesTo2019ConvertibleNotesMember 2019-01-01 2019-12-31 0001063197 crgs:ConvertibleNotesMember 2019-01-01 2019-12-31 0001063197 crgs:ConvertibleNotesMember srt:AffiliatedEntityMember 2019-01-01 2019-12-31 0001063197 crgs:ConvertibleNotesMember crgs:SixMembersOfTheBoardOfDirectorsMember 2019-01-01 2019-12-31 0001063197 crgs:CreditFacilityWithCoBorrowersMember 2019-01-01 2019-12-31 0001063197 crgs:July2018ConvertibleNotesMember 2019-01-01 2019-12-31 0001063197 crgs:The20162017And2019ConvertibleNotesMember 2019-01-01 2019-12-31 0001063197 crgs:The2016ConvertibleNotesMember 2019-01-01 2019-12-31 0001063197 crgs:The2017ConvertibleNotesMember 2019-01-01 2019-12-31 0001063197 crgs:The2018ConvertibleNotesMember 2019-01-01 2019-12-31 0001063197 crgs:The2019ConvertibleNotesAndDemandNotesMember 2019-01-01 2019-12-31 0001063197 crgs:The2019ConvertibleNotesMember 2019-01-01 2019-12-31 0001063197 crgs:ZCoachAviationWellnessProgramAnnualSubscriptionMember 2019-01-01 2019-12-31 0001063197 us-gaap:ComputerSoftwareIntangibleAssetMember 2019-01-01 2019-12-31 0001063197 crgs:The2011And2016StockOptionPlansMember 2019-01-01 2019-12-31 0001063197 crgs:PropertyAndEquipmentMember 2019-01-01 2019-12-31 0001063197 crgs:RightToUseBuildingMember 2019-01-01 2019-12-31 0001063197 us-gaap:SoftwareDevelopmentMember 2019-01-01 2019-12-31 0001063197 srt:MaximumMember 2019-01-01 2019-12-31 0001063197 srt:MinimumMember 2019-01-01 2019-12-31 0001063197 crgs:OfficeBuildingWithTerminatedLeaseObligationMember 2019-01-01 2019-12-31 0001063197 crgs:UnsecuredSubordinatedPromissoryNotesMember 2019-01-01 2019-12-31 0001063197 us-gaap:PreferredClassAMember 2019-01-01 2019-12-31 0001063197 us-gaap:PreferredClassAMember us-gaap:PreferredStockMember 2019-01-01 2019-12-31 0001063197 us-gaap:PreferredClassBMember 2019-01-01 2019-12-31 0001063197 us-gaap:PreferredClassBMember us-gaap:PreferredStockMember 2019-01-01 2019-12-31 0001063197 crgs:SeriesC2PreferredStockMember us-gaap:PreferredStockMember 2019-01-01 2019-12-31 0001063197 crgs:SeriesC3PreferredStockMember 2019-01-01 2019-12-31 0001063197 crgs:SeriesC3PreferredStockMember us-gaap:PreferredStockMember 2019-01-01 2019-12-31 0001063197 us-gaap:SeriesCPreferredStockMember 2019-01-01 2019-12-31 0001063197 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2019-01-01 2019-12-31 0001063197 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001063197 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001063197 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001063197 us-gaap:TransferredAtPointInTimeMember 2019-01-01 2019-12-31 0001063197 us-gaap:TransferredOverTimeMember 2019-01-01 2019-12-31 0001063197 crgs:CreditFacilityWithCoBorrowersMember 2019-07-23 2019-07-23 0001063197 us-gaap:EmployeeStockOptionMember us-gaap:SubsequentEventMember 2020-01-01 2020-03-27 0001063197 crgs:ConversionFromConvertibleNotesToCommonStockMember us-gaap:SubsequentEventMember 2020-01-01 2020-03-27 0001063197 crgs:The2019ConvertibleNotesMember us-gaap:SubsequentEventMember 2020-01-01 2020-03-27 0001063197 srt:MaximumMember us-gaap:SubsequentEventMember 2020-01-01 2020-03-27 0001063197 srt:MinimumMember us-gaap:SubsequentEventMember 2020-01-01 2020-03-27 0001063197 us-gaap:SubsequentEventMember 2020-01-01 2020-03-27 0001063197 crgs:SeriesC2PreferredStockMember 2014-03-31 0001063197 crgs:SeriesC3PreferredStockMember 2015-12-31 0001063197 crgs:WarrantsRelatedToThe2016ConvertibleNotesMember 2016-08-25 0001063197 crgs:The2016ConvertibleNotesMember 2016-08-25 0001063197 crgs:The2016ConvertibleNotesMember srt:MaximumMember 2016-08-25 0001063197 crgs:WarrantsRelatedToThe2017ConvertibleNotesMember 2017-05-31 0001063197 crgs:The2017ConvertibleNotesMember 2017-05-31 0001063197 2017-12-31 0001063197 us-gaap:PreferredClassAMember us-gaap:PreferredStockMember 2017-12-31 0001063197 us-gaap:PreferredClassBMember us-gaap:PreferredStockMember 2017-12-31 0001063197 crgs:SeriesC2PreferredStockMember us-gaap:PreferredStockMember 2017-12-31 0001063197 crgs:SeriesC3PreferredStockMember us-gaap:PreferredStockMember 2017-12-31 0001063197 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2017-12-31 0001063197 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001063197 us-gaap:CommonStockMember 2017-12-31 0001063197 us-gaap:RetainedEarningsMember 2017-12-31 0001063197 crgs:The2018ConvertibleNotesMember 2018-05-08 0001063197 crgs:WarrantsRelatedToThe2018ConvertibleNotesMember 2018-05-08 0001063197 crgs:July2018ConvertibleNotesMember 2018-07-24 0001063197 crgs:WarrantsRelatedToJuly2018ConvertibleNotesMember 2018-07-24 0001063197 crgs:WarrantsRelatedToThe2017ConvertibleNotesMember 2018-11-30 0001063197 crgs:The2017ConvertibleNotesMember 2018-11-30 0001063197 2018-12-31 0001063197 crgs:WarrantsNotDeterminedExercisePriceMember 2018-12-31 0001063197 crgs:WarrantsRelatedToJuly2018ConvertibleNotesMember crgs:July2018ConvertibleNotesMember 2018-12-31 0001063197 crgs:WarrantsRelatedToTheConvertibleNotesMember srt:AffiliatedEntityMember 2018-12-31 0001063197 crgs:WarrantsRelatedToTheConvertibleNotesMember crgs:SixMembersOfTheBoardOfDirectorsMember 2018-12-31 0001063197 us-gaap:CorporateNonSegmentMember 2018-12-31 0001063197 us-gaap:OperatingSegmentsMember crgs:AegisDivisionMember 2018-12-31 0001063197 us-gaap:OperatingSegmentsMember crgs:CURADivisionMember 2018-12-31 0001063197 crgs:ConvertibleNotesMember 2018-12-31 0001063197 crgs:ConvertibleNotesMember srt:AffiliatedEntityMember 2018-12-31 0001063197 crgs:ConvertibleNotesMember us-gaap:InvestorMember 2018-12-31 0001063197 crgs:ConvertibleNotesMember crgs:SixMembersOfTheBoardOfDirectorsMember 2018-12-31 0001063197 crgs:July2018ConvertibleNotesMember 2018-12-31 0001063197 crgs:The2016And2017ConvertibleNoteMember 2018-12-31 0001063197 crgs:The2016ConvertibleNotesMember 2018-12-31 0001063197 crgs:The2017ConvertibleNotesMember 2018-12-31 0001063197 crgs:The2018ConvertibleNotesMember 2018-12-31 0001063197 crgs:The2019ConvertibleNotesMember 2018-12-31 0001063197 us-gaap:PreferredClassAMember 2018-12-31 0001063197 us-gaap:PreferredClassAMember us-gaap:PreferredStockMember 2018-12-31 0001063197 us-gaap:PreferredClassBMember 2018-12-31 0001063197 us-gaap:PreferredClassBMember us-gaap:PreferredStockMember 2018-12-31 0001063197 crgs:PreferredClassCMember 2018-12-31 0001063197 crgs:SeriesC2PreferredStockMember 2018-12-31 0001063197 crgs:SeriesC2PreferredStockMember us-gaap:PreferredStockMember 2018-12-31 0001063197 crgs:SeriesC3PreferredStockMember 2018-12-31 0001063197 crgs:SeriesC3PreferredStockMember us-gaap:PreferredStockMember 2018-12-31 0001063197 us-gaap:SeriesCPreferredStockMember 2018-12-31 0001063197 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2018-12-31 0001063197 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001063197 us-gaap:CommonStockMember 2018-12-31 0001063197 us-gaap:RetainedEarningsMember 2018-12-31 0001063197 crgs:OfficeBuildingWithTerminatedLeaseObligationMember 2019-01-01 0001063197 2019-06-30 0001063197 crgs:CreditFacilityWithCoBorrowersMember 2019-07-23 0001063197 2019-08-01 0001063197 2019-12-31 0001063197 us-gaap:CommercialPaperMember us-gaap:CollateralPledgedMember 2019-12-31 0001063197 crgs:RightsRelatedToCreditFacilityWithCoBorrowersMember crgs:CreditFacilityWithCoBorrowersMember 2019-12-31 0001063197 crgs:WarrantsNotDeterminedExercisePriceMember 2019-12-31 0001063197 crgs:WarrantsRelatedToJuly2018ConvertibleNotesMember crgs:July2018ConvertibleNotesMember 2019-12-31 0001063197 crgs:WarrantsRelatedToTheConvertibleNotesMember srt:AffiliatedEntityMember 2019-12-31 0001063197 crgs:WarrantsRelatedToTheConvertibleNotesMember crgs:SixMembersOfTheBoardOfDirectorsMember 2019-12-31 0001063197 srt:SubsidiariesMember 2019-12-31 0001063197 us-gaap:CorporateNonSegmentMember 2019-12-31 0001063197 us-gaap:OperatingSegmentsMember crgs:AegisDivisionMember 2019-12-31 0001063197 us-gaap:OperatingSegmentsMember crgs:CURADivisionMember 2019-12-31 0001063197 crgs:ConvertibleNotesMember 2019-12-31 0001063197 crgs:ConvertibleNotesMember srt:AffiliatedEntityMember 2019-12-31 0001063197 crgs:ConvertibleNotesMember us-gaap:InvestorMember 2019-12-31 0001063197 crgs:ConvertibleNotesMember crgs:SixMembersOfTheBoardOfDirectorsMember 2019-12-31 0001063197 crgs:CreditFacilityWithCoBorrowersMember 2019-12-31 0001063197 crgs:CreditFacilityWithCoBorrowersMember us-gaap:PrimeRateMember 2019-12-31 0001063197 crgs:July2018ConvertibleNotesMember 2019-12-31 0001063197 crgs:SeniorConvertiblePromissoryNotesMember 2019-12-31 0001063197 crgs:The2016ConvertibleNotesMember 2019-12-31 0001063197 crgs:The2017ConvertibleNotesMember 2019-12-31 0001063197 crgs:The2017ConvertibleNotesMember srt:MaximumMember 2019-12-31 0001063197 crgs:The2018ConvertibleNotesMember 2019-12-31 0001063197 crgs:The2019ConvertibleNotesMember 2019-12-31 0001063197 crgs:UnsecuredSubordinatedPromissoryNotesMember srt:ChiefExecutiveOfficerMember 2019-12-31 0001063197 us-gaap:DomesticCountryMember us-gaap:InternalRevenueServiceIRSMember 2019-12-31 0001063197 us-gaap:StateAndLocalJurisdictionMember us-gaap:NewYorkStateDivisionOfTaxationAndFinanceMember 2019-12-31 0001063197 crgs:The2011And2016StockOptionPlansMember 2019-12-31 0001063197 crgs:OfficeBuildingWithTerminatedLeaseObligationMember 2019-12-31 0001063197 crgs:UnsecuredSubordinatedPromissoryNotesMember 2019-12-31 0001063197 us-gaap:PreferredClassAMember 2019-12-31 0001063197 us-gaap:PreferredClassAMember us-gaap:PreferredStockMember 2019-12-31 0001063197 us-gaap:PreferredClassBMember 2019-12-31 0001063197 us-gaap:PreferredClassBMember us-gaap:PreferredStockMember 2019-12-31 0001063197 crgs:PreferredClassCMember 2019-12-31 0001063197 crgs:SeriesC2PreferredStockMember 2019-12-31 0001063197 crgs:SeriesC2PreferredStockMember us-gaap:PreferredStockMember 2019-12-31 0001063197 crgs:SeriesC3PreferredStockMember 2019-12-31 0001063197 crgs:SeriesC3PreferredStockMember us-gaap:PreferredStockMember 2019-12-31 0001063197 us-gaap:SeriesCPreferredStockMember 2019-12-31 0001063197 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2019-12-31 0001063197 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001063197 us-gaap:CommonStockMember 2019-12-31 0001063197 us-gaap:RetainedEarningsMember 2019-12-31 0001063197 us-gaap:ResearchMember 2019-12-31 0001063197 2020-03-27 0001063197 crgs:ConversionFromConvertibleNotesToCommonStockMember us-gaap:SubsequentEventMember 2020-03-27

EX-101.SCH 7 crgs-20191231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficiency) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - The Company and Basis of Presentation link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Demand Note link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Senior Convertible Notes and Warrants link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Unsecured Subordinated Promissory Notes link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Right to Use Building Asset link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Software link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Property and Equipment link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 10 - Business Segments link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 11 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 12 - Preferred and Common Stock link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 13 - Stock Options link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 14 - Warrants link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 16 - Commitments and Other Matters link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 17 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 5 - Senior Convertible Notes and Warrants (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 9 - Property and Equipment (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 10 - Business Segments (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 11 - Income Taxes (Tables) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 13 - Stock Options (Tables) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 14 - Warrants (Tables) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 1 - The Company and Basis of Presentation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Depreciation and Amortization (Details) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 4 - Demand Note (Details Textual) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 5 - Senior Convertible Notes and Warrants (Details Textual) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 5 - Senior Convertible Notes and Warrants - Schedule of Senior Convertible Notes Outstanding (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 6 - Unsecured Subordinated Promissory Notes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 7 - Right to Use Building Asset (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 8 - Software (Details Textual) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 9 - Property and Equipment (Details Textual) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 9 - Property and Equipment - Property and Equipment (Details) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 10 - Business Segments (Details Textual) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 10 - Business Segments - Operation by Segments (Details) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 11 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 11 - Income Taxes - Provision (Benefit) for Income Taxes (Details) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 11 - Income Taxes - Effective Income Tax Rate Reconciliation (Details) link:calculationLink link:definitionLink link:presentationLink 050 - Disclosure - Note 11 - Income Taxes - Deferred Tax Asset (Details) link:calculationLink link:definitionLink link:presentationLink 051 - Disclosure - Note 11 - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) link:calculationLink link:definitionLink link:presentationLink 052 - Disclosure - Note 12 - Preferred and Common Stock (Details Textual) link:calculationLink link:definitionLink link:presentationLink 053 - Disclosure - Note 13 - Stock Options (Details Textual) link:calculationLink link:definitionLink link:presentationLink 054 - Disclosure - Note 13 - Stock Options - Stock Options Valuation Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 055 - Disclosure - Note 13 - Stock Options - Share-based Compensation, Stock Options, Activity (Details) link:calculationLink link:definitionLink link:presentationLink 056 - Disclosure - Note 14 - Warrants (Details Textual) link:calculationLink link:definitionLink link:presentationLink 057 - Disclosure - Note 14 - Warrants - Summary of Outstanding Warrants (Details) link:calculationLink link:definitionLink link:presentationLink 059 - Disclosure - Note 16 - Commitments and Other Matters (Details Textual) link:calculationLink link:definitionLink link:presentationLink 060 - Disclosure - Note 17 - Subsequent Events (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 crgs-20191231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 crgs-20191231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 crgs-20191231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Dividend yield Note To Financial Statement Details Textual us-gaap_ConvertibleDebtNoncurrent Senior convertible notes (net) Significant Accounting Policies Note 2 - Summary of Significant Accounting Policies us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Income tax benefit at federal statutory rate Note 3 - Inventory and Related Vendor Liability us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Risk-free rate Note 5 - Senior Convertible Notes and Warrants Note 9 - Property and Equipment Note 10 - Business Segments Note 11 - Income Taxes Note 13 - Stock Options Note 14 - Warrants Income Tax Disclosure [Text Block] Note 2 - Summary of Significant Accounting Policies - Depreciation and Amortization (Details) Note 3 - Inventory and Related Vendor Liability - Inventory (Details) Note 5 - Senior Convertible Notes and Warrants - Schedule of Senior Convertible Notes Outstanding (Details) Note 9 - Property and Equipment - Property and Equipment (Details) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Volatility Note 10 - Business Segments - Operation by Segments (Details) us-gaap_LiabilitiesCurrent Total current liabilities Note 11 - Income Taxes - Provision (Benefit) for Income Taxes (Details) Note 11 - Income Taxes - Effective Income Tax Rate Reconciliation (Details) Convertible Debt [Table Text Block] Note 11 - Income Taxes - Deferred Tax Asset (Details) Note 11 - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 Expected term (years) (Year) Other current liabilities Note 13 - Stock Options - Stock Options Valuation Assumptions (Details) Note 13 - Stock Options - Share-based Compensation, Stock Options, Activity (Details) Note 14 - Warrants - Summary of Outstanding Warrants (Details) Notes To Financial Statements Notes To Financial Statements [Abstract] Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Share-based Payment Arrangement, Option, Activity [Table Text Block] Weighted average exercise price, exercisable (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Exercisable- weighted average remaining contractual term (Year) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 Exercisable-aggregate intrinsic value us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value Software Property And Equipment [Policy Text Block] Disclosure of accounting policy for software, property and equipment physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments. Shares, exercisable (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 Outstanding - weighted average remaining contractual term (Year) Demand notes Outstanding - aggregate intrinsic value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Outstanding - weighted average exercise price (in dollars per share) outstanding - weighted average exercise price (in dollars per share) us-gaap_ConvertibleDebtCurrent Senior convertible notes (net) Weighted average exercise price, canceled or expired (in dollars per share) crgs_WarrantsWithoutExpirationDateExercisable Warrants without Expiration Date, Exercisable Warrants Without Expiration Date Exercisable crgs_WarrantsWithoutExpirationDateOutstanding Warrants without Expiration Date, Outstanding Warrants Without Expiration Date Outstanding Weighted average exercise price, granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average exercise price, exercised (in dollars per share) Series C2 Preferred Stock [Member] Accrued wages and benefits crgs_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate Expected forfeiture rate Warrants Not Determined, Exercise Price [Member] us-gaap_InterestPayableCurrent Accrued interest Lessee, Operating Leases [Text Block] us-gaap_AccountsPayableCurrent Accounts payable us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Outstanding shares (in shares) Outstanding shares (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Shares, canceled or expired (in shares) us-gaap_FreshStartAdjustmentIncreaseDecreaseDeferredIncomeTaxAssetsCurrent Deferred startup costs us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum us-gaap_PolicyTextBlockAbstract Accounting Policies us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Common shares issued in payment of interest us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date crgs_PrivatePlacementOfferingAmount Private Placement Offering Amount Value of shares being offered in a private placement to accredited investors. us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized crgs_AmountOfSeniorConvertiblePromissoryNotesAuthorizedToIssueInPrivatePlacement Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement The amount of senior convertible promissory notes authorized to be sold in a private placement. Senior Convertible Promissory Notes [Member] Presents information pertaining to senior convertible promissory notes. Current Liabilities: Weighted average number of shares of common stock crgs_PercentageOfSharesIssuableUponTheConversionOfThePromissoryNotess Percentage of Shares Issuable Upon the Conversion of the Promissory Notes Number of securities into which the class of warrant or right may be converted expressed as percentage of shares issuable upon the conversion of the promissory notes under agreement. Supplemental Disclosures: Assets Total Assets us-gaap_LongTermDebtFairValue Long-term Debt, Fair Value Plan Name [Axis] Plan Name [Domain] us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic Net loss attributable to common stockholders Stockholders Equity Note Warrants Or Rights [Text Block] The entire disclosure for a company's Warrants and rights outstanding. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. Computer Software, Intangible Asset [Member] Finite-Lived Intangible Assets by Major Class [Axis] Share-based Payment Arrangement [Text Block] Finite-Lived Intangible Assets, Major Class Name [Domain] Award Type [Domain] Award Type [Axis] Net Loss Net loss Net loss Share-based Payment Arrangement, Option [Member] Warrant [Member] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Less accumulated depreciation Property and equipment (net) Net property and equipment us-gaap_PropertyPlantAndEquipmentGross Shop equipment Leasehold improvements us-gaap_EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage Net loss per share attributable to common stockholders Accrued interest us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities Accrued wages and benefits us-gaap_LongTermDebtPercentageBearingVariableInterestRate Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate Related Party Transactions Disclosure [Text Block] us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Loss before income taxes Income taxes Provision for income tax Short-term Debt, Type [Axis] Short-term Debt, Type [Domain] Accounts payable us-gaap_OperatingExpenses Total costs and expenses us-gaap_DebtInstrumentTerm Debt Instrument, Term us-gaap_DefinedContributionPlanAdministrativeExpenses Defined Contribution Plan, Administrative Expense General and administrative Cash Cash and Cash Equivalents, at Carrying Value, Ending Balance Cash at beginning of year Cash at end of year us-gaap_IncreaseDecreaseInOtherCurrentLiabilities Other current liabilities us-gaap_DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price us-gaap_AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense Conversion of Promissory Notes to 2019 Convertible Notes [Member] Represents information pertaining to the conversion of Promissory Notes to 2019 Convertible Notes. us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments Debt Instrument, Convertible, Number of Equity Instruments Convertible debt interest expense Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to convertible debt interest expense. Additions based on enacted tax change in state rate Amount of increase in unrecognized tax benefits resulting from enacted tax change in state rate. The 2019 Convertible Notes and Demand Notes [Member] Represents information pertaining to the 2019 Convertible Notes and Demand Notes. The 2016, 2017 and 2019 Convertible Notes [Member] Represents information pertaining to the 2016, 2017 and 2019 Convertible Notes. Amendment Flag The 2011 and 2016 Stock Option Plans [Member] Represents information pertaining to the 2011 and 2016 Stock Option Plans. Use of Estimates, Policy [Policy Text Block] Reclassification, Policy [Policy Text Block] us-gaap_SharesOutstanding Balance (in shares) Balance (in shares) us-gaap_CommonStockSharesOutstanding Common stock, shares outstanding (in shares) us-gaap_PreferredStockSharesOutstanding Preferred stock, shares outstanding (in shares) Current Fiscal Year End Date us-gaap_DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaid expenses and other current assets Document Fiscal Period Focus us-gaap_OperatingLeaseCost Operating Lease, Cost Document Fiscal Year Focus Consolidation, Policy [Policy Text Block] Document Period End Date Entity Emerging Growth Company Document Type Entity Small Business Entity Shell Company Document Information [Line Items] us-gaap_DebtInstrumentCollateralAmount Debt Instrument, Collateral Amount Preferred stock dividends Document Information [Table] Entity Public Float Entity Filer Category Debt Instrument [Axis] Entity Current Reporting Status Debt Instrument, Name [Domain] Entity Voluntary Filers Entity Well-known Seasoned Issuer Conversion of C3 Preferred Shares to common stock The gross value of stock issued during the period upon the conversion of Preferred C3 convertible securities. Variable Rate [Domain] Software (net) Capitalized Computer Software, Net, Ending Balance Impairment of capitalized shop equipment Impairment loss Capitalized Computer Software, Impairments Prime Rate [Member] us-gaap_CapitalizedComputerSoftwareAmortization1 Capitalized Computer Software, Amortization Common shares issued upon conversion of debt The value of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period. Issuance of warrants with convertible note Variable Rate [Axis] us-gaap_ConcentrationRiskPercentage1 Concentration Risk, Percentage us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable Beneficial conversion feature on convertible note Entity Central Index Key Entity Registrant Name Stock-based compensation Entity [Domain] Customer Concentration Risk [Member] Legal Entity [Axis] crgs_PercentageOfSharesIssuableUponConversionOfThePromissoryNotesBelowInvestmentThreshold Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold Number of securities into which the class of warrant or right may be converted expressed as percentage of shares issuable upon the conversion of the promissory notes under agreement, if investment is below the $500,000 threshold. Concentration Risk Type [Axis] Concentration Risk Type [Domain] Entity Common Stock, Shares Outstanding (in shares) Revenue Benchmark [Member] us-gaap_PreferredStockDividendsShares Preferred Stock Dividends, Shares Long-term Debt [Text Block] Trading Symbol Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Investor [Member] Common shares issued upon note conversions Common shares issued upon note conversions (in shares) Stock Issued During Period, Shares, Conversion of Convertible Securities Shares, exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period EX-101.PRE 11 crgs-20191231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R47.htm IDEA: XBRL DOCUMENT

Note 10 - Business Segments - Operation by Segments (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenue	$ 15,000	$ 37,000
Gross margin (loss) on revenue	2,000	(73,000)
Loss from operations	(2,428,000)	(5,252,000)
Non-operating expense	(1,848,000)	(1,056,000)
Net loss	(4,276,000)	(6,308,000)
Stock based compensation	126,000	180,000
Depreciation and amortization	132,000	138,000
Assets	251,000	150,000
Operating Segments [Member] \| CURA Division [Member]
Revenue	15,000	37,000
Gross margin (loss) on revenue	2,000	(73,000)
Loss from operations	(614,000)	(3,155,000)
Non-operating expense
Net loss	(614,000)	(3,155,000)
Stock based compensation	3,000	1,000
Depreciation and amortization	14,000	110,000
Assets	1,000	15,000
Operating Segments [Member] \| Aegis Division [Member]
Revenue
Gross margin (loss) on revenue
Loss from operations	(513,000)	(658,000)
Non-operating expense
Net loss	(513,000)	(658,000)
Stock based compensation	17,000	44,000
Depreciation and amortization	18,000	20,000
Assets	36,000	54,000
Corporate, Non-Segment [Member]
Revenue
Gross margin (loss) on revenue
Loss from operations	(1,301,000)	(1,439,000)
Non-operating expense	(1,848,000)	(1,056,000)
Net loss	(3,149,000)	(2,495,000)
Stock based compensation	106,000	135,000
Depreciation and amortization	100,000	8,000
Assets	$ 214,000	$ 81,000

XML 13 R43.htm IDEA: XBRL DOCUMENT

Note 8 - Software (Details Textual) - USD ($)	12 Months Ended
Note 8 - Software (Details Textual) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Capitalized Computer Software, Amortization	$ 10,000	$ 92,000
Capitalized Computer Software, Net, Ending Balance		$ 10,000
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Asset, Useful Life	3 years

XML 14 R60.htm IDEA: XBRL DOCUMENT

Note 16 - Commitments and Other Matters (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Defined Contribution Plan, Administrative Expense	$ 2,000	$ 2,000

XML 15 R22.htm IDEA: XBRL DOCUMENT

Note 16 - Commitments and Other Matters	12 Months Ended
Note 16 - Commitments and Other Matters	Dec. 31, 2019
Notes to Financial Statements
Pension and Other Postretirement Benefits Disclosure [Text Block]	NOTE 1 6 — COMMITMENTS AND OTHER MATTERS 401 (k) Retirement Benefit Plan : The Company has a defined contribution 401 (k) plan covering substantially all employees. Employees can contribute a portion of their salary or wages as prescribed under Section 401 (k) of the Internal Revenue Code and, subject to certain limitations, we may, at management’s discretion, authorize an employer contribution based on a portion of the employees' contributions. At the present time, the Company does not provide for an employer match. During 2019 and 2018, we incurred administrative expenses of approximately $2,000 in each year related to this plan.

XML 16 R26.htm IDEA: XBRL DOCUMENT

Note 3 - Inventory and Related Vendor Liability (Tables)

12 Months Ended

Dec. 31, 2019

Notes Tables

Schedule of Inventory, Current [Table Text Block]

	December 31,
	2019			2018
Raw materials	$	1,665,000		$	1,678,000
Finished goods		69,000			69,000
		1,734,000			1,747,000
Less: Reserve		(1,734,000	)		(1,747,000	)
Inventory (net)	$	-		$	-

Liability for inventory held at vendor	$	1,764,000		$	1,462,000

XML 17 R18.htm IDEA: XBRL DOCUMENT

Note 12 - Preferred and Common Stock	12 Months Ended
Note 12 - Preferred and Common Stock	Dec. 31, 2019
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	NOTE 1 2 - PREFERRED and COMMON STOCK Common Stock We have authorized 400,000,000 shares of common stock, with a par value of $0.01 per share. During the year ended December 31, 2019 the Company issued 30,000 shares of common stock in connection with a conversion notice received from a preferred Series C- 3 shareholder, 195,415 shares of common stock in payment of interest on the Company’s 2016, 2017 and 2019 Convertible Notes and 390,000 shares of common stock in connection with the issuance of 2019 Convertible Notes and Demand Notes. During the year ended December 31, 2018, the Company issued 874,000 shares of common stock in connection with conversion notices received from various preferred shareholders and warrant exercises and 320,853 shares at $0.25 per share in payment of interest on the Company’s 2016 and 2017 Convertible Notes. The company also issued 190,150 common shares at $0.25 per share to note holders that initiated conversion of their debt during the year ended December 31, 2018. Preferred Stock Our certificate of incorporation permits the Company to issue up to 100,000,000 shares of $.01 par value preferred stock. The board of directors has the authority to allocate these shares into as many separate classes of preferred as it deems appropriate and with respect to each class, designate the number of preferred shares issuable and the relative rights, preferences, seniority with respect to other classes and to our common stock and any limitations and/or restrictions that may be applicable without obtaining shareholder approval. Class A Preferred Stock We have authorized the issuance of up to 3,300,000 Class A Non-Voting Cumulative Convertible Preferred Shares. Each Class A Preferred Share is convertible after a one year holding period, at the holder’s election, into one share of our common stock. The conversion rate is subject to adjustment in the event of the issuance of our common stock as a dividend or distribution and in the case of the subdivision or combination of our common stock. The Class A Preferred has no voting rights, except with respect to matters directly impacting upon the rights and privileges accorded to such Class. The holders of the Class A Preferred are entitled to receive cumulative preferential dividends in the amount of $.40 per share of Class A Preferred for each annual dividend period. Dividends payable on the Class A Preferred will be paid in cash out of any funds legally available for the payment of dividends or, in the discretion of the board, will be paid in Class A Preferred at a rate of 1 share of Class A Preferred for each $4.00 of dividends. If dividends are paid in shares of Class A Preferred, such dividend shares are not entitled to accumulate additional dividends and themselves may be converted into the common stock of the Company on a one for one basis. Holders of Class A Preferred are permitted to request that dividends payable in Class A Preferred be immediately converted into shares of our common stock. At times, our board may elect to settle the dividends through the issuance of common stock in lieu of cash. Accumulated and unpaid dividends on the Class A Preferred will not bear interest. Class A Preferred shares are also entitled to participate pro rata in dividends declared and/or distributions made with respect to all classes of our outstanding equity. We may, in the absolute discretion of our board, redeem at any time and from time to time from any source of funds legally available any and all of the outstanding Class A Preferred at the redemption price of $4.00 per Class A Preferred, plus all unpaid accumulated dividends payable with respect to each Class A Preferred Share. At December 31, 2019 and 2018, there were 468,221 outstanding shares of Class A Preferred stock, of which 8,709 shares resulted from the settlement of dividends due to conversion, and those shares no longer accrue dividends. The value of dividends payable upon the conversion of the remaining 468,221 outstanding shares of Class A Preferred stock amounted to approximately $2,713,000 and $2,530,000 at December 31, 2019 and 2018, respectively. In the event of a liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred shareholders, Class A Preferred shareholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class A Preferred shareholders’ liquidation preference was approximately $2,713,000 and $2,530,000 at December 31, 2019 and 2018, respectively. In the event of liquidation, dissolution or winding up of the Company, unpaid accumulated dividends on the Class A Preferred are payable in Class A Preferred at a rate of 1 share of Class A Preferred for each $4.00 of dividends. Class B Preferred Stock The Company authorized the issuance of up to 300,000 Class B Non-Voting, Cumulative Convertible Preferred Shares to fund the business operations of Iso-Torque Corporation, an entity incorporated to separately commercialize the Company’s Iso-Torque differential technology. Each Class B Preferred Share is convertible after a one year holding period, at the holder’s election, into one share of our common stock or one share of the common stock of Iso-Torque Corporation. The conversion rate is subject to adjustment in the event of the issuance of the Company’s or Iso-Torque Corporation’s common stock as a dividend or distribution and in the case of the subdivision or combination of such common stock. The Class B Preferred has no voting rights, except with respect to matters directly impacting upon the rights and privileges accorded to such Class. Subject to the dividend rights and privileges of our Class A Preferred, the holders of the Class B Preferred are entitled to receive cumulative dividends in the amount of $.50 per share of Class B Preferred for each annual dividend period. Dividends payable on the Class B Preferred will be paid in cash out of any funds legally available for the payment of dividends or, in the discretion of the board, will be paid in Class B Preferred at a rate of 1 share of Class B Preferred for each $5.00 of dividends. If dividends are paid in shares of Class B Preferred, such dividend shares are not entitled to accumulate additional dividends and themselves may be converted into the common stock of the Company on a one for one basis. Holders of Class B Preferred are permitted to request that dividends payable in Class B Preferred be immediately converted into shares of our common stock. Accumulated and unpaid dividends on the Class B Preferred will not bear interest. Class B Preferred shares are also entitled to participate pro rata in dividends declared and/or distributions made with respect to all classes of our outstanding equity. We may, in the absolute discretion of our board, redeem at any time and from time to time from any source of funds legally available any and all of the outstanding Class B Preferred at the redemption price of $5.00 per Class B Preferred, plus all unpaid accumulated dividends payable with respect to each Class B Preferred Share. Depending upon our cash position, from time to time we may request that a converting preferred shareholder receiving dividends in cash consent to receive shares of restricted common stock in lieu thereof. For the years ended December 31, 2019 and 2018, we settled no Class B Preferred dividends. At December 31, 2019, dividends payable upon the conversion of 67,500 outstanding shares of Class B Preferred amounted to approximately $488,000. In the event of liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred shareholders and our Class A Preferred shareholders, Class B Preferred shareholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class B Preferred shareholders’ liquidation preference was $488,000 and $454,000 at December 31, 2019 and 2018, respectively. In the event of a liquidation, dissolution or winding up of the Company, unpaid accumulated dividends on the Class B Preferred are payable in Class B Preferred shares at a rate of 1 share of Class B Preferred for each $5.00 of dividends. Series C Preferred Stock We have authorized and issued 16,250,000 shares of Series C Voting Convertible Preferred Stock. Each Series C Preferred share is convertible, at the holder’s election, into one share of our common stock. The conversion rate is subject to adjustment in the event of the issuance of common stock as a dividend or distribution, and the subdivision or combination of the outstanding common stock. The Series C Preferred shares have a liquidation preference at their stated value per share of $0.40 that is senior to our common stock, and the Company’s Class A Non-Voting Cumulative Convertible Preferred Shares and Class B Non-Voting Cumulative Convertible Preferred Shares. The liquidation preference is payable upon a liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, or upon a deemed liquidation of the Company. The Series C Preferred shares have no right to receive dividends and have no redemption right. The Series C Preferred shares vote with the common stock on an as-converted basis. During the year ended December 31, 2019 Series C Preferred shareholders converted 250,000 of Series C Preferred into common stock. At December 31, 2019 and 2018, there were 15,687,500 shares of Series C Preferred stock outstanding. The value of the Series C Preferred shareholders’ liquidation preference was $ 6,275,000 at December 31, 2019 and 2018. Series C- 2 Preferred Stock In March 2014, the board of directors authorized, and Class A Preferred, Class B Preferred and Series C Preferred shareholders approved, a series of preferred stock, namely 25,000,000 shares of Series C- 2 Voting Convertible Preferred Stock. Each Series C- 2 Preferred Share is convertible, at the holder’s election, into one share of our common stock, par value $0.01 per share. The conversion rate is subject to adjustment in the event of the issuance of common stock as a dividend or distribution, and the subdivision or combination of the outstanding common stock or a reorganization, recapitalization, reclassification, consolidation or merger of the Company. The Series C- 2 Preferred Shares have a liquidation preference at their stated value per share of $0.20 that ranks pari passu to our existing Series C Voting Convertible Preferred Shares and is senior to our common stock, and our Class A Non-Voting Cumulative Convertible Preferred Shares and Class B Non-Voting Cumulative Convertible Preferred Shares. The liquidation preference is payable upon a liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, or upon a deemed liquidation of the Company. A deemed liquidation includes, unless decided by the holders of at least two -thirds of the Series C- 2 Preferred Shares, any consolidation, merger, or reorganization of the Company in which the shareholders of the Company own less than fifty percent of the voting power of the resultant entity, or an acquisition to which the Company is a party in which at least fifty percent of the Company’s voting power is transferred, or the sale, lease, exclusive license or transfer of all or substantially all of the assets or intellectual property of the Company other than to a wholly owned subsidiary. The Series C- 2 Preferred Shares are not entitled to receive preferred dividends and have no redemption right, but are entitled to participate, on an as converted basis; with holders of outstanding shares of common stock in dividends and distributions on liquidation after all preferred shares have received payment in full of any preferred dividends or liquidation preferences. The Series C- 2 Preferred Shares vote with the common stock on an as-converted basis. We may not, without approval of the holders of at least two -thirds of the Series C- 2 Preferred Shares, (i) create any class or series of stock that is pari passu or senior to the Series C- 2 Preferred Shares; (ii) create any class or series of stock that would share in the liquidation preference of the Series C- 2 Preferred Shares or that is entitled to dividends payable other than in common stock or Series C- 2 Preferred Shares of its own series, (iii) acquire any equity security or pay any dividend, except dividends on a class or series of stock that is junior to the Series C Preferred Shares, payable in such junior stock, (iv) reissue any Series C- 2 Preferred Shares, (v) declare or pay any dividend that would impair the payment of the liquidation preference of the Series C- 2 Preferred Shares, (vi) authorize or issue any additional Preferred Shares, (vii) change the Certificate of Incorporation to adversely affect the rights of the holders of the Series C- 2 Preferred Shares, or (viii) authorize, commit to or consummate any liquidation, dissolution or winding up in which the liquidation preference of the Series C- 2 Preferred Shares would not be paid in full. The Series C- 2 Preferred Shares have not been registered under the Securities Act of 1933, as amended, or the Securities Act, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. During 2018, Series C- 2 Preferred shareholders converted 500,000 of Series C- 2 Preferred into common stock. At December 31, 2019 and 2018, there were 24,500,000 shares of Preferred C- 2 stock outstanding. The value of the Series C- 2 Preferred shareholders’ liquidation preference was $ 4,900,000 at December 31, 2019 and 2018. In connection with the issuance of the Series C- 2 Preferred Shares, the Company entered into an Investors’ Rights Agreement on September 23, 2011 (the “Investors’ Rights Agreement”). Pursuant to the Investors’ Rights Agreement, the Company granted registration rights to the investors covering Common Stock issued on the conversion of the Preferred Shares or exercise of the Warrants or other shares issued in connection with the Transaction (the “Underlying Shares”). The registration rights are triggered when the Company is eligible to utilize Form S- 3, and until such time as (i) the Company is sold, (ii) dissolved, or (iii) the Underlying Shares are eligible for resale without restriction in a three -month period under Rule 144. Investors holding shares for sale to receive at least $500,000 in gross proceeds have the right to make the demand up to one time in any such twelve -month period. The Investors’ Rights Agreement also contains a right of first offer for the future issuance of any equity securities of the Company. Pursuant to the terms of the Investors’ Rights Agreement, the Company may not (i) grant any equity based compensation; (ii) reduce the per-share exercise price or conversion price of any equity based compensation; (iii) create or incur indebtedness in excess of $1,000,000 in the aggregate at any time, or (iv) guarantee the indebtedness of any third party except for trade account payables arising in the ordinary course of business, without the consent of the lead investor. In the event the Company grants any equity based compensation or reduces the per-share exercise price or conversion price of any equity based compensation in violation of the terms of the Investors’ Rights Agreement, and with the effect that additional equity interests are issuable as a result, then the Company shall be obligated to immediately issue to each Investor such aggregate number of additional shares of Common Stock so that immediately following such violation such Investor’s ownership percentage is unaffected by the violation. The Investors also agreed to “Market Stand-off” provisions that may be requested by an underwriter in an underwritten public offering by the Company. In addition, pursuant to the terms of the Investors’ Rights Agreement, as long as the lead investor may acquire at least 3,000,000 shares of Common Stock by conversion or exercise of his Series C Securities, (i) the lead investor is entitled to inspect the properties, assets, business and operation of the Company and discuss its business and affairs with its officers, consultants, directors and key employees, (ii) the Company shall invite the lead investor or his representative to attend all meetings of the Board of Directors and provide all information provided to directors for such purpose, and (iii) at his request, the Company shall cause him to be appointed to serve as a director until the following annual meeting of shareholders and until a successor is elected. Series C- 3 Preferred Stock In 2015, the board of directors authorized and the Class A Preferred, Class B Preferred, Series C Preferred and C- 2 Preferred shareholders approved, a series of preferred stock, namely 10,000,000 shares of Series C- 3 Voting Convertible Preferred Stock. In 2015, the Company commenced the offering of up to $2,500,000 of the Series C- 3 Preferred Shares at the price of $0.25 per share in a private placement pursuant to Rule 506 (c) of Regulation D under the Securities Act of 1933. The offering was made only to “accredited investors” as defined in Rule 501 (a) of Regulation D under the Securities Act of 1933. The Series C- 3 Preferred Shares are convertible into shares of the Company’s common stock at the rate of one -to-one, subject to adjustment in some circumstances. The Series C- 3 Preferred Shares have an aggregate liquidation preference, ranking pari passu with the Series C Preferred Shares and Series C- 2 Preferred Shares and senior to the company’s common stock, the Class A Preferred Shares and Class B Preferred Shares. The Series C- 3 Preferred Shares are not entitled to receive preferred dividends and have no redemption rights, but are entitled to participate, on an as converted basis, with holders of the company’s common stock in dividends and distributions. The Series C- 3 Preferred Shares vote with the Company’s common stock on an as-converted basis and have certain protective provisions. The Series C- 3 Preferred Shares have not been registered under the Securities Act of 1933. Accordingly, those shares and the shares of common stock issuable upon their conversion are “restricted securities” within the meaning of Rule 144 under the Securities Act of 1933 and may not be offered for resale or resold or otherwise transferred except pursuant to a registration statement under the Securities Act of 1933 or an applicable exemption from registration requirements. During the year ended December 31, 2019, the Company issued 30,000 shares of common stock in connection with conversion notices received from a Series C- 3 convertible preferred shareholder. During the year ended December 31, 2018, the Company issued 120,000 shares of common stock in connection with conversion notices received from Series C- 3 convertible preferred shareholders. At December 31, 2019 and 2018, there were 3,238,000 and 3,268,000 shares of Preferred C- 3 stock outstanding, respectively.

XML 18 R10.htm IDEA: XBRL DOCUMENT

Note 4 - Demand Note	12 Months Ended
Note 4 - Demand Note	Dec. 31, 2019
Notes to Financial Statements
Long-term Debt [Text Block]	NOTE 4 - DEMAND NOTE The Company entered into a credit facility with a commercial bank in 2019 for up to $1,500,000 in advances to support working capital needs of the business. The demand notes issued in connection with this commercial bank are supported by individual co-borrowing agreements from certain accredited investors. In connection with this credit agreement, the Company entered into a general security agreement that provides the bank a continuing security interest in all of the Company's personal property and fixtures. The co-borrowers participating in this credit facility received 30,000 common shares for each $100,000 in principal co-borrowed. The fair market value of these shares was estimated on the date of the note issuance and is reflected in debt issuance costs. The co-borrowers were also granted the right to purchase common shares up to the amount co-borrowed, at a price per share determined based on the closing price of the Company’s common stock one day prior to the agreement. The fair market value of these future rights is reflected in debt issuance costs in the results of operations. The price per share for the future share rights is fixed at the higher of the closing price of the Company’s common stock one day prior to the co-borrowing arrangement or $0.15 per share. Each co-borrower has the right to purchase these common shares until the indebtedness is paid in full or within five business days after the consummation of the sale of the Company’s Aegis division. At December 31, 2019, the Company had issued $650,000 in demand notes and issued 195,000 shares of common stock in connection with the co-borrowing demand notes. The common shares issued in connection with the co-borrowing demand notes were valued at $21,000 on the date of issuance and have been reported in debt issuance costs. Coincident with the issuance of these notes, these co-borrowers also received the right to purchase up to 4,333,333 shares of the Company’s common stock at a fixed price of $0.15 per share. The fair market value of these future share rights was estimated at $276,000 on the date of the issuance of the notes utilizing the Black Scholes valuation model and has been reported in debt issuance costs. Advances drawn under this facility have been issued as demand notes with an adjustable interest rate set at the bank’s prime rate, which was 4.75% December 31, 2019. The Company incurred $37,000 in debt issuance costs related to bank and legal fees incurred in connection with this credit facility. The shares of the Company’s Common Stock are being offered and sold in a private placement exempt from registration under Section 4 (a)( 2 ) of the Securities Act of 1933 (“Securities Act”), as amended, and Rule 506 of Regulation D as promulgated by the United States Securities and Exchange Commission thereunder. The shares of the Company’s Common Stock will not be registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

ZIP 19 0001437749-20-006298-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-20-006298-xbrl.zip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end XML 20 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 21 R14.htm IDEA: XBRL DOCUMENT v3.20.1

Note 8 - Software
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Research, Development, and Computer Software Disclosure [Text Block]
NOTE
8
- SOFTWARE

The Company investment in software for the CURA division have been amortized over an estimated useful life of
3
years. Amortization expense recognized for the year ended
December 31, 2019
and
2018
was
$10,000
and
$92,000,
respectively. All capitalized software was fully amortized as of
December 31, 2019.
The net value of capitalized software at
December 31, 2018
was
$10,000.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for research, development, and computer software activities, including contracts and arrangements to be performed for others and with federal government. Includes costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility and in-process research and development acquired in a business combination consummated during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 730
-URI http://asc.fasb.org/subtopic&trid=2197926
+ Details

Name: us-gaap_ResearchDevelopmentAndComputerSoftwareDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 22 R9.htm IDEA: XBRL DOCUMENT v3.20.1

Note 3 - Inventory and Related Vendor Liability
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Inventory Disclosure [Text Block]
NOTE
3
– INVENTORY AND RELATED VENDOR LIABILITY

At
December 31, 2019
and
2018
inventory consisted of:

December 31,

2019

2018

Raw materials
$
1,665,000
$
1,678,000

Finished goods

69,000

69,000

1,734,000

1,747,000

Less: Reserve

(1,734,000
)
(1,747,000
)

Inventory (net)
$
-
$
-

Liability for inventory held at vendor
$
1,764,000
$
1,462,000

During
2017,
the Company initiated a purchase order with a
third
-party vendor to manufacture and assemble the myCadian watch. In connection with this agreement, the Company agreed to a cancellation charge for products purchased on behalf of the Company in the instance that the purchase order is subsequently modified, delayed or cancelled. At
December 31, 2018,
the Company had a reserve of
$1,747,000
reflecting a full reserve for all inventory on-hand at that date. Management will evaluate this reserve in future reporting periods.

During
2019,
the Company and the
third
-party vendor agreed to a
$300,000
penalty payable to the vendor to reflect the aging on this outstanding liability.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-URI http://asc.fasb.org/topic&trid=2126998
+ Details

Name: us-gaap_InventoryDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 23 R1.htm IDEA: XBRL DOCUMENT v3.20.1

Document And Entity Information - USD ($)
$ in Thousands
12 Months Ended

Dec. 31, 2019

Mar. 27, 2020

Jun. 30, 2019

Document Information [Line Items]

Entity Registrant Name CurAegis Technologies, Inc.

Entity Central Index Key 0001063197

Trading Symbol crgs

Current Fiscal Year End Date --12-31

Entity Filer Category Non-accelerated Filer

Entity Current Reporting Status Yes

Entity Voluntary Filers No

Entity Well-known Seasoned Issuer No

Entity Emerging Growth Company false

Entity Small Business true

Entity Interactive Data Current Yes

Entity Common Stock, Shares Outstanding (in shares) 51,187,236

Entity Public Float $ 5,554

Entity Shell Company false

Document Type 10-K

Document Period End Date Dec. 31, 2019

Document Fiscal Year Focus 2019

Document Fiscal Period Focus FY

Amendment Flag false

Title of 12(g) Security $.01 par value common voting stock

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: dei_DocumentInformationLineItems

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityCurrentReportingStatus

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-T
-Number 232
-Section 405
+ Details

Name: dei_EntityInteractiveDataCurrent

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.
+ References
No definition available.
+ Details

Name: dei_EntityPublicFloat

Namespace Prefix: dei_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityShellCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicates that the company is a Smaller Reporting Company (SRC).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntitySmallBusiness

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
+ References
No definition available.
+ Details

Name: dei_EntityVoluntaryFilers

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.
+ References
No definition available.
+ Details

Name: dei_EntityWellKnownSeasonedIssuer

Namespace Prefix: dei_

Data Type: dei:yesNoItemType

Balance Type: na

Period Type: duration

X

- Definition
Title of a 12(g) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection g
+ Details

Name: dei_Security12gTitle

Namespace Prefix: dei_

Data Type: dei:securityTitleItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: dei:tradingSymbolItemType

Balance Type: na

Period Type: duration

XML 24 R37.htm IDEA: XBRL DOCUMENT v3.20.1

Note 3 - Inventory and Related Vendor Liability - Inventory (Details) - USD ($)

Dec. 31, 2019

Dec. 31, 2018

Raw materials $ 1,665,000 $ 1,678,000

Finished goods 69,000 69,000

1,734,000 1,747,000

Less: Reserve (1,734,000) (1,747,000)

Inventory (net)

Liability for inventory held at vendor $ 1,764,000 $ 1,462,000

X

- Definition
Carrying value as of the balance sheet date of liabilities for inventory held at vendor.
+ References
No definition available.
+ Details

Name: crgs_LiabilityForInventoryHeldAtVendor

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryFinishedGoods

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a)(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryRawMaterials

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of valuation reserve for inventory.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 5.BB)
-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09)
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryValuationReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 25 R33.htm IDEA: XBRL DOCUMENT v3.20.1

Note 1 - The Company and Basis of Presentation (Details Textual)
12 Months Ended

Dec. 31, 2019

USD ($)

Dec. 31, 2018

USD ($)

Dec. 31, 2017

USD ($)

Number of Operating Segments 2

Cash and Cash Equivalents, at Carrying Value, Ending Balance $ 18,000 $ 53,000 $ 194,000

Working Capital (4,545,000)

Stockholders' Equity Attributable to Parent, Ending Balance (12,203,000) (8,479,000) $ (3,408,000)

Retained Earnings (Accumulated Deficit), Ending Balance (91,425,000) $ (87,149,000)

Proceeds From Convertible Debt, Gross 2,375,000

Minimum [Member]

Cash Needed During the Year to Fund Current and Future Commitments 1,500,000

Maximum [Member]

Cash Needed During the Year to Fund Current and Future Commitments $ 2,000,000

X

- Definition
Represents the amount of cash needed during the year to fund current and future commitments.
+ References
No definition available.
+ Details

Name: crgs_CashNeededDuringTheYearToFundCurrentAndFutureCommitments

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from the issuance of a long-term debt instrument, before debt issuance cost, which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
+ References
No definition available.
+ Details

Name: crgs_ProceedsFromConvertibleDebtGross

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Represents current assets minus current liabilities.
+ References
No definition available.
+ Details

Name: crgs_WorkingCapital

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfOperatingSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 26 R5.htm IDEA: XBRL DOCUMENT v3.20.1

Consolidated Statements of Changes in Stockholders' Equity (Deficiency) - USD ($)

Preferred Stock [Member]

Series C Preferred Stock [Member]

Preferred Stock [Member]

Series C2 Preferred Stock [Member]

Preferred Stock [Member]

Series C3 Preferred Stock [Member]

Preferred Stock [Member]

Preferred Class A [Member]

Preferred Stock [Member]

Preferred Class B [Member]

Common Stock [Member]

Additional Paid-in Capital [Member]

Retained Earnings [Member]

Series C2 Preferred Stock [Member]

Series C3 Preferred Stock [Member]

Total

Balance (in shares) at Dec. 31, 2017 15,937,500 25,000,000 3,388,000 468,221 67,500 48,979,546

Balance at Dec. 31, 2017 $ 159,000 $ 250,000 $ 34,000 $ 5,000 $ 1,000 $ 490,000 $ 76,494,000 $ (80,841,000) $ (3,408,000)

Conversion of C3 Preferred Shares to common stock (in shares) (120,000) 120,000

Conversion of C3 Preferred Shares to common stock $ (1,000) $ 1,000

Issuance of warrants with convertible note 557,000 557,000

Stock-based compensation 180,000 180,000

Common shares issued for interest (in shares) 320,853

Common shares issued for interest $ 3,000 77,000 80,000

Net Loss (6,308,000) (6,308,000)

Conversion of C Preferred Shares to common stock (in shares) (250,000) 250,000

Conversion of C Preferred Shares to common stock $ (2,000) $ 2,000

Conversion of C2 Preferred Shares to common stock (in shares) (500,000) 500,000

Conversion of C2 Preferred Shares to common stock $ (5,000) $ 5,000

Beneficial conversion feature on convertible note 369,000 $ 369,000

Common shares issued upon note conversions (in shares) 190,150 500,000 120,000 874,000

Common shares issued upon note conversions $ 2,000 47,000 $ 49,000

Exercise of common stock warrant (in shares) 4,000

Exercise of common stock warrant $ 1,000 1,000 2,000

Balance (in shares) at Dec. 31, 2018 15,687,500 24,500,000 3,268,000 468,221 67,500 50,364,549

Balance at Dec. 31, 2018 $ 157,000 $ 245,000 $ 33,000 $ 5,000 $ 1,000 $ 504,000 77,725,000 (87,149,000) (8,479,000)

Conversion of C3 Preferred Shares to common stock (in shares) (30,000) 30,000

Conversion of C3 Preferred Shares to common stock $ (1,000) $ 1,000

Issuance of warrants with convertible note 65,000 65,000

Stock-based compensation 126,000 126,000

Common shares issued for interest (in shares) 195,415

Common shares issued for interest $ 2,000 42,000 44,000

Common shares issued (in shares) 195,000

Common shares issued $ 2,000 19,000 21,000

Common shares issued with demand notes (in shares) 195,000

Common shares issued with demand notes $ 1,000 19,000 20,000

Share rights issued with demand notes 276,000 276,000

Net Loss (4,276,000) (4,276,000)

Common shares issued upon note conversions (in shares) 30,000

Balance (in shares) at Dec. 31, 2019 15,687,500 24,500,000 3,238,000 468,221 67,500 50,979,964

Balance at Dec. 31, 2019 $ 157,000 $ 245,000 $ 32,000 $ 5,000 $ 1,000 $ 510,000 $ 78,272,000 $ (91,425,000) $ (12,203,000)

X

- Definition
Amount of increase in additional paid in capital (APIC) resulting from the issuance of share rights.
+ References
No definition available.
+ Details

Name: crgs_AdjustmentsToAdditionalPaidInCapitalShareRightsIssued

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares issued during the period as a result of the conversion of Preferred C2 convertible securities.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedDuringPeriodSharesConversionOfPreferredC2ConvertibleSecurities

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued during the period as a result of the conversion of Preferred C3 convertible securities.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedDuringPeriodSharesConversionOfPreferredC3ConvertibleSecurities

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued during the period as a result of the conversion of Preferred C convertible securities.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedDuringPeriodSharesConversionOfPreferredCConvertibleSecurities

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares of stock issued as a result of the exercise of interest.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedDuringPeriodSharesInterest

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The gross value of stock issued during the period upon the conversion of Preferred C2 convertible securities.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedDuringPeriodValueConversionOfPreferredC2ConvertibleSecurities

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The gross value of stock issued during the period upon the conversion of Preferred C3 convertible securities.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedDuringPeriodValueConversionOfPreferredC3ConvertibleSecurities

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The gross value of stock issued during the period upon the conversion of Preferred C convertible securities.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedDuringPeriodValueConversionOfPreferredCConvertibleSecurities

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock issued as a result of the exercise of interest
+ References
No definition available.
+ Details

Name: crgs_StockIssuedDuringPeriodValueInterest

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock issued as a result of the exercise of warrant.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedDuringPeriodValueWarrantExercised

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of warrants exercised during the current period.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedDuringPeriodWarrantExercised

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued during the period in connection with debt issuance.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedInConnectionWithDebtIssuanceShares

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The value of new stock issued during the period in connection with debt issuance.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedInConnectionWithDebtIssuanceValue

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 55
-Paragraph 51
-URI http://asc.fasb.org/extlink&oid=117331294&loc=d3e34017-109320
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.
+ References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 25
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109126253&loc=d3e4724-112606

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of shares issued which are neither cancelled nor held in the treasury.
+ References
No definition available.
+ Details

Name: us-gaap_SharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued during the period as a result of the conversion of convertible securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The gross value of stock issued during the period upon the conversion of convertible securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 27 R52.htm IDEA: XBRL DOCUMENT v3.20.1

Note 11 - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Balance $ 1,112,000 $ 1,112,000

Additions based on tax positions related to current year

Additions based on enacted tax change in state rate

Additions for tax positions of prior years

Reductions for tax positions of prior years

Reductions based on enacted changes in tax rates

Settlements

Balance $ 1,112,000 $ 1,112,000

X

- Definition
Amount of decrease in unrecognized tax benefits resulting from enacted changes in tax rates.
+ References
No definition available.
+ Details

Name: crgs_UnrecognizedTaxBenefitsDecreaseResultingFromEnactedChangesInTaxRates

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase in unrecognized tax benefits resulting from enacted tax change in state rate.
+ References
No definition available.
+ Details

Name: crgs_UnrecognizedTaxBenefitsIncreaseResultingFromEnactedTaxChangeInStateRate

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of unrecognized tax benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 10B
-URI http://asc.fasb.org/extlink&oid=116821951&loc=SL37586934-109318

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefits

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of increase in unrecognized tax benefits resulting from settlements with taxing authorities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 28 R56.htm IDEA: XBRL DOCUMENT v3.20.1

Note 13 - Stock Options - Share-based Compensation, Stock Options, Activity (Details) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Outstanding shares (in shares) 11,028,500

Outstanding - weighted average exercise price (in dollars per share) $ 0.49

Outstanding - weighted average remaining contractual term (Year) 2 years 219 days 3 years 292 days

Outstanding - aggregate intrinsic value $ 94,000

Shares, granted (in shares) 0 1,787,500

Weighted average exercise price, granted (in dollars per share)

Shares, exercised (in shares) 0 0

Weighted average exercise price, exercised (in dollars per share)

Shares, canceled or expired (in shares) (288,000)

Weighted average exercise price, canceled or expired (in dollars per share) $ 0.28

Outstanding shares (in shares) 10,740,500 11,028,500

outstanding - weighted average exercise price (in dollars per share) $ 0.50 $ 0.49

Shares, exercisable (in shares) 7,522,750

Weighted average exercise price, exercisable (in dollars per share) $ 0.55

Exercisable- weighted average remaining contractual term (Year) 2 years 109 days

Exercisable-aggregate intrinsic value

X

- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)-(4)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average price of options that were either forfeited or expired.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)-(4)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Number of options outstanding, including both vested and non-vested options.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)-(ii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 29 R11.htm IDEA: XBRL DOCUMENT v3.20.1

Note 5 - Senior Convertible Notes and Warrants
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Debt Disclosure [Text Block]
NOTE
5
- SENIOR CONVERTIBLE NOTES AND WARRANTS

At
December 31, 2019,
the Company had
$10,310,000
in convertible notes outstanding which have been presented net of unamortized debt discounts of
$1,900,000,
resulting in a carrying value of
$8,410,000.
The
2019
convertible notes have been presented in current liabilities as of
December 31, 2019
as these notes mature on the earlier of the Aegis monetization event or
five
years from the date of issuance. As of
December 31, 2018,
the Company had
$9,160,000
in convertible notes outstanding, presented net of unamortized debt discounts of
$2,557,000
resulting in a carrying value of
$6,603,000.

Scheduled maturities on the Company’s convertible note are:
$650,000
in the
twelve
months ending
2020;

$2,990,000
in the
twelve
months ending
December 31, 2021;
$2,775,000
in the
twelve
months ending in
December 31, 2022;
$3,395,000
in the
twelve
months ending
December 31, 2023
and
$500,000
thereafter.

Included in the face value of convertible notes outstanding at
December 31, 2019
and
December 31, 2018,
is
$2,477,000
and
$2,252,000,
respectively in convertible notes payable to
six
of our directors and
$
1,170,000
in convertible notes payable to an investor that is deemed an affiliate.

Total

2019

6%

Notes

JULY

2018

Notes

2018

Notes

2017

6%

Notes

2016

6%

Notes

Face value 12/31/18
$
9,160,000
$
-
$
1,175,000
$
625,000
$
4,370,000
$
2,990,000

Notes issued

1,150,000

650,000

500,000

-

-

-

Face value 12/31/19

$

10,310,000

$

650,000

$

1,675,000

$

625,000

$

4,370,000

$

2,990,000

Debt discount 12/31/18
$
(2,557,000
) $
-
$
(360,000
) $
(231,000
) $
(456,000
) $
(1,510,000
)

Debt discount issued

(91,000
)
(26,000
)
(65,000
)
-

-

-

Amortization reported as interest

748,000

23,000

72,000

46,000

94,000

513,000

Debt discount 12/31/19

$

(1,900,000

)

$

(3,000

)

$

(353,000

)

$

(185,000

)

$

(362,000

)

$

(997,000

)

Senior c
onvertible
n
otes (net) 12/31/19

$

8,410,000

$

647,000

$

1,322,000

$

440,000

$

4,008,000

$

1,993,000

2019
Convertible Notes

The board of directors authorized the issuance of up to
$2.5
million in
6%
Convertible Promissory Notes (the
“2019
Convertible Notes”) in connection with the
May 28, 2019
Securities Purchase Agreement (the
“2019
SPA”). The
2019
Convertible Notes mature on the earlier of:
five
days after the sale of substantially all of the assets of the Aegis division or
five
years from the date of issuance.

The conversion rate of the notes is fixed at the greater of
$0.15
per share and the closing market price of the Company’s common stock on the trading day immediately prior to the issuance of the note. Investors receive
30,000
shares of common stock for each
$100,000
investment in the
2019
Convertible Notes. The notes were offered in a private placement exempt from registration under Section
4
(a)(
2
) of the Securities Act of
1933
as amended (the "Securities Act") and Rule
506
(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule
501
(a) of Regulation D under the Securities Act.

During the year ended
December 31, 2019,
the Company issued
$650,000
in new notes and allocated
$26,000
of the proceeds to debt discount based on the estimated fair value of the common shares issued and debt issuance costs on the date of investment. During the year ended
December 31, 2019,
the Company recorded
$40,000
in interest expense which includes
$23,000
of amortization on debt discount.

JULY 2018
Convertible Notes

The board of directors authorized the issuance of up to
$2.5
million in non-interest bearing Senior Convertible Promissory Notes and Warrants (the
“JULY 2018
Convertible Notes”) in connection with the
July 24, 2018
Securities Purchase Agreement (the
“JULY 2018
SPA”). The
JULY 2018
Convertible Notes have a
five
-year maturity. In
April 2019,
the Company’s board approved a resolution to complete this offering.

The conversion rate of the notes was fixed at
$0.25
per share as determined at the close of business on
July 24, 2018.
Investors in this offering were granted warrants to purchase common shares equal to
10%
or
25%
of the number of shares issuable upon the conversion of the notes based upon the amount of their investment. The warrants have a fixed exercise price of
$0.25
and a
ten
-year term from the date of issuance. The notes were offered in a private placement exempt from registration under Section
4
(a)(
2
) of the Securities Act of
1933
as amended (the "Securities Act") and Rule
506
(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule
501
(a) of Regulation D under the Securities Act.

During the year ended
December 31, 2019,
the Company issued
$500,000
in new convertible notes and allocated
$65,000
of the proceeds to debt discount based on the estimated fair value of the warrants issued and debt issuance costs incurred on the date of investment. In connection with the issuance of these convertible notes, the Company issued
350,000
warrants with an exercise price of
$0.25
per share and a
10
-year term.

During the year ended
December 31, 2019
and
December 31, 2018,
the Company recorded
$72,000
and
$20,000
respectively in interest expense which includes amortization of debt discount.

During the year ended
December 31, 2018,
the Company issued
$1,175,000,
in convertible notes and allocated
$380,000,
of the proceeds to debt discount based on the estimated fair value of the warrants issued and debt issuance costs incurred on the date of investment. In connection with the issuance of these convertible notes, the Company issued
590,000
warrants with an exercise price of
$0.25
per share and a
10
-year term.

2018
Convertible Notes

The board of directors authorized the issuance of up to
$1
million in non-interest bearing Senior Convertible Promissory Notes and Warrants (the
“2018
Convertible Notes”) in connection with the
May 8, 2018
Securities Purchase Agreement (the
“2018
SPA”). The
2018
Convertible Notes have
five
-year maturity. On
July 19, 2018,
the Company’s board approved a resolution to complete this offering.

The conversion rate of the notes was fixed at
$0.25
per share as determined at the close of business on
May 8, 2018.
Investors in this offering were granted warrants to purchase common stock equal to
10%
or
25%
of the number of shares issuable upon the conversion of the notes based upon the amount of their investment. The warrants have a fixed exercise price of
$0.25
and a
ten
-year term from the date of issuance. The notes were offered in a private placement exempt from registration under Section
4
(a)(
2
) of the Securities Act of
1933
as amended (the "Securities Act") and Rule
506
(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule
501
(a) of Regulation D under the Securities Act.

During the year ended
December 31, 2019
and
December 31, 2018,
the Company recorded
$45,000
and
$19,000
respectively in interest expense which reflects the amortization of debt discount.

2017
Convertible Notes

The board of directors authorized the issuance of up to
$5
million in
6%
Senior Convertible Promissory Notes and Warrants (the
“2017
Convertible Notes”) in connection with the
May 31, 2017
Securities Purchase Agreement (as amended, the
“2017
SPA”). The
2017
Convertible Notes have a
five
-year maturity and a fixed annual interest rate of
6%.
Investors in this offering were granted warrants to purchase warrants equal to
10%
or
25%
of the number of shares issuable upon the conversion of the notes based upon the amount of their investment.

The conversion rate of the
2017
Notes was originally set at
$0.50
per share and subsequently modified in
November 2018
to
$0.333
per share. The exercise price of related warrants issued in connection with the
2017
Notes was also subsequently modified in
November 2018
to
$0.333
per share. The
2017
Convertible Notes were offered in a private placement exempt from registration under Section
4
(a)(
2
) of the Securities Act and Rule
506
(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule
501
(a) of Regulation D under the Securities Act.

During the year ended
December 31, 2019
and
December 31, 2018
the Company recorded
$356,000
and
$355,000,
respectively, in interest expense including
$94,000
and
$105,000,
respectively of amortization of debt discount.

2016
Convertible Notes

The board of directors authorized, and the Company issued,
$3
million in
6%
Senior Convertible Promissory Notes and Warrants (the
“2016
Convertible Notes”) in connection with the
August 25, 2016
Securities Purchase Agreement (the
“2016
SPA”). The
2016
Convertible Notes have
five
-year maturity dates ranging from
August 2021
through
December 2021
and a fixed annual interest rate of
6%.

The conversion rate of the notes was fixed at
$0.25
per share as determined at the close of business on
August 25, 2016.
The investors were granted warrants to purchase an aggregate number of shares of common stock equal to
10%
of the number of shares issuable upon the conversion of the notes. The warrants have a fixed exercise price of
$0.25
and a
ten
-year term from the date of issuance. The notes were offered in a private placement exempt from registration under Section
4
(a)(
2
) of the Securities Act of
1934,
as amended and Rule
506
(c) of Regulation D as promulgated by the Securities and Exchange Commission. The offering was available only to “accredited investors” as defined in Rule
501
(a) of Regulation D under the Securities Act of
1933.

During the year ended
December 31, 2019
and
December 31, 2018
the Company recorded
$692,000
and
$664,000,
respectively, in interest expense including
$513,000
and
$483,000,
respectively of amortization of debt discount.

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564
+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 30 R15.htm IDEA: XBRL DOCUMENT v3.20.1

Note 9 - Property and Equipment
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Property, Plant and Equipment Disclosure [Text Block]
NOTE
9
- PROPERTY AND EQUIPMENT

At
December
31,

2019
and
2018
property and equipment consist of the following:

December 31,

2019

December 31,

2018

Office equipment
$
199,000
$
249,000

Shop equipment

132,000

182,000

Leasehold improvements

-

253,000

331,000

684,000

Less accumulated depreciation

(293,000

)

(622,000

)

Net property and equipment
$
38,000
$
62,000

Depreciation expense for the years
December 31, 2019
and
2018
was
$24,000
and
$46,000
respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-URI http://asc.fasb.org/topic&trid=2155823
+ Details

Name: us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 31 R19.htm IDEA: XBRL DOCUMENT v3.20.1

Note 13 - Stock Options
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Share-based Payment Arrangement [Text Block]
NOTE
13
- STOCK OPTIONS

The shareholders approved the
2011
and
2016
Stock Option Plans (the
“2016
Plan” and the
“2011
Plan”) which provide for the grant of up to
6,000,000
common stock options to provide equity incentives to directors, officers, employees and consultants. Two types of options
may
be granted under the plans: non-qualified stock options and incentive stock options.

Under the plans, non-qualified stock options
may
be granted to our officers, directors, employees and outside consultants. Incentive stock options
may
be granted only to our employees, including officers and directors who are also employees. In the case of incentive stock options, the exercise price
may
not
be less than such fair market value and in the case of an employee who owns more than
10%
of our common stock, the exercise price
may
not
be less than
110%
of such market price. Options generally are exercisable for
ten
years from the date of grant, except that the exercise period for incentive stock options granted to any employee who owns more than
10%
of our stock
may
not
be greater than
five
years.

As of
December 31, 2019,
there are
2,159,500
options are available for future grant under these plans.



Summary
   For the years ended
December 31, 2019
and
2018,
compensation expense related to stock option awards amounted to
$126,000
and
$180,000,
respectively. As of
December 31, 2019,
there was approximately
$105,000
of unrecognized compensation costs related to outstanding stock options, which are expected to be recognized over a weighted average term of
11
months.

No
employee stock options were granted in the year ended
December 31, 2019.
During the year ended
December 31, 2018,
the Company granted
1,787,500
stock options to employees and non-employee board members. The weighted average grant date fair value of stock options granted during the year ended
December 31, 2018
was
$0.23.
The total grant date fair value of stock options vested during the years ended
December 31, 2019
and
2018
was approximately
$173,000
and
$412,000,
respectively.

The fair value of options granted was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:

2019

2018

Expected term (years)

-

5.4

Expected forfeiture rate

-

0%

Risk-free rate

-

2.8%

Volatility

-

137%

Dividend yield

-

0.0%

The average risk-free interest rate is based on the U.S. treasury security rate in effect as of the grant date. We determined expected volatility using the historical closing stock price. The expected life was generally determined using the simplified method as we do
not
believe we have sufficient historical stock option exercise experience on which to base the expected term.

The following summarizes the activity of all of our outstanding stock options for the year ended
December 31, 2019:

Shares

Weighted

Average

Exercise

Price

Average

Remaining

Contractual

Term

(years)

Aggregate

Intrinsic

Value

Outstanding at January 1, 2019

11,028,500
$
0.49

3.8
$
94,000

Granted

-

-

Exercised

-

-

Canceled or expired

(288,000

)

0.28

Outstanding at December 31, 2019

10,740,500
$
0.50

2.6
$
-

Exercisable at December 31, 2019

7,522,750
$
0.55

2.3
$
-

During the year ended
December 31, 2019,
288,000
options were canceled due to employee turnover,
no
options expired unexercised, and
no
options were exercised. During the year ended
December 31, 2018,
no
options were exercised and
441,000
options were cancelled due to employee turnover,
no
options expired unexercised and
no
options were exercised. As of
December 31, 2019,
the exercise prices on outstanding stock options ranged from
$.22
per share to
$1.58
per share.

X

- Definition
The entire disclosure for share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-URI http://asc.fasb.org/topic&trid=2228938
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 32 R36.htm IDEA: XBRL DOCUMENT v3.20.1

Note 3 - Inventory and Related Vendor Liability (Details Textual) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Inventory Valuation Reserves, Ending Balance $ 1,734,000 $ 1,747,000

Vendor Penalty, Expense $ 300,000

X

- Definition
Amount of vendor penalty expense related to the inventory purchase order.
+ References
No definition available.
+ Details

Name: crgs_VendorPenaltyExpense

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of valuation reserve for inventory.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 5.BB)
-URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SX 210.12-09)
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryValuationReserves

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

XML 33 R4.htm IDEA: XBRL DOCUMENT v3.20.1

Consolidated Statements of Operations - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Revenue and Cost of revenue:

CURA revenue $ 15,000 $ 37,000

Cost of revenue 13,000 110,000

Gross margin (loss) on revenue 2,000 (73,000)

Costs and expenses:

Provision (recovery) inventory reserve (15,000) 1,741,000

Impairment loss 17,000

Engineering and development 809,000 1,262,000

General and administrative 1,636,000 2,159,000

Total costs and expenses 2,430,000 5,179,000

Loss from operations (2,428,000) (5,252,000)

Non-operating expense:

Interest expense (1,233,000) (1,057,000)

Debt issuance cost (333,000)

Vendor penalty (300,000)

Other income 18,000 1,000

Non-operating expense (1,848,000) (1,056,000)

Loss before income taxes (4,276,000) (6,308,000)

Income taxes

Net loss (4,276,000) (6,308,000)

Preferred stock dividends 218,000 218,000

Net loss attributable to common stockholders $ (4,494,000) $ (6,526,000)

Net loss per share attributable to common stockholders

Basic and Diluted (in dollars per share) $ (0.09) $ (0.13)

Weighted average number of shares of common stock

Basic and Diluted (in shares) 50,601,000 49,781,000

X

- Definition
Amount of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.
+ References
No definition available.
+ Details

Name: crgs_DebtIssuanceCosts

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of (recovery) loss from additions or reductions in inventory due to subsequent measurement adjustments, including, but not limited to, sale, physical deterioration, obsolescence, or changes in price levels.
+ References
No definition available.
+ Details

Name: crgs_InventoryRecoveryWriteDown

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of vendor penalty expense related to the inventory purchase order.
+ References
No definition available.
+ Details

Name: crgs_VendorPenaltyExpense

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of impairment loss from capitalized computer software costs.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756
+ Details

Name: us-gaap_CapitalizedComputerSoftwareImpairments1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate cost of goods produced and sold and services rendered during the reporting period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_CostOfRevenue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CostOfRevenueAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 405
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817
+ Details

Name: us-gaap_DividendsPreferredStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256
+ Details

Name: us-gaap_EarningsPerShareBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (210.5-03(11))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=117326831&loc=d3e1377-109256
+ Details

Name: us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.7)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_NonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NonoperatingIncomeExpenseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingExpenses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (expense) related to nonoperating activities, classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.9)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_OtherNonoperatingIncomeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373
+ Details

Name: us-gaap_ResearchAndDevelopmentExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_RevenuesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).
+ References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R32.htm IDEA: XBRL DOCUMENT v3.20.1

Note 14 - Warrants (Tables)
12 Months Ended

Dec. 31, 2019

Notes Tables

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

Weighted

Weighted

Average

Average

Remaining

Aggregate

Exercise

Contractual

Intrinsic

Shares

Price

Term

Value

Outstanding at January 1, 2019

7,381,707
$
0.46

(a)

7.0

(b)
$
39,000

Granted

350,000

0.25

Exercised

-

-

Canceled or expired

-

-

Outstanding at December 31, 2019

7,731,707
$
0.45

(a)

6.2

(b)
$
33,000

Exercisable at December 31, 2019

7,106,707
$
0.49

6.2

(c)
$
33,000

X

- Definition
Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775
+ Details

Name: us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

EXCEL 35 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 36 R8.htm IDEA: XBRL DOCUMENT v3.20.1

Note 2 - Summary of Significant Accounting Policies
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Significant Accounting Policies [Text Block]
NOTE
2
- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Consolidation:
The financial statements include the accounts of the Company, our wholly owned subsidiary Iso-Torque Corporation, and our majority-owned subsidiary, Ice Surface Development, Inc. (
56%
owned). These subsidiaries are non-operational.

Use of Estimates:
The preparation of financial statements in conformity with U.S. generally accepted accounting principles (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates are subject to a high degree of judgment and potential change. Actual results could differ from those estimates.

Reclassifications:
Certain reclassifications
may
have been made to prior year balances to conform to the current year’s presentation.

Cash:
We maintain cash at financial institutions which periodically
may
exceed federally insured amounts. We have a corporate credit card program through our primary financial institution, JPMorgan Chase Bank, N.A. In connection with this, the Company granted a security interest to the bank in our money market account to act as collateral for the activity within the corporate card program, up to
$5,000.

Accounts Receivable
: We carry our accounts receivable at invoice amount less an allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and establish an allowance for doubtful accounts, based on a history of past write-offs and collections and current credit conditions. We do
not
accrue interest on past due invoices. The allowance for doubtful accounts was
zero
at
December 31, 2019
and
December 31, 2018.

Inventory
: Inventory is stated at the lower of cost or net realizable value with cost determined under the average cost method. We record provisions for excess, obsolete or slow-moving inventory based on changes in customer demand, technology developments or other economic factors. Inventory on hand at
December 31, 2019
and
2018
has been fully reserved.

Depreciation and amortization:
Depreciation and amortization are computed using the straight-line method. Depreciation and amortization expense for the years ended
December 31, 2019
and
2018
are as follows:

For Years ended

December 31,

2019

2018

Amortization right-to-use asset
$
98,000
$
-

Software

10,000

92,000

Property and equipment

24,000

46,000

$
132,000
$
138,000

Right to use building asset:
The FASB issued ASU
No.

2016
-
02,
“Leases,” which requires a lessee to recognize on its balance sheet the assets and liabilities related to long-term leases that were classified as operating leases under previous guidance. An asset is recognized related to the Company's ability to retain the economic benefits and control of the underlying asset. A corresponding liability is recognized related to the Company's obligation to make lease payments over the term of the lease.

The standard became effective for the Company
January 1, 2019.
The Company utilized the modified retrospective approach to measure the right to use operating lease agreement associated with the office building used for our business operations located in Rochester, New York. The adoption of this accounting standard did
not
impact our consolidated loss from operations and had
no
impact on cash flows.

Software, Property and Equipment:
Capitalized software, property and equipment are stated at cost. Estimated useful lives for capitalized software is
3
years and for property and equipment is
5
to
7
years. Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense).

Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment
may
be indicated. The carrying amount is compared to the estimated discounted cash flows and if there is an excess such amount is recorded as impairment.

During the year ended
December 31, 2018
we recorded an impairment charge of
$17,000
on certain property and equipment.

Fair Value of Financial Instruments:
As defined by U.S. GAAP
,
fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A hierarchy for ranking the quality and reliability of the information is used to determine fair values. Assets and liabilities carried at fair value will be classified and disclosed in
one
of the following
three
categories:

Level
1:
Quoted market prices in active markets for identical assets or liabilities

Level
2:
Observable market-based inputs or unobservable inputs that are corroborated by market data

Level
3:
Unobservable inputs that are
not
corroborated by market data

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level
1
measurements) and the lowest priority to unobservable inputs (Level
3
measurements). The Financial Accounting Standards Board’s (“FASB”) guidance for the disclosure about fair value of financial instruments requires disclosure of an estimate of the fair value of certain financial instruments. The fair value of financial instruments pursuant to FASB’s guidance for the disclosure about fair value of financial instruments approximated their carrying values at
December 31, 2019
and
December 31, 2018.
The carrying amount of cash, prepaid expenses and other current assets, liability for inventory, accounts payable, accrued expenses, demand and promissory notes approximates their fair value due to their short maturity. The senior convertible notes can be converted into common stock with an underlying value of
$3,436,000
as of
December 31, 2019
based on the trading price on
December 31, 2019.

Revenue Recognition and Deferred Revenue:
On
January 1, 2018,
the Company adopted FASB ASC
606,
"Revenue from Contracts with Customers" and all related amendments for all contracts using the modified retrospective method. There was
no
impact upon the adoption of FASB ASC
606.
The Company has determined that the adoption of this standard did
not
require a cumulative effect adjustment. For contracts where performance obligations are satisfied at a point in time, the Company recognizes revenue when the product is shipped to the customer. For contracts where the performance obligation is satisfied over time, as in the Z-Coach sales, the Company recognizes revenue over the subscription period. Revenue from the sale of the Company's products is recognized net of cash discounts, sales returns and allowances. The Company has
two
sources of revenue: (i) from the sale of MyCadian system products and (ii) from stand-alone Z-Coach subscriptions.

The Company's net revenue is derived primarily from domestic customers. For the year ended
December 31, 2019
net revenue from products transferred over time amounted to
$13,000
and net revenue from products transferred at a point in time amounted to
$2,000.
One customer accounted for
43%
of total Z-Coach subscription sales made during the year ended
December 31, 2019.
Our collection terms provide customers standard terms of net
30
days. Future performance obligations are reflected in deferred revenue.

CURA revenue is recognized (a) upon receipt of payment at the point of sale of the CURA app, (b) upon the delivery of myCadian products and (c) upon the company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach Program provides fatigue training over an annual subscription period of
twelve
months. The Z-Coach Program allows the user unlimited access during the annual subscription period. Customers are billed at the acceptance of the subscription, and revenue is recognized ratably over the subscription period as our performance obligations are satisfied and when collection is reasonably assured. Our collection terms provide customers standard terms of net
30
days.

Engineering and Development and Patents:
Engineering and development costs and patent expenses are charged to operations as incurred. Engineering and development include personnel-related costs, materials and supplies, depreciation and consulting services. Patent costs for the years ended
December 31, 2019
and
2018
amounted to
$45,000
and
$150,000,
respectively, and are included in general and administrative expenses.

Stock-based Compensation:
FASB Accounting Standards Codification (“ASC”)
718
-
10
requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the service period (generally the vesting period) in the consolidated financial statements based on their fair values on the grant date. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity in accordance with FASB ASC
718
-
10.

No
tax benefits were attributed to the stock-based compensation expense because a valuation allowance was maintained for substantially all net deferred tax assets.

During
2018,
the Company adopted FASB ASU
2018
-
07,
“Equity-Based Payments to Non-Employees,” which requires all share-based payments to non-employees, including grants of stock options, to be recognized in the consolidated financial statements as expense generally over the service period of the consulting arrangement or as performance conditions are expected to be met. The Company utilized a modified retrospective approach effective as of
January 1, 2018
in the adoption of this accounting guidance which resulted in a
$10,000
reduction of stock compensation expense previously reported. FASB ASC
718
-
20
requires that modifications of the terms or conditions of equity awards be treated as an exchange of the original award for a new award. Incremental compensation cost is measured as the excess, if any, of the fair value of the modified award over the fair value of the original award immediately before its terms are modified.

Income Taxes:
We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax basis of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than
not
that some portion or all of the deferred tax assets will
not
be realized.

We account for uncertain tax positions using a more-likely-than-
not
recognition threshold based on the technical merits of the tax position taken. Tax benefits that meet the more-likely-than-
not
recognition threshold should be measured as the largest amount of tax benefits, determined on a cumulative probability basis, which is more likely than
not
to be realized upon ultimate settlement in the financial statements. It is our policy to recognize interest and penalties related to income tax matters as general and administrative expenses. As of
December 31, 2019,
and
December 31, 2018,
there were
no

accrued interest or penalties related to uncertain tax positions.

Loss per Common Share:
FASB’s ASC
260
-
10
(“Earnings Per Share”) requires the presentation of basic earnings per share, which is based on weighted average common stock outstanding, and dilutive earnings per share, which gives effect to options, warrants and convertible securities in periods when they are dilutive. At
December 31, 2019
and
2018,
we excluded
105,535,575
and
94,784,206
potential common shares, respectively, relating to convertible preferred stock, convertible notes, future share rights issued with demand notes, options and warrants outstanding from the diluted net loss per common share calculation because their inclusion would be anti-dilutive. In addition, we excluded
625,000
warrants from the diluted net loss per common share calculation at
December 31, 2019
and
2018
as the conditions for their vesting are
not
time-based.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for all significant accounting policies of the reporting entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-URI http://asc.fasb.org/topic&trid=2122369
+ Details

Name: us-gaap_SignificantAccountingPoliciesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R53.htm IDEA: XBRL DOCUMENT v3.20.1

Note 12 - Preferred and Common Stock (Details Textual) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Dec. 31, 2015

Mar. 31, 2014

Common stock, shares authorized (in shares) 400,000,000 400,000,000

Common stock, par value (in dollars per share) $ 0.01 $ 0.01

Stock Issued During Period, Shares, Conversion of Convertible Securities 874,000

Preferred stock, shares authorized (in shares) 100,000,000 100,000,000

Preferred Stock, Par or Stated Value Per Share $ 0.01 $ 0.01

Preferred stock, shares outstanding (in shares) 3,238,000

Investor Rights Agreement, Maximum Indebtedness $ 1,000,000

Investor Rights Agreement, Minimum Number Shares of Common Stock by Conversion or Exercise of Series C Securities 3,000,000

Preferred Class A [Member]

Preferred stock, shares authorized (in shares) 3,300,000

Convertible Preferred Stock, Holding Period Required for Conversion 1 year

Convertible Preferred Stock, Shares Issued upon Conversion 1

Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears $ 0.40

Preferred Stock, Redemption Price Per Share $ 4

Preferred stock, shares outstanding (in shares) 468,221 468,221

Preferred Stock, Shares Outstanding, Not Accruing Dividends 8,709 8,709

Dividends Payable $ 2,713,000 $ 2,530,000

Preferred Stock, Liquidation Preference, Value $ 2,713,000 $ 2,530,000

Preferred Class B [Member]

Preferred stock, shares authorized (in shares) 300,000

Convertible Preferred Stock, Holding Period Required for Conversion 1 year

Convertible Preferred Stock, Shares Issued upon Conversion 1

Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears $ 0.50

Preferred Stock, Redemption Price Per Share $ 5

Preferred stock, shares outstanding (in shares) 67,500 67,500

Dividends Payable $ 488,000

Preferred Stock, Liquidation Preference, Value $ 488,000 $ 454,000

Preferred Stock Dividends, Shares 0 0

Series C Preferred Stock [Member]

Preferred stock, shares authorized (in shares) 16,250,000

Convertible Preferred Stock, Shares Issued upon Conversion 1

Preferred stock, shares outstanding (in shares) 15,687,500 15,687,500

Preferred Stock, Liquidation Preference, Value $ 6,275,000 $ 6,275,000

Preferred Stock, Liquidation Preference Per Share $ 0.40

Conversion of Stock, Shares Converted 250,000

Series C2 Preferred Stock [Member]

Stock Issued During Period, Shares, Conversion of Convertible Securities 500,000

Preferred stock, shares authorized (in shares) 25,000,000

Preferred Stock, Par or Stated Value Per Share $ 0.01

Convertible Preferred Stock, Shares Issued upon Conversion 1

Preferred stock, shares outstanding (in shares) 24,500,000 24,500,000

Preferred Stock, Liquidation Preference, Value $ 4,900,000 $ 4,900,000

Preferred Stock, Liquidation Preference Per Share $ 0.20

Series C3 Preferred Stock [Member]

Stock Issued During Period, Shares, Conversion of Convertible Securities 30,000 120,000

Preferred stock, shares authorized (in shares) 10,000,000

Preferred stock, shares outstanding (in shares) 3,238,000 3,268,000

Private Placement Offering Amount $ 2,500,000

Sale of Stock, Price Per Share $ 0.25

The 2016, 2017 and 2019 Convertible Notes [Member]

Stock Issued During Period, Shares, Conversion of Convertible Securities 30,000

Stock Issued During Period, Shares, Interest 195,415

The 2019 Convertible Notes and Demand Notes [Member]

Stock Issued in Connection with Debt Issuance, Shares 390,000

The 2016 and 2017 Convertible Note [Member]

Stock Issued During Period, Shares, Conversion of Convertible Securities 190,150

Stock Issued During Period, Shares, New Issues 320,853

Shares Issued, Price Per Share $ 0.25

X

- Definition
The holding period required for convertible preferred stock to be eligible for conversion.
+ References
No definition available.
+ Details

Name: crgs_ConvertiblePreferredStockHoldingPeriodRequiredForConversion

Namespace Prefix: crgs_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum indebtedness for the company pursuant to the investor's rights agreement.
+ References
No definition available.
+ Details

Name: crgs_InvestorRightsAgreementMaximumIndebtedness

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The minimum number shares of common stock by conversion or exercise of securities held by the investor to quality as lead investor.
+ References
No definition available.
+ Details

Name: crgs_InvestorRightsAgreementMinimumNumberSharesOfCommonStockByConversionOrExerciseOfSeriesCSecurities

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Represents number of preferred stock outstanding that do not accrue dividends.
+ References
No definition available.
+ Details

Name: crgs_PreferredStockSharesOutstandingNotAccruingDividends

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Value of shares being offered in a private placement to accredited investors.
+ References
No definition available.
+ Details

Name: crgs_PrivatePlacementOfferingAmount

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares of stock issued as a result of the exercise of interest.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedDuringPeriodSharesInterest

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued during the period in connection with debt issuance.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedInConnectionWithDebtIssuanceShares

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586
+ Details

Name: us-gaap_ConversionOfStockSharesConverted1

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued for each share of convertible preferred stock that is converted.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644
+ Details

Name: us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(24))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(15)(5))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(20))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(15)(5))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910
+ Details

Name: us-gaap_DividendsPayableCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares of preferred stock issued as dividends during the period. Excludes stock splits.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_PreferredStockDividendsShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644
+ Details

Name: us-gaap_PreferredStockLiquidationPreference

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Value of the difference between preference in liquidation and the par or stated values of the preferred shares.
+ References
No definition available.
+ Details

Name: us-gaap_PreferredStockLiquidationPreferenceValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Per share amount of cumulative preferred dividends in arrears.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644
+ Details

Name: us-gaap_PreferredStockPerShareAmountsOfPreferredDividendsInArrears

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The price per share at which the preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity is redeemed or may be called at. The redemption features of this preferred stock are solely within the control of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21564-112644
+ Details

Name: us-gaap_PreferredStockRedemptionPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.
+ References
No definition available.
+ Details

Name: us-gaap_SaleOfStockPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Per share or per unit amount of equity securities issued.
+ References
No definition available.
+ Details

Name: us-gaap_SharesIssuedPricePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares issued during the period as a result of the conversion of convertible securities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of new stock issued during the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=crgs_SeriesC2PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=crgs_SeriesC3PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_The20162017And2019ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_The2019ConvertibleNotesAndDemandNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_The2016And2017ConvertibleNoteMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 38 R57.htm IDEA: XBRL DOCUMENT v3.20.1

Note 14 - Warrants (Details Textual) - shares

Dec. 31, 2019

Dec. 31, 2018

Class of Warrant or Right, Outstanding 7,731,707 7,381,707

Warrants without Expiration Date, Outstanding 743,500 743,500

Warrants without Expiration Date, Exercisable 118,500 118,500

Warrants Not Determined, Exercise Price [Member]

Class of Warrant or Right, Outstanding 1,750,000 1,750,000

X

- Definition
Warrants Without Expiration Date Exercisable
+ References
No definition available.
+ Details

Name: crgs_WarrantsWithoutExpirationDateExercisable

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Warrants Without Expiration Date Outstanding
+ References
No definition available.
+ Details

Name: crgs_WarrantsWithoutExpirationDateOutstanding

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of warrants or rights outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_ClassOfWarrantOrRightAxis=crgs_WarrantsNotDeterminedExercisePriceMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 39 R46.htm IDEA: XBRL DOCUMENT v3.20.1

Note 10 - Business Segments (Details Textual)
12 Months Ended

Dec. 31, 2019

Number of Operating Segments 2

X

- Definition
Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.
+ References
No definition available.
+ Details

Name: us-gaap_NumberOfOperatingSegments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

XML 40 R42.htm IDEA: XBRL DOCUMENT v3.20.1

Note 7 - Right to Use Building Asset (Details Textual)
12 Months Ended

Dec. 31, 2019

USD ($)

Aug. 01, 2019

USD ($)

Jan. 01, 2019

USD ($)

Operating Lease, Liability, Total $ 212,000

Lessee, Operating Lease, Discount Rate 6.00%

Operating Lease, Cost $ 26,000

Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months 64,000

Lessee, Operating Lease, Liability, Payments, Due Year Two 64,000

Lessee, Operating Lease, Liability, Payments, Due Year Three 63,000

Lessee, Operating Lease, Liability, Payments, Due, Total 212,000

Lessee, Operating Lease, Liability, Undiscounted Excess Amount $ 21,000

Office Building with Terminated Lease Obligation [Member]

Operating Lease, Liability, Total $ 257,000

Lessee, Operating Lease, Discount Rate 6.00%

Lessee, Operating Lease, Renewal Term 1 year

Operating Lease, Cost $ 80,000

Lessee, Operating Lease, Number of Right-of-Use Assets with One Year Renewal Options 2

X

- Definition
Represents the number of right-of-use assets with one year renewal options.
+ References
No definition available.
+ Details

Name: crgs_LesseeOperatingLeaseNumberOfRighOfUseAssetsWithOneYearRenewalOptions

Namespace Prefix: crgs_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Discount rate used by lessee to determine present value of operating lease payments.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseDiscountRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980
+ Details

Name: us-gaap_LesseeOperatingLeaseRenewalTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 55
-Paragraph 53
-URI http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980
+ Details

Name: us-gaap_OperatingLeaseCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=crgs_OfficeBuildingWithTerminatedLeaseObligationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 41 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 42 R61.htm IDEA: XBRL DOCUMENT v3.20.1

Note 17 - Subsequent Events (Details Textual) - USD ($)
3 Months Ended 12 Months Ended

Mar. 27, 2020

Dec. 31, 2019

Dec. 31, 2018

Proceeds from Convertible Debt $ 1,150,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 1,787,500

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

The 2019 Convertible Notes [Member]

Proceeds from Convertible Debt $ 650,000

Subsequent Event [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 2,100,000

Subsequent Event [Member] | Minimum [Member]

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 0.12

Subsequent Event [Member] | Maximum [Member]

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 0.15

Subsequent Event [Member] | Share-based Payment Arrangement, Option [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 10 years

Subsequent Event [Member] | Conversion from Convertible Notes to Common Stock [Member]

Stock Issued During Period, Shares, Interest 94,772

Debt Conversion, Accrued Interest, Amount $ 14,000

Subsequent Event [Member] | The 2019 Convertible Notes [Member]

Proceeds from Convertible Debt $ 435,000

Stock Issued in Connection with Debt Issuance, Shares 112,500

X

- Definition
The amount of accrued interest being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
No definition available.
+ Details

Name: crgs_DebtConversionAccruedInterestAmount

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Number of shares of stock issued as a result of the exercise of interest.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedDuringPeriodSharesInterest

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued during the period in connection with debt issuance.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedInConnectionWithDebtIssuanceShares

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromConvertibleDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_The2019ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtConversionByUniqueDescriptionAxis=crgs_ConversionFromConvertibleNotesToCommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 44 R23.htm IDEA: XBRL DOCUMENT v3.20.1

Note 17 - Subsequent Events
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Subsequent Events [Text Block]
NOTE
1
7
- SUBSEQUENT EVENTS

2019
Convertible Notes

Subsequent to
December 31, 2019,
the Company issued
$435,000
in new
2019
convertible notes and
112,500
of new common shares to the investors in these notes.

Common Shares Issued in Payment of Interest Expense

Subsequent to
December 31, 2019,
the Company issued
94,772
shares of common stock representing
$14,000
in payment of interest to noteholders.


Stock Compensation Grants

Subsequent to
December 31, 2019,
the Company granted
2,100,000
incentive stock options exercisable for
10
years from the date of grant at prices ranging from
$0.12
to
$0.15
per share.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774
+ Details

Name: us-gaap_SubsequentEventsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 45 R27.htm IDEA: XBRL DOCUMENT v3.20.1

Note 5 - Senior Convertible Notes and Warrants (Tables)
12 Months Ended

Dec. 31, 2019

Notes Tables

Convertible Debt [Table Text Block]

Total

2019

6%

Notes

JULY

2018

Notes

2018

Notes

2017

6%

Notes

2016

6%

Notes

Face value 12/31/18
$
9,160,000
$
-
$
1,175,000
$
625,000
$
4,370,000
$
2,990,000

Notes issued

1,150,000

650,000

500,000

-

-

-

Face value 12/31/19

$

10,310,000

$

650,000

$

1,675,000

$

625,000

$

4,370,000

$

2,990,000

Debt discount 12/31/18
$
(2,557,000
) $
-
$
(360,000
) $
(231,000
) $
(456,000
) $
(1,510,000
)

Debt discount issued

(91,000
)
(26,000
)
(65,000
)
-

-

-

Amortization reported as interest

748,000

23,000

72,000

46,000

94,000

513,000

Debt discount 12/31/19

$

(1,900,000

)

$

(3,000

)

$

(353,000

)

$

(185,000

)

$

(362,000

)

$

(997,000

)

Senior c
onvertible
n
otes (net) 12/31/19

$

8,410,000

$

647,000

$

1,322,000

$

440,000

$

4,008,000

$

1,993,000

X

- Definition
Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.
+ References
No definition available.
+ Details

Name: us-gaap_ConvertibleDebtTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 46 R2.htm IDEA: XBRL DOCUMENT v3.20.1

Consolidated Balance Sheets - USD ($)

Dec. 31, 2019

Dec. 31, 2018

Current Assets:

Cash $ 18,000 $ 53,000

Prepaid expenses and other current assets 2,000 25,000

Total current assets 20,000 78,000

Right to use asset (net) 193,000

Property and equipment (net) 38,000 62,000

Software (net) 10,000

Total non-current assets 231,000 72,000

Total Assets 251,000 150,000

Current Liabilities:

Liability for inventory held at vendor 1,764,000 1,462,000

Demand notes 650,000

Senior convertible notes (net) 647,000

Promissory notes 425,000

Accounts payable 420,000 323,000

Accrued interest 509,000 166,000

Current right to use obligation 64,000

Other current liabilities 36,000 40,000

Accrued wages and benefits 50,000 35,000

Total current liabilities 4,565,000 2,026,000

Non-current right to use obligation 126,000

Senior convertible notes (net) 7,763,000 6,603,000

Total Liabilities 12,454,000 8,629,000

Commitments and other matters (Note 16)

Stockholders' Deficiency:

Common stock, $.01 par value, 400,000,000 shares authorized; shares issued and outstanding at December 31, 2019 and 2018: 50,979,964 and 50,364,549, respectively 510,000 504,000

Additional paid-in capital 78,272,000 77,725,000

Accumulated deficit (91,425,000) (87,149,000)

Total Stockholders' Deficiency (12,203,000) (8,479,000)

Total Liabilities and Stockholders' Deficiency 251,000 150,000

Preferred Class C [Member]

Stockholders' Deficiency:

Preferred stock, value 157,000 157,000

Series C2 Preferred Stock [Member]

Stockholders' Deficiency:

Preferred stock, value 245,000 245,000

Series C3 Preferred Stock [Member]

Stockholders' Deficiency:

Preferred stock, value 32,000 33,000

Preferred Class A [Member]

Stockholders' Deficiency:

Preferred stock, value 5,000 5,000

Preferred Class B [Member]

Stockholders' Deficiency:

Preferred stock, value $ 1,000 $ 1,000

X

- Definition
Carrying value as of the balance sheet date of liabilities for inventory held at vendor.
+ References
No definition available.
+ Details

Name: crgs_LiabilityForInventoryHeldAtVendor

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapital

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(11))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(12))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(15))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(17))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(16))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(10))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756
+ Details

Name: us-gaap_CapitalizedComputerSoftwareNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_ConvertibleDebtCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying amount of long-term convertible debt as of the balance sheet date, net of the amount due in the next twelve months or greater than the normal operating cycle, if longer. The debt is convertible into another form of financial instrument, typically the entity's common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_ConvertibleDebtNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InterestPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(13))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LinesOfCreditCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseLiabilityNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of lessee's right to use underlying asset under operating lease.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977
+ Details

Name: us-gaap_OperatingLeaseRightOfUseAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6904-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(7))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(8))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PrepaidExpenseAndOtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19)(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16)(a)(1))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(13))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_ShortTermBorrowings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementClassOfStockAxis=crgs_PreferredClassCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=crgs_SeriesC2PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=crgs_SeriesC3PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 47 R34.htm IDEA: XBRL DOCUMENT v3.20.1

Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Capitalized Computer Software, Impairments $ 17,000

Revenue from Contract with Customer, Including Assessed Tax 15,000 37,000

Patent Cost 45,000 150,000

Excess Tax Benefit from Share-based Compensation, Operating Activities 0

Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total $ 0 $ 0

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 105,535,575 94,784,206

Accounts Receivable, Allowance for Credit Loss, Current $ 0 $ 0

Warrant [Member]

Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 625,000 625,000

Z-Coach Aviation Wellness Program Annual Subscription [Member]

Deferred Revenue Arrangement, Subscription Period 1 year

Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member]

Concentration Risk, Percentage 43.00%

Transferred over Time [Member]

Revenue from Contract with Customer, Including Assessed Tax $ 13,000

Transferred at Point in Time [Member]

Revenue from Contract with Customer, Including Assessed Tax 2,000

Senior Convertible Promissory Notes [Member]

Long-term Debt, Fair Value $ 3,436,000

Minimum [Member]

Property, Plant and Equipment, Useful Life 5 years

Maximum [Member]

Property, Plant and Equipment, Useful Life 7 years

Computer Software, Intangible Asset [Member]

Finite-Lived Intangible Asset, Useful Life 3 years

Commercial Paper [Member] | Collateral Pledged [Member]

Debt Instrument, Collateral Amount $ 5,000

Subsidiaries [Member]

Equity Method Investment, Ownership Percentage 56.00%

X

- Definition
Represents the term of the subscription in a deferred revenue arrangement.
+ References
No definition available.
+ Details

Name: crgs_DeferredRevenueArrangementSubscriptionPeriod

Namespace Prefix: crgs_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents the amount of patent cost incurred during the period.
+ References
No definition available.
+ Details

Name: crgs_PatentCost

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of allowance for credit loss on accounts receivable, classified as current.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of impairment loss from capitalized computer software costs.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756
+ Details

Name: us-gaap_CapitalizedComputerSoftwareImpairments1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592
+ Details

Name: us-gaap_ConcentrationRiskPercentage1

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of assets pledged to secure a debt instrument.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823
+ Details

Name: us-gaap_DebtInstrumentCollateralAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571
+ Details

Name: us-gaap_EquityMethodInvestmentOwnershipPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of cash outflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 20
-Section 55
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118258462&loc=d3e11374-113907
+ Details

Name: us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.
+ References
No definition available.
+ Details

Name: us-gaap_LongTermDebtFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.
+ References
No definition available.
+ Details

Name: us-gaap_PropertyPlantAndEquipmentUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045
+ Details

Name: us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319
+ Details

Name: us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DeferredRevenueArrangementTypeAxis=crgs_ZCoachAviationWellnessProgramAnnualSubscriptionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_MajorCustomersAxis=crgs_CustomerOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_SeniorConvertiblePromissoryNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CashAndCashEquivalentsAxis=us-gaap_CommercialPaperMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_CollateralAxis=us-gaap_CollateralPledgedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 48 R30.htm IDEA: XBRL DOCUMENT v3.20.1

Note 11 - Income Taxes (Tables)
12 Months Ended

Dec. 31, 2019

Notes Tables

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

2019

2018

Current tax expense (benefit):

Federal
$
-
$
-

State

-

-

Deferred tax expense (benefit):

Federal

583,000

1,093,000

State

131,000

252,000

Change in valuation allowance

(714,000

)

(1,345,000

)

Provision for income tax
$
-
$
-

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

2019

2018

Income tax benefit at federal statutory rate
$
(898,000

)
$
(1,325,000

)

State income tax (benefit), net of effect of federal taxes

(103,000

)

(199,000

)

Non-deductible debt discount

157,000

132,000

Convertible debt interest expense
96,000

-

Debt issuance expense
70,000

-

Other

(36,000
)
47,000

Increase in valuation allowance
714,000

1,345,000

Provision for income taxes
$
-
$
-

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

2019

2018

Deferred income tax assets:

Net operating loss carryforwards
$
3,277,000
$
3,044,000

Deferred startup costs

11,224,000

10,787,000

Stock-based compensation

1,321,000

1,302,000

Other

141,000

117,000

15,963,000

15,250,000

Less: Valuation allowance

(15,963,000

)

(15,250,000

)

Net deferred tax asset
$
-
$
-

Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]

2019 2018

Balance as of January 1 $
1,112,000
$
1,112,000

Additions based on tax positions related to current year
-

-

Additions based on enacted tax change in state rate
-

-

Additions for tax positions of prior years
-

-

Reductions for tax positions of prior years
-

-

Reductions based on enacted changes in tax rates
-

-

Settlements
-

-

Balance as of December 31 $
1,112,000
$
1,112,000

X

- Definition
Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319
+ Details

Name: us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the change in unrecognized tax benefits.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 55
-Paragraph 217
-URI http://asc.fasb.org/extlink&oid=117331294&loc=d3e36027-109320

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15A
-URI http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319
+ Details

Name: us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 49 R6.htm IDEA: XBRL DOCUMENT v3.20.1

Consolidated Statements of Cash Flows - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Cash flows from operating activities:

Net loss $ (4,276,000) $ (6,308,000)

Adjustments to reconcile net loss to net cash used in operating activities:

Amortization of discount reported as interest 748,000 627,000

Depreciation and amortization 132,000 138,000

Fair market value of share rights issued with demand notes 276,000

Stock-based compensation 126,000 180,000

Interest paid in shares 44,000 81,000

Provision for inventory reserve 1,741,000

Impairment of capitalized shop equipment 17,000

Changes in working capital items:

Accounts receivable 8,000

Prepaid expenses and other current assets 23,000 2,000

Liability for inventory held at vendor 302,000 (216,000)

Accounts payable 63,000 172,000

Accrued interest 299,000 79,000

Accrued wages and benefits 7,000 (12,000)

Other current liabilities (4,000) (39,000)

Net cash used in operating activities (2,260,000) (3,530,000)

Cash flows from financing activities:

Proceeds from issuance of senior convertible notes (net) 925,000 3,388,000

Proceeds from demand notes 650,000

Proceeds from promissory notes 800,000

Repayment of promissory notes (150,000)

Proceeds from exercise of common stock warrant 1,000

Net cash provided by financing activities 2,225,000 3,389,000

Net decrease in cash (35,000) (141,000)

Cash at beginning of year 53,000 194,000

Cash at end of year 18,000 53,000

Supplemental Disclosures:

Cash used for payment of interest 86,000 271,000

Right to use asset 279,000

Exchange of promissory notes for convertible notes 225,000

Debt discount related to issuance of convertible notes 91,000 933,000

Common shares issued in payment of interest 44,000 80,000

Conversion of preferred shares to common 1,000 8,000

Common shares issued upon conversion of debt $ 49,000

X

- Definition
The value of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.
+ References
No definition available.
+ Details

Name: crgs_DebtConversionConvertedInstrumentValueOfSharesIssued

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The value of discount on the debt being converted in a noncash (or part noncash) transaction that is related to warrants and beneficial conversion feature.
+ References
No definition available.
+ Details

Name: crgs_DebtDiscountRelatedToWarrantsAndBeneficialConversionFeature

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Fair value of share rights issued with demand notes.
+ References
No definition available.
+ Details

Name: crgs_FairValueOfShareRightsIssuedWithDemandNotes

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in liability for inventory.
+ References
No definition available.
+ Details

Name: crgs_IncreaseDecreaseInLiabilityForInventory

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase of lessee's right to use underlying asset under operating lease.
+ References
No definition available.
+ Details

Name: crgs_OperatingLeaseRightofuseAssetAssumed

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Stock based compensation related to stock options and warrants.
+ References
No definition available.
+ Details

Name: crgs_StockBasedCompensationRelatedToStockOptionsAndWarrants

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of impairment loss from capitalized computer software costs.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756
+ Details

Name: us-gaap_CapitalizedComputerSoftwareImpairments1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586
+ Details

Name: us-gaap_ConversionOfStockAmountConverted1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586
+ Details

Name: us-gaap_DebtConversionOriginalDebtAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsReceivable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInInterestPayableNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in current liabilities classified as other.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInOtherCurrentLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) in prepaid expenses, and assets classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 17
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585
+ Details

Name: us-gaap_InterestPaidNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314
+ Details

Name: us-gaap_InventoryWriteDown

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_PaidInKindInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ProceedsFromLinesOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from an obligation which places a lender in a lien position behind debt having a higher priority of repayment (senior loan) in liquidation of the entity's assets scheduled to be repaid within one year or in the normal operating cycle of the entity, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromSubordinatedShortTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow associated with the amount received from holders exercising their stock warrants.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromWarrantExercises

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for an obligation which places a lender in a lien position behind debt having a higher priority of repayment (senior loan) in liquidation of the entity's assets scheduled to be repaid within one year or in the normal operating cycle of the entity, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfSubordinatedShortTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The fair value of stock issued in noncash financing activities.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586
+ Details

Name: us-gaap_StockIssued1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SupplementalCashFlowInformationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 50 R38.htm IDEA: XBRL DOCUMENT v3.20.1

Note 4 - Demand Note (Details Textual)
12 Months Ended

Jul. 23, 2019

USD ($)

$ / shares

Dec. 31, 2019

USD ($)

$ / shares

shares

Dec. 31, 2018

USD ($)

Long-term Debt, Gross $ 10,310,000 $ 9,160,000

Stock Issued During Period, Value, New Issues 21,000

Credit Facility with Co-borrowers [Member]

Line of Credit Facility, Maximum Borrowing Capacity $ 1,500,000

Debt Instrument, Convertible, Number of Equity Instruments 30,000

Debt Instrument, Convertible, Threshold Amount Needed to Invest to Convert a Specified Number of Equity Instruments $ 100,000

Debt Instrument, Convertible, Conversion Price | $ / shares $ 0.15

Debt Instrument, Term, Number of Days after Substantial Sale of Aegis Division 5 days

Long-term Debt, Gross $ 650,000

Stock Issued in Connection with Debt Issuance, Shares | shares 195,000

Stock Issued During Period, Value, New Issues $ 21,000

Debt Issuance Costs, Net, Total $ 37,000

Credit Facility with Co-borrowers [Member] | Prime Rate [Member]

Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate 4.75%

Credit Facility with Co-borrowers [Member] | Rights Related to Credit Facility with Co-borrowers [Member]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares 4,333,333

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 0.15

Warrants and Rights Outstanding $ 276,000

X

- Definition
The threshold amount needed to invest in order to convert the debt instrument into a specified number of equity instruments.
+ References
No definition available.
+ Details

Name: crgs_DebtInstrumentConvertibleThresholdAmountNeededToInvestToConvertASpecifiedNumberOfEquityInstruments

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of specified days after the sale of substantially all of the assets of the Aegis division for the debt instrument to mature, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: crgs_DebtInstrumentTermNumberOfDaysAfterSubstantialSaleOfAegisDivision

Namespace Prefix: crgs_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares issued during the period in connection with debt issuance.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedInConnectionWithDebtIssuanceShares

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(16))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_DebtInstrumentCarryingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The price per share of the conversion feature embedded in the debt instrument.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 5
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6031898-161870
+ Details

Name: us-gaap_DebtInstrumentConvertibleConversionPrice1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(5))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399
+ Details

Name: us-gaap_DeferredFinanceCostsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The interest rate applicable to the portion of the carrying amount of long-term borrowings outstanding as of the balance sheet date, including current maturities, which accrues interest at a rate subject to change from time to time.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtPercentageBearingVariableInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueNewIssues

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_WarrantsAndRightsOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_CreditFacilityWithCoBorrowersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_VariableRateAxis=us-gaap_PrimeRateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ClassOfWarrantOrRightAxis=crgs_RightsRelatedToCreditFacilityWithCoBorrowersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 51 R13.htm IDEA: XBRL DOCUMENT v3.20.1

Note 7 - Right to Use Building Asset
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Lessee, Operating Leases [Text Block]
NOTE
7
- RIGHT TO USE BUILDING ASSET

The FASB issued ASU
No.

2016
-
02,
“Leases,” which requires a lessee to recognize in its balance sheet the assets and liabilities related to long-term leases that were classified as operating leases under previous guidance. An asset is recognized related to the right to use the underlying asset and a liability is recognized related to the obligation to make lease payments over the term of the lease. The standard became effective for the Company
January 1, 2019.

As of
January 1, 2019,
the Company utilized the modified retrospective approach to measure the right to use operating lease agreement associated with the office building located at
1999
Mt. Read Blvd in Rochester New York. The adoption of this accounting standard did
not
impact our consolidated loss from operations and had
no
impact on cash flows. Upon adoption, the Company determined the present value of future lease costs at
$257,000,
which included monthly rental, common area costs, and taxes. The Company assumed an incremental borrowing rate of
6%
as the building lease agreement did
not
include an implicit rate. The right-to-use asset included
two
,
one
-year renewal options that ran through
May 2021.
On
September 1, 2019,
the Company vacated this property at the request of the landlord and relocated to a new office. The Company terminated the lease obligation without penalty or liability for unused periods associated with the original lease obligation and as such, the Company did
not
incur an impairment as a result of this change in lease term. Operating lease costs for this lease aggregated
$80,000
for year ended
December 31, 2019.

On
August 1, 2019,
the Company entered into an operating lease obligation for office space located at
350
Linden Oaks in Rochester New York. The Company determined the present value of future lease costs at the inception of the lease was
$212,000.
The Company assumed an incremental borrowing rate of
6%
as the building lease agreement did
not
include an implicit rate. The lease has a termination date of
December 30, 2022.
Operating lease costs for the year ended
December 31, 2019
were
$26,000
with future maturing lease obligations as follows:
$64,000
in
2020;

$64,000
in
2021
and
$63,000
in
2022.
Total future lease payments are
$212,000
including imputed interest of
$21,000.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=77888251
+ Details

Name: us-gaap_LesseeOperatingLeasesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 52 R17.htm IDEA: XBRL DOCUMENT v3.20.1

Note 11 - Income Taxes
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Income Tax Disclosure [Text Block]
NOTE
11
- INCOME TAXES

We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax bases of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than
not
that some portion or all of the deferred tax assets will
not
be realized.

The provision (benefit) for income taxes for the years ended
December 31, 2019
and
2018
is summarized below:

2019

2018

Current tax expense (benefit):

Federal
$
-
$
-

State

-

-

Deferred tax expense (benefit):

Federal

583,000

1,093,000

State

131,000

252,000

Change in valuation allowance

(714,000

)

(1,345,000

)

Provision for income tax
$
-
$
-

The difference between income taxes at the statutory federal income tax rate and income taxes reported in the statements of operations for each of the years ended
December 31, 2019
and
2018
is attributable to the following:

2019

2018

Income tax benefit at federal statutory rate
$
(898,000

)
$
(1,325,000

)

State income tax (benefit), net of effect of federal taxes

(103,000

)

(199,000

)

Non-deductible debt discount

157,000

132,000

Convertible debt interest expense
96,000

-

Debt issuance expense
70,000

-

Other

(36,000
)
47,000

Increase in valuation allowance
714,000

1,345,000

Provision for income taxes
$
-
$
-

The deferred tax asset at
December 31, 2019
and
2018
consists of the following:

2019

2018

Deferred income tax assets:

Net operating loss carryforwards
$
3,277,000
$
3,044,000

Deferred startup costs

11,224,000

10,787,000

Stock-based compensation

1,321,000

1,302,000

Other

141,000

117,000

15,963,000

15,250,000

Less: Valuation allowance

(15,963,000

)

(15,250,000

)

Net deferred tax asset
$
-
$
-

At
December 31, 2019,
we have approximately
$12,799,000
and
$12,095,000
of adjusted federal net operating loss carryforwards and New York State net operating loss carryforwards, respectively, to offset future taxable income. These net operating losses begin expiring in
2023
through
2038.
Beginning with tax years starting after
December 31, 2017,
NOL’s created can be carried forward indefinitely, however they can only be utilized in any given year, up to
80%
of taxable income in that year. In addition, we have
$249,000
of research and development tax credits carryforwards to offset future tax. These credits expire in
2039.
Furthermore, from the date of inception through
2019,
we have accumulated approximately
$43,413,000
of adjusted deferred startup costs. Start-up costs will be amortized over a
15
-year period beginning in the year we begin an active trade or business, with the exception of a nominal portion of these costs related to the sale of CURA software currently being amortized. We have provided a full valuation allowance on the net deferred tax assets due to uncertainty of realization through future earnings.

The amortization period for a nominal portion of the startup expenses,
$273,000,
under IRC Section
195
began in
2018
because the active trade or business related to those startup expenses commenced. The Company received revenue in
2018
and
2019
for the sale of subscription software services and demos of the CURA watch. An inventory reserve was booked in
2018
based on changes in technology developments. A full reserve was recorded for all inventory on hand and the Company is
no
longer pursuing sales of the related product. The Company expects CURA software sales will continue to be relevant to the Company's business. An election was made in
2018
to begin to amortize the IRC Section
195
costs related to the CURA software’s original cost, and modifications, which the Company is currently reselling. The remaining Section
195
costs will be amortized over a
15
-year period beginning in the year the Company begins as an active trade or business.

Based upon the change in ownership rules under Section
382
of the Internal Revenue Act of
1986,
if a company issues common stock or other equity instruments convertible into common shares which results in an ownership change exceeding a
50%
limitation threshold over a rolling
three
-year time frame as imposed by that Section, all of that company's net operating loss carryforwards
may
be significantly limited as to the amount of use in a particular year. Utilization of the NOL carry-forwards
may
be subject to an annual limitation in the case of sufficient equity ownership changes under Section
382
of the tax law or the NOLs
may
expire unutilized.



Reconciliations of the beginning and ending amounts of unrecognized tax benefits for the years ended
December 31, 2019
and
2018
are as follows:

2019 2018

Balance as of January 1 $
1,112,000
$
1,112,000

Additions based on tax positions related to current year
-

-

Additions based on enacted tax change in state rate
-

-

Additions for tax positions of prior years
-

-

Reductions for tax positions of prior years
-

-

Reductions based on enacted changes in tax rates
-

-

Settlements
-

-

Balance as of December 31 $
1,112,000
$
1,112,000

Tax years that remain subject to examination for our major tax jurisdictions include the years ended
December 31, 2016
through
December 31, 2019.
NOL's generated in previous years
may
also be subject to examination.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI http://asc.fasb.org/topic&trid=2144680
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 53 R59.htm IDEA: XBRL DOCUMENT v3.20.1

Note 15 - Related Party Transactions (Details Textual)
9 Months Ended 12 Months Ended

Sep. 30, 2019

shares

Dec. 31, 2019

USD ($)

shares

Dec. 31, 2018

USD ($)

shares

Proceeds from Subordinated Short-term Debt $ 800,000

Debt Conversion, Original Debt, Amount 225,000

Repayments of Subordinated Short-term Debt 150,000

Short-term Debt, Total 425,000

Conversion of Promissory Notes to 2019 Convertible Notes [Member]

Debt Conversion, Original Debt, Amount 225,000

Unsecured Subordinated Promissory Notes [Member]

Proceeds from Subordinated Short-term Debt 800,000

Repayments of Subordinated Short-term Debt 150,000

Short-term Debt, Total $ 425,000

Debt Instrument, Interest Rate, Stated Percentage 6.00%

Interest Expense, Debt, Total $ 15,000

The 2019 Convertible Notes [Member]

Debt Instrument, Convertible, Number of Equity Instruments 30,000

Debt Instrument, Interest Rate, Stated Percentage 6.00%

Six Members of the Board of Directors [Member] | Warrants Related to the Convertible Notes [Member]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares 1,239,288 1,239,288

Six Members of the Board of Directors [Member] | Convertible Notes [Member]

Notes Payable, Related Parties $ 2,477,000 $ 2,252,000

Debt Instrument, Convertible, Number of Equity Instruments 9,388,378 7,888,378

Interest Payable $ 164,000 $ 33,000

Chief Executive Officer [Member] | The 2019 Convertible Notes [Member]

Stock Issued in Connection with Debt Issuance, Shares | shares 60,000

Chief Executive Officer [Member] | Unsecured Subordinated Promissory Notes [Member]

Debt Instrument, Interest Rate, Stated Percentage 6.00%

Board Member [Member] | The 2019 Convertible Notes [Member]

Stock Issued in Connection with Debt Issuance, Shares | shares 7,500

Affiliated Entity [Member] | Warrants Related to the Convertible Notes [Member]

Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares 468,000 468,000

Interest Payable $ 88,000 $ 17,000

Affiliated Entity [Member] | Convertible Notes [Member]

Notes Payable, Related Parties $ 1,170,000 $ 1,170,000

Debt Instrument, Convertible, Number of Equity Instruments 4,680,000 4,680,000

X

- Definition
Number of shares issued during the period in connection with debt issuance.
+ References
No definition available.
+ Details

Name: crgs_StockIssuedInConnectionWithDebtIssuanceShares

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586
+ Details

Name: us-gaap_DebtConversionOriginalDebtAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(5))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense for debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_InterestExpenseDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of interest payable on debt, including, but not limited to, trade payables.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(5))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.15(a))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910
+ Details

Name: us-gaap_InterestPayableCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount for notes payable (written promise to pay), due to related parties.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.17)
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910
+ Details

Name: us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash inflow from an obligation which places a lender in a lien position behind debt having a higher priority of repayment (senior loan) in liquidation of the entity's assets scheduled to be repaid within one year or in the normal operating cycle of the entity, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromSubordinatedShortTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for an obligation which places a lender in a lien position behind debt having a higher priority of repayment (senior loan) in liquidation of the entity's assets scheduled to be repaid within one year or in the normal operating cycle of the entity, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfSubordinatedShortTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19)(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16)(a)(1))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(13))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_ShortTermBorrowings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_DebtConversionByUniqueDescriptionAxis=crgs_ConversionOfPromissoryNotesTo2019ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=crgs_UnsecuredSubordinatedPromissoryNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_The2019ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=crgs_SixMembersOfTheBoardOfDirectorsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ClassOfWarrantOrRightAxis=crgs_WarrantsRelatedToTheConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_UnsecuredSubordinatedPromissoryNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=crgs_BoardMemberMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 54 R51.htm IDEA: XBRL DOCUMENT v3.20.1

Note 11 - Income Taxes - Deferred Tax Asset (Details) - USD ($)

Dec. 31, 2019

Dec. 31, 2018

Deferred income tax assets:

Net operating loss carryforwards $ 3,277,000 $ 3,044,000

Deferred startup costs 11,224,000 10,787,000

Stock-based compensation 1,321,000 1,302,000

Other 141,000 117,000

15,963,000 15,250,000

Less: Valuation allowance (15,963,000) (15,250,000)

Net deferred tax asset

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredTaxAssetsNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314
+ Details

Name: us-gaap_DeferredTaxAssetsOperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 25
-Paragraph 20
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319
+ Details

Name: us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of fresh-start adjustment to current deferred income tax assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 740
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=99398922&loc=d3e57478-112775
+ Details

Name: us-gaap_FreshStartAdjustmentIncreaseDecreaseDeferredIncomeTaxAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 55 R55.htm IDEA: XBRL DOCUMENT v3.20.1

Note 13 - Stock Options - Stock Options Valuation Assumptions (Details)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Expected term (years) (Year) 5 years 146 days

Expected forfeiture rate 0.00%

Risk-free rate 2.80%

Volatility 137.00%

Dividend yield 0.00%

X

- References
No definition available.
+ Details

Name: crgs_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate

Namespace Prefix: crgs_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.D.2)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

XML 56 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 185 414 1 true 68 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.curaegis.com/20191231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.curaegis.com/20191231/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.curaegis.com/20191231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://www.curaegis.com/20191231/role/statement-consolidated-statements-of-operations Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Changes in Stockholders' Equity (Deficiency) Sheet http://www.curaegis.com/20191231/role/statement-consolidated-statements-of-changes-in-stockholders-equity-deficiency Consolidated Statements of Changes in Stockholders' Equity (Deficiency) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.curaegis.com/20191231/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Note 1 - The Company and Basis of Presentation Sheet http://www.curaegis.com/20191231/role/statement-note-1-the-company-and-basis-of-presentation Note 1 - The Company and Basis of Presentation Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Summary of Significant Accounting Policies Sheet http://www.curaegis.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies Note 2 - Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Inventory and Related Vendor Liability Sheet http://www.curaegis.com/20191231/role/statement-note-3-inventory-and-related-vendor-liability Note 3 - Inventory and Related Vendor Liability Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Demand Note Sheet http://www.curaegis.com/20191231/role/statement-note-4-demand-note- Note 4 - Demand Note Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Senior Convertible Notes and Warrants Notes http://www.curaegis.com/20191231/role/statement-note-5-senior-convertible-notes-and-warrants Note 5 - Senior Convertible Notes and Warrants Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Unsecured Subordinated Promissory Notes Notes http://www.curaegis.com/20191231/role/statement-note-6-unsecured-subordinated-promissory-notes Note 6 - Unsecured Subordinated Promissory Notes Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Right to Use Building Asset Sheet http://www.curaegis.com/20191231/role/statement-note-7-right-to-use-building-asset Note 7 - Right to Use Building Asset Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Software Sheet http://www.curaegis.com/20191231/role/statement-note-8-software- Note 8 - Software Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Property and Equipment Sheet http://www.curaegis.com/20191231/role/statement-note-9-property-and-equipment Note 9 - Property and Equipment Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Business Segments Sheet http://www.curaegis.com/20191231/role/statement-note-10-business-segments- Note 10 - Business Segments Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Income Taxes Sheet http://www.curaegis.com/20191231/role/statement-note-11-income-taxes Note 11 - Income Taxes Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Preferred and Common Stock Sheet http://www.curaegis.com/20191231/role/statement-note-12-preferred-and-common-stock Note 12 - Preferred and Common Stock Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Stock Options Sheet http://www.curaegis.com/20191231/role/statement-note-13-stock-options Note 13 - Stock Options Notes 19 false false R20.htm 019 - Disclosure - Note 14 - Warrants Sheet http://www.curaegis.com/20191231/role/statement-note-14-warrants- Note 14 - Warrants Notes 20 false false R21.htm 020 - Disclosure - Note 15 - Related Party Transactions Sheet http://www.curaegis.com/20191231/role/statement-note-15-related-party-transactions Note 15 - Related Party Transactions Notes 21 false false R22.htm 021 - Disclosure - Note 16 - Commitments and Other Matters Sheet http://www.curaegis.com/20191231/role/statement-note-16-commitments-and-other-matters Note 16 - Commitments and Other Matters Notes 22 false false R23.htm 022 - Disclosure - Note 17 - Subsequent Events Sheet http://www.curaegis.com/20191231/role/statement-note-17-subsequent-events Note 17 - Subsequent Events Notes 23 false false R24.htm 023 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.curaegis.com/20191231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.curaegis.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies 24 false false R25.htm 024 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Tables) Sheet http://www.curaegis.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-tables Note 2 - Summary of Significant Accounting Policies (Tables) Tables http://www.curaegis.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies 25 false false R26.htm 025 - Disclosure - Note 3 - Inventory and Related Vendor Liability (Tables) Sheet http://www.curaegis.com/20191231/role/statement-note-3-inventory-and-related-vendor-liability-tables Note 3 - Inventory and Related Vendor Liability (Tables) Tables http://www.curaegis.com/20191231/role/statement-note-3-inventory-and-related-vendor-liability 26 false false R27.htm 026 - Disclosure - Note 5 - Senior Convertible Notes and Warrants (Tables) Notes http://www.curaegis.com/20191231/role/statement-note-5-senior-convertible-notes-and-warrants-tables Note 5 - Senior Convertible Notes and Warrants (Tables) Tables http://www.curaegis.com/20191231/role/statement-note-5-senior-convertible-notes-and-warrants 27 false false R28.htm 027 - Disclosure - Note 9 - Property and Equipment (Tables) Sheet http://www.curaegis.com/20191231/role/statement-note-9-property-and-equipment-tables Note 9 - Property and Equipment (Tables) Tables http://www.curaegis.com/20191231/role/statement-note-9-property-and-equipment 28 false false R29.htm 028 - Disclosure - Note 10 - Business Segments (Tables) Sheet http://www.curaegis.com/20191231/role/statement-note-10-business-segments-tables Note 10 - Business Segments (Tables) Tables http://www.curaegis.com/20191231/role/statement-note-10-business-segments- 29 false false R30.htm 029 - Disclosure - Note 11 - Income Taxes (Tables) Sheet http://www.curaegis.com/20191231/role/statement-note-11-income-taxes-tables Note 11 - Income Taxes (Tables) Tables http://www.curaegis.com/20191231/role/statement-note-11-income-taxes 30 false false R31.htm 030 - Disclosure - Note 13 - Stock Options (Tables) Sheet http://www.curaegis.com/20191231/role/statement-note-13-stock-options-tables Note 13 - Stock Options (Tables) Tables http://www.curaegis.com/20191231/role/statement-note-13-stock-options 31 false false R32.htm 031 - Disclosure - Note 14 - Warrants (Tables) Sheet http://www.curaegis.com/20191231/role/statement-note-14-warrants-tables Note 14 - Warrants (Tables) Tables http://www.curaegis.com/20191231/role/statement-note-14-warrants- 32 false false R33.htm 032 - Disclosure - Note 1 - The Company and Basis of Presentation (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-1-the-company-and-basis-of-presentation-details-textual Note 1 - The Company and Basis of Presentation (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-1-the-company-and-basis-of-presentation 33 false false R34.htm 033 - Disclosure - Note 2 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-details-textual Note 2 - Summary of Significant Accounting Policies (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-tables 34 false false R35.htm 034 - Disclosure - Note 2 - Summary of Significant Accounting Policies - Depreciation and Amortization (Details) Sheet http://www.curaegis.com/20191231/role/statement-note-2-summary-of-significant-accounting-policies-depreciation-and-amortization-details Note 2 - Summary of Significant Accounting Policies - Depreciation and Amortization (Details) Details 35 false false R36.htm 035 - Disclosure - Note 3 - Inventory and Related Vendor Liability (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-3-inventory-and-related-vendor-liability-details-textual Note 3 - Inventory and Related Vendor Liability (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-3-inventory-and-related-vendor-liability-tables 36 false false R37.htm 036 - Disclosure - Note 3 - Inventory and Related Vendor Liability - Inventory (Details) Sheet http://www.curaegis.com/20191231/role/statement-note-3-inventory-and-related-vendor-liability-inventory-details Note 3 - Inventory and Related Vendor Liability - Inventory (Details) Details 37 false false R38.htm 037 - Disclosure - Note 4 - Demand Note (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-4-demand-note-details-textual Note 4 - Demand Note (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-4-demand-note- 38 false false R39.htm 038 - Disclosure - Note 5 - Senior Convertible Notes and Warrants (Details Textual) Notes http://www.curaegis.com/20191231/role/statement-note-5-senior-convertible-notes-and-warrants-details-textual Note 5 - Senior Convertible Notes and Warrants (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-5-senior-convertible-notes-and-warrants-tables 39 false false R40.htm 039 - Disclosure - Note 5 - Senior Convertible Notes and Warrants - Schedule of Senior Convertible Notes Outstanding (Details) Notes http://www.curaegis.com/20191231/role/statement-note-5-senior-convertible-notes-and-warrants-schedule-of-senior-convertible-notes-outstanding-details Note 5 - Senior Convertible Notes and Warrants - Schedule of Senior Convertible Notes Outstanding (Details) Details 40 false false R41.htm 040 - Disclosure - Note 6 - Unsecured Subordinated Promissory Notes (Details Textual) Notes http://www.curaegis.com/20191231/role/statement-note-6-unsecured-subordinated-promissory-notes-details-textual Note 6 - Unsecured Subordinated Promissory Notes (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-6-unsecured-subordinated-promissory-notes 41 false false R42.htm 041 - Disclosure - Note 7 - Right to Use Building Asset (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-7-right-to-use-building-asset-details-textual Note 7 - Right to Use Building Asset (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-7-right-to-use-building-asset 42 false false R43.htm 042 - Disclosure - Note 8 - Software (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-8-software-details-textual Note 8 - Software (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-8-software- 43 false false R44.htm 043 - Disclosure - Note 9 - Property and Equipment (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-9-property-and-equipment-details-textual Note 9 - Property and Equipment (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-9-property-and-equipment-tables 44 false false R45.htm 044 - Disclosure - Note 9 - Property and Equipment - Property and Equipment (Details) Sheet http://www.curaegis.com/20191231/role/statement-note-9-property-and-equipment-property-and-equipment-details Note 9 - Property and Equipment - Property and Equipment (Details) Details 45 false false R46.htm 045 - Disclosure - Note 10 - Business Segments (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-10-business-segments-details-textual Note 10 - Business Segments (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-10-business-segments-tables 46 false false R47.htm 046 - Disclosure - Note 10 - Business Segments - Operation by Segments (Details) Sheet http://www.curaegis.com/20191231/role/statement-note-10-business-segments-operation-by-segments-details Note 10 - Business Segments - Operation by Segments (Details) Details 47 false false R48.htm 047 - Disclosure - Note 11 - Income Taxes (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-11-income-taxes-details-textual Note 11 - Income Taxes (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-11-income-taxes-tables 48 false false R49.htm 048 - Disclosure - Note 11 - Income Taxes - Provision (Benefit) for Income Taxes (Details) Sheet http://www.curaegis.com/20191231/role/statement-note-11-income-taxes-provision-benefit-for-income-taxes-details Note 11 - Income Taxes - Provision (Benefit) for Income Taxes (Details) Details 49 false false R50.htm 049 - Disclosure - Note 11 - Income Taxes - Effective Income Tax Rate Reconciliation (Details) Sheet http://www.curaegis.com/20191231/role/statement-note-11-income-taxes-effective-income-tax-rate-reconciliation-details Note 11 - Income Taxes - Effective Income Tax Rate Reconciliation (Details) Details 50 false false R51.htm 050 - Disclosure - Note 11 - Income Taxes - Deferred Tax Asset (Details) Sheet http://www.curaegis.com/20191231/role/statement-note-11-income-taxes-deferred-tax-asset-details Note 11 - Income Taxes - Deferred Tax Asset (Details) Details 51 false false R52.htm 051 - Disclosure - Note 11 - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) Sheet http://www.curaegis.com/20191231/role/statement-note-11-income-taxes-reconciliation-of-unrecognized-tax-benefits-details Note 11 - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) Details 52 false false R53.htm 052 - Disclosure - Note 12 - Preferred and Common Stock (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-12-preferred-and-common-stock-details-textual Note 12 - Preferred and Common Stock (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-12-preferred-and-common-stock 53 false false R54.htm 053 - Disclosure - Note 13 - Stock Options (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-13-stock-options-details-textual Note 13 - Stock Options (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-13-stock-options-tables 54 false false R55.htm 054 - Disclosure - Note 13 - Stock Options - Stock Options Valuation Assumptions (Details) Sheet http://www.curaegis.com/20191231/role/statement-note-13-stock-options-stock-options-valuation-assumptions-details Note 13 - Stock Options - Stock Options Valuation Assumptions (Details) Details 55 false false R56.htm 055 - Disclosure - Note 13 - Stock Options - Share-based Compensation, Stock Options, Activity (Details) Sheet http://www.curaegis.com/20191231/role/statement-note-13-stock-options-sharebased-compensation-stock-options-activity-details Note 13 - Stock Options - Share-based Compensation, Stock Options, Activity (Details) Details 56 false false R57.htm 056 - Disclosure - Note 14 - Warrants (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-14-warrants-details-textual Note 14 - Warrants (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-14-warrants-tables 57 false false R58.htm 057 - Disclosure - Note 14 - Warrants - Summary of Outstanding Warrants (Details) Sheet http://www.curaegis.com/20191231/role/statement-note-14-warrants-summary-of-outstanding-warrants-details Note 14 - Warrants - Summary of Outstanding Warrants (Details) Details 58 false false R59.htm 058 - Disclosure - Note 15 - Related Party Transactions (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-15-related-party-transactions-details-textual Note 15 - Related Party Transactions (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-15-related-party-transactions 59 false false R60.htm 059 - Disclosure - Note 16 - Commitments and Other Matters (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-16-commitments-and-other-matters-details-textual Note 16 - Commitments and Other Matters (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-16-commitments-and-other-matters 60 false false R61.htm 060 - Disclosure - Note 17 - Subsequent Events (Details Textual) Sheet http://www.curaegis.com/20191231/role/statement-note-17-subsequent-events-details-textual Note 17 - Subsequent Events (Details Textual) Details http://www.curaegis.com/20191231/role/statement-note-17-subsequent-events 61 false false All Reports Book All Reports crgs-20191231.xml crgs-20191231.xsd crgs-20191231_cal.xml crgs-20191231_def.xml crgs-20191231_lab.xml crgs-20191231_pre.xml http://fasb.org/srt/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true XML 57 R44.htm IDEA: XBRL DOCUMENT v3.20.1

Note 9 - Property and Equipment (Details Textual) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Depreciation, Total $ 24,000 $ 46,000

X

- Definition
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_Depreciation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 58 R40.htm IDEA: XBRL DOCUMENT v3.20.1

Note 5 - Senior Convertible Notes and Warrants - Schedule of Senior Convertible Notes Outstanding (Details) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Face value $ 9,160,000

Notes issued 1,150,000

Face value 10,310,000 $ 9,160,000

Debt discount (2,557,000)

Debt discount issued (91,000)

Amortization reported as interest 748,000 627,000

Debt discount (1,900,000) (2,557,000)

Senior convertible notes (net) 8,410,000

The 2019 Convertible Notes [Member]

Face value

Notes issued 650,000

Face value 650,000

Debt discount

Debt discount issued (26,000)

Amortization reported as interest 23,000

Debt discount (3,000)

Senior convertible notes (net) 647,000

July 2018 Convertible Notes [Member]

Face value 1,175,000

Notes issued 500,000 1,175,000

Face value 1,675,000 1,175,000

Debt discount (360,000)

Debt discount issued (65,000) (380,000)

Amortization reported as interest 72,000

Debt discount (353,000) (360,000)

Senior convertible notes (net) 1,322,000

The 2018 Convertible Notes [Member]

Face value 625,000

Notes issued

Face value 625,000 625,000

Debt discount (231,000)

Debt discount issued

Amortization reported as interest 46,000

Debt discount (185,000) (231,000)

Senior convertible notes (net) 440,000

The 2017 Convertible Notes [Member]

Face value 4,370,000

Notes issued

Face value 4,370,000 4,370,000

Debt discount (456,000)

Debt discount issued

Amortization reported as interest 94,000 105,000

Debt discount (362,000) (456,000)

Senior convertible notes (net) 4,008,000

The 2016 Convertible Notes [Member]

Face value 2,990,000

Notes issued

Face value 2,990,000 2,990,000

Debt discount (1,510,000)

Debt discount issued

Amortization reported as interest 513,000 483,000

Debt discount (997,000) $ (1,510,000)

Senior convertible notes (net) $ 1,993,000

X

- Definition
The amount of increase in unamortized debt discount due to issuance.
+ References
No definition available.
+ Details

Name: crgs_IncreaseInUnamortizedDebtDiscountDueToIssuance

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(16))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_DebtInstrumentCarryingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after accumulated amortization, of debt discount.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400
+ Details

Name: us-gaap_DebtInstrumentUnamortizedDiscount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)(3)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromConvertibleDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_The2019ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_July2018ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_The2018ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_The2017ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_The2016ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 59 R48.htm IDEA: XBRL DOCUMENT v3.20.1

Note 11 - Income Taxes (Details Textual)
12 Months Ended

Dec. 31, 2019

USD ($)

Accumulated Deferred Startup Costs $ 43,413,000

Amortization of Startup Costs $ 273,000

Amortization Period Of Startup Costs 15 years

Research Tax Credit Carryforward [Member]

Tax Credit Carryforward, Amount $ 249,000

Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]

Operating Loss Carryforwards, Total 12,799,000

State and Local Jurisdiction [Member] | New York State Division of Taxation and Finance [Member]

Operating Loss Carryforwards, Total $ 12,095,000

X

- Definition
The amount of accumulated deferred startup costs.
+ References
No definition available.
+ Details

Name: crgs_AccumulatedDeferredStartupCosts

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The amount of expense recognized in the current period that reflects the amortization of accrued startup costs.
+ References
No definition available.
+ Details

Name: crgs_AmortizationOfStartupCosts

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Period when deferred startup costs are amortized upon active trade or business, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: crgs_AmortizationPeriodOfStartupCosts

Namespace Prefix: crgs_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319
+ Details

Name: us-gaap_OperatingLossCarryforwards

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319
+ Details

Name: us-gaap_TaxCreditCarryforwardAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_NewYorkStateDivisionOfTaxationAndFinanceMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 60 R29.htm IDEA: XBRL DOCUMENT v3.20.1

Note 10 - Business Segments (Tables)
12 Months Ended

Dec. 31, 2019

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

CURA

Aegis

Corporate

Total

Revenue
$
15,000
$
-
$
-
$
15,000

Gross margin

2,000

-

-

2,000

Loss from operations

(614,000
)
(513,000
)
(1,301,000
)
(2,428,000
)

Non-operating expense

-

-

(1,848,000
)
(1,848,000
)

Net loss
$
(614,000
) $
(513,000
) $
(3,149,000
) $
(4,276,000
)

Stock based compensation
$
3,000
$
17,000
$
106,000
$
126,000

Depreciation and amortization
$
14,000
$
18,000
$
100,000
$
132,000

Assets at December 31, 2019
$
1,000
$
36,000
$
214,000
$
251,000

CURA

Aegis

Corporate

Total

Revenue
$
37,000
$
-
$
-
$
37,000

Gross margin (loss) on revenue

(73,000)

-

-

(73,000)

Loss from operations

(3,155,000
)
(658,000
)
(1,439,000
)
(5,252,000
)

Non-operating expense

-

-

(1,056,000
)
(1,056,000
)

Net loss
$
(3,155,000
) $
(658,000
) $
(2,495,000
) $
(6,308,000
)

Stock based compensation
$
1,000
$
44,000
$
135,000
$
180,000

Depreciation and amortization
$
110,000
$
20,000
$
8,000
$
138,000

Assets at December 31, 2018
$
15,000
$
54,000
$
81,000
$
150,000

X

- Definition
Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599
+ Details

Name: us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 61 R21.htm IDEA: XBRL DOCUMENT v3.20.1

Note 15 - Related Party Transactions
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Related Party Transactions Disclosure [Text Block]
NOTE
1
5
-
RELATED PARTY TRANSACTIONS

As of
December 31, 2019,
and
December 31, 2018,
the Company had outstanding
$2,477,000
and
$2,252,000,
respectively, in senior convertible notes held by
six
members of our board of directors. These notes represent
9,388,378
of potential shares of common stock at
December 31, 2019
and
7,888,378
at
December 31, 2018.
The Company granted
1,239,288
warrants to these board members in connection with their investment in the convertible notes. During
2019,
the Company issued
60,000
and
7,500
common shares to the Company's Chief Executive Officer and to another board member in connection with their investment in the
2019
Convertible Notes, as further described in Note
5.
The Company had
$164,000
and
$33,000
in accrued interest on convertible and promissory notes due to board members outstanding at
December 31, 2019
and
December 31, 2018,
respectively.

As of
December 31, 2019,
and
December 31, 2018,
the Company had outstanding a
$
1,170,000
senior convertible note held by an investor that is deemed an affiliate. This note represents
4,680,000
of potential shares of common stock as of these reporting dates. Underlying warrants associated with this note represent
468,000
of potential shares of common stock. At
December 31, 2019
and
December 31, 2018,
the Company had
$88,000
and
$17,000
respectively, in accrued interest outstanding on this convertible note.

During
2019,
the Company issued unsecured subordinated promissory notes of
$800,000
of which
$225,000
was subsequently converted into
2019
convertible notes and
$150,000
was repaid resulting in
$425,000
of outstanding promissory notes payable to our Chief Executive Officer as of
December 31, 2019.
The unsecured promissory notes have maturity date of
June 30, 2020
and accrue interest at
6%
per annum. Accrued and unpaid interest due on the promissory notes was
$15,000
as of
December 31, 2019.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-URI http://asc.fasb.org/topic&trid=2122745
+ Details

Name: us-gaap_RelatedPartyTransactionsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 62 R25.htm IDEA: XBRL DOCUMENT v3.20.1

Note 2 - Summary of Significant Accounting Policies (Tables)
12 Months Ended

Dec. 31, 2019

Notes Tables

Depreciation and Amortization [Table Text Block]

For Years ended

December 31,

2019

2018

Amortization right-to-use asset
$
98,000
$
-

Software

10,000

92,000

Property and equipment

24,000

46,000

$
132,000
$
138,000

X

- Definition
Tabular disclosure of depreciation and amortization.
+ References
No definition available.
+ Details

Name: crgs_DepreciationAndAmortizationTableTextBlock

Namespace Prefix: crgs_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 63 R49.htm IDEA: XBRL DOCUMENT v3.20.1

Note 11 - Income Taxes - Provision (Benefit) for Income Taxes (Details) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Current tax expense (benefit):

Federal

State

Deferred tax expense (benefit):

Federal 583,000 1,093,000

State 131,000 252,000

Change in valuation allowance (714,000) (1,345,000)

Provision for income tax

X

- Definition
Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_CurrentFederalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_CurrentStateAndLocalTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817
+ Details

Name: us-gaap_DeferredFederalIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319
+ Details

Name: us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=116821951&loc=d3e32123-109318
+ Details

Name: us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 64 R45.htm IDEA: XBRL DOCUMENT v3.20.1

Note 9 - Property and Equipment - Property and Equipment (Details) - USD ($)

Dec. 31, 2019

Dec. 31, 2018

Office equipment $ 199,000 $ 249,000

Shop equipment 132,000 182,000

Leasehold improvements 253,000

331,000 684,000

Less accumulated depreciation (293,000) (622,000)

Net property and equipment $ 38,000 $ 62,000

X

- Definition
Represents for office equipment, gross.
+ References
No definition available.
+ Details

Name: crgs_OfficeEquipmentGross

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.14)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 4
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_LeaseholdImprovementsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 4
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_MachineryAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 65 R41.htm IDEA: XBRL DOCUMENT v3.20.1

Note 6 - Unsecured Subordinated Promissory Notes (Details Textual) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Proceeds from Subordinated Short-term Debt $ 800,000

Short-term Debt, Total 425,000

Repayments of Subordinated Short-term Debt 150,000

Debt Conversion, Original Debt, Amount 225,000

Conversion of Promissory Notes to 2019 Convertible Notes [Member]

Debt Conversion, Original Debt, Amount 225,000

Unsecured Subordinated Promissory Notes [Member]

Proceeds from Subordinated Short-term Debt $ 800,000

Debt Instrument, Interest Rate, Stated Percentage 6.00%

Debt Instrument, Term 90 days

Short-term Debt, Total $ 425,000

Repayments of Subordinated Short-term Debt 150,000

Interest Expense, Debt, Total $ 15,000

X

- Definition
The amount of the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586
+ Details

Name: us-gaap_DebtConversionOriginalDebtAmount1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense for debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_InterestExpenseDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash inflow from an obligation which places a lender in a lien position behind debt having a higher priority of repayment (senior loan) in liquidation of the entity's assets scheduled to be repaid within one year or in the normal operating cycle of the entity, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromSubordinatedShortTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The cash outflow for an obligation which places a lender in a lien position behind debt having a higher priority of repayment (senior loan) in liquidation of the entity's assets scheduled to be repaid within one year or in the normal operating cycle of the entity, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585
+ Details

Name: us-gaap_RepaymentsOfSubordinatedShortTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19)(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16)(a)(1))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(13))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_ShortTermBorrowings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_DebtConversionByUniqueDescriptionAxis=crgs_ConversionOfPromissoryNotesTo2019ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ShortTermDebtTypeAxis=crgs_UnsecuredSubordinatedPromissoryNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 66 R20.htm IDEA: XBRL DOCUMENT v3.20.1

Note 14 - Warrants
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Stockholders Equity Note Warrants Or Rights [Text Block]
NOTE
14
- WARRANTS

The following summarizes the activity of our outstanding warrants as of
December 31, 2019:

Weighted

Weighted

Average

Average

Remaining

Aggregate

Exercise

Contractual

Intrinsic

Shares

Price

Term

Value

Outstanding at January 1, 2019

7,381,707
$
0.46

(a)

7.0

(b)
$
39,000

Granted

350,000

0.25

Exercised

-

-

Canceled or expired

-

-

Outstanding at December 31, 2019

7,731,707
$
0.45

(a)

6.2

(b)
$
33,000

Exercisable at December 31, 2019

7,106,707
$
0.49

6.2

(c)
$
33,000

(a)

The weighted average exercise price for warrants outstanding excludes
1,750,000
warrants in each period with
no
determined exercise price.

(b)

The weighted average remaining contractual term for warrants outstanding excludes

743,500
warrants with
no
expiration date.

(c)

The weighted average remaining contractual term for warrants exercisable excludes
118,500
warrants with
no
expiration date.

X

- Definition
The entire disclosure for a company's Warrants and rights outstanding. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.
+ References
No definition available.
+ Details

Name: crgs_StockholdersEquityNoteWarrantsOrRightsTextBlock

Namespace Prefix: crgs_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 67 R24.htm IDEA: XBRL DOCUMENT v3.20.1

Significant Accounting Policies (Policies)
12 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Consolidation, Policy [Policy Text Block]
Consolidation:
The financial statements include the accounts of the Company, our wholly-owned subsidiary Iso-Torque Corporation, and our majority-owned subsidiary, Ice Surface Development, Inc. (
56%
owned). These subsidiaries are non-operational.

Use of Estimates, Policy [Policy Text Block]
Use of Estimates:
The preparation of financial statements in conformity with U.S. generally accepted accounting principles (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates are subject to a high degree of judgment and potential change. Actual results could differ from those estimates.

Reclassification, Policy [Policy Text Block]
Reclassifications:
Certain reclassifications
may
have been made to prior year balances to conform to the current year’s presentation.

Cash and Cash Equivalents, Policy [Policy Text Block]
Cash:
We maintain cash at financial institutions which periodically
may
exceed federally insured amounts. We have a corporate credit card program through our primary financial institution, JPMorgan Chase Bank, N.A. In connection with this, the Company granted a security interest to the bank in our money market account to act as collateral for the activity within the corporate card program, up to
$5,000.

Receivable [Policy Text Block]
Accounts Receivable
: We carry our accounts receivable at invoice amount less an allowance for doubtful accounts. On a periodic basis, we evaluate our accounts receivable and establish an allowance for doubtful accounts, based on a history of past write-offs and collections and current credit conditions. We do
not
accrue interest on past due invoices. The allowance for doubtful accounts was
zero

at
December 31, 2019
and
December 31, 2018.

Inventory, Policy [Policy Text Block]
Inventory
: Inventory is stated at the lower of cost or net realizable value with cost determined under the average cost method. We record provisions for excess, obsolete or slow-moving inventory based on changes in customer demand, technology developments or other economic factors. Inventory on hand at
December 31, 2019
and
2018
has been fully reserved.

Depreciation, Depletion, and Amortization [Policy Text Block]
Depreciation and amortization:
Depreciation and amortization are computed using the straight-line method. Depreciation and amortization expense for the years ended
December 31, 2019
and
2018
are as follows:

For Years ended

December 31,

2019

2018

Amortization right-to-use asset
$
98,000
$
-

Software

10,000

92,000

Property and equipment

24,000

46,000

$
132,000
$
138,000

Lessee, Leases [Policy Text Block]
Right to use building asset:
The FASB issued ASU
No.

2016
-
02,
“Leases,” which requires a lessee to recognize on its balance sheet the assets and liabilities related to long-term leases that were classified as operating leases under previous guidance. An asset is recognized related to the Company's ability to retain the economic benefits and control of the underlying asset. A corresponding liability is recognized related to the Company's obligation to make lease payments over the term of the lease.

The standard became effective for the Company
January 1, 2019.
The Company utilized the modified retrospective approach to measure the right to use operating lease agreement associated with the office building used for our business operations located in Rochester, New York. The adoption of this accounting standard did
not
impact our consolidated loss from operations and had
no
impact on cash flows.

Software Property And Equipment [Policy Text Block]
Software, Property and Equipment:
Capitalized software, property and equipment are stated at cost. Estimated useful lives for capitalized software is
3
years and for property and equipment is
5
to
7
years. Betterments, renewals and significant repairs that extend the life of the assets are capitalized. Other repairs and maintenance costs are expensed when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in other income (expense).

Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment
may
be indicated. The carrying amount is compared to the estimated discounted cash flows and if there is an excess such amount is recorded as impairment.

During the year ended
December 31, 2018
we recorded an impairment charge of
$17,000
on certain property and equipment.

Fair Value Measurement, Policy [Policy Text Block]
Fair Value of Financial Instruments:
As defined by U.S. GAAP
,
fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A hierarchy for ranking the quality and reliability of the information is used to determine fair values. Assets and liabilities carried at fair value will be classified and disclosed in
one
of the following
three
categories:

Level
1:
Quoted market prices in active markets for identical assets or liabilities

Level
2:
Observable market-based inputs or unobservable inputs that are corroborated by market data

Level
3:
Unobservable inputs that are
not
corroborated by market data

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level
1
measurements) and the lowest priority to unobservable inputs (Level
3
measurements). The Financial Accounting Standards Board’s (“FASB”) guidance for the disclosure about fair value of financial instruments requires disclosure of an estimate of the fair value of certain financial instruments. The fair value of financial instruments pursuant to FASB’s guidance for the disclosure about fair value of financial instruments approximated their carrying values at
December 31, 2019
and
December 31, 2018.
The carrying amount of cash, prepaid expenses and other current assets, liability for inventory, accounts payable, accrued expenses, demand and promissory notes approximates their fair value due to their short maturity. The senior convertible notes can be converted into common stock with an underlying value of
$3,436,000
as of
December 31, 2019
based on the trading price on
December 31, 2019.

Revenue [Policy Text Block]
Revenue Recognition and Deferred Revenue:
On
January 1, 2018,
the Company adopted FASB ASC
606,
"Revenue from Contracts with Customers" and all related amendments for all contracts using the modified retrospective method. There was
no
impact upon the adoption of FASB ASC
606.
The Company has determined that the adoption of this standard did
not
require a cumulative effect adjustment. For contracts where performance obligations are satisfied at a point in time, the Company recognizes revenue when the product is shipped to the customer. For contracts where the performance obligation is satisfied over time, as in the Z-Coach sales, the Company recognizes revenue over the subscription period. Revenue from the sale of the Company's products is recognized net of cash discounts, sales returns and allowances. The Company has
two
sources of revenue: (i) from the sale of MyCadian system products and (ii) from stand-alone Z-Coach subscriptions.

The Company's net revenue is derived primarily from domestic customers. For the year ended
December 31, 2019
net revenue from products transferred over time amounted to
$13,000
and net revenue from products transferred at a point in time amounted to
$2,000.
One customer accounted for
43%
of total Z-Coach subscription sales made during the year ended
December 31, 2019.
Our collection terms provide customers standard terms of net
30
days. Future performance obligations are reflected in deferred revenue.

CURA revenue is recognized (a) upon receipt of payment at the point of sale of the CURA app, (b) upon the delivery of myCadian products and (c) upon the company’s satisfaction of all performance obligations as described in customer agreements. The Z-Coach Program provides fatigue training over an annual subscription period of
twelve
months. The Z-Coach Program allows the user unlimited access during the annual subscription period. Customers are billed at the acceptance of the subscription, and revenue is recognized ratably over the subscription period as our performance obligations are satisfied and when collection is reasonably assured. Our collection terms provide customers standard terms of net
30
days.

In Process Research and Development, Policy [Policy Text Block]
Engineering and Development and Patents:
Engineering and development costs and patent expenses are charged to operations as incurred. Engineering and development include personnel-related costs, materials and supplies, depreciation and consulting services. Patent costs for the years ended
December 31, 2019
and
2018
amounted to
$45,000
and
$150,000,
respectively, and are included in general and administrative expenses.

Share-based Payment Arrangement [Policy Text Block]
Stock-based Compensation:
FASB Accounting Standards Codification (“ASC”)
718
-
10
requires all share-based payments to employees, including grants of employee stock options, to be recognized as compensation expense over the service period (generally the vesting period) in the consolidated financial statements based on their fair values on the grant date. In addition, the realization of tax benefits in excess of amounts recognized for financial reporting purposes will be recognized as a financing activity in accordance with FASB ASC
718
-
10.

No
tax benefits were attributed to the stock-based compensation expense because a valuation allowance was maintained for substantially all net deferred tax assets.

During
2018,
the Company adopted FASB ASU
2018
-
07,
“Equity-Based Payments to Non-Employees,” which requires all share-based payments to non-employees, including grants of stock options, to be recognized in the consolidated financial statements as expense generally over the service period of the consulting arrangement or as performance conditions are expected to be met. The Company utilized a modified retrospective approach effective as of
January 1, 2018
in the adoption of this accounting guidance which resulted in a
$10,000
reduction of stock compensation expense previously reported. FASB ASC
718
-
20
requires that modifications of the terms or conditions of equity awards be treated as an exchange of the original award for a new award. Incremental compensation cost is measured as the excess, if any, of the fair value of the modified award over the fair value of the original award immediately before its terms are modified.

Income Tax, Policy [Policy Text Block]
Income Taxes:
We account for income taxes using the asset and liability method, the objective of which is to establish deferred tax assets and liabilities for the temporary differences between the financial reporting and the tax basis of our assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. A valuation allowance related to deferred tax assets is recorded when it is more likely than
not
that some portion or all of the deferred tax assets will
not
be realized.

We account for uncertain tax positions using a more-likely-than-
not
recognition threshold based on the technical merits of the tax position taken. Tax benefits that meet the more-likely-than-
not
recognition threshold should be measured as the largest amount of tax benefits, determined on a cumulative probability basis, which is more likely than
not
to be realized upon ultimate settlement in the financial statements. It is our policy to recognize interest and penalties related to income tax matters as general and administrative expenses. As of
December 31, 2019,
and
December 31, 2018,
there were
no

accrued interest or penalties related to uncertain tax positions.

Earnings Per Share, Policy [Policy Text Block]
Loss per Common Share:
FASB’s ASC
260
-
10
(“Earnings Per Share”) requires the presentation of basic earnings per share, which is based on weighted average common stock outstanding, and dilutive earnings per share, which gives effect to options, warrants and convertible securities in periods when they are dilutive. At
December 31, 2019
and
2018,
we excluded
105,535,575
and
94,784,206
potential common shares, respectively, relating to convertible preferred stock, convertible notes, future share rights issued with demand notes, options and warrants outstanding from the diluted net loss per common share calculation because their inclusion would be anti-dilutive. In addition, we excluded
625,000
warrants from the diluted net loss per common share calculation at
December 31, 2019
and
2018
as the conditions for their vesting are
not
time-based.

X

- Definition
Disclosure of accounting policy for software, property and equipment physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.
+ References
No definition available.
+ Details

Name: crgs_SoftwarePropertyAndEquipmentPolicyTextBlock

Namespace Prefix: crgs_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790
+ Details

Name: us-gaap_CashAndCashEquivalentsPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02)
-URI http://asc.fasb.org/extlink&oid=116822174&loc=d3e355033-122828

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.3A-03)
-URI http://asc.fasb.org/extlink&oid=116822174&loc=d3e355100-122828

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684
+ Details

Name: us-gaap_ConsolidationPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for depreciation, depletion, and amortization of property and equipment costs, including methods used and estimated useful lives and how impairment of such assets is assessed and recognized.
+ References
No definition available.
+ Details

Name: us-gaap_DepreciationDepletionAndAmortizationPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257
+ Details

Name: us-gaap_EarningsPerSharePolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.
+ References
No definition available.
+ Details

Name: us-gaap_FairValueMeasurementPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for costs assigned to identifiable tangible and intangible assets of an acquired entity to be used in the research and development activities of the combined enterprise. An entity also may disclose the appraisal method or significant assumptions used to value acquired research and development assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.15)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380
+ Details

Name: us-gaap_InProcessResearchAndDevelopmentPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 954
-SubTopic 740
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=116821951&loc=d3e32247-109318

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=116821951&loc=d3e32280-109318

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 05
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327
+ Details

Name: us-gaap_IncomeTaxPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 6
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for leasing arrangement entered into by lessee.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 842
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=77888426&loc=SL77918666-209980
+ Details

Name: us-gaap_LesseeLeasesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755
+ Details

Name: us-gaap_PriorPeriodReclassificationAdjustmentDescription

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=118936363&loc=d3e5033-111524

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534

Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534

Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534
+ Details

Name: us-gaap_ReceivablesPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.
+ References
Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790
+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b),(f)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901
+ Details

Name: us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592
+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 68 R28.htm IDEA: XBRL DOCUMENT v3.20.1

Note 9 - Property and Equipment (Tables)
12 Months Ended

Dec. 31, 2019

Notes Tables

Property, Plant and Equipment [Table Text Block]

December 31,

2019

December 31,

2018

Office equipment
$
199,000
$
249,000

Shop equipment

132,000

182,000

Leasehold improvements

-

253,000

331,000

684,000

Less accumulated depreciation

(293,000

)

(622,000

)

Net property and equipment
$
38,000
$
62,000

X

- Definition
Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 69 R39.htm IDEA: XBRL DOCUMENT v3.20.1

Note 5 - Senior Convertible Notes and Warrants (Details Textual)
12 Months Ended

Jul. 24, 2018

USD ($)

$ / shares

May 08, 2018

USD ($)

$ / shares

Aug. 25, 2016

USD ($)

$ / shares

Dec. 31, 2019

USD ($)

$ / shares

Dec. 31, 2018

USD ($)

$ / shares

Nov. 30, 2018

$ / shares

May 31, 2017

$ / shares

Long-term Debt, Gross $ 10,310,000 $ 9,160,000

Debt Instrument, Unamortized Discount, Total 1,900,000 2,557,000

Long-term Debt, Total 8,410,000

Proceeds from Convertible Debt 1,150,000

Increase in Unamortized Debt Discount Due to Issuance 91,000

Interest Expense, Total 1,233,000 1,057,000

Amortization of Debt Discount (Premium) 748,000 627,000

Warrants Related to the 2017 Convertible Notes [Member]

Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold 10.00%

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 0.333

Percentage of Shares Issuable Upon the Conversion of the Promissory Notes 25.00%

Warrants Related to the 2016 Convertible Notes [Member]

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 0.25

Warrants and Rights Outstanding, Term 10 years

Percentage of Shares Issuable Upon the Conversion of the Promissory Notes 10.00%

Convertible Notes [Member]

Long-term Debt, Gross 10,310,000 9,160,000

Debt Instrument, Unamortized Discount, Total 1,900,000 2,557,000

Long-term Debt, Total $ 8,410,000 6,603,000

Debt Instrument, Term 5 years

Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year $ 650,000

Long-term Debt, Maturities, Repayments of Principal in Year Two 2,990,000

Long-term Debt, Maturities, Repayments of Principal in Year Three 2,775,000

Long-term Debt, Maturities, Repayments of Principal in Year Four 3,395,000

Long-term Debt, Maturities, Repayments of Principal in Year Five 500,000

Convertible Notes [Member] | Investor [Member]

Long-term Debt, Total 2,477,000 2,252,000

Convertible Notes [Member] | Affiliated Entity [Member]

Long-term Debt, Total $ 1,170,000 $ 1,170,000

Debt Instrument, Convertible, Number of Equity Instruments 4,680,000 4,680,000

The 2019 Convertible Notes [Member]

Long-term Debt, Gross $ 650,000

Debt Instrument, Unamortized Discount, Total 3,000

Long-term Debt, Total $ 647,000

Debt Instrument, Term 5 years

Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement $ 2,500,000

Debt Instrument, Interest Rate, Stated Percentage 6.00%

Debt Instrument, Term, Number of Days after Substantial Sale of Aegis Division 5 days

Debt Instrument, Convertible, Conversion Price | $ / shares $ 0.15

Debt Instrument, Convertible, Number of Equity Instruments 30,000

Debt Instrument, Convertible, Threshold Amount Needed to Invest to Convert a Specified Number of Equity Instruments $ 100,000

Proceeds from Convertible Debt 650,000

Increase in Unamortized Debt Discount Due to Issuance 26,000

Interest Expense, Total 40,000

Amortization of Debt Discount (Premium) 23,000

July 2018 Convertible Notes [Member]

Long-term Debt, Gross 1,675,000 1,175,000

Debt Instrument, Unamortized Discount, Total 353,000 360,000

Long-term Debt, Total 1,322,000

Debt Instrument, Term 5 years

Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement $ 2,500,000

Debt Instrument, Convertible, Conversion Price | $ / shares $ 0.25

Proceeds from Convertible Debt 500,000 1,175,000

Increase in Unamortized Debt Discount Due to Issuance 65,000 380,000

Interest Expense, Total 72,000 $ 20,000

Amortization of Debt Discount (Premium) $ 72,000

July 2018 Convertible Notes [Member] | Warrants Related to July 2018 Convertible Notes [Member]

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 0.25 $ 0.25

Warrants and Rights Outstanding, Term 10 years 10 years

Warrants and Rights Outstanding $ 350,000 $ 590,000

Warrants Related to July 2018 Convertible Notes [Member]

Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold 10.00%

Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold 25.00%

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 0.25

Warrants and Rights Outstanding, Term 10 years

The 2018 Convertible Notes [Member]

Long-term Debt, Gross 625,000 625,000

Debt Instrument, Unamortized Discount, Total 185,000 231,000

Long-term Debt, Total 440,000

Debt Instrument, Term 5 years

Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement $ 1,000,000

Debt Instrument, Convertible, Conversion Price | $ / shares $ 0.25

Proceeds from Convertible Debt

Increase in Unamortized Debt Discount Due to Issuance

Interest Expense, Total 45,000 19,000

Amortization of Debt Discount (Premium) 46,000

Warrants Related to the 2018 Convertible Notes [Member]

Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold 10.00%

Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold 25.00%

Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 0.25

Warrants and Rights Outstanding, Term 10 years

The 2017 Convertible Notes [Member]

Long-term Debt, Gross 4,370,000 4,370,000

Debt Instrument, Unamortized Discount, Total 362,000 456,000

Long-term Debt, Total $ 4,008,000

Debt Instrument, Term 5 years

Debt Instrument, Interest Rate, Stated Percentage 6.00%

Debt Instrument, Convertible, Conversion Price | $ / shares $ 0.333 $ 0.50

Proceeds from Convertible Debt

Increase in Unamortized Debt Discount Due to Issuance

Interest Expense, Total 356,000 355,000

Amortization of Debt Discount (Premium) 94,000 105,000

The 2017 Convertible Notes [Member] | Maximum [Member]

Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement 5,000,000

The 2016 Convertible Notes [Member]

Long-term Debt, Gross 2,990,000 2,990,000

Debt Instrument, Unamortized Discount, Total 997,000 1,510,000

Long-term Debt, Total 1,993,000

Debt Instrument, Term 5 years

Debt Instrument, Interest Rate, Stated Percentage 6.00%

Debt Instrument, Convertible, Conversion Price | $ / shares $ 0.25

Proceeds from Convertible Debt

Increase in Unamortized Debt Discount Due to Issuance

Interest Expense, Total 692,000 664,000

Amortization of Debt Discount (Premium) $ 513,000 $ 483,000

The 2016 Convertible Notes [Member] | Maximum [Member]

Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement $ 3,000,000

X

- Definition
The amount of senior convertible promissory notes authorized to be sold in a private placement.
+ References
No definition available.
+ Details

Name: crgs_AmountOfSeniorConvertiblePromissoryNotesAuthorizedToIssueInPrivatePlacement

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The threshold amount needed to invest in order to convert the debt instrument into a specified number of equity instruments.
+ References
No definition available.
+ Details

Name: crgs_DebtInstrumentConvertibleThresholdAmountNeededToInvestToConvertASpecifiedNumberOfEquityInstruments

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of specified days after the sale of substantially all of the assets of the Aegis division for the debt instrument to mature, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: crgs_DebtInstrumentTermNumberOfDaysAfterSubstantialSaleOfAegisDivision

Namespace Prefix: crgs_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of increase in unamortized debt discount due to issuance.
+ References
No definition available.
+ Details

Name: crgs_IncreaseInUnamortizedDebtDiscountDueToIssuance

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of securities into which the class of warrant or right may be converted expressed as percentage of shares issuable upon the conversion of the promissory notes under agreement, if investment is abovethe $500,000 threshold.
+ References
No definition available.
+ Details

Name: crgs_PercentageOfSharesIssuableUponConversionOfThePromissoryNotesAboveInvestmentThreshold

Namespace Prefix: crgs_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of securities into which the class of warrant or right may be converted expressed as percentage of shares issuable upon the conversion of the promissory notes under agreement, if investment is below the $500,000 threshold.
+ References
No definition available.
+ Details

Name: crgs_PercentageOfSharesIssuableUponConversionOfThePromissoryNotesBelowInvestmentThreshold

Namespace Prefix: crgs_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of securities into which the class of warrant or right may be converted expressed as percentage of shares issuable upon the conversion of the promissory notes under agreement.
+ References
No definition available.
+ Details

Name: crgs_PercentageOfSharesIssuableUponTheConversionOfThePromissoryNotess

Namespace Prefix: crgs_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.8)
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227
+ Details

Name: us-gaap_AmortizationOfDebtDiscountPremium

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Exercise price per share or per unit of warrants or rights outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(16))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_DebtInstrumentCarryingAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The price per share of the conversion feature embedded in the debt instrument.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 5
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6031898-161870
+ Details

Name: us-gaap_DebtInstrumentConvertibleConversionPrice1

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The number of equity instruments that the holder of the debt instrument would receive if the debt was converted to equity.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(5))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentConvertibleNumberOfEquityInstruments

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount, after accumulated amortization, of debt discount.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400
+ Details

Name: us-gaap_DebtInstrumentUnamortizedDiscount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of the cost of borrowed funds accounted for as interest expense.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (210.5-03(11))
-URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.9)
-URI http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260
+ Details

Name: us-gaap_InterestExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (b)(3)
-URI http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16))
-URI http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04.(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601
+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04.(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601
+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04.(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601
+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04.(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601
+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt payable, sinking fund requirements, and other securities issued that are redeemable by holder at fixed or determinable prices and dates maturing in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04.(a))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690
+ Details

Name: us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585
+ Details

Name: us-gaap_ProceedsFromConvertibleDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_WarrantsAndRightsOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258
+ Details

Name: us-gaap_WarrantsAndRightsOutstandingTerm

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_ClassOfWarrantOrRightAxis=crgs_WarrantsRelatedToThe2017ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ClassOfWarrantOrRightAxis=crgs_WarrantsRelatedToThe2016ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_The2019ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_July2018ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ClassOfWarrantOrRightAxis=crgs_WarrantsRelatedToJuly2018ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_WarrantsRelatedToJuly2018ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_The2018ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_WarrantsRelatedToThe2018ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_The2017ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: srt_RangeAxis=srt_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=crgs_The2016ConvertibleNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 70 R35.htm IDEA: XBRL DOCUMENT v3.20.1

Note 2 - Summary of Significant Accounting Policies - Depreciation and Amortization (Details) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Depreciation and amortization $ 132,000 $ 138,000

Right-to-use Building [Member]

Depreciation and amortization 98,000

Software Development [Member]

Depreciation and amortization 10,000 92,000

Property and Equipment [Member]

Depreciation and amortization $ 24,000 $ 46,000

X

- Definition
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationDepletionAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=crgs_RightToUseBuildingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PropertyPlantAndEquipmentByTypeAxis=crgs_PropertyAndEquipmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 71 R3.htm IDEA: XBRL DOCUMENT v3.20.1

Consolidated Balance Sheets (Parentheticals) - $ / shares

Dec. 31, 2019

Dec. 31, 2018

Preferred stock, shares outstanding (in shares) 3,238,000

Preferred stock, shares authorized (in shares) 100,000,000 100,000,000

Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01

Common stock, par value (in dollars per share) $ 0.01 $ 0.01

Common stock, shares authorized (in shares) 400,000,000 400,000,000

Common stock, shares issued (in shares) 50,979,964 50,364,549

Common stock, shares outstanding (in shares) 50,979,964 50,364,549

Preferred Class C [Member]

Preferred stock, cumulative dividend per share (in dollars per share) $ 0 $ 0

Preferred stock, shares issued (in shares) 15,687,500 15,687,500

Preferred stock, shares outstanding (in shares) 15,687,500 15,687,500

Series C2 Preferred Stock [Member]

Preferred stock, cumulative dividend per share (in dollars per share) $ 0 $ 0

Preferred stock, shares issued (in shares) 24,500,000 24,500,000

Preferred stock, shares outstanding (in shares) 24,500,000 24,500,000

Preferred stock, par value (in dollars per share) $ 0.01

Series C3 Preferred Stock [Member]

Preferred stock, cumulative dividend per share (in dollars per share) $ 0 $ 0

Preferred stock, shares issued (in shares) 3,238,000 3,268,000

Preferred stock, shares outstanding (in shares) 3,238,000 3,268,000

Preferred Class A [Member]

Preferred stock, cumulative dividend per share (in dollars per share) $ 0.40 $ 0.40

Preferred stock, shares issued (in shares) 468,221 468,221

Preferred stock, shares outstanding (in shares) 468,221 468,221

Preferred stock, shares authorized (in shares) 3,300,000

Preferred Class B [Member]

Preferred stock, cumulative dividend per share (in dollars per share) $ 0.50 $ 0.50

Preferred stock, shares issued (in shares) 67,500 67,500

Preferred stock, shares outstanding (in shares) 67,500 67,500

Preferred stock, shares authorized (in shares) 300,000

X

- Definition
Face amount or stated value per share of common stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The per share amount of a dividend declared, but not paid, as of the financial reporting date.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586
+ Details

Name: us-gaap_DividendsPayableAmountPerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockParOrStatedValuePerShare

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PreferredStockSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Details

Name: us-gaap_StatementClassOfStockAxis=crgs_PreferredClassCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=crgs_SeriesC2PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=crgs_SeriesC3PreferredStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassBMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 72 R7.htm IDEA: XBRL DOCUMENT v3.20.1

Note 1 - The Company and Basis of Presentation
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
NOTE
1

- THE COMPANY AND BASIS OF PRESENTATION

CurAegis Technologies, Inc. (“CurAegis”, “the Company”) was incorporated as a New York business corporation in
September
1996
under the name Torvec, Inc. The Company’s name was changed to CurAegis Technologies, Inc. in
2016
in connection with the establishment of its
two
business divisions. The CURA (Circadian User Risk Assessment) division is engaged in the fatigue management business and the Aegis division is engaged in the power and hydraulic business.

The Company develops and markets advanced technologies in the areas of safety, wellness and power. The Company is focused on the commercialization of a wellness and safety system (the myCadian system) and a uniquely designed hydraulic pump that will be smaller, lighter, less expensive and more efficient than current technology. The Company has
not
had any significant revenue-producing operations.

It is important to note, regarding both the CURA and Aegis products, that the cycle time from the initiation of the sales process to revenue realization can be highly variable especially as a start-up entity. In addition to the activities to be undertaken to implement our plan of operations, we
may
expand and/or refocus our activities depending upon future circumstances and developments.



CURA Division: the myCadian system

The Company’s CURA division has developed a proprietary technology designed to (i) measure the decrease in a person’s alertness and (ii) to train individuals on how to improve alertness levels. The myCadian system will enable the user to anticipate and avert undesired or disastrous situations caused by the degradation of alertness. With the information provided from the myCadian software analytics, employees can work with Z-Coach, our proprietary sleep training and education solution to correct sleep issues and improve overall wellness.

The myCadian platform is designed to predict and detect a degradation of alertness in a user. The myCadian platform will support multiple wearable technology including IOS and android devices. The myCadian system will include:

●
a risk assessment that identifies the degradation of alertness that
may
affect a wearer’s ability to perform tasks,

●
real-time reporting that distills complex user data into actionable information on mobile devices,

●
predictive reporting for a user to take action when alertness begins to wane, before fatigue becomes dangerous,

●
flexible settings to provide employers a customized tool using their defined safety criteria and to create protocols for action,

●
pricing that makes it affordable across a broad-based workforce, and

●
the Z-Coach wellness program.

The Z-Coach wellness program is a key component of the myCadian system. Z-Coach learning topics include: Risks and Costs of Fatigue, Fundamentals of Sleep, Fatigue Mitigation and Countermeasures. Z-Coach participants gain an awareness of the dangers inherent in the lack of sleep and learn to utilize lifestyle tools to make changes to improve their health, mood, productivity and safety.

Aegis Division: Hydraulic Pump



During
2019,
the Company initiated discussions with investment bankers and certain hydraulics companies to evaluate the possible monetization of the AEGIS technologies. Management believes these technologies have the potential to fundamentally shift the design and manufacture of future products in the hydraulics pump and motor industries.

The Aegis hydraulic pump technology has been designed to bring to the marketplace a unique concept in hydraulic pumps and motors that will be:

●

smaller, lighter and less expensive than conventional pumps and motors,

●

more efficient, and

●

unique in its ability to scale larger, allowing more powerful pumps and motors.

The Company has completed a production prototype and is working to align the prototype capability with specific customer applications. The Company achieved significant milestones in the design and testing of this prototype and engineering testing and design of pump and motor functionality is continuing. Our engineering team has progressively made adjustments to traditional valve and piston technologies which have resulted in improvement in the measured efficiency of the pump. We have filed for patent protection for our novel non-rotating group pump concept and continue to file patents as a engineering breakthroughs in our design are identified.

Current Cash Outlook and Management Plans

As of
December 31, 2019,
we have cash on hand of
$18,000,
negative working capital of
$4,545,000,
a stockholders’ deficiency of
$12,203,000
and an accumulated deficit of
$91,425,000.
During the year ended
December 31, 2019
we raised
$2,375,000
in proceeds through the issuance of demand notes, convertible notes and promissory notes. The proceeds from these private placements have been used to support the ongoing development and marketing of our core technologies and product initiatives.

Management estimates that the
2020
cash needs will be approximately
$1.5
to
2
million, based upon the cash used in operations in the
fourth
quarter of
2019.
As of
December 31, 2019,
the Company’s cash on hand is
not
sufficient to cover the Company’s future working capital requirements. This raises substantial doubt as to the Company’s ability to continue as a going concern. Management continues to use its best efforts to develop financing opportunities to fund the development and commercialization of the CURA and Aegis products.

Since inception, we have financed our operations by the sale of our securities and debt financings. We need to raise additional funds to meet our working capital needs, to fund expansion of our business, to complete development, testing and marketing of our products, or to make strategic acquisitions or investments.
No
assurance can be given that necessary funds will be available for us to finance our development on acceptable terms, if at all. Furthermore, such additional financings will involve dilution to our shareholders or
may
require that we relinquish rights to certain of our technologies or products. In addition, we will experience operational difficulties and delays due to working capital restrictions. If adequate funds are
not
available from additional sources of financing, we will have to delay or scale back our growth plans.

The Company’s ability to fund its current and future commitments from its available cash depends on a number of factors. These factors include the Company’s ability to (i) launch and generate sales from the CURA products or (ii) generate proceeds from the monetization of our hydraulic technologies. If these and other factors are
not
met, the Company would need to raise funds in order to meet its working capital needs and pursue its growth strategy. Although there can be
no
such assurances, management believes that sources for these additional funds will be available through either current or future investors.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-URI http://asc.fasb.org/topic&trid=2122149

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-URI http://asc.fasb.org/topic&trid=2197479
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 73 R31.htm IDEA: XBRL DOCUMENT v3.20.1

Note 13 - Stock Options (Tables)
12 Months Ended

Dec. 31, 2019

Notes Tables

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

2019

2018

Expected term (years)

-

5.4

Expected forfeiture rate

-

0%

Risk-free rate

-

2.8%

Volatility

-

137%

Dividend yield

-

0.0%

Share-based Payment Arrangement, Option, Activity [Table Text Block]

Shares

Weighted

Average

Exercise

Price

Average

Remaining

Contractual

Term

(years)

Aggregate

Intrinsic

Value

Outstanding at January 1, 2019

11,028,500
$
0.49

3.8
$
94,000

Granted

-

-

Exercised

-

-

Canceled or expired

(288,000

)

0.28

Outstanding at December 31, 2019

10,740,500
$
0.50

2.6
$
-

Exercisable at December 31, 2019

7,522,750
$
0.55

2.3
$
-

X

- Definition
Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_TableTextBlock

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 74 R12.htm IDEA: XBRL DOCUMENT v3.20.1

Note 6 - Unsecured Subordinated Promissory Notes
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Short-term Debt [Text Block]
NOTE
6
- UNSECURED SUBORDINATED PROMISSORY NOTES

During the year ended
December 31, 2019,
the Company issued
$800,000,
in unsecured subordinated promissory notes to the Company’s Chief Executive Officer and to another board member. These notes bear interest at a rate of
6%
per annum and have a maturity date of
ninety
days from the date of issuance. As of
December 31, 2019,
all promissory notes outstanding were payable to our Chief Executive Officer and aggregated
$425,000
at this date. The maturity dates on the outstanding promissory notes have been amended to reflect a
June 30, 2020
date.

During
2019,
the Company paid off
$150,000
and converted
$225,000
of the promissory notes to
2019
convertible notes. The Company recognized interest expense of
$15,000
on these notes during the year ended
December 31, 2019.

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for short-term debt.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-URI http://asc.fasb.org/topic&trid=2208564
+ Details

Name: us-gaap_ShortTermDebtTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 75 R16.htm IDEA: XBRL DOCUMENT v3.20.1

Note 10 - Business Segments
12 Months Ended

Dec. 31, 2019

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]
NOTE
10
- BUSINESS SEGMENTS

The Company has
two
operating business segments. The CURA business operates in the fatigue management industry and the Aegis business is focused in the power and hydraulic industry.

Segment information for the year ended
December 31, 2019
for the Company’s business segments follows:

CURA

Aegis

Corporate

Total

Revenue
$
15,000
$
-
$
-
$
15,000

Gross margin

2,000

-

-

2,000

Loss from operations

(614,000
)
(513,000
)
(1,301,000
)
(2,428,000
)

Non-operating expense

-

-

(1,848,000
)
(1,848,000
)

Net loss
$
(614,000
) $
(513,000
) $
(3,149,000
) $
(4,276,000
)

Stock based compensation
$
3,000
$
17,000
$
106,000
$
126,000

Depreciation and amortization
$
14,000
$
18,000
$
100,000
$
132,000

Assets at December 31, 2019
$
1,000
$
36,000
$
214,000
$
251,000

Segment information for the year ended
December 31, 2018
for the Company’s business segments follows:

CURA

Aegis

Corporate

Total

Revenue
$
37,000
$
-
$
-
$
37,000

Gross margin (loss) on revenue

(73,000)

-

-

(73,000)

Loss from operations

(3,155,000
)
(658,000
)
(1,439,000
)
(5,252,000
)

Non-operating expense

-

-

(1,056,000
)
(1,056,000
)

Net loss
$
(3,155,000
) $
(658,000
) $
(2,495,000
) $
(6,308,000
)

Stock based compensation
$
1,000
$
44,000
$
135,000
$
180,000

Depreciation and amortization
$
110,000
$
20,000
$
8,000
$
138,000

Assets at December 31, 2018
$
15,000
$
54,000
$
81,000
$
150,000

32

Table of Contents

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureTextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI http://asc.fasb.org/topic&trid=2134510
+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 76 R50.htm IDEA: XBRL DOCUMENT v3.20.1

Note 11 - Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Income tax benefit at federal statutory rate $ (898,000) $ (1,325,000)

State income tax (benefit), net of effect of federal taxes (103,000) (199,000)

Non-deductible debt discount 157,000 132,000

Convertible debt interest expense 96,000

Debt issuance expense 70,000

Other (36,000) 47,000

Increase in valuation allowance 714,000 1,345,000

Provision for income tax

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to convertible debt interest expense.
+ References
No definition available.
+ Details

Name: crgs_EffectiveIncomeTaxRateReconciliationConvertibleDebtInterestExpense

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to debt issuance expense.
+ References
No definition available.
+ Details

Name: crgs_EffectiveIncomeTaxRateReconciliationDebtIssuanceExpense

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 20
-Section 45
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=116821951&loc=d3e32123-109318
+ Details

Name: us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319
+ Details

Name: us-gaap_IncomeTaxReconciliationNondeductibleExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319
+ Details

Name: us-gaap_IncomeTaxReconciliationOtherAdjustments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319
+ Details

Name: us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 77 R54.htm IDEA: XBRL DOCUMENT v3.20.1

Note 13 - Stock Options (Details Textual) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Share-based Payment Arrangement, Expense $ 126,000 $ 180,000

Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total $ 105,000

Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition 11 years

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 1,787,500

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value $ 0.23

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value $ 173,000 $ 412,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 288,000 441,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 0 0

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 0 0

Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit $ 0.22

Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit $ 1.58

The 2011 and 2016 Stock Option Plans [Member]

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 6,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum 10.00%

Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date 110.00%

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period 10 years

Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 2,159,500

X

- Definition
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cost not yet recognized for nonvested award under share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Discount rate from fair value on offering date that participants pay for shares.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of shares authorized for issuance under share-based payment arrangement.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(4)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(3)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Gross number of share options (or share units) granted during the period.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Number of share options (or share units) exercised during the current period.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(2)
-URI http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644
+ Details

Name: us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_PlanNameAxis=crgs_The2011And2016StockOptionPlansMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 78 R58.htm IDEA: XBRL DOCUMENT v3.20.1

Note 14 - Warrants - Summary of Outstanding Warrants (Details) - USD ($)
12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Shares outstanding (in shares) 7,381,707

Outstanding, weighted average exercise price (in dollars per share) ^[1] $ 0.46

Outstanding, weighted average remaining contractual term (Year) ^[2] 6 years 73 days 7 years

Outstanding, aggregate intrinsic value $ 33,000 $ 39,000

Shares granted (in shares) 350,000

Granted, weighted average exercise price (in dollars per share) $ 0.25

Shares exercised (in shares)

Exercised, weighted average exercise price (in dollars per share)

Shares canceled or expired (in shares)

Canceled or expired, weighted average exercise price (in dollars per share)

Shares outstanding (in shares) 7,731,707 7,381,707

Outstanding, weighted average exercise price (in dollars per share) ^[1] $ 0.45 $ 0.46

Shares exercisable (in shares) 7,106,707

Exercisable, weighted average exercise price (in dollars per share) $ 0.49

Exercisable, weighted average remaining contractual term (Year) ^[3] 6 years 73 days

Exercisable, aggregate intrinsic value $ 33,000

[1] The weighted average exercise price for warrants outstanding excludes 1,750,000 warrants in each period with no determined exercise price.

[2] The weighted average remaining contractual term for warrants outstanding excludes 743,500 warrants with no expiration date.

[3] The weighted average remaining contractual term for warrants exercisable excludes 118,500 warrants with no expiration date.

X

- Definition
The number of warrants or rights cancelled or expired during period.
+ References
No definition available.
+ Details

Name: crgs_ClassOfWarrantOrRightCancelledOrExpiredDuringPeriod

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted exercise price per share of warrants or rights cancelled or expired.
+ References
No definition available.
+ Details

Name: crgs_ClassOfWarrantOrRightCancelledOrExpiredWeightedAverageExercisePrice

Namespace Prefix: crgs_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of warrants or rights exercisable.
+ References
No definition available.
+ Details

Name: crgs_ClassOfWarrantOrRightExercisable

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Intrinsic value of warrants or rights exercisable.
+ References
No definition available.
+ Details

Name: crgs_ClassOfWarrantOrRightExercisableIntrinsicValue

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted exercise price per share of warrants or rights exercisable.
+ References
No definition available.
+ Details

Name: crgs_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice

Namespace Prefix: crgs_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average remaining contractual term of warrants or rights exercisable.
+ References
No definition available.
+ Details

Name: crgs_ClassOfWarrantOrRightExercisableWeightedAverageRemainingContractualTerm

Namespace Prefix: crgs_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of warrants or rights exercised during period.
+ References
No definition available.
+ Details

Name: crgs_ClassOfWarrantOrRightExercisedDuringPeriod

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted exercise price per share of warrants or rights exercised.
+ References
No definition available.
+ Details

Name: crgs_ClassOfWarrantOrRightExercisedWeightedAverageExercisePrice

Namespace Prefix: crgs_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of warrants or rights issued during period.
+ References
No definition available.
+ Details

Name: crgs_ClassOfWarrantOrRightIssuedDuringPeriod

Namespace Prefix: crgs_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Weighted exercise price per share of warrants or rights issued.
+ References
No definition available.
+ Details

Name: crgs_ClassOfWarrantOrRightIssuedWeightedAverageExercisePrice

Namespace Prefix: crgs_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Intrinsic value of warrants or rights outstanding.
+ References
No definition available.
+ Details

Name: crgs_ClassOfWarrantOrRightOutstandingIntrinsicValue

Namespace Prefix: crgs_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Weighted exercise price per share of warrants or rights outstanding.
+ References
No definition available.
+ Details

Name: crgs_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice

Namespace Prefix: crgs_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Weighted average remaining contractual term of warrants or rights outstanding.
+ References
No definition available.
+ Details

Name: crgs_ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm

Namespace Prefix: crgs_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of warrants or rights outstanding.
+ References
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ClassOfWarrantOrRightOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

Note 8 - Software	12 Months Ended
Note 8 - Software	Dec. 31, 2019
Notes to Financial Statements
Research, Development, and Computer Software Disclosure [Text Block]	NOTE 8 - SOFTWARE The Company investment in software for the CURA division have been amortized over an estimated useful life of 3 years. Amortization expense recognized for the year ended December 31, 2019 and 2018 was $10,000 and $92,000, respectively. All capitalized software was fully amortized as of December 31, 2019. The net value of capitalized software at December 31, 2018 was $10,000.

Document And Entity Information - USD ($) $ in Thousands	12 Months Ended
Document And Entity Information - USD ($) $ in Thousands	Dec. 31, 2019	Mar. 27, 2020	Jun. 30, 2019
Document Information [Line Items]
Entity Registrant Name	CurAegis Technologies, Inc.
Entity Central Index Key	0001063197
Trading Symbol	crgs
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Emerging Growth Company	false
Entity Small Business	true
Entity Interactive Data Current	Yes
Entity Common Stock, Shares Outstanding (in shares)		51,187,236
Entity Public Float			$ 5,554
Entity Shell Company	false
Document Type	10-K
Document Period End Date	Dec. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Amendment Flag	false
Title of 12(g) Security	$.01 par value common voting stock

Note 3 - Inventory and Related Vendor Liability - Inventory (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Raw materials	$ 1,665,000	$ 1,678,000
Finished goods	69,000	69,000
	1,734,000	1,747,000
Less: Reserve	(1,734,000)	(1,747,000)
Inventory (net)
Liability for inventory held at vendor	$ 1,764,000	$ 1,462,000

Note 1 - The Company and Basis of Presentation (Details Textual)	12 Months Ended
	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)
Number of Operating Segments	2
Cash and Cash Equivalents, at Carrying Value, Ending Balance	$ 18,000	$ 53,000	$ 194,000
Working Capital	(4,545,000)
Stockholders' Equity Attributable to Parent, Ending Balance	(12,203,000)	(8,479,000)	$ (3,408,000)
Retained Earnings (Accumulated Deficit), Ending Balance	(91,425,000)	$ (87,149,000)
Proceeds From Convertible Debt, Gross	2,375,000
Minimum [Member]
Cash Needed During the Year to Fund Current and Future Commitments	1,500,000
Maximum [Member]
Cash Needed During the Year to Fund Current and Future Commitments	$ 2,000,000

Consolidated Statements of Changes in Stockholders' Equity (Deficiency) - USD ($)	Preferred Stock [Member] Series C Preferred Stock [Member]	Preferred Stock [Member] Series C2 Preferred Stock [Member]	Preferred Stock [Member] Series C3 Preferred Stock [Member]	Preferred Stock [Member] Preferred Class A [Member]	Preferred Stock [Member] Preferred Class B [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Series C2 Preferred Stock [Member]	Series C3 Preferred Stock [Member]	Total
Balance (in shares) at Dec. 31, 2017	15,937,500	25,000,000	3,388,000	468,221	67,500	48,979,546
Balance at Dec. 31, 2017	$ 159,000	$ 250,000	$ 34,000	$ 5,000	$ 1,000	$ 490,000	$ 76,494,000	$ (80,841,000)			$ (3,408,000)
Conversion of C3 Preferred Shares to common stock (in shares)			(120,000)			120,000
Conversion of C3 Preferred Shares to common stock			$ (1,000)			$ 1,000
Issuance of warrants with convertible note							557,000				557,000
Stock-based compensation							180,000				180,000
Common shares issued for interest (in shares)						320,853
Common shares issued for interest						$ 3,000	77,000				80,000
Net Loss								(6,308,000)			(6,308,000)
Conversion of C Preferred Shares to common stock (in shares)	(250,000)					250,000
Conversion of C Preferred Shares to common stock	$ (2,000)					$ 2,000
Conversion of C2 Preferred Shares to common stock (in shares)		(500,000)				500,000
Conversion of C2 Preferred Shares to common stock		$ (5,000)				$ 5,000
Beneficial conversion feature on convertible note							369,000				$ 369,000
Common shares issued upon note conversions (in shares)						190,150			500,000	120,000	874,000
Common shares issued upon note conversions						$ 2,000	47,000				$ 49,000
Exercise of common stock warrant (in shares)						4,000
Exercise of common stock warrant						$ 1,000	1,000				2,000
Balance (in shares) at Dec. 31, 2018	15,687,500	24,500,000	3,268,000	468,221	67,500	50,364,549
Balance at Dec. 31, 2018	$ 157,000	$ 245,000	$ 33,000	$ 5,000	$ 1,000	$ 504,000	77,725,000	(87,149,000)			(8,479,000)
Conversion of C3 Preferred Shares to common stock (in shares)			(30,000)			30,000
Conversion of C3 Preferred Shares to common stock			$ (1,000)			$ 1,000
Issuance of warrants with convertible note							65,000				65,000
Stock-based compensation							126,000				126,000
Common shares issued for interest (in shares)						195,415
Common shares issued for interest						$ 2,000	42,000				44,000
Common shares issued (in shares)						195,000
Common shares issued						$ 2,000	19,000				21,000
Common shares issued with demand notes (in shares)						195,000
Common shares issued with demand notes						$ 1,000	19,000				20,000
Share rights issued with demand notes							276,000				276,000
Net Loss								(4,276,000)			(4,276,000)
Common shares issued upon note conversions (in shares)										30,000
Balance (in shares) at Dec. 31, 2019	15,687,500	24,500,000	3,238,000	468,221	67,500	50,979,964
Balance at Dec. 31, 2019	$ 157,000	$ 245,000	$ 32,000	$ 5,000	$ 1,000	$ 510,000	$ 78,272,000	$ (91,425,000)			$ (12,203,000)

Note 11 - Income Taxes - Reconciliation of Unrecognized Tax Benefits (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Balance	$ 1,112,000	$ 1,112,000
Additions based on tax positions related to current year
Additions based on enacted tax change in state rate
Additions for tax positions of prior years
Reductions for tax positions of prior years
Reductions based on enacted changes in tax rates
Settlements
Balance	$ 1,112,000	$ 1,112,000

Note 13 - Stock Options - Share-based Compensation, Stock Options, Activity (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Outstanding shares (in shares)	11,028,500
Outstanding - weighted average exercise price (in dollars per share)	$ 0.49
Outstanding - weighted average remaining contractual term (Year)	2 years 219 days	3 years 292 days
Outstanding - aggregate intrinsic value		$ 94,000
Shares, granted (in shares)	0	1,787,500
Weighted average exercise price, granted (in dollars per share)
Shares, exercised (in shares)	0	0
Weighted average exercise price, exercised (in dollars per share)
Shares, canceled or expired (in shares)	(288,000)
Weighted average exercise price, canceled or expired (in dollars per share)	$ 0.28
Outstanding shares (in shares)	10,740,500	11,028,500
outstanding - weighted average exercise price (in dollars per share)	$ 0.50	$ 0.49
Shares, exercisable (in shares)	7,522,750
Weighted average exercise price, exercisable (in dollars per share)	$ 0.55
Exercisable- weighted average remaining contractual term (Year)	2 years 109 days
Exercisable-aggregate intrinsic value

Note 3 - Inventory and Related Vendor Liability (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Inventory Valuation Reserves, Ending Balance	$ 1,734,000	$ 1,747,000
Vendor Penalty, Expense	$ 300,000

Consolidated Statements of Operations - USD ($)	12 Months Ended
Consolidated Statements of Operations - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Revenue and Cost of revenue:
CURA revenue	$ 15,000	$ 37,000
Cost of revenue	13,000	110,000
Gross margin (loss) on revenue	2,000	(73,000)
Costs and expenses:
Provision (recovery) inventory reserve	(15,000)	1,741,000
Impairment loss		17,000
Engineering and development	809,000	1,262,000
General and administrative	1,636,000	2,159,000
Total costs and expenses	2,430,000	5,179,000
Loss from operations	(2,428,000)	(5,252,000)
Non-operating expense:
Interest expense	(1,233,000)	(1,057,000)
Debt issuance cost	(333,000)
Vendor penalty	(300,000)
Other income	18,000	1,000
Non-operating expense	(1,848,000)	(1,056,000)
Loss before income taxes	(4,276,000)	(6,308,000)
Income taxes
Net loss	(4,276,000)	(6,308,000)
Preferred stock dividends	218,000	218,000
Net loss attributable to common stockholders	$ (4,494,000)	$ (6,526,000)
Net loss per share attributable to common stockholders
Basic and Diluted (in dollars per share)	$ (0.09)	$ (0.13)
Weighted average number of shares of common stock
Basic and Diluted (in shares)	50,601,000	49,781,000

Note 12 - Preferred and Common Stock (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2015	Mar. 31, 2014
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Stock Issued During Period, Shares, Conversion of Convertible Securities		874,000
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.01	$ 0.01
Preferred stock, shares outstanding (in shares)	3,238,000
Investor Rights Agreement, Maximum Indebtedness		$ 1,000,000
Investor Rights Agreement, Minimum Number Shares of Common Stock by Conversion or Exercise of Series C Securities		3,000,000
Preferred Class A [Member]
Preferred stock, shares authorized (in shares)	3,300,000
Convertible Preferred Stock, Holding Period Required for Conversion	1 year
Convertible Preferred Stock, Shares Issued upon Conversion	1
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears	$ 0.40
Preferred Stock, Redemption Price Per Share	$ 4
Preferred stock, shares outstanding (in shares)	468,221	468,221
Preferred Stock, Shares Outstanding, Not Accruing Dividends	8,709	8,709
Dividends Payable	$ 2,713,000	$ 2,530,000
Preferred Stock, Liquidation Preference, Value	$ 2,713,000	$ 2,530,000
Preferred Class B [Member]
Preferred stock, shares authorized (in shares)	300,000
Convertible Preferred Stock, Holding Period Required for Conversion	1 year
Convertible Preferred Stock, Shares Issued upon Conversion	1
Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears	$ 0.50
Preferred Stock, Redemption Price Per Share	$ 5
Preferred stock, shares outstanding (in shares)	67,500	67,500
Dividends Payable	$ 488,000
Preferred Stock, Liquidation Preference, Value	$ 488,000	$ 454,000
Preferred Stock Dividends, Shares	0	0
Series C Preferred Stock [Member]
Preferred stock, shares authorized (in shares)	16,250,000
Convertible Preferred Stock, Shares Issued upon Conversion	1
Preferred stock, shares outstanding (in shares)	15,687,500	15,687,500
Preferred Stock, Liquidation Preference, Value	$ 6,275,000	$ 6,275,000
Preferred Stock, Liquidation Preference Per Share	$ 0.40
Conversion of Stock, Shares Converted	250,000
Series C2 Preferred Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities		500,000
Preferred stock, shares authorized (in shares)				25,000,000
Preferred Stock, Par or Stated Value Per Share	$ 0.01
Convertible Preferred Stock, Shares Issued upon Conversion	1
Preferred stock, shares outstanding (in shares)	24,500,000	24,500,000
Preferred Stock, Liquidation Preference, Value	$ 4,900,000	$ 4,900,000
Preferred Stock, Liquidation Preference Per Share	$ 0.20
Series C3 Preferred Stock [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	30,000	120,000
Preferred stock, shares authorized (in shares)			10,000,000
Preferred stock, shares outstanding (in shares)	3,238,000	3,268,000
Private Placement Offering Amount			$ 2,500,000
Sale of Stock, Price Per Share			$ 0.25
The 2016, 2017 and 2019 Convertible Notes [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities	30,000
Stock Issued During Period, Shares, Interest	195,415
The 2019 Convertible Notes and Demand Notes [Member]
Stock Issued in Connection with Debt Issuance, Shares	390,000
The 2016 and 2017 Convertible Note [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities		190,150
Stock Issued During Period, Shares, New Issues		320,853
Shares Issued, Price Per Share		$ 0.25

Note 14 - Warrants (Details Textual) - shares	Dec. 31, 2019	Dec. 31, 2018
Class of Warrant or Right, Outstanding	7,731,707	7,381,707
Warrants without Expiration Date, Outstanding	743,500	743,500
Warrants without Expiration Date, Exercisable	118,500	118,500
Warrants Not Determined, Exercise Price [Member]
Class of Warrant or Right, Outstanding	1,750,000	1,750,000

Note 10 - Business Segments (Details Textual)	12 Months Ended
Note 10 - Business Segments (Details Textual)	Dec. 31, 2019
Number of Operating Segments	2

Note 7 - Right to Use Building Asset (Details Textual)	12 Months Ended
Note 7 - Right to Use Building Asset (Details Textual)	Dec. 31, 2019 USD ($)	Aug. 01, 2019 USD ($)	Jan. 01, 2019 USD ($)
Operating Lease, Liability, Total		$ 212,000
Lessee, Operating Lease, Discount Rate	6.00%
Operating Lease, Cost	$ 26,000
Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months	64,000
Lessee, Operating Lease, Liability, Payments, Due Year Two	64,000
Lessee, Operating Lease, Liability, Payments, Due Year Three	63,000
Lessee, Operating Lease, Liability, Payments, Due, Total	212,000
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	$ 21,000
Office Building with Terminated Lease Obligation [Member]
Operating Lease, Liability, Total			$ 257,000
Lessee, Operating Lease, Discount Rate	6.00%
Lessee, Operating Lease, Renewal Term	1 year
Operating Lease, Cost	$ 80,000
Lessee, Operating Lease, Number of Right-of-Use Assets with One Year Renewal Options	2

Note 17 - Subsequent Events (Details Textual) - USD ($)	3 Months Ended	12 Months Ended
Note 17 - Subsequent Events (Details Textual) - USD ($)	Mar. 27, 2020	Dec. 31, 2019	Dec. 31, 2018
Proceeds from Convertible Debt		$ 1,150,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		0	1,787,500
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
The 2019 Convertible Notes [Member]
Proceeds from Convertible Debt		$ 650,000
Subsequent Event [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	2,100,000
Subsequent Event [Member] \| Minimum [Member]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 0.12
Subsequent Event [Member] \| Maximum [Member]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price	$ 0.15
Subsequent Event [Member] \| Share-based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Subsequent Event [Member] \| Conversion from Convertible Notes to Common Stock [Member]
Stock Issued During Period, Shares, Interest	94,772
Debt Conversion, Accrued Interest, Amount	$ 14,000
Subsequent Event [Member] \| The 2019 Convertible Notes [Member]
Proceeds from Convertible Debt	$ 435,000
Stock Issued in Connection with Debt Issuance, Shares	112,500

Note 17 - Subsequent Events	12 Months Ended
Note 17 - Subsequent Events	Dec. 31, 2019
Notes to Financial Statements
Subsequent Events [Text Block]	NOTE 1 7 - SUBSEQUENT EVENTS 2019 Convertible Notes Subsequent to December 31, 2019, the Company issued $435,000 in new 2019 convertible notes and 112,500 of new common shares to the investors in these notes. Common Shares Issued in Payment of Interest Expense Subsequent to December 31, 2019, the Company issued 94,772 shares of common stock representing $14,000 in payment of interest to noteholders. Stock Compensation Grants Subsequent to December 31, 2019, the Company granted 2,100,000 incentive stock options exercisable for 10 years from the date of grant at prices ranging from $0.12 to $0.15 per share.

Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Current Assets:
Cash	$ 18,000	$ 53,000
Prepaid expenses and other current assets	2,000	25,000
Total current assets	20,000	78,000
Right to use asset (net)	193,000
Property and equipment (net)	38,000	62,000
Software (net)		10,000
Total non-current assets	231,000	72,000
Total Assets	251,000	150,000
Current Liabilities:
Liability for inventory held at vendor	1,764,000	1,462,000
Demand notes	650,000
Senior convertible notes (net)	647,000
Promissory notes	425,000
Accounts payable	420,000	323,000
Accrued interest	509,000	166,000
Current right to use obligation	64,000
Other current liabilities	36,000	40,000
Accrued wages and benefits	50,000	35,000
Total current liabilities	4,565,000	2,026,000
Non-current right to use obligation	126,000
Senior convertible notes (net)	7,763,000	6,603,000
Total Liabilities	12,454,000	8,629,000
Commitments and other matters (Note 16)
Stockholders' Deficiency:
Common stock, $.01 par value, 400,000,000 shares authorized; shares issued and outstanding at December 31, 2019 and 2018: 50,979,964 and 50,364,549, respectively	510,000	504,000
Additional paid-in capital	78,272,000	77,725,000
Accumulated deficit	(91,425,000)	(87,149,000)
Total Stockholders' Deficiency	(12,203,000)	(8,479,000)
Total Liabilities and Stockholders' Deficiency	251,000	150,000
Preferred Class C [Member]
Stockholders' Deficiency:
Preferred stock, value	157,000	157,000
Series C2 Preferred Stock [Member]
Stockholders' Deficiency:
Preferred stock, value	245,000	245,000
Series C3 Preferred Stock [Member]
Stockholders' Deficiency:
Preferred stock, value	32,000	33,000
Preferred Class A [Member]
Stockholders' Deficiency:
Preferred stock, value	5,000	5,000
Preferred Class B [Member]
Stockholders' Deficiency:
Preferred stock, value	$ 1,000	$ 1,000

Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Capitalized Computer Software, Impairments		$ 17,000
Revenue from Contract with Customer, Including Assessed Tax	15,000	37,000
Patent Cost	45,000	150,000
Excess Tax Benefit from Share-based Compensation, Operating Activities	0
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total	$ 0	$ 0
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	105,535,575	94,784,206
Accounts Receivable, Allowance for Credit Loss, Current	$ 0	$ 0
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	625,000	625,000
Z-Coach Aviation Wellness Program Annual Subscription [Member]
Deferred Revenue Arrangement, Subscription Period	1 year
Revenue Benchmark [Member] \| Customer Concentration Risk [Member] \| Customer One [Member]
Concentration Risk, Percentage	43.00%
Transferred over Time [Member]
Revenue from Contract with Customer, Including Assessed Tax	$ 13,000
Transferred at Point in Time [Member]
Revenue from Contract with Customer, Including Assessed Tax	2,000
Senior Convertible Promissory Notes [Member]
Long-term Debt, Fair Value	$ 3,436,000
Minimum [Member]
Property, Plant and Equipment, Useful Life	5 years
Maximum [Member]
Property, Plant and Equipment, Useful Life	7 years
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Asset, Useful Life	3 years
Commercial Paper [Member] \| Collateral Pledged [Member]
Debt Instrument, Collateral Amount	$ 5,000
Subsidiaries [Member]
Equity Method Investment, Ownership Percentage	56.00%

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net loss	$ (4,276,000)	$ (6,308,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of discount reported as interest	748,000	627,000
Depreciation and amortization	132,000	138,000
Fair market value of share rights issued with demand notes	276,000
Stock-based compensation	126,000	180,000
Interest paid in shares	44,000	81,000
Provision for inventory reserve		1,741,000
Impairment of capitalized shop equipment		17,000
Changes in working capital items:
Accounts receivable		8,000
Prepaid expenses and other current assets	23,000	2,000
Liability for inventory held at vendor	302,000	(216,000)
Accounts payable	63,000	172,000
Accrued interest	299,000	79,000
Accrued wages and benefits	7,000	(12,000)
Other current liabilities	(4,000)	(39,000)
Net cash used in operating activities	(2,260,000)	(3,530,000)
Cash flows from financing activities:
Proceeds from issuance of senior convertible notes (net)	925,000	3,388,000
Proceeds from demand notes	650,000
Proceeds from promissory notes	800,000
Repayment of promissory notes	(150,000)
Proceeds from exercise of common stock warrant		1,000
Net cash provided by financing activities	2,225,000	3,389,000
Net decrease in cash	(35,000)	(141,000)
Cash at beginning of year	53,000	194,000
Cash at end of year	18,000	53,000
Supplemental Disclosures:
Cash used for payment of interest	86,000	271,000
Right to use asset	279,000
Exchange of promissory notes for convertible notes	225,000
Debt discount related to issuance of convertible notes	91,000	933,000
Common shares issued in payment of interest	44,000	80,000
Conversion of preferred shares to common	1,000	8,000
Common shares issued upon conversion of debt		$ 49,000

Note 4 - Demand Note (Details Textual)		12 Months Ended
Note 4 - Demand Note (Details Textual)	Jul. 23, 2019 USD ($) $ / shares	Dec. 31, 2019 USD ($) $ / shares shares	Dec. 31, 2018 USD ($)
Long-term Debt, Gross		$ 10,310,000	$ 9,160,000
Stock Issued During Period, Value, New Issues		21,000
Credit Facility with Co-borrowers [Member]
Line of Credit Facility, Maximum Borrowing Capacity	$ 1,500,000
Debt Instrument, Convertible, Number of Equity Instruments	30,000
Debt Instrument, Convertible, Threshold Amount Needed to Invest to Convert a Specified Number of Equity Instruments	$ 100,000
Debt Instrument, Convertible, Conversion Price \| $ / shares	$ 0.15
Debt Instrument, Term, Number of Days after Substantial Sale of Aegis Division	5 days
Long-term Debt, Gross		$ 650,000
Stock Issued in Connection with Debt Issuance, Shares \| shares		195,000
Stock Issued During Period, Value, New Issues		$ 21,000
Debt Issuance Costs, Net, Total		$ 37,000
Credit Facility with Co-borrowers [Member] \| Prime Rate [Member]
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate		4.75%
Credit Facility with Co-borrowers [Member] \| Rights Related to Credit Facility with Co-borrowers [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares		4,333,333
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares		$ 0.15
Warrants and Rights Outstanding		$ 276,000

Note 15 - Related Party Transactions (Details Textual)	9 Months Ended	12 Months Ended
Note 15 - Related Party Transactions (Details Textual)	Sep. 30, 2019 shares	Dec. 31, 2019 USD ($) shares	Dec. 31, 2018 USD ($) shares
Proceeds from Subordinated Short-term Debt		$ 800,000
Debt Conversion, Original Debt, Amount		225,000
Repayments of Subordinated Short-term Debt		150,000
Short-term Debt, Total		425,000
Conversion of Promissory Notes to 2019 Convertible Notes [Member]
Debt Conversion, Original Debt, Amount		225,000
Unsecured Subordinated Promissory Notes [Member]
Proceeds from Subordinated Short-term Debt		800,000
Repayments of Subordinated Short-term Debt		150,000
Short-term Debt, Total		$ 425,000
Debt Instrument, Interest Rate, Stated Percentage		6.00%
Interest Expense, Debt, Total		$ 15,000
The 2019 Convertible Notes [Member]
Debt Instrument, Convertible, Number of Equity Instruments		30,000
Debt Instrument, Interest Rate, Stated Percentage		6.00%
Six Members of the Board of Directors [Member] \| Warrants Related to the Convertible Notes [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares		1,239,288	1,239,288
Six Members of the Board of Directors [Member] \| Convertible Notes [Member]
Notes Payable, Related Parties		$ 2,477,000	$ 2,252,000
Debt Instrument, Convertible, Number of Equity Instruments		9,388,378	7,888,378
Interest Payable		$ 164,000	$ 33,000
Chief Executive Officer [Member] \| The 2019 Convertible Notes [Member]
Stock Issued in Connection with Debt Issuance, Shares \| shares	60,000
Chief Executive Officer [Member] \| Unsecured Subordinated Promissory Notes [Member]
Debt Instrument, Interest Rate, Stated Percentage		6.00%
Board Member [Member] \| The 2019 Convertible Notes [Member]
Stock Issued in Connection with Debt Issuance, Shares \| shares	7,500
Affiliated Entity [Member] \| Warrants Related to the Convertible Notes [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights \| shares		468,000	468,000
Interest Payable		$ 88,000	$ 17,000
Affiliated Entity [Member] \| Convertible Notes [Member]
Notes Payable, Related Parties		$ 1,170,000	$ 1,170,000
Debt Instrument, Convertible, Number of Equity Instruments		4,680,000	4,680,000

Note 11 - Income Taxes - Deferred Tax Asset (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Deferred income tax assets:
Net operating loss carryforwards	$ 3,277,000	$ 3,044,000
Deferred startup costs	11,224,000	10,787,000
Stock-based compensation	1,321,000	1,302,000
Other	141,000	117,000
	15,963,000	15,250,000
Less: Valuation allowance	(15,963,000)	(15,250,000)
Net deferred tax asset

Note 13 - Stock Options - Stock Options Valuation Assumptions (Details)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Expected term (years) (Year)		5 years 146 days
Expected forfeiture rate		0.00%
Risk-free rate		2.80%
Volatility		137.00%
Dividend yield		0.00%

Note 9 - Property and Equipment (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Depreciation, Total	$ 24,000	$ 46,000

Note 5 - Senior Convertible Notes and Warrants - Schedule of Senior Convertible Notes Outstanding (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Face value	$ 9,160,000
Notes issued	1,150,000
Face value	10,310,000	$ 9,160,000
Debt discount	(2,557,000)
Debt discount issued	(91,000)
Amortization reported as interest	748,000	627,000
Debt discount	(1,900,000)	(2,557,000)
Senior convertible notes (net)	8,410,000
The 2019 Convertible Notes [Member]
Face value
Notes issued	650,000
Face value	650,000
Debt discount
Debt discount issued	(26,000)
Amortization reported as interest	23,000
Debt discount	(3,000)
Senior convertible notes (net)	647,000
July 2018 Convertible Notes [Member]
Face value	1,175,000
Notes issued	500,000	1,175,000
Face value	1,675,000	1,175,000
Debt discount	(360,000)
Debt discount issued	(65,000)	(380,000)
Amortization reported as interest	72,000
Debt discount	(353,000)	(360,000)
Senior convertible notes (net)	1,322,000
The 2018 Convertible Notes [Member]
Face value	625,000
Notes issued
Face value	625,000	625,000
Debt discount	(231,000)
Debt discount issued
Amortization reported as interest	46,000
Debt discount	(185,000)	(231,000)
Senior convertible notes (net)	440,000
The 2017 Convertible Notes [Member]
Face value	4,370,000
Notes issued
Face value	4,370,000	4,370,000
Debt discount	(456,000)
Debt discount issued
Amortization reported as interest	94,000	105,000
Debt discount	(362,000)	(456,000)
Senior convertible notes (net)	4,008,000
The 2016 Convertible Notes [Member]
Face value	2,990,000
Notes issued
Face value	2,990,000	2,990,000
Debt discount	(1,510,000)
Debt discount issued
Amortization reported as interest	513,000	483,000
Debt discount	(997,000)	$ (1,510,000)
Senior convertible notes (net)	$ 1,993,000

Note 11 - Income Taxes (Details Textual)	12 Months Ended
Note 11 - Income Taxes (Details Textual)	Dec. 31, 2019 USD ($)
Accumulated Deferred Startup Costs	$ 43,413,000
Amortization of Startup Costs	$ 273,000
Amortization Period Of Startup Costs	15 years
Research Tax Credit Carryforward [Member]
Tax Credit Carryforward, Amount	$ 249,000
Domestic Tax Authority [Member] \| Internal Revenue Service (IRS) [Member]
Operating Loss Carryforwards, Total	12,799,000
State and Local Jurisdiction [Member] \| New York State Division of Taxation and Finance [Member]
Operating Loss Carryforwards, Total	$ 12,095,000

Note 15 - Related Party Transactions	12 Months Ended
Note 15 - Related Party Transactions	Dec. 31, 2019
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	NOTE 1 5 - RELATED PARTY TRANSACTIONS As of December 31, 2019, and December 31, 2018, the Company had outstanding $2,477,000 and $2,252,000, respectively, in senior convertible notes held by six members of our board of directors. These notes represent 9,388,378 of potential shares of common stock at December 31, 2019 and 7,888,378 at December 31, 2018. The Company granted 1,239,288 warrants to these board members in connection with their investment in the convertible notes. During 2019, the Company issued 60,000 and 7,500 common shares to the Company's Chief Executive Officer and to another board member in connection with their investment in the 2019 Convertible Notes, as further described in Note 5. The Company had $164,000 and $33,000 in accrued interest on convertible and promissory notes due to board members outstanding at December 31, 2019 and December 31, 2018, respectively. As of December 31, 2019, and December 31, 2018, the Company had outstanding a $ 1,170,000 senior convertible note held by an investor that is deemed an affiliate. This note represents 4,680,000 of potential shares of common stock as of these reporting dates. Underlying warrants associated with this note represent 468,000 of potential shares of common stock. At December 31, 2019 and December 31, 2018, the Company had $88,000 and $17,000 respectively, in accrued interest outstanding on this convertible note. During 2019, the Company issued unsecured subordinated promissory notes of $800,000 of which $225,000 was subsequently converted into 2019 convertible notes and $150,000 was repaid resulting in $425,000 of outstanding promissory notes payable to our Chief Executive Officer as of December 31, 2019. The unsecured promissory notes have maturity date of June 30, 2020 and accrue interest at 6% per annum. Accrued and unpaid interest due on the promissory notes was $15,000 as of December 31, 2019.

Note 11 - Income Taxes - Provision (Benefit) for Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Current tax expense (benefit):
Federal
State
Deferred tax expense (benefit):
Federal	583,000	1,093,000
State	131,000	252,000
Change in valuation allowance	(714,000)	(1,345,000)
Provision for income tax

Note 9 - Property and Equipment - Property and Equipment (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Office equipment	$ 199,000	$ 249,000
Shop equipment	132,000	182,000
Leasehold improvements		253,000
	331,000	684,000
Less accumulated depreciation	(293,000)	(622,000)
Net property and equipment	$ 38,000	$ 62,000

Note 5 - Senior Convertible Notes and Warrants (Details Textual)				12 Months Ended
	Jul. 24, 2018 USD ($) $ / shares	May 08, 2018 USD ($) $ / shares	Aug. 25, 2016 USD ($) $ / shares	Dec. 31, 2019 USD ($) $ / shares	Dec. 31, 2018 USD ($) $ / shares	Nov. 30, 2018 $ / shares	May 31, 2017 $ / shares
Long-term Debt, Gross				$ 10,310,000	$ 9,160,000
Debt Instrument, Unamortized Discount, Total				1,900,000	2,557,000
Long-term Debt, Total				8,410,000
Proceeds from Convertible Debt				1,150,000
Increase in Unamortized Debt Discount Due to Issuance				91,000
Interest Expense, Total				1,233,000	1,057,000
Amortization of Debt Discount (Premium)				748,000	627,000
Warrants Related to the 2017 Convertible Notes [Member]
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold							10.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares						$ 0.333
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes							25.00%
Warrants Related to the 2016 Convertible Notes [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares			$ 0.25
Warrants and Rights Outstanding, Term			10 years
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes			10.00%
Convertible Notes [Member]
Long-term Debt, Gross				10,310,000	9,160,000
Debt Instrument, Unamortized Discount, Total				1,900,000	2,557,000
Long-term Debt, Total				$ 8,410,000	6,603,000
Debt Instrument, Term				5 years
Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year				$ 650,000
Long-term Debt, Maturities, Repayments of Principal in Year Two				2,990,000
Long-term Debt, Maturities, Repayments of Principal in Year Three				2,775,000
Long-term Debt, Maturities, Repayments of Principal in Year Four				3,395,000
Long-term Debt, Maturities, Repayments of Principal in Year Five				500,000
Convertible Notes [Member] \| Investor [Member]
Long-term Debt, Total				2,477,000	2,252,000
Convertible Notes [Member] \| Affiliated Entity [Member]
Long-term Debt, Total				$ 1,170,000	$ 1,170,000
Debt Instrument, Convertible, Number of Equity Instruments				4,680,000	4,680,000
The 2019 Convertible Notes [Member]
Long-term Debt, Gross				$ 650,000
Debt Instrument, Unamortized Discount, Total				3,000
Long-term Debt, Total				$ 647,000
Debt Instrument, Term				5 years
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement				$ 2,500,000
Debt Instrument, Interest Rate, Stated Percentage				6.00%
Debt Instrument, Term, Number of Days after Substantial Sale of Aegis Division				5 days
Debt Instrument, Convertible, Conversion Price \| $ / shares				$ 0.15
Debt Instrument, Convertible, Number of Equity Instruments				30,000
Debt Instrument, Convertible, Threshold Amount Needed to Invest to Convert a Specified Number of Equity Instruments				$ 100,000
Proceeds from Convertible Debt				650,000
Increase in Unamortized Debt Discount Due to Issuance				26,000
Interest Expense, Total				40,000
Amortization of Debt Discount (Premium)				23,000
July 2018 Convertible Notes [Member]
Long-term Debt, Gross				1,675,000	1,175,000
Debt Instrument, Unamortized Discount, Total				353,000	360,000
Long-term Debt, Total				1,322,000
Debt Instrument, Term	5 years
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement	$ 2,500,000
Debt Instrument, Convertible, Conversion Price \| $ / shares	$ 0.25
Proceeds from Convertible Debt				500,000	1,175,000
Increase in Unamortized Debt Discount Due to Issuance				65,000	380,000
Interest Expense, Total				72,000	$ 20,000
Amortization of Debt Discount (Premium)				$ 72,000
July 2018 Convertible Notes [Member] \| Warrants Related to July 2018 Convertible Notes [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares				$ 0.25	$ 0.25
Warrants and Rights Outstanding, Term				10 years	10 years
Warrants and Rights Outstanding				$ 350,000	$ 590,000
Warrants Related to July 2018 Convertible Notes [Member]
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold	10.00%
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold	25.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares	$ 0.25
Warrants and Rights Outstanding, Term	10 years
The 2018 Convertible Notes [Member]
Long-term Debt, Gross				625,000	625,000
Debt Instrument, Unamortized Discount, Total				185,000	231,000
Long-term Debt, Total				440,000
Debt Instrument, Term		5 years
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement		$ 1,000,000
Debt Instrument, Convertible, Conversion Price \| $ / shares		$ 0.25
Proceeds from Convertible Debt
Increase in Unamortized Debt Discount Due to Issuance
Interest Expense, Total				45,000	19,000
Amortization of Debt Discount (Premium)				46,000
Warrants Related to the 2018 Convertible Notes [Member]
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold		10.00%
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold		25.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares		$ 0.25
Warrants and Rights Outstanding, Term		10 years
The 2017 Convertible Notes [Member]
Long-term Debt, Gross				4,370,000	4,370,000
Debt Instrument, Unamortized Discount, Total				362,000	456,000
Long-term Debt, Total				$ 4,008,000
Debt Instrument, Term				5 years
Debt Instrument, Interest Rate, Stated Percentage				6.00%
Debt Instrument, Convertible, Conversion Price \| $ / shares						$ 0.333	$ 0.50
Proceeds from Convertible Debt
Increase in Unamortized Debt Discount Due to Issuance
Interest Expense, Total				356,000	355,000
Amortization of Debt Discount (Premium)				94,000	105,000
The 2017 Convertible Notes [Member] \| Maximum [Member]
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement				5,000,000
The 2016 Convertible Notes [Member]
Long-term Debt, Gross				2,990,000	2,990,000
Debt Instrument, Unamortized Discount, Total				997,000	1,510,000
Long-term Debt, Total				1,993,000
Debt Instrument, Term			5 years
Debt Instrument, Interest Rate, Stated Percentage			6.00%
Debt Instrument, Convertible, Conversion Price \| $ / shares			$ 0.25
Proceeds from Convertible Debt
Increase in Unamortized Debt Discount Due to Issuance
Interest Expense, Total				692,000	664,000
Amortization of Debt Discount (Premium)				$ 513,000	$ 483,000
The 2016 Convertible Notes [Member] \| Maximum [Member]
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement			$ 3,000,000

Note 6 - Unsecured Subordinated Promissory Notes	12 Months Ended
Note 6 - Unsecured Subordinated Promissory Notes	Dec. 31, 2019
Notes to Financial Statements
Short-term Debt [Text Block]	NOTE 6 - UNSECURED SUBORDINATED PROMISSORY NOTES During the year ended December 31, 2019, the Company issued $800,000, in unsecured subordinated promissory notes to the Company’s Chief Executive Officer and to another board member. These notes bear interest at a rate of 6% per annum and have a maturity date of ninety days from the date of issuance. As of December 31, 2019, all promissory notes outstanding were payable to our Chief Executive Officer and aggregated $425,000 at this date. The maturity dates on the outstanding promissory notes have been amended to reflect a June 30, 2020 date. During 2019, the Company paid off $150,000 and converted $225,000 of the promissory notes to 2019 convertible notes. The Company recognized interest expense of $15,000 on these notes during the year ended December 31, 2019.